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Chapter 5 Part B: R&D, Dispersion and Revisions of 
Forecasted Earnings: Evidence from the UK 
5B. 1 Introduction and Literature Review 
The properties of analyst earnings' forecasts is a highly researched topic, both for the US 
and for the UK. With respect to forecast accuracy, there is evidence that analyst 
forecasts outperform earnings forecasts from time-series models (Fried and Givoly, 
1982; Brown and Rozeff, 1978; Brown et al, 1987; for the UK Bhaskar and Morris, 
1984; Patz, 1989; Capstaff, Paudyal and Rees, 1995). The overperformance of the 
analysts over time series models could be attributed to a timing advantage they have 
over naive models, by using information acquired after the initiation date of the model 
up to the time when they produce their forecasts (Brown et al, 1987; Kross, Byung and 
Schroeder, 1990). Despite the existence of a certain amount of accuracy in analyst 
forecast, there exists significant evidence that analysts are overoptimistic (O'Brien, 
1988; Butler and Lang, 1991; All, Klein and Rosenfeld, 1992, Easterwood and Nutt, 
1999 for the US and Capstaff, Paudyal. and Rees, 1995; Hussain, 1996 for the UK), with 
optimism to be decreasing as the time horizon decreases (Das, Levine and 
Sivaramakrishnan, 1998 for the US, Hussain, 1996 for the UK). Despite the existence of 
older research that describes analyst underreaction in the UK (Bhaskar and Morris, 
1984; O'Hanlon and Whoddett, 1991), more recent evidence testifies overly optimistic 
analyst forecasts for the UK as well (Capstaff, Paudyal. and Rees. 1995, Hussain, 1996). 
Hussain (1996) provides evidence for the UK that analyst optimism increases if analysts 
also act as brokers, and Hodgkinson (2001) finds that close relationships between 
analysts and firms also contribute to optimism. 
Heyes (1998) testifies the tendency by analysts to follow stocks that do well, 
consistent with Capstaff, Paudyal and Rees (1995), who find that forecasts are more 
accurate when earnings are increasing. McNichols and O'Brien (1997) also give the 
explanation of selection bias from the side of the analysts as a possibility that justifies 
their optimism. There is also evidence that forecasts improve at the end of the financial 
year (Crichfield, Dyckman and Lakonishok, 1978), and that the basis for the forecast 
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changes from the beginning to the end of the financial year, with initial forecasts 
focusing on permanent earnings revised over the year (Helbok and Walker, 2003 for the 
UK). Industry factors also appear to be influencing forecasts (Richards, Benjamin and 
Strawser, 1977 for the US; Patz, 1989 for the UK). 
Regarding whether analyst forecasts incorporate all information included in 
previous changes in earnings and dividends, Abarbanell and Bernard (1992) and All, 
Klein and Rosenfeld (1992) testify underestimation of current earnings surprise, 
producing forecasts that are thus not efficient. On the other hand, Givoly and 
Lakonishok (1984) find that analysts produce unbiased forecasts, with no relationship 
between current forecast errors and past change in earnings, a fact that also makes their 
forecasts efficient, consistent with DeBondt and Thaler (1990) who suggest that forecast 
errors are accidental, resulting from cognitive bias. 
There exist additionally specific firm characteristics that tend to make earnings 
forecasts more or less difficult to predict. For example, firm size has been empirically 
linked positively to the accuracy of forecasts, with earnings being more difficult to 
predict for smaller firms (Das, Levine and Sivaramakrishnan, 1998 for the US and Patz, 
1989; Hussain, 1996 for the UK). In specific Das, Levine and Sivaramakrishnan (1998) 
argue that if one assumes that optimism facilitates the analyst access to non-public 
information, analysts will tend to be using more optimistic forecasts for firms with less 
predictable earnings. Moreover, Bryan and Tiras (2007) testify that in the presence of 
high information asymmetry, analysts tend to focus less on fundamentals and more on 
non-accounting information. 
Regarding analyst forecast dispersion, empirical literature states that analyst 
forecast dispersion is both the result of higher uncertainty and lack of market consensus 
(Barry and Jennings, 1992, Barron et al 1998). Barry and Jennings (1992) in specific 
develop an analytical model that shows that divergence of opinion overstates the 
estimation of risk. Barron et al (1998) argue that forecast dispersion is a combination of 
uncertainty and divergence of opinions. 
Diether, Malloy and Scherbina (2002) testify a negative association between 
analyst forecast dispersion, which they interpret as evidence of differences of opinion, 
and subsequent excess stock returns. They argue that analyst forecast dispersion is a 
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proxy for divergence of opinion, an argument in contrast with Barron et al (1998). With 
respect to the theoretical framework on the association between forecast dispersion and 
stock returns, there exist a number of theoretical explanations that predict either positive 
or negative relationship between analyst disagreement and subsequent stock returns, or a 
non directional relationship, which are very well summarised in Diether, Malloy and 
Scherbina (2002). They argue in favour of the Miller (1977) framework, where a 
negative association between forecast dispersion and returns is predicted: this is because 
upon analyst disagreement, the optimistic investors are the ones who set process, since 
pessimistic investors do not trade due to high short selling costs and this leads to higher 
asset prices and therefore lower stock returns. At the same time, there are models that do 
not predict such pricing of stocks and argue in favour of a non directional relationship 
between forecast dispersion and stock returns (Diamond and Verecchia, 1987; Hong and 
Stein, 2000) A final theoretical framework on dispersion and stock returns mentioned in 
Diether, Malloy and Scherbina (2002) is the one that views dispersion as a risk proxy 
and predicts a positive relation between forecast dispersion and returns: if forecast 
dispersion is indication of a less predictable stream of future earnings, stocks with higher 
dispersion should be earning higher returns, and dispersion in forecasts `will hold 
explanatory power beyond the standard risk factors', but their evidence does not support 
this hypothesis and they interpret their findings to be in accordance with the Miller 
(1997) divergence of opinion premium hypothesis. They argue that given their evidence, 
analyst forecast dispersion, as a proxy for differences of opinion, does not represent risk. 
The findings of Diether, Malloy and Scherbina are supported by Bike and Park (2003) 
and Park (2005). Johnson (2004) provides an analytical model in accordance with 
Diether, Malloy and Scherbina, that also predicts that highly distressed firms, and not 
firms with high intangible value, are more prone to analyst disagreement, despite the fact 
that these firms with high leverage and poor past performance may possess lower 
intangible value: when a firm is levered, its equity has the value of a call option, and this 
value increases with uncertainty. If this uncertainty is idiosyncratic it will not be priced 
and will thus result in lower expected returns. 
Doukas, Kim and Pantzalis (2006) find evidence that does not support the 
negative relationship between divergence of opinion and stock returns testified by 
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Diether, Malloy and Scherbina (2002). They testify that uncertainty, that plays a part in 
forecast dispersion, has a negative association with stock returns, and that Diether, 
Malloy and Scherbina (2002) observe a negative association between uncertainty and 
future returns and not differences of opinion and returns. Doukas, Kim and Pantzalis 
(2006) argue that the view that the more investor views differ, the more overpriced stock 
are does not hold, because dispersion in analysts' forecasts is driven by uncertainty. 
They argue in favour of the Barron et al (1998) definition of forecast dispersion, where 
dispersion is a function of uncertainty and diversity (disagreement-divergence of 
opinion). In this context, they argue that analyst forecast dispersion is a poor proxy for 
divergence of opinion and they find that the Diether, Malloy and Scherbina findings are 
reversed when they control for uncertainty in analyst forecasts, and that high divergence 
of opinion stocks actually earn higher returns than low disagreement stocks. Doukas, 
Kim and Pantzalis (2006) finally argue that if dispersion in analyst forecasts (according 
to the Diether, Malloy and Scherbina, 2002 definition) is a risk proxy associated with 
uncertain information about future firm performance, the negative relationship between 
dispersion and returns presented in Diether, Malloy and Scherbina (2002) implies that 
investors desire more and not less risk. 
Chen and Jiambalvo (2004) find evidence and argue that the low returns earned 
by high dispersion firms, as predicted by Diether, Malloy and Scherbina (2002), are 
simply explained by the post announcement drift phenomenon. They also put in question 
the argument in Diether, Malloy and Scherbina (2002) that prices reflect the views of 
optimistic investors in the presence of high dispersion, leading to low returns, since they 
find that lower earnings response coefficients relate to negative earnings surprises for 
high compared to low dispersion firms, which puts the optimism argument into doubt. 
On differences of opinion and stock returns, Zhang (2006) testifies that greater 
information uncertainty provides higher expected returns following good news and 
relatively lower expected returns following bad news. Clement, Frankel and Miller 
(2003) find that the confirmation of forecasts by firms reduces dispersion in forecasts 
and this reduction in `uncertainty' as they call it is priced by the market positively. 
Kwon (2002) testifies lower analyst forecast dispersion (and unsigned forecast errors) 
for high tech versus low tech firms, attributed to the information effect being stronger 
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than a noise effect. Barron and Stuerke (1998) find evidence that analyst forecast 
dispersion is a useful indicator of uncertainty about future firm performance, since they 
find a positive association between forecast dispersion after earnings announcements 
and the demand for more information, and also greater price reactions around 
subsequent earnings announcements. 
From the above presentation of empirical findings, it is deduced that the 
underlying disagreement on the literature on dispersion and stock returns is whether 
dispersion is associated negatively with returns, as Diether, Malloy and Scherbina 
(2002) find, or whether actually forecast uncertainty, and not divergence of opinion, is 
associated negatively with returns, since differences of opinion and dispersion do not 
mean the same thing, with divergence of opinion to be forming only a part of forecast 
dispersion, and actually divergence of opinion to be associated positively with returns, 
as argued by Doukas, Kim and Pantzalis (2006). 
At the same time, there exists evidence on greater analyst forecast bias for firms 
intensive in R&D investments, or firms that belong to R&D intensive sectors, such as 
technology firms. The inherently risky and uncertain nature of R&D investments and 
investments in new technologies in some sectors, as is the case with any kind of 
innovation, justifies in theory greater bias when financial analysts forecast earnings in 
the presence of significant R&D investments. R&D investments have been empirically 
associated already with greater analyst following and effort (Barth, Kasznik and 
McNichols, 2001), greater analyst incremental contribution for explaining stock returns 
and greater analyst forecast errors (Amir, Lev and Sougiannis, 2003; Gu and Wang, 
2005) for the US market. There also exists evidence on greater forecast errors for 
technology firms (Gu and Wang, 2005). 
R&D intensity has also been associated with higher analyst disagreement. This 
can take the form of either lower consensus, measured as the correlation in analyst 
forecast errors (Barron et at, 2002), or higher analyst forecast dispersion for R&D 
intensive firms, in the form of higher coefficients of variation (Chambers, Jennings and 
Thomson, 2002). The theoretical background of this relationship that has been testified 
empirically relates to the inherent uncertainty of R&D future benefits, which makes 
forecasting earnings particularly difficult in the presence of high R&D. At this point, 
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Chambers, Jennings and Thomson (2002) interpret their findings on forecast dispersion 
as an indication of the riskiness of R&D. 
From the previous discussion on dispersion of analysts' forecasts, it is deduced 
that R&D is expected to influence the uncertainty of analysts' forecast formation, due to 
the difficult predictability of future benefits, and thus influence forecast dispersion. This 
way, if there is assumed that analyst forecast dispersion results from both uncertainty 
and divergence of opinion (Barron et al, 1998), R&D should definitely influence the 
uncertainty part. But R&D (among other intangibles) has been shown to influence both 
forecast dispersion (in the form of coefficients of variation in Chambers, Jennings and 
Thomson, 2002), and also the divergence of opinions (the second forming part of 
dispersion according to Barron et al, 1998), even after controlling for forecast 
uncertainty (Barron et al, 2002). 
What I get therefore from existing literature, is that forecast dispersion and each 
one of its possible components (forecast uncertainty and divergence of opinions) are 
potentially associated with stock returns for different reasons (and have been found to be 
so in a statistically significant manner), when R&D intensity should also be theoretically 
associated with forecast dispersion and its components, and has been indeed empirically 
found to be so. 
At the same time, there exists strong empirical evidence that high R&D intensity 
is positively associated high higher excess risk-adjusted returns (for example 
Sougiannis, 1994; Lev and Sougiannis, 1996,1999; Chan, Lakonishok and Sougiannis, 
2001; Eberhart, Maxwell and Sidique, 2004; Chambers, Jennings and Thomson, 2002 
for the US and Al-Horani, Pope and stark, 2003; Green, Stark and Thomas, 1996 and 
Toivanen, Stoneman and Bosworth 2002 for the UK), and this is attributed to either a 
compensation for risk (Chambers, Jennings and Thomson, 2002) or a mispricing 
explanation (Eberhart, Maxwell and Sidique, 2004; Lev, Sarath and Sougiannis, 2005). 
In Part A of Chapter 5 of the study there was also testified a positive and persistent 
relationship between R&D and returns. 
The question asked is whether there exists an association between dispersion and 
returns after controlling for the role of R&D, given the influence of R&D separately on 
dispersion, and also on stock returns. Existing literature has assessed the influenced of 
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R&D on analyst disagreement, which has been defined either as simple forecast 
dispersion or by using more accurate definitions through decomposing dispersion into 
forecast uncertainty and pure divergence of opinions. At the same time, forecast 
dispersion or its components have been found to relate to returns in a statistically 
significant manner (Diether, Malloy and Scherbina, 2002 testify a negative relation 
between forecast dispersion and returns, and Doukas, Kim and Pantzalis, 2006 testify a 
negative relation between forecast uncertainty and returns and a positive relation 
between forecast divergence of opinions and returns). Leaving aside the dispersion- 
return discussion, R&D intensity on its own has been theoretically related with 
subsequent stock returns in a positive manner, and has been indeed empirically found to 
relate positively with future market performance. 
The contribution of this study at this point is exactly the assessment of the 
association between dispersion in forecasts and subsequent returns, when R&D has been 
observed to influence separately forecast dispersion, and also to influence stock returns, 
without controlling for dispersion. Previous studies have not included controls for R&D, 
when assessing the relation between dispersion and returns, despite the identified 
influence of R&D on dispersion. In order to be consistent with all aspects of the matter 
examined in prior literature, dispersion is defined as a function of both forecast 
uncertainty and pure divergence of opinions among analysts, according to the conceptual 
framework of Barron et at (1998). I therefore wish to assess the relation between 
dispersion and divergence of opinion on stock returns, after controlling for the role of 
R&D. Therefore after performing a thorough analysis on the impact of R&D for analyst 
forecast dispersion for the UK dataset used in this study, which also represents a matter 
unexplored by prior studies, there will be assessed the importance of R&D for stock 
returns for different degrees of forecast dispersion and differences of opinion. Previous 
studies for the UK such as Al-Horani, Pope and Stark (2003) on R&D and market 
performance were dedicated in assessing the impact of R&D on stock returns, by using 
different research designs in order to perform the analysis, and have used a framework 
that did not include any discussion on a possible impact of R&D on forecast dispersion 
and the impact of dispersion on returns. This was done because the research hypotheses 
S 
of these studies involved no discussion at all on dispersion in analyst forecasts and its 
possible association with stock returns. 
I additionally focus on another aspect of analyst forecast accuracy as a result of 
R&D intensity. As already explained, empirical research has already identified greater 
analyst bias as a result of R&D, in the form of greater analyst forecast errors (Amir, Lev 
and Sougiannis, 2003; Gu and Wang, 2005, also in Chambers, Jennings and Thomson, 
2002), from the direction of which there is implied more optimism. These greater errors 
for R&D intensive firms are attributed to the uncertain nature of the R&D investment. 
This uncertain context and probable nature, by construction, of the R&D future benefits, 
could also influence the magnitude of analyst forecast revisions, when made in the 
presence of high R&D. This is because analyst forecast bias is expected to be influenced 
by the degree of uncertainly under which they are made, with greeter uncertainty leading 
to higher bias. For example, Gu and Wang (2005) find indeed that forecast errors are 
significantly greater for firms that invest in more innovative technologies and with an 
increasing rate of innovation. When financial analysts are called therefore to revise their 
earnings forecasts, prior to the end of the financial year for which they are forecasting, 
for R&D intensive firms, they are called to improve their accuracy in the presence of a 
great degree of uncertainty. In such case, the amount by which they adjust their 
predictions can also be uncertain and therefore earnings revisions are expected to be 
greater in the presence of high R&D intensity. This expectation lies on the assumption 
that analysts improve their learning as the end of the financial year approaches, but the 
outcome of this learning process is influenced by the uncertain nature of R&D, leading 
to higher revisions in the presence of high R&D investments. 
The expectation that R&D intensity should influence the magnitude of earnings 
revisions does not mean that I ignore the influence earnings revisions receive from news, 
corporate announcements or changes in company fundamentals. For example, Helbok 
and Walker (2004) find that analysts tend to focus on sustainable earnings early in the 
financial year when they make forecasts, and as the end of the financial year approaches, 
they revise in order to incorporate any piece of information associated with large 
transitory items. In this study, after examining the impact of R&D on forecast errors, as 
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was done previously in the literature, I assess the influence of R&D on the changes in 
analyst expectations as the end of the financial year approaches. 
In this empirically testified context of forecast bias increasing with uncertainty, I 
expect that forecast revisions are greater and more pronounced as R&D intensity 
increases. Regarding the sign of the greater revisions expected, consistent with the 
existing evidence on optimistic bias from analysts in the presence of high R&D intensity 
(from the direction of forecast errors), my expectation is in favour of greater revisions as 
R&D intensity gets higher, of a positive sign. At this point, Das, Levine and 
Sivaramakrishnan (1998) also argue that if one assumes that optimism facilitates the 
analyst access to non-public information, analysts will tend to be using more optimistic 
forecasts for firms with less predictable earnings, if this is the case for R&D firms due to 
the uncertain nature of the investment by definition. Lin (2001) and Jackson (2005) also 
argue in favour of optimistic analyst forecasts when earnings are uncertain. I therefore 
hypothesise in favour of greater and positive revisions as a result of R&D intensity. 
I use all UK listed firms during the period 1990-2003 with analyst forecasts on 
IBES and find that R&D intensity is a contributing factor for analyst forecast dispersion 
even after controlling for other firm characteristics. The finding is robust to different 
definitions of R&D intensity, and is consistent with prior findings for the US. In 
addition, I confirm a negative relationship between dispersion and returns, consistent 
with Diether, Malloy and Scherbina (2002) for the US, with the bottom forecast 
dispersion portfolio to be exhibiting a positive but not statistically significant excess 
return (alpha), and alphas to be getting negative for higher dispersion portfolios, which 
are generally not statistically significant as well. I also find that upon the inclusion of the 
R&D factor in the traditional Fama and French three factor model, the previously 
testified negative relationship between dispersion and returns is still holding: even after 
controlling for the impact of R&D on stock returns, I find that the bottom dispersion 
portfolio exhibits a positive alpha which is not significant, and alphas tend to get 
negative for higher dispersion portfolios. Most importantly, I find that for R&D firms, 
the inclusion of the RD factor makes the alpha for the top dispersion portfolio become 
statistically different from zero. After decomposing dispersion in analysts' forecasts into 
analyst forecast uncertainty and a pure differences in opinion part, I find that as 
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dispersion increases, the ability of R&D to influence returns continuously increases, but 
when divergence of opinion increases, the relative impact of R&D on returns is 
constantly getting lower. Given that dispersion is defined as a function of both 
divergence of opinion and uncertainty in analyst forecasts, the above finding implies an 
increase in the impact of analyst forecast uncertainty for returns as R&D intensity 
increases. 
In addition, there is not observed a linear positive trend for signed errors and 
revisions to increase as R&D intensity increases regardless of the way I define R&D 
intensity, without controlling for other factors. There is though observed such a trend 
when there are used unsigned errors and revisions. I find that R&D intensity is 
associated positively with forecast errors and revisions, and that this relationship is 
generally statistically significant in the case of revisions, when there exists a reasonable 
amount of time between the initial and the revised analyst forecast, but not for errors, 
after controlling for other factors. As a final, comment, I get evidence that stock returns 
relate negatively with revisions and errors, in addition to forecast dispersion, and this 
relationship is statistically significant in all cases. 
The Chapter is organised as follows: In Section 5B. 2, I present a draft of the 
methodology used. Sections 5B. 3 and 5B. 4 contain the empirical results, and I conclude 
with Section 5B. 5 which also summarises the study limitations. 
5B. 2. Data and Methodology 
The sample of companies used in this study is based on all UK listed (in both the 
London Stock Exchange and the Alternative Investment Market) non-financial firms for 
the period 1990-2003. As already explained in Chapter 4, data on analyst earnings 
forecasts, actual reported earnings, financial year ends and stock prices have been taken 
from IBES. Accounting figures have been taken from the Worldscope database and 
information on stock returns and market values has been taken from Datastream. For a 
firm to be included in the study, there must exist data on the book-to-market ratio, 
market value of equity, sales and total assets at year end, and have at least one 
observation of one year ahead forecasted earnings during the 12 months before financial 
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year end, as well as a figure for actual reported earnings from IBES for the particular 
year. One year ahead forecast data are used. 
Given that accounting years end at different times during the calendar year in the 
UK, there are used accounting year ends for accounting data, and calendar year ends for 
market based data. Firms that change financial year end more than once during the 
sample period according to IBES have been eliminated. Following the discussion in 
Chapter 4, there is used yearly R&D expense taken from the income statement. 
As seen in Chapter 4, the above sample selection process results in a total of 
10,653 firm-year observations (1,647 firms) for the period 1990-2003, out of which 
35.69% report R&D (3,802 firm-year observations and 610 firms). 
R&D intensity is defined in two ways: first, as R&D expense from the income 
statement divided by annual sales, second, as R&D expense divided by firm Total 
Assets. In the cases though, that the analyses involve the use of stock returns, I also 
make use of R&D/MVE as a proxy for R&D intensity. This is because Chan, 
Lakonishok and Sougiannis (2001) have shown that using R&D/MV as a proxy for 
R&D intensity instead of R&D/Sales increases the association of R&D intensity 
portfolios with subsequent stock returns. 
In order to assess the influence of R&D on stock returns, after controlling for 
forecast dispersion, I first assess dispersion (with and without decomposing dispersion 
into an uncertainty and a differences of opinion component) according to R&D intensity 
and other firm characteristics, such as TA, MV or BM, and then according to matched 
size-BM portfolios for the R&D, zero R&D, and R&D intensive firms for the sample. I 
then use regression analysis with the scope to assess whether the impact of R&D on 
forecast dispersion is statistically significant. After calculating returns for the R&D, zero 
R&D, R&D intensive and very R&D intensive firms that belong to similar in magnitude 
analyst dispersion portfolios with simple descriptive statistics, I finally assess the impact 
of R&D on stock returns through time-series Fama and French type regressions. In that 
case, I regress the returns of five dispersion portfolios on the market factor, a size factor 
(SMB), a factor that accounts for the returns of different BM portfolios (HML) and 
additionally a factor that controls for the impact of R&D on stock returns. This latter RD 
factor is first constructed according to the methodology by Al Horani, Pope and Stark 
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(2003), which make use of the BM factor in order to construct the RD factor, and as a 
second step, it is constructed on its own by taking the returns of different R&D intensity 
portfolios. I proceed by decomposing forecast dispersion into an uncertainty and a 
divergence of opinion part, where I repeat the Fama-French time series regressions 
according this time to portfolios formed according to pure divergence of opinion, instead 
of dispersion, quintiles. 
With respect now to assessing the influence of R&D on forecast revisions, I first 
examine the magnitude of revisions according to R&D intensity and other firm 
characteristics, and then according to matched size-BM portfolios for the R&D, zero 
R&D, and R&D intensive firms. I finally use regression analysis in order to assess the 
influence of R&D intensity on the magnitude and sign of forecast revisions, after 
controlling for other possibly influencing factors. The analysis of the impact of R&D on 
forecast revisions is preceded by relative analyses of the impact of R&D on errors, given 
the close conceptual link between these two attributes of analyst forecasts, errors and 
revisions. The study also includes regression analysis in order to assess the impact of 
R&D and forecast dispersion directly on stock returns, in the process of which both 
errors and revisions are included among the regressors. 
5B. 3 R&D, Dispersion in Analyst Earnings Forecasts and Subsequent Stock Returns 
5B. 3. ]R&D and Analyst Forecast Dispersion: Descriptive Statistics 
I define forecast dispersion as the standard deviation of one year ahead analyst forecasts 
for a particular company for a specific month (given by IBES), standardised by the 
absolute value of the one year ahead mean analyst forecast for this company for the 
month. The standardisation procedure follows Diether, Malloy and Scherbina (2002). To 
avoid outliers, observations below the 0.02 and above the 0.98 percentile are eliminated. 
There are used all of minus twelve, six and one month prior to year end one year ahead 
forecasts. 
As a first step, I assess analyst forecast dispersion, using minus twelve, six and 
one month prior to year end data for the whole sample, R&D firms, zero R&D firms and 
according to R&D intensity quartiles, defined using R&D/Sales, R&D/TA and 
R&D/MVE. Quartiles are rebalanced 'annually. Table 5B. 1 shows the average dispersion 
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in analyst forecasts for the whole sample, the R&D firms, the zero R&D firms and for a 
particular R&D intensity, TA, MV or BM quartile throughout the sample period. As can 
be observed from the Table, zero R&D firms tend to exhibit slightly higher dispersion 
than R&D firms, a fact that could be receive influence by the significantly higher 
number of observations without R&D compared to R&D reporting firms. Among R&D 
reporting firms, as R&D intensity though increases, so does forecast dispersion, no 
matter which proxy we use for R&D intensity. Consistent with prior literature (e. g. 
Chambers, Jennings and Thomson, 2002), the higher R&D intensity quartiles exhibit 
higher dispersion compared to the lower ones, and the highest R&D intensity quartile 
exhibits by far the highest dispersion, no matter which R&D intensity proxy we use or 
whether we use minus twelve, six and one month prior to year end forecast data. Finally, 
smaller firms in terms of TA and MV appear to be associated with higher analyst 
forecast dispersion, and dispersion clearly decreases as firm size gets higher. The 
opposite is true though as the BM ratio increases: higher BM firms show higher 
dispersion than lower BM ones. 
Insert Table 5B. I here. 
As a last comment, there appears to exist an upward trend for most of the 
dispersion quartiles as we move from minus twelve month to minus six and then to 
minus one month prior to year end data. This observation would imply that dispersion 
increases as we move closer to the end of financial year for which the forecast is made, 
which implies greater disagreement when there should in theory exist more certainty, 
which is a fact that appears quite counter intuitive. 
Finally, one could argue that a firm's forecast dispersion depends on the number 
of analysts that produce forecasts for this firm, and therefore a firm that is covered by 
more analysts will tend to exhibit higher dispersion in its earnings forecasts. In order to 
control for this limitation, I have repeated the analysis on Table 5. B. 1 after including 
only the firms for which the forecasted EPS is produced by five or more analysts. The 
relevant results are presented in Appendix 5B. A Part A, and observe no qualitative 
difference on the direction of the results of Table 5B. 1. 
Next I assess dispersion for R&D firms, R&D intensive firms and zero R&D 
firms matched according to firm size, using MVE as the proxy for size, and the book-to 
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market ratio. This way, the sample firms are divided into two market value of equity 
portfolios, using the median MVE as of the end of December in each year. Then the 
firms in each of the two MVE portfolios are divided into three book-to-market (BM) 
portfolios: one containing the lower 30% values for BM, another one with the middle 
40%, and finally, a portfolio containing the top 30% of BM ratios. This results in six 
size-value portfolios (2 by 3 size-BM portfolio analysis). Portfolio breakpoints are 
rebalanced every year. I define R&D intensive firms as the ones with an R&D/Sales or 
R&D/TA ratio above the sample median for a particular year. I use minus twelve, six 
and one month prior to year end data. I then report on Table 5B. 2 the average sample 
period dispersion for the R&D, zero R&D and R&D intensive firms that belong to the 
six MV-BM portfolios. 
Insert Table 5B. 2 here. 
" 
As can be seen from the table, after controlling for the firm characteristics of size 
(MV) and BM, there is a tendency for R&D and especially R&D intensive firms to 
exhibit greater analyst forecast dispersion than zero R&D firms. This tendency is more 
pronounced for the low MV portfolios. On average, R&D firms tend to exhibit slightly 
higher dispersion than zero R&D firms in their respective MV-BM portfolios, especially 
when minus six or one month prior to year end, instead of twelve months prior to year 
end data are used. In the case of the R&D intensive firms though, no matter whether we 
use R&D/Sales or R&D/TA as a proxy for R&D intensity, consistent with prior 
literature, for the majority of the portfolios there are the exactly these firms that show 
signs of greater analyst disagreement, compared to both R&D reporting firms in general 
as well as zero R&D firms. 
5B. 3.2 R&D and Analyst Divergence of Opinion: Descriptive Statistics 
As already mentioned on the introduction, there exists criticism in the literature on the 
validity of forecast dispersion as a measure of differences of opinion (Doukas, Kim and 
Pantzalis, 2006), who argue that forecast dispersion is actually the result of both forecast 
uncertainty and differences of opinion. In order to be consistent with all aspects of the 
matter examined by prior literature, I have also decomposed forecast dispersion into a 
forecast uncertainty and differences of opinion part following conceptually Barron et at 
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(1998) and Doukas, Kim and Pantzalis (2006), who exactly differentiate between the 
uncertainty and differences of opinion parts of forecast dispersion. I therefore 
decompose the dispersion measure as in Doukas, Kim and Pantzalis (2006) (who follow 
conceptually an idea by Barron et at, 1998) as D=V(1-p), where 1- p represents 
differences of opinion (with p to be the correlation of forecast errors across analysts, a 
measure of analyst consensus) and V is uncertainty. D equals nothing more than scaled 
variance in analyst forecasts, therefore ((standard deviation in forecasts) *(standard 
deviation in forecasts)/(absolute value of mean EPS forecast)) 
- 
also multiplied by 10, 
with the standard deviation of forecasts to be the one previously used for dispersion 
calculation (standard deviation in forecasts scaled by absolute mean EPS forecast equals 
dispersion used in the previous analysis). 
With respect to the calculation of other variables, p =h/(h+s), and V=D/(1-p), 
where h=precision of common information and s=precision of idiosyncratic information 
and h=(SE-(D/N))/((SE. (D/N))+D)2, s=D/((SE-(D/N))+D)2, 
with SE to be the squared error of the mean forecast (deflated by the absolute 
value of actual EPS at year end), D is the scaled variance in forecasts described right 
above (multiplied by 10), deflated by the absolute value of actual EPS at year end and N 
is the number of forecasts. 
One could argue here that this dispersion measure that follows Doukas, Kim and 
Pantzalis p. 603-604 is not consistent with the previous measure of dispersion that 
follows Diether, Malloy and Scherbina (2002), as the standard deviation in EPS 
forecasts divided by the absolute value of the mean forecast in question. For this reason, 
I have recalculated forecast uncertainty (V) in two additional ways: first, as V= D/(1-p), 
where (1-p) was calculated as in p. 603 of Doukas, Kim and Pantzalis, that is by using 
deflation by absolute actual EPS in the components of rho where deflation is necessary, 
and D is the scaled variance (squared standard deviation or squared dispersion of 
Diether, Malloy and Scherbina employed else in the thesis 
- 
multiplied by 10), using the 
Diether, Malloy and Scherbina dispersion definition, which involves scaling by absolute 
mean EPS forecast. I have also recalculated V as D/(1-p), with D to be the scaled 
variance (squared standard deviation or squared dispersion of Diether, Malloy and 
Scherbina employed else in the thesis 
- 
multiplied by 10), using the Diether, Malloy and 
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Scherbina dispersion definition, which involves scaling by absolute mean EPS forecast, 
and (1-p) to be calculated by using here again by scaling by the absolute mean EPS 
forecast when scaling is necessary for p calculation. It goes without saying that this final 
way of calculating (1-p) and V is absolutely consistent with the calculation of dispersion 
employed in the previous analyses in part 5B. 3.1 of the Chapter 513, since scaling by 
absolute value of mean EPS forecast is used in all cases, and also the scaled variance D 
used for (I-p) and V calculation is the squared scaled standard deviation in forecasts or 
squared dispersion used in part 5B. 3.1. 
I report in Appendix 5B. A Part B the average V, (1-p), and D (D=V(1-p)), 
calculated using minus 1 month 1 year ahead EPS forecast data prior to year end, for the 
whole sample, the R&D and zero R&D firms and according to R&D/Sales, R&D/TA, 
R&D/MV, TA, BM and MV quartiles. 
What we observe from other results in Appendix 5B. A is that dispersion is more 
driven by uncertainty and not by differences of opinion (despite the fact that dispersion 
D in Table 1 of the Appendix 5B. A is defined by standardising by absolute actual EPS 
and not by absolute forecast as in Table 5B. 1), since as R&D intensity, firm size or BM 
change the part of D that changes is V and not (1-p). As R&D intensity increases, V and 
not (1-p) steadily increases as well, leading to an increase in overall dispersion D. 
Without controlling for other factors, this finding constitutes some preliminary evidence 
that R&D intensity has an impact on the uncertainty about future performance part of 
analyst forecasts. As a final comment, from the findings in Table 3 of the Appendix 
5B. A, no matter how I scale D (scaled variance, not standard deviation of forecasts), by 
absolute actual EPS or mean forecast, V increases as R&D intensity increases, and D 
also increases, but (1-p) does not increase. So the uncertainty component of dispersion 
appears to be driving dispersion up as R&D intensity increases and not the lack of 
consensus part (1-p). 
5B. 3.3 R&D and Analyst Forecast Dispersion: Regression Analysis 
In addition, I use regression analysis in order to assess directly whether R&D intensity 
influences analyst forecast dispersion in a statistically significant manner. I run the 
following regression using panel data for the period 1990-2003: 
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Dispersion =ßo+ #81 RD +ß2 BM +ß3 MV +ß4 AF +83 
STDEV 
+ Eis 
(5B. 1) where: 
Dispersion 
- 
analyst forecast dispersion defined as the standard deviation in one year 
ahead analyst forecasts of EPS for a particular month divided by the absolute 
value of the mean forecast in the specific month. There are used forecasts 12 and 
6 months prior to year end 
RD 
- 
R&D/Sales or R&D/Total Assets or R&D/Market value of equity at year end 
BM 
- 
the book-to-market ratio at year end 
MV 
- 
MVE at year end 
AF 
- 
analyst following that equals the number of analysts that issued one year ahead 
EPS forecasts for a particular firm for a particular month, using minus 12 or 6 
month prior to year end data, depending on what data are used for dispersion 
each time. 
STDEV 
-the standard deviation of reported EPS for a three year period prior to base 
year (e. g. 1988-1990 for the base year 1990) 
The regression is run using OLS and Whites Heteroskedasticity robust standard 
errors. Observations above the 98 and below the 2 percentile were eliminated. All 
variables have been transformed using natural logs since this improved 
heteroskedasticity in the model and provided a better functional form for the model. As a 
result, the Durbin Watson Statistics improved to a great extend and got values between 
1.9 and 2.05. The relevant results for the errors regression are presented on Table 5B. 3. 
Insert Table 5B. 3 here. 
As can be observed from Table 5B. 3, consistent with the intuition, firm size, 
expressed as MV appears to relate negatively to analyst forecast dispersion, no matter 
whether I use minus 12,6 or 1 month prior to year end analyst forecast data for 
dispersion calculation, and is always statistically significant. BM is also statistically 
significant, but always positive. Consistent with common intuition, past volatility in 
reported EPS, expressed by the STDEV variable also relates positively to dispersion and 
is very much statistically significant. Analyst following also relates positively to 
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dispersion, but in this case it is only significant at a meaningful level of significance 
only when minus 6 or 1 month prior to year end analyst forecast data are used, as 
opposed to minus 12 month data, when it is not significant. The p- values of the F 
statistics are always zero, and the adjusted R squares are almost always around 30%. 
The R&D intensity variable is always positive and it is statistically significant 
when at 5% significance level when minus 12 month prior to year end forecast data are 
used, no matter how we define it. As dispersion data become more recent to the end of 
the financial year for which analyst forecasts are made, its significance is reduced, but it 
still remains positive. When using minus 6 or 1 month prior to year end data, the R&D 
intensity variable is mostly significant when defined as R&D/MVE. 
The regression results are robust to replacing MV with a variable that accounts 
for firm age (defined as the natural log of the difference in years between year t and the 
year when data is recorded for the first time for a particular firms in LSPD-item G6), 
which is also statistically significant with a negative sign (results included in Appendix 
5B. B Part A). The results are also robust to the inclusion of industry dummy variables, 
both simple and multiplicative with R&D, to account for four industries which are 
perceived as intensive in R&D activity: Information Technology Chemicals, General 
Industries and Health grouped together with Pharmaceuticals and Biotechnology results 
included in Appendix 5B. B Part B). Even in the case of industry dummy variables 
multiplicative with R&D, the significance of the R&D intensity variable is reduced 
below 5% (to 10%) only in a couple of cases upon the inclusion of the multiplicative 
industry dummies. Finally, the results are robust to possible time period effects during 
the years of the New Economy, since I have rerun the regressions by excluding the base 
years 1999 until 2001, and I observed no significant difference in the direction of the 
results. I have also rerun the regressions for the whole sample period 1990-2003 by 
including a dummy variable that took the value of 1 if the data referred to the base years 
1999,2000 or 2001 and zero otherwise, and there was overall observed no qualitative 
difference in the results (results included in Appendix 5B. B Part Q. Finally, I have 
controlled for period fixed and random effects. Running the regression with period fixed 
and random effects along with adding an AR(1) term was not permitted by econometric 
software (in order to correct for 1st order serial correlation, see Park, Sickles and Simar, 
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2003; Baltagi and Chang, 1992), so I report the relevant results in Appendix 5B. B Part D 
with much caution due to the presence of a serial correlation problem. Nonetheless, the 
significance of all factors does not change and the R&D intensity variable remains both 
economically and statistically significant. 
Taking the findings from Tables 5B. 1,5B. 2 and 5B. 3, and also Appendix 5B. A 
Part B as a whole, I get evidence that R&D intensity is a contributing factor for analyst 
forecast dispersion in one year ahead forecasts, even after controlling for other firm 
characteristics, such as firm size, the BM ratio, analyst following and the volatility in 
past income. The finding is robust to defining R&D intensity either as R&D divided by 
sales or TA, or MVE and is more robust when referring to older analyst forecast date 
relative to the end of the financial year for which the forecast is made for dispersion 
calculation, and is consistent with prior findings for the US on R&D intensity being 
positively associated with greater analyst dispersion (Chambers, Jennings and 
Thompson, 2002). If forecast dispersion is decomposed into an uncertainty and a 
divergence of opinion component, as was done in prior literature (Barron et al, 1998, 
Doukas, Kim and Pantzalis, 2006), I get indications that the influence of R&D is 
primarily on the uncertainty component of analyst forecasts, in contrast to the findings 
of Barron et al (2002) for the US that R&D has a negative impact on forecast consensus 
even after controlling for uncertainty. 
5B. 3.4 R&D, Dispersion and Stock Returns: Descriptive Statistics 
Having testified a positive association between R&D intensity and forecast dispersion, 
the next step is to assess stock returns for the R&D, zero R&D and R&D firms that 
differ in terms of R&D intensity depending on the amount of analyst dispersion present 
in their earnings forecasts. Diether, Malloy and Scherbina (2002) examine the impact of 
analyst dispersion on very short term returns, even for the next month in specific. In this 
study though, I want to examine the impact of R&D intensity on returns, after 
controlling for analyst dispersion: R&D is an investment that is expected by definition to 
affect the operating performance of a firm over a period of years, therefore it is a long 
term investment. In this context, I will be assessing market performance stock returns for 
the next one year. I calculate both cumulative and buy-and-hold (BAH) total raw returns, 
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which include dividends. Sample firms are divided into four annually rebalanced 
dispersion portfolios, and I assess average returns for the firms with an R&D intensity 
ratio below or above the sample R&D intensity median, and in the top R&D intensity 
quartile, that belong to each dispersion quartile. Cumulative and buy-and-hold returns 
are calculated on a 12 month basis, from July at year t+I until June of year t+2. The first 
month for which a return is used is July 1991, corresponding to the base year 1990 (in 
order to allow enough time for accounting information to be made public), and the last 
month is June 2004, for the base year 2002. R&D intensity is defined as R&D/Sales, 
R&D/TA and R&D/MVE (taking the MVE as of the end of December of year t). 
Dispersion quartiles are rebalanced annually, and I make use of minus one month 
prior to financial year end forecast data for the calculation of dispersion. The results 
appear on Table 5B. 4, which shows the respective equal-weighted returns (cumulative 
and buy-and-hold) for the next year according to dispersion quartiles for the whole 
sample (Panel A) and then for firms with R&D intensity below and above the median, or 
in the top quartile, as well as for zero R&D firms (Panel B). 
Insert Table 5B. 4 here. 
As can be observed from Table 5B. 4, Panel A, with plain descriptive statistical 
data using forecast dispersion data one month prior to year end for the calculation of 
dispersion, at the sample level there appears to exist no particular trend for the direction 
of returns as analyst forecast dispersion changes, without controlling for any other 
factor. This observation is not consistent with Diether, Malloy and Scherbina (2002), 
who testify a negative relationship between dispersion and returns. In this study though, 
I do not assess stock returns immediately after analyst forecast dispersion in assessed for 
all firms, given that accounting years end throughout the calendar year in the UK, and 
this later fact could be influencing the results. In the case of Panel B, which assesses raw 
stock returns for the firms with R&D intensity below/above the median, in the top 
intensity quartile and zero R&D firms, a casual comparison of the different categories of 
firms indicates that R&D intensive (R&D intensity ratio above median) and especially 
very R&D intensive (R&D intensity ratio in top quartile) firms tend exhibit higher 
returns than zero R&D firms in their respective dispersion quartiles. This particular 
result is more striking when R&D/MVE is used as a proxy for R&D intensity. Again, I 
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observe no generalized trend for returns as dispersion changes, with the exception 
maybe of the most R&D intensive firms, which tend to exhibit higher returns for the 
highest dispersion quartiles. 
A limitation inherent by construction in the analysis presented in Table 5B. 4 
relates to the fact that returns are every time taken from July t+1 to June t+2 for the base 
year t, when accounting years finish throughout the financial year in the UK, so 
dispersion calculated with minus I month prior to year end data is taken at different 
months for different firms. This would imply that more forecast data (and therefore 
dispersion data) has been made available for some firms before the firms month of 
return calculation in the UK for some firms and fewer for other firms, with their relative 
probable influence on stock returns. 
In order to overcome this problem, I repeat the analysis in Table 5B. 4 with one 
modification: I calculate returns from July t+l until June t+2 for the whole sample, and 
then for the firms with and R&D intensity ratio below/above the sample median, or in 
the top intensity quartile, and the zero R&D firms according to dispersion quartiles (as in 
Table 5B. 4) but this time using dispersion data of June t+l (accounting data for year t), 
only for these firms whose accounting year ends between July t+1 
- 
December t+l. June 
t+l is the closest month for which there exist forecast data for dispersion calculation 
prior to the firms' month of return calculation. The reason for limiting the sample and 
including only these firms with an accounting year tending between July t+l and 
December t+l is in order to assure that the 1 year ahead EPS forecasts, out of which 
dispersion is calculated, refer to the accounting year that finishes within the calendar 
year t+1, and I therefore use only one year ahead forecast data that refer to the calendar 
year t+l (for example, for a firm whose accounting year ends in March of t+2, the one 
year ahead EPS forecasts issued in June t+l refer to an accounting year that will end 
after the first calendar year of return calculation). 
Table 5B. 5 presents exactly these average returns according to dispersion 
quartiles for the whole sample (Panel A) and for firms with, an R&D intensity ratio 
below/above the sample median, or in the top intensity quartile, and the zero R&D firms 
(Panel B). Consistent with Diether, Malloy and Scherbina (2002) this time, in the sample 
level (Panel A) the lowest dispersion firms exhibit higher returns, other things equal. 
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This observation appears to be valid for zero R&D firms too. In the case of R&D 
intensive and very R&D intensive firms, there appears to exist no particular trend using 
this simple descriptive statistics analysis regarding the direction of returns for different 
analyst forecast dispersion. Overall, the findings from Table 5B. 5 are not so much 
different from the ones in Table 5B. 4, indicating that the fact that I included firms with 
accounting years that end throughout the calendar year in Table 5B. 4 does not produce 
great changes in the results. 
Insert Table 5B. 5 here. 
5B. 3.5 R&D, Dispersion and Stock Returns: Fama-French Time-Series Regressions and 
other Regression Analysis 
I then explicitly assess the impact of R&D on stock returns when analyst earnings 
forecast dispersion differs across firms. Diether, Malloy and Scherbina (2002) use time 
series Fama and French type regressions, where the monthly returns of five dispersion 
portfolios are regressed on the market factor (market excess return), a size factor (SMB), 
a value factor (HML) and a momentum factor, and find that alphas are positive and not 
statistically significant for their low dispersion portfolios, but negative (and significant 
for the top dispersion portfolio) for their higher dispersion ones, and thus they deduce a 
negative relationship between dispersion and stock returns. They make use of dispersion 
data that refer to the month immediately before return calculation. 
In this study, I replicate their Fama and French time series model by regressing 
monthly excess returns for a total of 156 months, from July 1991 until June 2004, on the 
market factor, SMB, HML and additionally a factor that accounts for the effect of RD on 
stock returns. I consider that in order to assess the influence of forecast dispersion on 
stock returns after taking into account the role of R&D, such a modification to the 
Diether, Malloy and Scherbina is necessary: I receive motivation from the Al-Horani, 
Pope and Stark (2003) modification to the traditional Fama-French time series model, 
which includes the addition of a factor that accounts for the returns of different R&D 
intensity firms. This way, I perform the Fama-French time series test for different 
dispersion portfolios by also controlling for the possible impact of R&D on stock 
returns. Al-Horani, Pope and Stark (2003) had run Fama and French time series 
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regressions with the addition of an RD Factor according to different R&D intensity 
portfolios for the R&D firms, and also for the zero R&D firms, given that their scope 
was to assess the influence of R&D for stock returns. In this study, I run Fama-French 
time series, with and without the addition of a factor to account for the role of R&D for 
returns, according to different dispersion portfolios, since the research hypothesis relates 
to assessing the relation between analyst forecast dispersion and returns after accounting 
for the role of R&D. 
For model construction purposes, up to a certain point I follow quite closely the 
methodology by Al Horani, Pope and Stark (2003). The market factor is defined as the 
difference between the monthly value-weighted return of all the sample firms minus the 
risk free rate (1 month UK Treasury Bill rate). Then I divide sample firms in two size 
portfolios, using the median MVE as at the end of June of year t, and 3 BM portfolios, 
with BM calculated with BE for the accounting year that ended within the calendar year 
t-1 and MVE as at the end of December of year t-1. The lowest BM portfolio consists of 
the values of the lowest 30% of BM values, the mid BM portfolio includes the values of 
the mid 40% of values for BM and finally the top BM portfolio consists of the top 30% 
of firms. This procedure results in the construction of 6 (2 by 3) annually rebalanced 
size-BM portfolios, using the intersections of the MV and BM portfolios: Small-low 
(SL: small MVE-low BM), small-mid (SM: small MVE-mid BM), small-high (SII: 
small MVE-high BM), big-low (BL: big MVE-low BM), big-mid (BM: big MVE-mid 
BM) and finally big-high (BH: big MVE-high BM). The SML factor is calculated by 
using the difference between the average monthly returns of three small and three large 
MVE portfolios: (SL+SM+SH)/3-(BL+BM+BH)/3. In the same direction, the value 
factor HMI, is defined as the difference between the average monthly returns between 
two high BM and two low BM portfolios: (SH+BH)/2-(SL+BL)/2. Following Diether, 
Malloy and Scherbina (2002), all portfolio returns for the construction of the SMB and 
HML factors are equal-weighted. In order to allow for accounting data to become public, 
returns are taken from July in year t until June in year t+1 for annually rebalanced data 
that refers to the base year t (MVE as of the end of June t, BM with BVE for the 
accounting year that ended within the calendar year t-1 and MVE as at the end of 
December at t-1). 
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With respect to the RD factor, I construct it by performing a modification to what 
is done by Al Horani, Pope and Stark (2003): They construct the RD factor by dividing 
sample firms in three BM portfolios, low, mid and high, and each BM portfolio is the 
divided in further two portfolios, depending on whether each firm is an R&D reporting 
one (LRD, MRD and HRD) or a zero R&D firm (LZRD, MZRD and HZRD). Their 
factor is constructed by taking the difference between the average monthly returns of 
three R&D reporting BM portfolios and three zero R&D portfolios: 
(LRD+MRD+HRD)/3-(LZRD+MZRD+HZRD)/3. The returns of their six R&D or 
ZRD, low-mid or high BM portfolios are value weighted. I decided though to construct 
the RD factor on its own, without making use of any other firm characteristics as 
previously done with BM. I proceed to this modification to make sure that the RD factor, 
the way it is constructed by Al-Horani, Pope and Stark (2003) with the use of BM, does 
not capture any BM effects already captured by HML, and this way provide an 
alternative RD factor based only on the returns of firms that differ in terms of R&D 
intensity. I therefore construct the RD factor by subtracting the monthly equal weighted 
returns of zero R&D firms from the returns of R&D intensive firms as (High RD-Zero 
RD). High R&D firms are defined as the ones with R&D/Sales above the 70`h percentile 
(High R&D-HRD). The reason for using equal weighted returns in order to calculate the 
RD factor is because I calculate the excess returns of the different dispersion portfolios 
as equally weighted following Diether, Malloy and Scherbina (2002), so there should 
exist consistency between the way of calculating portfolio returns on the right and left 
side variables of the regression. Al Horani, Pope and Stark (2003) calculate the RD 
factor by making use of value weighted returns for their above described 6 R&D-no 
R&D, different BM portfolios, but I argue that there should exist consistency between 
the way of calculating portfolio returns on the right and left side variables of the 
regression, because in a different case there could exist biases from the inclusion of both 
value and equal weighted factors in the same regression. I therefore calculate the excess 
returns of the different dispersion portfolios as equally weighted, I do the same for the 
construction of the RD factor. 
For reasons of completeness of the analyses, I have repeated the analyses by 
constructing the RD factor according to the methodology by Al Horani, Pope and Stark 
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(2003) as described above, with equal weighted returns though. The relevant results are 
included in Appendix 5B. C Part A Panel A. In addition, I have repeated the analysis by 
constructing the RD factor again on its own, but this time using also the returns of lower 
RD intensity portfolios. In this case, I divide sample firms in four portfolios: zero R&D 
firms (ZRD), firms with and R&D/Sales ratio below the 30th percentile (low R&D- 
LRD), firms with and R&D/Sales ratio between the 30th and the 70th percentile (mid 
R&D-MRD) and finally firms with R&D/Sales above the 70th percentile (High R&D- 
HRD). I then subtract the average monthly returns of the low R&D and zero R&D firms 
from the relevant returns of the mid and high R&D portfolios: (high RD+Mid RD)/2- 
(Low RD+Zero RD)/2. In the case of the R&D and R&D intensive firms (firms with an 
R&D/Sales ratio above the sample median for a particular year), I also construct the RD 
factor without the use of any zero R&D firm returns by simply using the returns of the 
highest and lowest R&D portfolio as (High RD-Low RD). The relevant results are 
included in the Appendix 5B. C Part A Panels A and B. 
Following the argumentation described above on the issue of the RD factor 
construction with equal versus value weighted returns, the returns of the four portfolios 
(Zero RD, low RD, mid RD and high RD) are equal weighted, and so are the RD/ZRD- 
BM portfolios for the RD factor construction according to the Al Horani, Pope and Stark 
methodology. Nonetheless, I have repeated all analyses by constructing the RD factor 
using the value-weighted returns all portfolios, with the relevant results included in 
Appendix 5B. C Part B. As intuitively expected, the results in that case tend to become 
implausible for some regressions. 
The use of the R&D/Sales ratio instead of another R&D intensity measure such 
as R&D/MVE is justified by the fact that I wish to isolate the ratio from the influence of 
market volatility. Nonetheless, I have repeated some of the analysis in Table 5B. 6 Panel 
B by using R&D/TA for the construction of the R&D factor with no great qualitative 
change in the direction of the results, as can be observed in Appendix 5B. C Part C. 
This way, the following regression is run using time series monthly data for a 





= alpha + 8, (Rm 
- 
Rf) +ß2 SMB + #8 3 HML +ß4 RDFactor +c 
(5B. 2) where: 
Rp-Rf- the difference between the equal-weighted monthly returns of five annually 
rebalanced dispersion portfolios and the risk free rate (1 month UK Treasury Bill 
rate).. One month prior to year end 1 year ahead analyst forecast data are used for 
dispersion calculation. The analysis is repeated by including only the R&D, zero 
R&D and firms with an R&D/Sales ratio above median according to 5 dispersion 
portfolios. The average number of observations included in each of the five 
dispersion portfolios for the whole sample, the R&D, zero R&D and firms with 
an R&D/Sales ratio above median is reported in Appendix 5B. C Part F. 
Rm-Rf- the difference between the monthly value-weighted return of all the sample 
firms and the risk free rate (I month UK Treasury Bill rate). 
SMB- the size factor, calculated by using the difference between the average equal- 
weighted monthly returns of three small and three large MVE portfolios: 
(SL+SM+SH)/3-(BL+BM+BH)/3. 
HML- the value factor, defined as the difference between the average equal-weighted 
monthly returns between two high BM and two low BM portfolios: (SH+BH)/2- 
(SL+BL)/2. 
RDFactor- the factor that accounts for the difference in the returns of differing R&D 
intensity firms, calculated by subtracting the average monthly returns of zero 
R&D firms from the monthly returns of high RD firms with R&D/Sales above 
70th percentile. I also repeat the analyses by constructing the RD factor as in Al- 
Horani, Pope and Stark (2003), by taking the difference between the average 
(equal-weighted) monthly returns of three R&D reporting BM port folios and 
three zero R&D portfolios: (LRD+MRD+HRD)/3-(LZRD+MZRD+HZRD)/3, 
and secondly by subtracting the average monthly returns of low R&D 
(R&D/Sales) and zero R&D firms from the returns of mid and high R&D 
portfolios: (High RD+Mid RD)/2-(Low RD+Zero RD)/2. In the case of the R&D 
and R&D intensive firms, I also repeat the analysis by constructing the RD factor 
using just the returns of the highest and lowest R&D portfolio (High RD-Low 
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RD)_ The relevant results of these alternative RD factor construction 
methodologies, as well as the RD factors constructed with value instead of equal 
weighted returns, are included in the Appendix 5B. C Parts A and B. 
Regarding dispersion portfolio calculation, sample firms are divided in 5 
dispersion portfolios, from low (DI) to high (D5), using 1 month prior to year end 
forecast data for dispersion calculation. For example, for the year 1990, if a firm's 
accounting year ends in December 1990, there are used dispersion data as of November 
1990. For a firm with an accounting year end in March 1990, there are used dispersion 
data as of February 1990. For the dispersion portfolios of the base year 1990, in order to 
allow for accounting data to be made public, returns are taken from July 1991-June 
1992. Dispersion portfolios are annually rebalanced. In the case of Diether, Malloy and 
Scherbina (2002), dispersion portfolios are monthly rebalanced, based on dispersion of 
the previous month for returns of the current month. This monthly rebalancing would 
not be quite feasible in this study though, given the multiple accounting year ends in the 
UK. For example, if we were to take dispersion quintiles as of June 1991, and calculate 
the relative returns for July 1991,1 year ahead EPS forecast data used for dispersion 
calculation would include forecasts for both the fiscal years 1991 and 1992, depending 
on the accounting year end of each firm. Given that the return calculation period must be 
obviously homogeneous across firms, I make use of 1 month prior to year end forecast 
data for dispersion calculation, which implies that dispersion data are taken at different 
months for different firms. The problem of differing months for accounting year ends is 
inherent in all type of empirical research for the UK, that makes use of both accounting 
and market based data. I explicitly make use of 1 month prior to year end forecast data 
in order to minimise the lag between dispersion and return calculation. As previously 
stated, dispersion is defined as the standard deviation in 1 year ahead EPS analyst 
forecast divided by the absolute value of the mean forecast for the month in question. 
The time-series regressions are run using OLS and Whites Heteroskedasticity 
robust errors. The regression results are reported on Table 5B. 6, Panels A (no RD factor 
included), and B (RD factor calculated using the returns of a high R&D portfolio minus 
the returns of a zero R&D portfolio, RD factor constructed with equal-weighted returns) 
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In Appendix 5B. C Part A there are reported the results when using an factor according 
to Al-Horani, Pope and Stark, 2003 with equal weighted returns (Panel A), an RD factor 
calculated on its own using the returns of a high and a medium R&D intensity portfolio 
minus the returns of a low R&D and a zero R&D portfolio with equal weighted returns 
(Panel B), and finally an R&D factor calculated using the returns of a high R&D 
portfolio minus the returns of a low R&D portfolio for the R&D and R&D intensive 
firms, again with equal-weighted returns (Panel Q. In Appendix 5B. C Part B there are 
reported the relevant results from Table 5B. 6, as well as from Appendix 5B. C Part A, 
but this time by using an RD factor calculated with value-weighted returns. In Appendix 
5B. C Part G there are presented the average number values of the factors included in the 
Fama-French time-series regressions on Table 5B. 6 and also Appendix 5BC Part A and 
Part B for the 156 months used in the regressions (July 1991-June 2004), and also the 
average raw and excess returns of the five dispersion portfolios formed according to all 
sample data. 
Insert Table 5B. 6 here. 
I also report on Table 5B. 7 the Pearson correlation coefficients among the 
regression independent variables Rm-Rf (RM), SMB, HML and the RD factor. As can 
be observed from the table, the correlation coefficients among RM, SMB and HML get 
values at reasonable levels for the purpose of inclusion in a regression. In the case of the 
RD factor, its correlation with other factors depends very much on the way it is 
constructed. When I use equal-weighted returns for its construction for the reasons 
previously stated, the only case when it gets no Pearson correlation coefficient with a 
value above 0.5 is when the Al Horani, Pope and Stark methodology is used. This way, 
the results with the inclusion of this particular R&D factor could be considered more 
reliable for this reason, but nonetheless I although I report the Pearson correlation 
coefficients among the regression independent variables for all constructed RD factors, 
including the one used in Table 5B. 6. 
Regarding the regression results on Table 5B. 6, in the case of Panel A, when the 
regressions are run for five dispersion portfolios for all the sample firms, and for the 
R&D, zero R&D and R&D intensive firms separately without the RD factor, I observe 
that consistent with prior literature, all of the Rm-Rf, SMB and HMG factors are positive 
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and statistically significant at 1% significance level. The coefficient of the market factor 
increases as we move to higher dispersion portfolios, and so do the coefficients for SMB 
and HML. Alphas are statistically not significant for all dispersion portfolios at any 
reasonable level of significance, but consistent with Diether, Malloy and Scherbina 
(2002), alpha is positive for the bottom dispersion portfolio and starts getting negative 
for higher dispersion portfolios, indicative of a negative relation between dispersion and 
returns. Adjusted R squares remain steadily above 70% for all dispersion portfolios and 
the F statistics always get very high values. 
Interestingly, when I repeat the regressions for five dispersion portfolios for the 
R&D, zero R&D and R&D intensive firms, in the case of the R&D intensive firms, 
alphas are always positive and also significant at 5% for the bottom dispersion portfolio, 
but additionally the HML factor gets a negative coefficient of limited overall 
significance, consistent with prior literature (e. g. Lev and Sougiannis, 1999) on limited 
significance of the value factor for R&D intensive firms. Alphas are always negative and 
not statistically significant for the zero R&D firms (HML always with a positive and 
significant coefficient). Lastly, in the case of the R&D firms, alpha is positive for three 
out of four dispersion portfolios (including the two lower ones) but overall not 
statistically significant, and HML gets a positive and significant coefficient in all cases 
but for the bottom dispersion portfolio, where it is both negative and not statistically 
significant. 
When the RD factor is included in the regression (Table 5B. 6 Panel B), 
calculated from the difference of the average equal-weighted monthly returns between 
zero R&D firms and high R&D firms, the RD factor is always positive. It is statistically 
significant for the R&D and R&D intensive firms, and of limited overall significance in 
the sample level. The factor is also positive contrary to the intuition in the case of the 
zero R&D firms, although not statistically significant. Alphas are negative and not 
significant in the sample level and also for the zero R&D firms. In the case of the R&D 
and R&D intensive firms, alphas are positive (not significant always) for the low 
dispersion portfolio and tend to get negative for the higher dispersion portfolios. 
Interestingly, upon the inclusion of the RD factor, alpha is negative and gets 
significantly different from zero at 5% level for the top dispersion R&D portfolio 
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indicating that the excess returns for very high dispersion R&D firms are statistically 
significantly negative, even after I control for the RD factor. Finally, consistent with the 
results of the value factor for R&D intensive firms by Lev and Sougiannis (1999), upon 
the inclusion of the RD factor, HML loses its significance for the R&D and R&D 
intensive firms, despite the fact that it remains significant in the sample level and also 
for zero R&D firms. 
When the RD factor of Al-Horani, Pope and Stark (2003) type is included in the 
regression (Appendix 5B. C Part A Panel A), the results no not change much with respect 
to the significance of the market factor, SMB and HML compared to the relative results 
when no RD factor is included. In the sample level, the RD factor is generally not 
statistically significant and neither are the alphas, with both the RD factor and the alpha 
for the bottom dispersion portfolio to be positive (as previously in the case of the alpha, 
for the regression without the RD factor) and to be getting negative for higher dispersion 
portfolios. When I repeat the analysis for 5 dispersion portfolios for the R&D firms only, 
the RD factor gets steadily positive and signif icant, and alpha behaves as in the previous 
cases, being steadily statistically not significant and positive when dispersion is low and 
negative as it increases. This is the case when I repeat the results for the firms with an 
R&D/Sales ratio above the sample median: in that case though, the economical 
significance if the RD factor is even greater compared to the case when the regressions 
are run for the R&D firms in general. When I repeat the regressions for dispersion 
portfolios for the zero R&D firms, the coefficients of the RD factors are always 
negative, and for three out of five dispersion portfolios statistically significant at 5% 
significance level. Therefore even after I control for the influence of RD on stock 
returns, there is testified a negative relation between dispersion and returns. 
When I include an R&D factor calculated from the difference of the average 
equal-weighted monthly returns between low R&D/zero R&D firms and mid R&D/high 
R&D firms (Appendix 5B. C Part A Panel B) alpha is negative and not statistically 
significant in every case but for the top dispersion portfolio, where it is statistically 
significant at 10% significance level. Alpha gets though a value very close to zero for 
the bottom dispersion portfolio. There are no great qualitative differences with respect to 
the previous cases regarding the behaviour of the market factor and SMB and IlML. 
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When I repeat the analysis for the R&D and R&D intensive firms, the RD factor remains 
positive and its economic significance increases in the case of the R&D firms, compared 
to the relevant results for the whole sample, and even more for R&D intensive firms. For 
both the R&D and R&D intensive firms, alpha is now positive although not statistically 
significant for the bottom dispersion portfolio and gets negative for higher dispersion 
portfolios. Interestingly, for the R&D firms in the case of the top dispersion portfolio 
alpha is negative and statistically significant at 5% significance level. When I repeat the 
analysis for the zero R&D firms, alphas are always negative and generally not 
statistically significant and the coefficient of the R&D factor, contrary to the intuition, 
remains positive. 
Finally, when I construct the RD factor using the difference in the returns 
between very high and low R&D intensity firms (Appendix 5B. C Part A Panel C), and I 
limit the analysis into only R&D and R&D intensive firms, again I observe no dramatic 
changes in the direction of the results. The RD factor is positive and significant in every 
case, and of much greater economical significance for the R&D intensive compared to 
the R&D firms overall. Except in the case of the top dispersion portfolio for R&D firms, 
where the alpha is negative and significantly different from zero at 5% level, alphas are 
overall not statistically significant. As in previous analyses, they are positive for the 
bottom dispersion portfolio but tend to get negative for higher dispersion portfolios. 
As already examined with the analysis in Table 5B. 5, the fact that dispersion data 
are taken at different months for different firms, depending on the specific month that 
the accounting year ends for each firm may introduce the limitation that more forecast 
data (and therefore dispersion data) has been made available for some firms before the 
firms month of return calculation in the UK for some firms and fewer for other firms, 
with their relative probable influence on stock returns. In order to overcome this 
problem, I repeat the analysis in Table 5B. 6 with one modification: I use dispersion data 
for portfolio formation as of June t but only for these f inns whose accounting years end 
between July t- December t. June t is the closest month for which I have forecast data 
for dispersion calculation prior to the firms month of return calculation. Again, the 
reason for limiting the sample and including only these firms with an accounting year 
ending between July t and December t is in order to assure that the 1 year ahead EPS 
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forecasts, out of which dispersion is calculated, refer to the accounting year that finishes 
within the calendar year t, and I therefore use only one year ahead forecast data that refer 
to the calendar year t (for example, for a firm whose accounting year ends in March of 
t+1, the one year ahead EPS forecasts issued in June t refer to an accounting year that 
will end after the first calendar year of return calculation). I therefore repeat the analysis 
from Table 5B. 6 in Appendix 5B. C Part D by performing this modification, in order to 
make sure that the results I get on Table 5B. 6 are not biased from the fact that 
accounting years end at different times during the calendar year in the UK, with the 
relative impact on the months I take for dispersion calculation. As can be observed from 
the results in Table 5B. 6 in Appendix 5B. C Part D, Panels A (regressions run without an 
RD factor), B (regressions run with an RD factor, calculated from the equal-weighted 
returns of High R&D and zero R&D firms), and C (regressions run with an RD factor, 
calculated as in Al Horani, Pope and Stark with equal-weighted returns) for the whole 
sample, and separate R&D and zero R&D firm portfolios, the main observation from 
these results is that the positive alphas for the bottom dispersion portfolios are 
statistically significant at 5% significance level in the sample level, and also for R&D 
and zero R&D firms separately, both when the RD factor is included and not included in 
the regressions. The RD factor is negative in the sample level and for zero R&D firms 
too, and interestingly it turns negative in a couple of cases for the R&D firms too, and is 
overall of limited significance, probably an indication of the fact that the effects of R&D 
should be more tong-term. Finally, the HML factor is also of limited overall 
significance, and it tends to be negative for low dispersion portfolios, both when the RD 
Factor is included or excluded from the regressions. The same qualitative changes in the 
results apply when I use an RD factor calculated according to the Al Horani, Pope and 
Stark methodology with equal-weighted returns. 
In order to control for possible effects from the New Economy years on the 
results (late 1990's 
- 
early 2000), 1 have repeated the regressions in Panels A and B of 
the Table 5B. 6 by excluding the months from January 1999-December 2001. The 
regressions have also been repeated by using an RD Factor calculated with equal 
weighted returns according to the Al-Horani, Pope and Stark (2003) methodology. The 
relevant results are reported in Part E of the Appendix 5B. C. When the RD Factor is not 
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included in the regression (Panel A of Part E of Appendix 5B. C), the main observation 
relates to the reduction in the significance of the HML factor, both in the sample level 
and for R&D firms as well, which turns to not statistically significant for the low 
dispersion portfolios. The HML factor continues to be negative in the case of the R&D 
intensive firms. There are no great changes with respect to the direction of the results for 
the alphas. A very interesting observation though is that for the reduced sample period, 
alpha is positive and statistically significant at 5% for the bottom dispersion portfolio in 
the case of the R&D intensive firms, and for the same group of firms alpha is negative 
but with increased statistical significance at 10% for the top dispersion portfolio. 
When the RD factor is included in the reduced sample regressions (Panel B of 
Part E of Appendix 5B. C), in the sample level there is not one single positive alpha for 
any dispersion portfolio. In the sample level, the trend for reduced statistical significance 
for the HML factor in the reduced sample continues with the inclusion of the RD Factor, 
and the same trend applies for R&D, zero R&D and R&D intensive firms. The RD 
Factor shows reduced statistical significance for the zero R&D firms (and remains 
negative) and there are no great changes with respect to its significance for the R&D and 
R&D intensive firms. The main great change with respect to the direction of the results 
for the alphas relates to the alphas for the top dispersion portfolios: with the exception of 
the zero R&D firms, alpha is statistically significant at 5% significance level and 
negative for the top dispersion portfolio in the sample level and for the R&D and R&D 
intensive firms. Alpha is negative and statistically significant at 10% level for the top 
dispersion portfolio for the zero R&D firms. These results generally hold when making 
use of an RD Factor calculated according to the Al-Horani, Pope and Stark (2003) 
methodology in Panel C of the Appendix 5B. C Part E, with the alphas for the top 
dispersion portfolios to be exhibiting high t statistics in absolute terms of a negative 
sign. 
The Diether, Malloy and Scherbina (2002) study on which I extensively based all 
the previous analyses has received though fierce criticism by Doukas, Kim and Pantzalis 
(2006), that it makes use of analyst forecast dispersion which is a poor proxy for 
divergence of opinion, since it does not account for forecast uncertainty. Doukas, Kim 
and Pantzalis (2006) testify a negative relationship between returns and uncertainty, but 
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a positive relationship between diversity of opinion and stock returns. I have therefore 
repeated the previous analysis by running the Fama-French three factor time-series 
model (with and without adding an RD factor) by running the regressions this time 
according to 5 portfolios formed according to diversity of opinion (1-p) and not forecast 
dispersion. This way I run the regression 5B. 2 (with and without adding the RD factor) 
using as dependent variable the equal-weighted returns of 5 (1-p) portfolios for the 
whole sample and then the R&D, zero R&D and firms with an R&D/Sales ratio above 
the sample median. Running Fama-French type time-series regressions according to 
analyst divergence of opinions (1-p) portfolios, with and without adding an RD Factor 
into the model represents an extension into the previous analysis of assessing the relation 
between dispersion and returns after accounting for the role of R&D for returns, since at 
this point there, is isolated the divergence of opinion component of forecast dispersion 
(assuming that forecast dispersion consists of both a forecast uncertainty part and a. 
divergence of opinions part). When the RD factor is added, this is calculated with equal- 
weighted returns either by subtracting the returns the zero R&D firms from the returns 
of the top 30 percentile R&D/Sales f inns as in Table 5B. 6, or as in Al Horani-Pope and 
Stark (2003), as is done in Appendix 5B. C Part A. Panel A. The relevant results are 
presented in Appendix 5B. P Panels A (no RD factor), B (RD factor as High RD-Zero 
RD as in Table 5B. 6) and C (RD factor as in Al Horani-Pope and Stark, 2003, as is done 
in Appendix 5B. C Part A. Panel A). The scaling used for (1-p) calculation in Appendix 
5B. P is by the absolute value of actual EPS and is consistent with the scaling used for D 
calculation on the Tables on p. 85 of this second Volume. 
When an RD factor is not included in the regressions, I observe not so great 
differences compared to Table 5B. 6 with respect to the sign and significance of the 
market factor, SMB and HML, but in the case of alpha, there is no longer observed the 
previous pattern of a positive alpha for low dispersion portfolios and negative alphas 
with continuously lower t stats thereafter as dispersion changed, all alphas being 
statistically not significant. Alphas tend to be positive for the bottom divergence of 
opinion portfolio (with the exception of the zero R&D firms) and again positive for the 
medium divergence portfolios (1-p)3. 
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When an RD factor is added (calculated from the returns of High RD-zero RD 
firms), the first interesting observation is that unlike the relevant results in Table 5B. 6, 
the top divergence of opinion portfolio for the R&D firms no longer gets a negative 
alpha that is statistically significant. Consistent with the previous results when no RD 
factor was included, when I construct portfolios according to divergence of opinion and 
not dispersion, there is again no longer observed the previous pattern in Table 5B. 6 of a 
positive alpha for low dispersion portfolios and negative alphas with continuously lower 
t stats as dispersion increased, no matter how I define the RD factor in Panels B and C of 
the Appendix 5B.. O. This absence of evidence on a negative association between returns 
and divergence of opinion is in accordance with Doukas, Kim and Pantzalis (2006), but 
in this study I do not find a positive relation between (1-p) and subsequent returns as 
they do either. 
The most interesting finding though, when I construct portfolios according to 
divergence of opinion instead of dispersion, has to do with the significance of the RD 
factor for the RD and RD intensive firms, no matter how I define it in Panels B and C of 
the Appendix 5B. P. In table 5B. 6 and also in Appendix 5ß. C Part A Panel A, as 
dispersion increased, so did the significance of the RD factor, with the t statistics to be 
getting constantly higher. When I construct though the portfolios according to 
divergence of opinion (1-p) instead of dispersion, as divergence gets higher, the 
significance of the RD factor is continuously reduced and the t stats get lower and lower, 
particularly when the RD factor is calculated as from the returns of High RD-Zero RD 
firms. 
In addition, in Appendix 5B. R Part A, I rerun the Fama-French time series 
regressions presented in Appendix 5B. P according to (1-p) portfolios, for the whole 
sample, the R&D, zero R&D and R&D intensive firms (firms with R&D/Sales above 
sample median), without including an RD Factor (Panel A) and by including an RD 
Factor calculated as in Al-Horani, Pope and Stark (2003) with equal-weighted returns 
(Panel B) or by including an RD Factor calculated from the equal-weighted returns of 
(High RD-Zero RD) firms (Panel C), when calculating (1-p) using scaling by the 
absolute value of mean EPS forecast one month prior to accounting year end. In other 
words, (1-p) used in Appendix 5B. R Part A is calculated as in Table 3 of the Appendix 
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5B. A Part B, when (1-p) used in Appendix 5B. P is calculated as in Table I of the 
Appendix 5B. A Part B. Therefore the (1-p) calculation in Appendix 5B. R Part A is 
completely consistent with the dispersion calculation when running Fama-French time- 
series regressions according to five dispersion portfolios in other parts of the Thesis 
(Table 5B. C and Appendix 5B. C Parts A to G), which is a fact that makes comparisons 
across the different empirical findings when running the regressions according to five 
dispersion as opposed to divergence of opinions (1-p) portfolios particularly useful. 
In the same direction, there is also observed from the results in the Appendix 
5B. R Part A that as divergence of opinions increases, in the case of the R&D and 
especially the R&D intensive firms the significance of the RD Factor is constantly 
getting lower. When an RD Factor calculated using the Al-Horani, Pope and Stark 
(2003) methodology is used in Panel B (which is expected to lead to more unbiased 
results given the fact that it exhibits a very reasonable Pearson correlation coefficient 
with other regressors, unlike the RD Factor when constructed from the returns of High 
R&D-Zero R&D firms, which exhibits a Pearson coefficient of above 0.7 in absolute 
value with HML), the RD Factor exhibits a much lower t statistic for the top (1-p) 
portfolio for the R&D firms, compared to its significance for higher (1-p) portfolios, 
with the significance of the RD Factor to be exhibiting a diminishing trend as divergence 
of opinions increases for these firms. More importantly, the RD Factor, which shows the 
same diminishing trend in terms of statistical significance for the R&D intensive firms 
too as (1-p) increases, is not statistically significant at any reasonable level of 
significance for the top (1-p) portfolio for these firms, confirming this way the low 
power of R&D for to influence returns for R&D intensity firms in the presence of high 
divergence of opinions. 
Appendix 5B. R Part B continues with running Fama-French time series 
regressions according to analyst forecast uncertainty V portfolios, for the whole sample, 
the R&D, zero R&D and R&D intensive firms (firms with R&D/Sales above sample 
median), without including an RD Factor (Panel A) and by including an RD Factor 
calculated as in Al-Horani, Pope and Stark (2003) with equal-weighted returns (Panel B) 
or by including an RD Factor calculated from the equal-weighted returns of (High RD- 
Zero RD) firms (Panel C), when calculating V using scaling by the absolute value of 
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mean EPS forecast one month prior to accounting year end, as was done for (1-p) 
calculation in Appendix 5B. R Part A. So, analyst forecast uncertainty V in Appendix 
5B. R Part B is calculated as in Table 3 of the Appendix 5ß. A Part B, and the V 
calculation in Appendix 5B. R Part B is completely consistent with the dispersion 
calculation when running Fama-French time-series regressions according to five 
dispersion portfolios in other parts of the Thesis. 
What is observed from Appendix 5B. R is that both in terms of alphas as well as 
in terms of the behaviour of the RD Factor, the results when running Fama French 
regressions according to V portfolios are close to the relevant results when performing 
the same analysis according to dispersion portfolios. As far as alphas are concerned, 
there are no cases where alpha is statistically significant in Panels A and B, and the signs 
of the alphas seem to follow the respective signs of the alphas when running the 
regressions according to dispersion portfolios. Regarding the RD Factor, it can be 
observed that as forecast uncertainty V increases, for the R&D and particularly R&D 
intensive firms the t statistics of the RD Factor tend to increase and get very high for the 
top V portfolio. In Panel B, in the case of the top V portfolio for the R&D intensive 
firms, the t statistic of the positive RD Factor gets its highest value, and the same result 
is confirmed in Panel C. This result on a very strong significance of the RD factor as 
R&D intensity gets high for high forecast uncertainty is very similar to the observed 
very strong significance of the RD Factor for very high dispersion firms in the case of 
R&D intensive firms previously testified. 
The above findings imply that when forecast dispersion is decomposed into a 
forecast uncertainty and a pure differences of opinion part, as R&D intensity increases, 
the ability of R&D to influence returns also increases for high dispersion and high 
forecast uncertainty (V) firms, but the ability of R&D to influence returns is very week 
for high divergence of opinion (1-p) firms. This finding implies at the same time that in 
the presence of high R&D intensity, dispersion has an impact on returns mainly through 
the forecast uncertainty component of forecast dispersion, and not through the 
divergence of opinion component. 
Despite the fact that the theoretical relation between dispersion and subsequent 
returns is an issue of fierce academic debate this moment, with contradicting views in 
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the field (Diether, Malloy and Scherbina, 2002; Doukas, Kim and Pantzalis, 2006), when 
trying to interpret this finding by using the Doukas, Kim and Pantzalis (2006) 
conceptual framework, high uncertainty in forecasts should be associated with lower 
returns according to theorisation by Doukas, Kim and Pantzalis (2006). Therefore this 
testified strong uncertainty component should be driving returns downwards for these 
high R&D intensity firms, which is not the case at all though for high R&D firms, given 
that high R&D firms have been generally associated with very high returns in the 
literature and also in this study in specific in Chapter SA. Following this line of 
reasoning, the returns of these high R&D and high forecast uncertainty firms should be 
more due to market mispricing. 
Appendix 5B. Q also reports the average 156 month (July 1991-June 2004) 
monthly returns, both raw and risk-adjusted for the whole sample and the R&D, zero 
R&D, and R&D intensive firms (firms with an R&D/Sales ratio above the sample 
median for a particular year) according to 5 analysts forecast dispersion (D) and 5 
analyst diversity in opinion portfolios (1-p) from low (1) to high (5). Dispersion is 
defined as the standard deviation in 1 year ahead EPS forecasts, standardised by the 
absolute value of the mean forecast, and (1-p) is calculated by using scaling by the 
absolute value of actual EPS. One month prior to year end data are used for D and (1-p) 
calculation (details on the calculation of risk adjusted returns, calculated with reference 
to the value weighted-returns of 6 (2 by 3) MV-BM portfolios, are included in the 
Appendix). 
As can be observed from the relative Appendix, there is observed no clear or 
readily observable trend with respect to the direction of returns as dispersion or 
divergence in opinion changes, even when I control for firm size and BM through the 
calculation of returns. 
As a final robustness check, I wish to see whether the fact that the standard 
deviation is scaled by the absolute value of the mean forecast drives this result, in sense 
that the mean analyst forecast is associated with future stock returns and not the standard 
deviation in analyst forecasts. Following a previous such control by Diether, Malloy and 
Scherbina, I regress stock returns on both dispersion, R&D intensity and other control 
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variables by running the following regression for the period 1990-2002 with panel data: 
Re turns u=ßo+ßID+ /3 2 RD + #8 3 
PASTS +ß4 MEANEPS + /3, MV + 
/J6 BM + Eq 
(5B. 3) where: 
RET 
- 
the 12 month raw cumulative return from July of year t until June of year t+1. The 
first month for which the return is included is July 1991 and the last one is June 
2004. 
D- analyst forecast dispersion defined as the standard deviation in one year ahead 
analyst forecasts of EPS for a particular month divided by the absolute value of 
the mean forecast in the specific month. There are used forecasts 6 months prior 
to year end (in the thesis, dispersion is calculated with 
-12,6, and 1 month before 




R&D/Total Assets or R&D/Market value of equity at year end. The choice of 
R&D/TA and R&D/MV instead of R&D/Sales is justified by the fact that I use a 
past sales variable among the regressors. 
MEANEPS 
- 
Mean analyst earnings forecast 6 months prior to year end 
PASTS 
- 
the sales growth over the two years prior to year t (geometric mean) 
BM 
- 
the book-to-market ratio at year end 
MV 
- 
MVE at year end (natural log) 
The regression is run using OLS and Whites HIeteroskedasticity robust standard 
errors. Observations above the 98 and below the 2 percentile were eliminated. 
As can be observed from the Appendix 5B. C Part H, the dispersion variable 
always gets a negative sing, consistent with prior literature for the US (Diether Malloy 
and Scherbina, 2002), and is statistically significant at 5%. BM is positive and very 
much statistically significant and MV is generally of limited significance and negative. 
The past sales growth variable PASTS is also positive but generally not significant in the 
regression at any reasonable level. Conforming to the hypotheses and prior literature, the 
R&D intensity variable is always positive and statistically significant at 5% significance 
level, no matter if we define it as R&D/TA or R&DIMV. The EPS forecast variable 
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MEANEPS is also positive and statistically significant at 5% level, but gets values of t 
statistics lower than the ones of the dispersion variable. Finally, the p values of the F 
statistics are generally zero, and the adjusted R squares are very low, an indication of the 
difficulty to explain stock returns. 
The fact that dispersion is found to play a significant role for stock returns, when 
the mean EPS forecast is also statistically significant but with lower t statistics is 
consistent with Diether, Malloy and Scherbina (2002), constitutes evidence that the 
results are not driven by the behaviour of the dispersion denominator. The negative and 
significant coefficient of the dispersion variable is consistent with the previous results on 
the negative and significant role of dispersion on stock returns, even after controlling for 
R&D. I acknowledge in the specific regression that the results could be biased from the 
fact that accounting year ends end at different times during the calendar year, and 
therefore analyst forecast data are taken at different times during the calendar year, but I 
have made controls for this problem in previous parts of Chapter 5 Part B and thus I 
expect that this limitation should not be determining the direction of the results. 
The results are robust to the addition of an analyst following independent 
variable (data in Appendix 5B. C Part H main table, Panel B) The results are robust to 
possible time period effects during the years of the New Economy, with the inclusion of 
a time dummy variable for the base years 1998,1999 or 2000 (data in Appendix 5B. C 
Part H). 
This regression setting also permits controlling whether industry effects 
influence the results regarding dispersion, R&D and stock returns. Al-Horani, Pope and 
Stark (2003) control for these in their study by including industry dummies in another 
part of their paper, which involves running cross-sectional regressions. Diether, Malloy 
and Scherbina (2002) do not control for industry factors at all. In Part A of Chapter 5 of 
the thesis, I have regressed size and BM adjusted stock returns on R&D intensity and 
industry dummies to account for very R&D intensive industries, both simple and 
multiplicative with R&D, and found no significant change in the power of R&D to 
influence returns. In this panel setting, I control for industry effects by including 
industry dummy variables, both simple and multiplicative with R&D, to account for four 
industries which arc perceived as intensive in R&D activity: Information Technology 
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(INDD1), Chemicals (INDD2), General Industries (INDD3) and Health grouped 
together with Pharmaceuticals and Biotechnology (INDD4) (data presented in Appendix 
5B. C Part H). I observe from the relevant results no significant difference in the sign or 
significance of neither the R&D nor the dispersion variables upon the inclusion of the 
dummy variables, except for the case cases of the General Industries simple and 
multiplicative dummy when R&D intensity is defined as R&D/ TA, and therefore I 
conclude that industry factors should not be the cause for return behaviour. 
Taking the above findings from Table 5B. 6 Panels A and B, and also Appendices 
5B. C, 5B. P and 5B. R as a whole, keeping in mind the econometrical problems due to 
increased correlation of the RD factor with the other independent variables depending on 
how this is constructed, I confirm a negative relationship between dispersion and 
returns. The results in the overall sample level are consistent with the ones by Diether, 
Malloy and Scherbina (2002) for the US, in the sense that the bottom dispersion 
portfolio exhibits a positive alpha which is not significant, and alphas tend to get 
negative for higher dispersion portfolios, which are generally not statistically significant 
as well. This later finding is in contrast to the one by Diether, Malloy and Scherbina 
(2002), who find that the alpha for their top dispersion portfolio is negative and 
statistically different from zero. 
I also observe that the inclusion of the RD factor in the traditional Fama-French 
model, according to several methods used for its construction, improves the performance 
of the model since I generally get higher adjusted R squares. Upon the inclusion of the 
RD factor the previously testified negative relationship between dispersion and returns is 
still found to hold: again, even after controlling for the impact of R&D on stock returns, 
I find that the bottom dispersion portfolio exhibits a positive alpha which is not 
significant, and alphas tend to get negative for higher dispersion portfolios. A very 
interesting finding is that in the case of the R&D firms, in Table 5B. 6, the inclusion of 
the RD factor makes the alpha for the top dispersion portfolio become statistically 
different from zero at 5% significance level, consistent at this particular point with 
Diether, Malloy and Scherbina (2002). The R&D factor, along with a high t statistic for 
the top dispersion portfolio also gets a high coefficient, suggesting that RD plays a larger 
part in explaining negative abnormal returns for high dispersion firms. After 
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decomposing though dispersion in analysts' forecasts into uncertainty and pure 
differences in opinion, I also find that as R&D intensity increases, the ability of R&D to 
influence returns also increases for high dispersion and high forecast uncertainty firms, 
but the ability of R&D to influence returns is very week for high divergence of opinion 
firms. This is a finding which implies that in the presence of high R&D intensity, 
dispersion has an impact on returns mainly through the forecast uncertainty component 
of forecast dispersion, and not through the divergence of opinion component. When 
interpreting this finding by using the Doukas, Kim and Pantzalis (2006) conceptual 
framework, high uncertainty in forecasts should be associated with lower returns 
according to theorisation by Doukas, Kim and Pantzalis (2006). Therefore this testified 
strong uncertainty component should be driving returns downwards for these high R&D 
intensity firms, which is not the case at all though for high R&D firms, given that high 
R&D firms have been generally associated with very high returns. Following this line of 
reasoning, the returns of these high R&D and high forecast uncertainty firms should be 
more due to market mispricing. 
5B. 4 Forecast Errors and Revisions 
5B. 4.1 Forecast Errors and Revisions: Descriptive Statistics 
Having considered the issue of R&D intensity and stock returns, when forecast 
dispersion is taken Into account, I proceed with assessing the impact of R&D on forecast 
errors and revisions. 
Consistent with previous literature, I use two definitions about (signed) forecast 
errors: Forecasted minus actual EPS divided by the absolute value of actual EPS and by 
the firm stock price twelve months prior to year end (Capstaff, Paudyal and Rees, 1995; 
Helbok and Walker, 2004 for the rationale for scaling by price). As previously, I make 
use of the mean one year ahead EPS forecast and I use all of the minus 12,6 and I 
month previous to year end forecasts. In Table 5B. 8 Panel AI present the average signed 
errors throughout the sample period 1990-2003, for the two definitions of forecast errors 
for the whole sample, R&D and zero R&D firms. As expected, the closer the forecast to 
the end of the financial year, the lower the errors, which is more striking when I scale 
errors by the absolute value of actual EPS. When scaling errors by the absolute value of 
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actual EPS, errors are higher for the R&D compared to the zero R&D firms, but this 
result does not hol4 when scaling errors by price, errors for R&D firms are pretty stable 
and are not reduced as move towards the end of the financial year. As one would 
intuitively observe, errors are generally lower when scaling by price as opposed to 
absolute value of actual EPS, given that stock prices tend to be greater than EPS ratios. 
Insert Table 5B. 8 here. 
Table 5B. 8 Panel B proceeds with showing the sample period average forecast 
signed errors in quartiles, formed according to R&D intensity (for the R&D firms only, 
using all of R&D/Sales, R&D/TA and R&D/MV as proxies for R&D intensity). 
As can be observed from Panel B, when assessing singed errors according to 
R&D intensity for ]R&D firms, the way we define R&D intensity plays a role for error 
behaviour. Errors are optimistic forecasts and steadily get larger as R&D/MVE 
increases, with optimism to be decreasing as the end of the accounting year gets closer. 
When I define R&D intensity as R&D/Sales or TA though, optimism continues to 
decrease as year end approaches, but I do not observe any clear trend for error behaviour 
as R&D intensity increases. Finally, error behaviour is a lot smoother when we scale by 
absolute actual EPS instead of price, which implies that scaling by price may result in 
denominator driven biases. 
In Appendix 5B. D Part A there are also reported the sample period average 
signed forecast errors in quartiles, formed according to TA, MV and BM. Conforming to 
the intuition and prior findings in the literature, errors appear to be higher for smaller 
size firms, both in terms of TA and MV. On the other direction, errors appear to increase 
as BM increases, no matter how I def ine them. 
In Appendix 5B. D Part B, I report the average sample period absolute (unsigned) 
errors for the whple sample, R&D and zero R&D firms, and then according to 
R&D/Sales, R&D/TA, R&D/MV, TA, MV and BM quartiles. In this case we get much 
clearer trends about the behaviour of errors as R&D intensity, firm size and BM change. 
There is a clear trend though not always linear for absolute errors to increase as R&D 
intensity increases, particularly when R&D/MV is used as a proxy for R&D intensity. 
Errors as in the previous non-absolute case are larger for smaller firms and increase as 
BM increases. The fact that we get indications for larger unsigned errors when R&D 
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intensity increases when we use their absolute form, but no such indication when we use 
non-absolute raw errors, implies biases in the data that result from the relative 
magnitude of positive and negative errors for different degrees of R&D intensity. 
Having observed that the average signed errors steadily increase as R&D/MVE 
increases, without controlling for any other factors, I proceed with the descriptive 
analysis of forecast revisions according to different degrees of R&D intensity. It goes 
without saying that if signed errors are larger as R&D intensity gets higher, but are 
expected to decrease as year end approaches, the underlying expectation is that signed 
revisions should be also getting larger as year end gets closer. According to the research 
hypothesis, I expect signed forecast revisions to increase with R&D intensity. Errors 
should decrease as year end gets closer, but at the same time both signed errors and 
revisions are expected to be higher as R&D intensity gets larger. 
I use two definitions for signed forecast revisions (using one year ahead forecast 
data): In the first one, I subtract the mean analyst forecast twelve months prior to 
financial year end from the mean analyst forecast six months prior to year end, and I 
divide the result by the stock price twelve months prior to year end (stock price given by 
IBES). In the second one, I subtract the mean analyst forecast twelve months prior to 
financial year end from the mean analyst forecast one month prior to year end, and I 
divide the result by the stock price twelve months prior to year end (stock price given by 
IBES). The standardisation by stock price is consistent with prior literature (Capstaff, 
Paudyal and Rees, 1995, Helbok and Walker, 2004). Also following Helbok and Walker 
(2004), if revision exceeds +/-100%, it is considered an outlier and is removed. I repeat 
the analysis by standardising the change in forecasts by the absolute value of the median 
one year ahead EPS forecast twelve months prior to year end instead of price. 
I first assess signed forecast revisions according to R&D intensity and other firm 
characteristics. Table 5B. 9 reports the average signed forecast revisions during the 
sample period for the whole sample, the R&D and zero R&D firms and according to 
quartiles formed by R&D intensity (using R&D/Sales, R&D/TA and R&D/MV as 
proxies of R&D intensity), when scaling revisions both by price and the absolute value 
of the median one year ahead EPS forecast twelve months prior to year end. As can be 
observed from the table, as one would intuitively expect, revisions between 12 and 6 
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months prior to year end are much smaller than revisions between 12 and 1 month. 
Revisions are also higher when scaled by median forecasted EPS compared to prices, as 
prices tend to be higher than EPS ratios. 
In addition, signed revisions appear to be slightly higher for non R&D reporting 
firms compared to R&D firms, maybe due to the fact that the non R&D reporting firm 
population is almost double the R&D one. Moreover, given the way they are defined, 
positive revisions imply upgrades as the end of the financial year approaches. I generally 
observe positive average revisions, both for the whole sample and as well for the R&D 
and non R&D samples separately This observation is contradictory to existing empirical 
evidence for the US but for the UK as well (Hussain, 1996) that testifies a decrease in 
optimism in analyst forecasts as the end of the financial year gets closer, and also with 
the relative results of the thesis for errors. 
Among R&D firms, signed revisions appear to be particularly high for the top 
R&D intensity portfolio, no matter if we use R&D/Sales or R&D/TA as proxies (or use 
price instead of the absolute value of the median one year ahead EPS forecast twelve 
months prior to year end to scale revisions), and they also appear to be positive. Despite 
the fact that very high R&D/Sales or R&D/TA firms consistently show very high 
revisions, there does not appear to exist any clear trend for revisions as R&D intensity 
increases and we move from lower to higher R&D intensity quartiles. The positive sign 
of the revisions given the ways they are defined implies an increase in optimism for 
these firms as year end approaches. The surprising observation is that when we define 
R&D intensity as R&D/MVE, these results no longer hold: as we move from higher to 
lower R&D/MV quartiles, revisions increase, a result that could receive influence by the 
denominator in R&D/MV. Interestingly, the top quartile R&D/MV firms exhibit 
negative revisions, Implying decrease in optimism. 
Insert Table 5B. 9 here. 
As a final robustness check, I report in Appendix 5B. E Part A the average 
sample period signed forecast revisions according to TA, MV and BM quartiles. 
Interestingly, just like in the case of errors, revisions appear to be higher for smaller 
firms in terms of TA, but just the opposite occurs when we use MV as a proxy for firm 
size. This latter fact could provide some light into the previous observation that the 
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highest R&D/MV firms are the ones with the lowest revisions. In the case of BM, 
contrary to the results for errors, the smaller BM firms are the ones with the highest 
revisions, without controlling for other factors. 
In Appendix 5B. E Part B, I also report the average sample period absolute 
revisions for the whole sample, R&D and zero R&D firms, and then according to 
R&D/Sales, R&D/TA, R&D/MV, TA, MV and BM quartiles. In this case, we get much 
clearer trends about the behaviour of errors as R&D intensity, firm size and BM change. 
There is a clear trcnd for absolute revisions to increase as R&D intensity increases, 
particularly when R&D/MV is used as a proxy for R&D intensity. This comes in 
contrast with the previous case where I used non absolute revisions, where revisions 
increased as R&D/Sales or R&D/TA increased, but decreased as R&D/MV increased. 
Revisions as in the previous non-absolute case are larger for smaller firms and, contrary 
to the result when I was using non absolute revisions, revisions increase as BM 
increases. The fact that we get indications for larger revisions when R&D intensity 
increases when we use their absolute form, no matter which proxy we use for R&D 
intensity, and also larger absolute revisions when BM increases, but no such results 
when we use non-absolute raw revisions, implies, as in the case with absolute and non 
absolute errors, biases in the data that result from the relative magnitude of positive and 
negative revisions for different degrees of R&D intensity and BM ratios. 
An issue that appears relatively strange has to do with the fact that (signed) 
errors are generally positive (given the way they are defined'), with analyst optimism to 
be decreasing as the end of the financial year for which they are forecasting approaches, 
and at the same time signed forecast revisions appear to be also positive. This latter fact 
implies that forecast get more optimistic as year end approaches, when we get 
indications from errors that earnings forecasts become less optimistic. 
In order to investigate this issue, I conduct a detailed analysis of both errors and 
revisions as the end of the financial year for which earnings forecasts are made gets 
near. The issue just described can be observed from Appendix 5B. L, Table I, which 
shows exactly the average and median signed errors and revisions for the sample period 
' Errors are defined as Forecasted minus actual EPS, and revisions as forecasts made six or one month 
prior to year end minus forecasts made twelve months prior to year end. 
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1990-2003. Errors are positive and from their direction there is implied a decrease in 
optimism as year end approaches. At the same time, revisions are positive, and they get 
larger values between 12 and 1 month before year end, compared to 12 and 6 months, as 
one would intuitivcly expect. When I impose stricter criteria for outlier removal for 
forecast errors (eliminating actual and forecasted EPS observations above the 0.98 and 
below the 0.02 percentile in Panel A, and well and above that removing error 
observations above the 0.98 and below the 0.02 percentile for Panel B), average and 
median errors become smaller, but there is no qualitative change towards the direction of 
the results. 
When it comes to observing the percentages of positive and negative errors as we 
move towards the cnd of the financial year (Appendix 5B. L, p. 130, Table II), we see 
that positive errors tend to become more the case as a percentage of total errors as we 
move from 12 to 6 and then to 1 month prior to year end, implying a very slight increase 
in optimism. The increase though in the percentage of positive errors is quite small as 
we move from minis 12 months with 42.4% (Panel A) to 6 (46.8%) and then to I month 
before year end with 49.2%. In the case of revisions now, as can also be observed from 
Appendix 5B. L Table II, consistent with the fact that the average and median sample 
period revisions are positive, a greater percentage of revisions are positive than negative. 
The above observations for the percentages of positive and negative errors and 
revisions could have implications about the relative magnitude of errors and revisions of 
different sign. This way, in Appendix 5B. L Table III I calculate the average and median 
errors and revisions for the whole sample and then for positive and negative errors and 
revisions. In the case of errors, as can be observed from the table, in absolute terms 
positive errors are much larger than negative ones, and this finding is stronger when I 
use less strict outlier removal criteria. This fact could lead to very large average errors. 
Positive errors slightly increase as year end approaches, but the values of the positive 
and optimistic errors are much higher than the ones of the negative errors. In the case of 
revisions now, in absolute terms a casual comparison shows not so great differences 
between positive and negative revisions. Negative revisions in absolute terms are 
actually slightly larger than positive ones. 
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This way, in the case of errors, I observe a decrease in optimism in terms of 
mean and median errors, but the number of positive errors slightly increases as year end 
approaches. The values of the positive errors are though much larger than the ones of the 
negative errors. This could provide an explanation on why revisions are positive, both in 
terms of mean and median values as well as in terms of the percentage of positive and 
negative revisions. 
The findings in Appendix 5B. L are completely in accordance with the findings 
when we were assessing absolute versus non absolute errors and revisions for different 
degrees of R&D intensity and BM, and we were getting conflicting results in some 
cases. They confirm the fact that the relative magnitude and number of positive versus 
negative errors and revisions causes distortion when average or even median values are 
computed. 
In addition, in order to assess errors and revisions for the R&D as opposed to the 
zero R&D and R&D intensive firms, while controlling for other firm characteristics, I 
have calculated the sample period medians of the average signed errors, and the sample 
period averages of the signed analyst forecast revisions for the whole sample, the R&D, 
zero R&D and R&D intensive firms that belong to the same MV BM portfolios. R&D 
intensive firms are considered the ones with an R&D/Sales or R&D/TA ratio above the 
sample median for a particular year. There are constructed six (2 by 3) MV-BM 
portfolios, annually rebalanced, as described in the section 5. B. 4 on R&D, analyst 
forecast dispersion and subsequent stock returns of the Chapter, and I assess the errors 
and revisions (when scaling errors by absolute actual EPS and revisions by absolute 
median forecasted EPS) for the sample firms in general, and then the R&D, zero R&D 
and R&D intensive firms that belong to each portfolio. The relevant results are reported 
in Table 5B. 10 for crrors and 58.11 for revisions. 
Insert Tables 5B. 10 and 5B. 11 here. 
In the case of signed errors, I observe that for some portfolios, the R&D and 
particularly the R&D intensive firms tend to exhibit very high errors, and for some other 
portfolios, the zero R&D firms are the ones with the largest errors. In specific, the R&D 
and R&D intensive firms exhibit the largest errors for the high MV-high BM portfolios, 
but for other portfolios, e. g. low MV-low BM, the zero R&D firms exhibit larger errors. 
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This way, there can be drawn no categorical conclusion as to whether R&D and R&D 
intensive firm tend to exhibit larger forecast errors than zero R&D firms, after 
controlling for other firm characteristics. 
Regarding signed forecast revisions, the situation is more or less the same, with 
the R&D and R&D intensive firms to be showing larger revisions than zero R&D firm 
for some portfolios, especially for the low MV-low BM ones, and the zero R&D firms to 
be the ones with the largest revisions for other portfolios. Thus, the data does not permit 
to draw again any clear conclusion as to whether R&D and R&D intensive firm tend to 
exhibit larger revisions than zero R&D firms, after controlling for the firm 
characteristics of size and BM. 
Taking the findings from Tables 5B. 8 and 5B. 9, and combining them with the 
ones from Tables 5B. 10 and 5B. 11, and also Appendices 5B. D and 5B. E for absolute 
errors and revisions, there is not observed any linear positive trend for signed errors and 
revisions to increase as R&D intensity increases, without controlling for other factors, 
regardless of the way we define R&D intensity. When I control for the firm 
characteristics of size and BM, I get mixed evidence as to whether R&D intensive firms 
show larger signed errors and revisions than zero R&D firms. When I make use of 
unsigned errors and revision compared to signed ones, there exists evidence on a trend 
for both errors and revisions to increase as R&D intensity increases. 
5B. 4.2 Errors and Revisions for Different Degrees of Analyst forecast Dispersion 
Before proceeding with the application of detailed regression analysis in order to assess 
whether the impact of R&D on errors first and more importantly on revisions, since the 
last constitutes part of the research hypothesis, I proceed with the examination of signed 
and unsigned errors and revisions as analyst forecast dispersion changes. This is because 
the underlying hypothesis is that uncertainty on future firm performance (in this study 
due to R&D) should contribute to higher analyst forecast dispersion errors and revisions. 
In this context, I wish to see whether high forecast dispersion is accompanied by higher 
errors and revisions. I therefore report on Appendix 5B. M Part A the average errors end 
revisions according to dispersion quintiles, from D1 (low) to D5 (High). Dispersion is 
defined as previous'y in the thesis, following the Diether, Malloy and Scherbina (2002) 
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definition. What we. observe is that in the case of errors, as dispersion increases so do 
signed errors in general, which get more positive, implying increase in optimism. When 
we assess absolute errors according to 5 dispersion quartiles in Appendix 5B. M Part B, 
the previous trend appears to hold as with signed errors. In the case of revisions, the 
result is more interesting. As dispersion increases, revisions increase in absolute values 
(Appendix 5B. M Pert B), but when it comes to their signed values (Appendix 5B. M Part 
A), they start from slightly positive for the low dispersion portfolios and get much larger 
negative values for the top dispersion portfolios. The result is more striking when minus 
I month dispersion data are used. Errors and revisions are therefore found to be high 
when uncertainty for future operating results is high, as testified by high analyst 
disagreement. Appendix 5B. M Part C reports the Pearson correlation coefficients 
between the various definitions of revisions, errors (both non absolute) and dispersion, 
which does not confirm any strong relationship between the three, indicating probably 
that the relationship between the three variables is not completely linear. Errors and 
revisions appear to get a slightly negative Pearson coefficient in some cases. 
I found that errors tend to be larger and positive for larger dispersion portfolios, 
and revisions tend to be high and negative (pessimistic analysts) for higher dispersion 
portfolios. This would provide some intuition and confirm the 1St hypothesis (p. 2114 of 
their paper) of Diether, Malloy and Scherbina (2002), on a negative association between 
dispersion and returns, since when analyst disagreement is high, the pessimistic 
investors of the high dispersion portfolios appear to be kept out of the market because of 
high short sale costs as Diether, Malloy and Scherbina argue, so the remaining optimistic 
investors will keep the market price high, and returns will be lower for high dispersion 
portfolios. 
SB. 4.3 The Impact of R&D Intensity on Forecast Errors and Revisions: Regression 
Analysis 
In order now to assess the impact of R&D intensity on forecast errors and revisions, I 
use regression analysis. Despite the fact that the research hypothesis of the thesis is on 
the impact of R&D on forecast revisions, as before I start with forecast errors and in 
order to assess the i(npact of the same factors on errors as opposed to forecast revisions, 
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I regress both signed and unsigned forecast errors and forecast revisions on the same set 
of regressors. 
In the case of errors, the following regression is run with OLS using panel data 
for the period 1990,2003: 
Error 
=ßo+ fi i RD +ß2 BM + fl 3 MV + /34 PASTR + /3 s STDEV 
+ Sit 
(5B. 4) where: 
Error 
- 
both signed and unsigned, defined in two ways, using one year ahead mean EPS 
analyst forecasts scaled either by stock price or by the actual EPS and using analyst 
forecast data 12 and 6 months prior to year end: 
1) 1 year ahcad mean Forecasted EPS using data for 12 and 6 
months prior to year end-Actual EPS/Share Price 12 months prior to year end 
2) 1 year ahead mean Forecasted EPS using data for 12 and 6 
months prior to year end-Actual EPS/Absolute value of actual EPS 
RD 
- 




-market ratio at year end 
MV 
- 
the natural dog of MVE at year end 
PASTR 
- 




the standard deviation of reported EPS for a three year period prior to base 
year (e. g. 1988-1990 for the base year 1990) 
and in the case of revisions: 
Re visions #6 o+ #6 1 RD +ß2 BM + 
-8 3 
MV +ß4 PASTR +8s STDEV 
+ Sit 




both singed and unsigned, with the dependent variable defined in four ways, 
using one year ahead mean EPS analyst forecasts scaled either by stock price or by 
median EPS forecast: 
1) Forecast Revision: 12 6 (Mean Forecast 6m prior to year end-Mean Forecast 
12m prior to year end)/Share price 12m prior to year end 
2) Forecast Revision: 12 1(Mean Forecast Im prior to year end-Mean Forecast 
12m prior to year end)/Share price 12m prior to year end 
3) Forecast Revision: 12 6 (Mean Forecast 6m prior to year end-Mean Forecast 
12m prior to year end)/Absolute value of median forecast 12m prior to year 
end 
4) Forecast Revision: 12 1(Mean forecast lm prior to year end-Mean forecast 




R&D/Sales or R&D/Total Assets or R&D/Market value of equity at year end 
BM 
- 
the book-to-market ratio at year end 
MV 
- 
the natural log of MVE at year end 
PASTR 
- 
the 6 month prior to previous year end geometric average of monthly stock 
returns 
STDEV 
-the standard deviation of reported EPS for a three year period prior to base 
year (e. g, 1988-1990 for the base year 1990) 
The regressions are run using OLS and Whites Heteroskedasticity robust standard 
errors. Observations above the 98 and below the 2 percentile were eliminated. All 
variables have been transformed using natural logs since this improved 
heteroskedasticity in the models and provided a better functional form for the model. 
The regressors used in the error equation follow the example of Amir, Lev and 
Sougiannis (2003). There was used though no firm age variable due to high correlation 
with the firm size variable of MV. In the case of both regressions, there are used both 
absolute and non absolute revisions. Non absolute revisions and errors have been 
adjusted as follows in order to be able to use logs: (100+revision)/100 e. g. if a revision 
was 3%, it will appcar as 103 or 97 for 
-3%, and similarly for errors. 
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The relevant results for errors and revisions are presented in Tables 5B. 12 for 
errors and 5B. 13 for revisions. 
Insert Tables 5B. 12 and 5B. 13 here. 
As can be observed from Table 58.12 Panel A, which uses absolute errors, errors 
relate positively to the BM ratio, which is a statistically significant regressor when 
minus 6 instead of 12 months prior to year end error data are used. MV is also 
statistically significant and negative, consistent with previous literature that testifies 
larger errors for smaller firms. The standard deviation in previous earnings also relates 
positively with errgrs, consistent with the intuition. The variable is always statistically 
significant at 1% and also shows strong economic significance. The regression p-values 
of the F statistics are always significant at 1% significance level, and the adjusted R 
squares are close or above 20%. The past return variable is negative and significant 
when errors are scaled by actual EPS instead of stock prices, and exhibits lower 
significance and a varying sign in the regression where errors are scaled by stock prices. 
In the case of the R&D intensity variable, after controlling for other factors, 
when R&D intensity is defined as R&D divided by Sales or TA or MV, the variable is 
always not significant at any reasonable significance level, despite the fact that it is in 
every case positive, When I exclude MV and BM from the regression though, the R&D 
intensity variable remains positive and is always significant at 1% level. Despite the fact 
that the Pearson correlation coefficients between R&D intensity and BM or the MV 
variables never exceed 0.3 in absolute terms, there is concluded that after taking into 
account firm size and the book-to-market factor, R&D intensity has a positive influence 
on absolute forecast errors but remains statistically not significant. 
When we move from regressing absolute errors to regressing non absolute errors 
in Table 5B. 12 Pancl B though, the situation changes with respect to the very sign of the 
R&D intensity variable. In this case, the MV variable steadily gets a negative sign and is 
significant conforming to the intuition, and the STDEV variable is always positive and 
significant as one would expect. BM is always positive and significant and so is PASTR, 
which is always negative though. In the case of the R&D intensity variable, it is always 
very much statisticIlly significant with a negative sign though, which goes against the 
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expectations and prior findings in the literature by Amir, Lev and Sougiannis (2003), 
implying that the lower the R&D, the lower the analyst optimism in EPS forecasts. 
Given that this latter finding goes against the research hypothesis, I investigated 
the matter a little bit further, and I rerun all regressions from Table 5B. 12 for both 
Panels A (Absolute errors) and B (non absolute errors), without including two of the 
regressors this time: MV and BM. The relevant results are presented in Appendix 5B. F. 
What we observe when we run the regressions without controlling for firm size and BM 
is that the R&D intensity variable, for the absolute and in the non absolute error 
regressions, gets I positive sign and is strongly statistically significant. The only 
exception is the non absolute errors regressions when errors are scaled by the absolute 
value of actual EPS, when R&D is not significant though. This way, I observe clear bias 
in the initial regression arising from the inclusion of all of the R&D, MV and BM 
variables together as regressors. I observe therefore a positive and statistically 
significant relation between R&D intensity and absolute and non absolute forecast 
errors, but which is not generally robust when I control for other firm characteristics, 
firm size and BM in specific. The power of R&D to influence analyst forecast errors 
does not appear to be strong enough on its own, and it appears to be interrelated with the 
influence of other firm characteristics and their influence on analyst forecast errors. 
In the case pf the absolute revisions regression now, as we observe from Table 
5B. 13 Panel A, when the same full set of regressors are used, including MV and BM, 
MV is always negative and significant and so is BM in the case of revisions scaled by 
the absolute value pf the median forecast 12 months prior to year end. In the case of 
revisions scaled by stock price, BM is positive but not statistically significant at any 
reasonable level of significance. Past returns are generally of limited significance in the 
revisions between 12 and 6 months prior to year end, but positive and significant at 1% 
in the regressions with revisions between 12 and 1 month prior to year end. This variable 
is also the one with the highest economical significance. The standard deviation of past 
EPS is also very strongly statistically significant and always positive, conforming to the 
intuition. The p-va'ues of the F statistics are always zero and the explanatory power of 
the model is better Muhen we assess revisions between 12 and 1 month prior to year end, 
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compared to 12 and 6 months, given that in the first case, adjusted R squares are around 
20% and in the latter around 15%. 
The R&D intensity variable is always positive and statistically significant at 5% 
significance level in the case of absolute revisions between 12 and 1 month prior to year 
end, no matter how we define it, when revisions are scaled by the absolute value of the 
median forecast 12 months before year end. The highest t statistics and coefficients for 
the R&D variable are observed when it is defined as R&D/MV. The R&D intensity 
variable though is not significant even at 10% significance level, although positive in the 
equivalent regressigns when revisions are scaled by price. In the case of revisions 
between 12 and 6 months before year end though, the R&D intensity variable is not 
significant, and even gets a negative sign when revisions are scaled by price. This 
provides evidence that R&D is able to influence the magnitude of forecast revisions, 
when there exists a reasonable amount of time between the initial and the revised analyst 
forecast, but the definition of revisions plays a role in the robustness of the results. 
Given that I have hypothesised in favour of a positive sign in forecast revisions 
as R&D intensity increases, I have also regressed raw as opposed to absolute revisions 
on the same regressors, and the relevant results appear on Table 5B. 13 Panel B. When 
taking the sign of revisions into account, BM relates negatively to revisions and is 
always statistically significant, as was the case with absolute revisions when BM was 
negative. Contrary to the intuition, MV is generally positive in these regressions and its 
significance varies with the regression. Strong past returns also relate positively to 
forecast revisions, and this particular variable is statistically significant at 5% 
significance level. This variable is also the one with the highest economical significance, 
as was the case in the absolute revisions regressions. The standard deviation of past EPS 
is also statistically significant, but it relates negatively to forecast revisions, contrary to 
the intuition, implying that lower volatility in past earnings would relate to higher 
revisions. The finding is also in contrast with the positive sign of the same variable in 
the absolute revisiois and errors regression. The p-values of the F statistics are always 
zero and the explanatory power of the model is better when we assess revisions between 
12 and I month prier to year end, compared to 12 and 6 months, given that in the first 
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case, adjusted R squares are around 15% and in the latter around 10%, generally lower 
than the adjusted R squares in the absolute revisions regressions. 
The R&D intensity variable is always positive but it is statistically significant at 
5% significance level only in the regressions for revisions between 12 and I month 
before year end, as opposed to 12 and 6 months, no matter how we define it. This 
provides evidence that R&D is able to influence the magnitude as well as the direction 
of forecast revisions, given the way I define the revisions variable I use in these last 
regression. The significance of the R&D intensity variable though as in the case of the 
absolute revisions is stronger when there exists a reasonable amount of time between the 
initial and the reviscd analyst forecast, and not for shorter term revisions. 
I have also added industry dummy variables in the regressions, both simple and 
multiplicative with R&D, to account for four industries which are perceived as intensive 
in R&D activity: Ipformation Technology Chemicals, General Industries and Health 
grouped together with Pharmaceuticals and Biotechnology, taking the value of I if the 
firm belongs to the specific industry, and 0 otherwise. As can be observed from 
Appendix 5B. G for errors (using both absolute and non absolute forecast errors, scaled 
by price, defining R&D intensity as R&D/Sales, and using minus 12 months prior to 
year end error data, when I include MV and BM in the regression as regressors) and 
5B. H for revisions (using both absolute and non absolute forecast revisions, scaled by 
the absolute value of the median minus twelve month 1 year ahead EPS forecast, 
defining R&D intensity as R&D/Sales, and using revisions between minus 12 and 1 
month prior to year end), apart form a couple of cases, where the significance of the 
R&D intensity variable was reduced at 10% significance level upon the inclusion of the 
industry dummy variable, the industry dummies did not cause any change in the 
regression results overall and in the significance of the R&D intensity variable in 
specific. 
In addition, in order to control for possible time period effects arising from 
influence from the New Economy years in the late 1990's early 2000,1 have rerun the 
regressions by exclyding the base years 1999 until 2001, both inclusive, and I observed 
no significant difference in the direction of the results, as can be observed in Appendix 
SB. I. I have also rerun the regressions for the whole sample period 1990-2003 by 
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including a dummy variable that took the value of 1 if the data referred to the base years 
1999,2000 or 2001 and zero otherwise. The relevant results both for errors and revisions 
appear in Appendix 5B. I. There was overall observed no qualitative difference in the 
results, and the time dummy proved to be significant (and negative) in the errors 
regressions, and significant but positive in the revisions regressions. 
I have also rerun the panel data error and revision regressions (indicatively using 
absolute and non absolute errors, scaled by stock price, with 12 month prior to year end 
forecast data and absolute and absolute and non absolute revisions, scaled by the 
absolute value of the median minus 12 months prior to year end 1 year ahead EPS 
forecast, taking revisions between 12 and 1 month prior to year end, when R&D 
intensity is defined as R&D/Sales) making use of period fixed and random effects model 
specifications and I observed no qualitative change in the direction of the results. These 
results are reported in Appendix 5B. J with much caution though, because econometric 
software did not permit period fixed and random effects model estimation along with 
running the model ýy adding an AR(1) term to correct for first order serial correlation 
(Park, Sickles and Simar, 2003; Baltagi and Chang, 1992). Therefore the resulting 
Durbin Watson statistics when period fixed and random effects estimation was applied 
get values around 1.2. I chose though to report these results anyway, in order for the 
regression estimation and robustness checks to be as complete as possible. 
Finally, I report in Appendix 513.0 Part A the regression results as in Tables 
5B. 12 and 5B. 13 (the impact of R&D intensity on forecast errors and revisions) by 
including this time the same regressors as in Table 5B. 3. In the case of absolute errors, 
the results are slightly more encouraging regarding the significance of the R&D intensity 
variable, compared to the ones reported in Table 5B. 12, even that t statistics are lower. 
BM remains positive but its statistical significance is increased, and MV remains 
negative and statistically significant. STDEV exhibits still very high economic and 
statistical significance. AF shows very poor statistical significance. Qualitatively the 
same results hold f9r BM, MV, STDEV and AF when non absolute errors are included 
as the dependent Variable in the regression, and again as in Table 5B. 12 the R&D 
intensity variable has a negative sign and is statistically significant. In the case of 
revisions, the t statistics of the R&D intensity variable get slightly higher values in some 
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cases and lower in others, and more or less the same trends apply regarding the 
significance of MV and BM. STDEV remains positive and very much statistically 
significant. AF lastly gets a negative coefficient and is in most cases not statistically 
significant. I also report Appendix 513.0 Part B regression results as in Tables 5B. 12 and 
5B. 13 by including this time the regressors one by one. This means adding an R&D, 
MV, BM, and STDEV regressor one by one to see how the results evolve, when 
defining errors and revisions according to all mentioned definition in the chapter. The 
indications we get from these results is that MV and BM manage to have a distorting 
effect on the significance of the R&D variable for both errors and revisions, especially 
for non absolute errors and revisions. Non absolute errors and revisions appear to have a 
much less statistically significant (although positive) relationship with the RD variable, 
but R&D intensity as a sole regressor is always statistically significant with a positive 
coefficient for absolute errors and revisions. 
This difference in the significance and even in the sign of the R&D intensity 
variable for absolute as opposed to non absolute errors and revisions should not come as 
a surprise: from the calculation of descriptive statistics (absolute and non absolute errors 
and revisions according to R&D intensity) we had gotten the indication that R&D relates 
differently to absolute versus non absolute measures, and this should be the result of the 
differences in the r@lative magnitudes and numbers of positive versus negative error and 
revision observations. 
Taking the findings from Tables 5B. 12 and 5B. 13, as well as the results from the 
different model specifications included in the appendices as a whole, I conclude that 
after controlling for firm size and BM, R&D intensity does not appear to play a 
significant role for analyst forecast errors, but it has a stronger influence in the case of 
revisions. R&D intensity appears to have a positive influence and is shown to be a 
statistically significant factor for analyst forecast revisions, even when taking the sign of 
revisions into account, when there exists a reasonable amount of time between the initial 
and the revised analyst forecast, and not for shorter term revisions. The influence of 
R&D on both errors and revisions appears to be very sensitive to other possible 
influencing factors for errors and revisions, such as firm size and BM. This result 
though, although gcnerally valid, does not hold in every single regression, therefore the 
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way we define forecast revisions and R&D intensity as well plays a role in the validity 
of the result. 
5B. 4.4 R&D, Forecast Dispersion, Errors, Revisions and Stock Returns: Regression 
Analysis 
Given the findings in Appendix 5B. M that high analyst forecast dispersion portfolios are 
accompanied by high forecast errors and revisions, I have repeated the regression in 
Appendix 5B. C Part H by including on the right hand size error and revisions along with 
analyst forecast dispersion when the dependent variable is stock returns, and also by 
replacing dispersion by either errors or revisions, without the inclusion of all three 
variables (dispersion, revisions and errors). The relevant results are reported in 
Appendix 5B. N Part B. I observe that when non absolute errors and revisions are 
included along with dispersion among the regressors in the regression, errors and 
revisions (only revisions between 12 and I months prior to year end and not revisions 
between 12 and 6 months) are statistically significant at 5% and get a negative 
coefficient. This result holds even when we add these three variables one by one in the 
regression, by replacing dispersion by errors and then by revisions. I therefore get 
evidence that stock returns relate negatively with all of dispersion, revisions and errors, 
and this relationship is statistically significant in all three cases. The R&D intensity 
variable is found positive and generally statistically significant at 5% significance level 
in all cases. 
When I use absolute errors and revisions, revisions between 12 and 1 month 
prior to year end appear to relate now positively with returns, with the relation to be 
statistically significant. Forecast errors appear to relate negatively with returns, but their 
influence is not found to be statistically significant. The negative relation between errors 
and returns is consistent with Aitken, Frino and Winn (1996) and also Ciccone (2003). 
Revisions between 12 and 6 months prior to year end are found to relate negatively with 
returns but the values of their t statistics are very low. This result holds even when we 
add these three variables one by one in the regression, by replacing dispersion by errors 
and then by revisior#s. The R&D intensity variable is again found positive and generally 
statistically significant at 5% significance level in all cases. 
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As a robustness check, Appendix 5B. N Part A presents the results when 
rerunning the regression as in Appendix 5B. C Part H by adding factors one by one in 
order to assess the relative influence of each factor upon its addition in the model. MV 
and BM are used as single regressors in the model (one by one and both together) and 
then and R&D intensity variable is added (defining R&D intensity as R&D/Sales, 
R&D/TA and R&D/BM). Then I add a forecast dispersion variable (D) using 
-1, -6 and - 
12 month forecast data for dispersion calculation, when R&D intensity is defined in all 
these different ways, before Appendix 5B. N Part B proceeds with adding Forecast Error 
(FE) and Forecast Revision (FR) regressors. We then observe that both BM and MV get 
positive and negative coefficients respectively and are statistically significant when 
included as single regressors in the regression. When we include MV with BM though, 
MV preserves its ncgative sign, but turns to statistically not significant. When we add an 
R&D intensity variable to BM and MV, only when defined as R&D/MV is itstatistically 
significant at 5% significance level. When the additional forecast dispersion variable is 
added, it always comes with a negative sing, no matter whether we use minus 12,6 or 1 
month data previous to year end for dispersion calculation. The R&D intensity variable 
becomes statistically significant (and is positive) upon the inclusion of the dispersion 
variable almost in every single one case. Finally the dispersion variable is statistically 
significant when using minus I and particularly minus 6 month EPS analyst forecast 
data before year end for its calculation, and not minus 12 month data. 
From the results in Appendix 5B. N Part BI therefore observe that given the 
finding on higher absolute errors and revisions for high analyst forecast dispersion firms, 
when we include non absolute errors and revisions along with forecast dispersion and 
R&D among the regressors when stock returns is the dependent variable, all three 
variables are four d to relate negatively with returns, with their influence to be 
statistically significant. When we use absolute errors and revisions though, the influence 
of revisions on retgrns turns positive and is still statistically significant. The impact of 
errors on returns is still negative, buts becomes statistically not significant. Dispersion, 
revisions and foreclst errors are fount to exhibit a similar (negative) impact on stock 
returns only when revisions and errors are non absolute and taken raw. 
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5B. 5 Conclusion 
Existing literature has associated R&D intensity both theoretically and empirically with 
higher analyst forecast dispersion and stock returns. At the same time, existing research 
testifies that high analyst disagreement is associated with lower returns. In this context, 
the first issue that I wish to examine for the first time is whether R&D plays a role in the 
relationship between dispersion and returns, given that it has be testified empirically that 
it has an influencing power on both forecast dispersion and stock returns individually. 
This examination is, performed by additionally contributing to existing literature with the 
assessment of this issue using a very detailed definition of forecast dispersion, by 
decomposing dispersion in analyst forecasts into pure lack of consensus among analysts 
and uncertainty in analyst forecasts. 
I use all UK listed firms during the period 1990-2003 with analyst forecasts on 
IBES and first find for the first time for the UK context that R&D intensity is a 
contributing factor for analyst forecast dispersion even after controlling for other firm 
characteristics thropgh descriptive statistics and explicitly via regression analysis. The 
finding is robust to different definitions of R&D intensity, and is consistent with prior 
findings for the US. If forecast dispersion is decomposed though into an uncertainty and 
a divergence of opinion component, as was done in prior literature in other contexts of 
research, there are indications that the influence of R&D is primarily on the uncertainty 
component of analyst forecasts. I also confirm a negative relationship between 
dispersion and returns, consistent with Diether, Malloy and Scherbina (2002) for the US, 
with the bottom f9recast dispersion portfolio to be exhibiting a positive but not 
statistically significant excess return (alpha), and alphas to be getting negative for higher 
dispersion portfolios, which are generally not statistically significant as well, even after 
accounting for the Tole of R&D. When dispersion is decomposed into uncertainty and 
pure differences in opinion, I also find that as R&D intensity increases, the ability of 
R&D to influence returns also increases for high dispersion and high forecast 
uncertainty firms, but the ability of R&D to influence returns is very week for high 
divergence of opinion firms. This finding implies that in the presence of high R&D 
intensity, dispersioq has an impact on returns mainly through the forecast uncertainty 
component of forecast dispersion, and not through the divergence of opinion component. 
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When trying to interpret this finding by using the Doukas, Kim and Pantzalis (2006) 
conceptual framewprk, high uncertainty in forecasts should be associated with lower 
returns, and therefore this testified strong uncertainty component should be driving 
returns downwards for these high R&D intensity firms. This is not the case at all though 
for high R&D firms, given that high R&D firms have been generally associated with 
very high returns. Following this line of reasoning, the returns of these high R&D and 
high forecast uncertainty firms should be more due to market mispricing. 
In addition, existing empirical research has identified R&D intensity as a factor 
to contribute to analyst forecast errors, implying more optimism. Starting from forecast 
errors, the study goes one step further and assesses the impact of R&D intensity on the 
magnitude of forecast revisions. When financial analysts revise their earnings forecasts 
for R&D intensive firms, they are called to improve their accuracy in the presence of a 
highly uncertain investment. In such case, the amount by which they adjust their 
predictions can also be uncertain and therefore earnings revisions are expected to be 
greater in the presence of high R&D intensity. The assumption underneath this 
expectation is that analysts improve their learning as the end of the financial year 
approaches, but thc outcome of this learning process is influenced by the uncertain 
nature of R&D, leading to higher revisions in the presence of high R&D investments. In 
the process of assessing the impact of R&D investments on analyst forecast revisions, 
the study also examines for the first time the impact of R&D on analyst forecast errors 
for the UK context, and also provides some insight into the joint impact of the analyst 
forecast characteristics of dispersion, errors and revisions on subsequent stock returns. 
I do not observe any linear positive trend for signed errors and revisions to 
increase as R&D iptensity increases, without controlling for other factors. I observe 
though such a trend when I use unsigned errors and revisions. There is also observed a 
contradiction in the behaviour of errors and revisions: forecast errors indicate a decrease 
in analyst optimisnl as year end approaches, but at the same time forecast revisions are 
found to be positive, which implies that forecasts get more optimistic as year end 
approaches, when we get indications from errors that earnings' forecasts become less 
optimistic. There ig'observed though that in the case of errors, optimism decreases in 
terms of mean and median errors, but the values of the positive errors are much larger 
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than the ones of the negative errors, providing this way an explanation on why revisions 
are positive in terms of mean and median values when the magnitude of the errors 
indicates a decrease in optimism as year end approaches. I also find that R&D intensity 
is associated positively with (mostly unsigned) forecast errors and revisions, and that 
this relationship is generally statistically significant in the case of revisions but not for 
errors, when there exists a reasonable amount of time between the initial and the revised 
analyst forecast, aftcr controlling for other factors. 
There is also found evidence that both signed and unsigned analyst forecast 
errors and revisions increase as analyst forecast dispersion increases. Finally, I get 
evidence that stock returns relate negatively with revisions and errors, well and above 
analyst forecast dispersion, and this relationship is statistically significant in all cases, 
which constitutes evidence for the first time of for the UK that forecast dispersion, errors 
and revisions can both individually as well as in terms of joint influence be negatively 
associated with subsequent stock returns in a statistically significant manner. 
As a final comment, there are certainly two issues that one has to take into 
consideration as possible study limitations. The first one relates to the probability that a 
firm may try to manage/smooth its earnings by deciding on how much R&D it should 
spend. This way, the amount of R&D that we observe on the income statement and that 
we use in the study will receive influence by factors we cannot control. This issue 
becomes even more serious if we consider that a firm may try to meet analyst EPS 
targets by managing the amount of R&D spending. In such cases, the R&D amount is 
clearly affected by managerial/earnings management decisions and would not reflect the 
real amount of R&D that a firm may need to spend in order to reach corporate or 
competition targets. The second issue relates to the fact that the EPS figures, actual or 
forecasted, refer to earnings after the expensing of R&D. Therefore any change in R&D 
spending, or major managerial decision to increaseldecrease R&D will affect the final 
EPS figures and show increased or decreased earnings that simply reflect changes in 
R&D spending, and not sales or gross income changes. This problem exists by definition 
when an earnings measure in the lower steps of the income statement such as EPS is 
used. These issues though, appear more or less self built in the very design of the study, 
but nonetheless I acknowledge them. 
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Chapter 5B Tables: 
Table SB. I. One year ahead analyst forecast dispersion according to R&D intensity 
The table shows the averagc Sample period dispersion for the whole sample, R&D, 
zero R&D firms and accqrding to quartiles formed by R&D/Sales, R&D/TA, 
R&D/MV, TA, MV and 1IM (from low to high). Dispersion is defined as the 
standard deviation in analyst forecasts divided by the absolute value of the mean 
forecast in the specific mopth. Observations below the 0.02 and above the 0.98 
percentile have been elimin4ted. There are used forecasts 12,6 and 1 month prior to 
year end. 
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Sample 0.105 0.117 0.123 
R&D firms 0.098 0.114 0.116 




0.081 0.089 0.086 
0.090 0.109 0.114 
0.098 0.129 0.112 
High 0.150 0.151 0.174 
R&D/TA 
Low 0.080 0.082 0.085 
0.084 0.115 0.116 
0.118 0.134 0.124 
High 0.129 0.140 0.162 
R&D/MV 
Low 0.071 0.074 0.077 
0.082 0.083 0.087 
0.118 0.142 0.148 
High 0.140 0.181 0.184 
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Table 5R 1. Continued 
TA 
Low 0.132 9.154 0.152 
0.119 0.131 0.131 
0.104 0.116 0.131 
High 0.087 0.097 0.102 
MV 
LOW 0.151 0.206 0.215 
0.127 0.135 0.140 
0.099 0.108 0.113 
High 0.078 0.088 0.094 
BM 
Low 0.085 9.097 0.103 
0.082 q. 088 0.093 
0.106 4.120 0.124 
High 0.151 1.177 0.187 
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Table 5B. 2. One year ahead analyst forecast dispersion for R&D, zero R&D and R&D intensive firms matched according to 
MV-BM 
The table shows the average sample period dispersion for the R&D, zero R&D and R&D intensive firms that belong to six 
annually rebalanced portfolios fgrmed according to MVE and BM. R&D intensive firms are defined as the ones with an 
R&D/Sales or R&D/TA ratio above the sample median for a particular year. Dispersion is defined as the standard deviation 
in analyst forecasts divided by the absolute value of the mean forecast in the specific month. Observations below the 0.02 
and above the 0.98 percentile have been eliminated. There are used forecasts 12,6 and I month prior to year end. 
12 month prior to year end data used 
Zero R&D 
MV-BM R&D firms firms Firms with R&D/Sales above median Firms with R&D/TA above median 
low-low 0.152 0.114 0.139 0.155 
low-mid 0.115 0.119 0.132 0.142 
low-high 0.162 0.168 0.167 0.170 
high-low 0.086 0.081 0.101 0.103 
high-mid 0.079 0.079 0.106 0.100 
high-high 0.100 0.112 0.117 0.118 
6 month prior to year end data used 
Zero R&D Firms with R&D/Sales above 
MV-BM R&D firms firms' Firms with R&D/Sales above median median 
low-low 0.137 0.105 0.149 0.142 
low-mid 0.171 0.122 0.191 0.193 
low-high 0.233 0.192 0.219 0.231 
high-low 0.094 0.088 0.103 0.099 
high-mid 0.079 0.087 0.095 0.089 
high-high 0.117 0.126 0.135 0.166 
1 month prior to year end data used 
Zero R&D Firms with R&D/Sales above 
MV-BM R&D firms firms ` Firms with R&D/Sales above median median 
low-low 0.152 0.125 0.187 0.177 
low-mid 0.144 0.154 0.144 0.144 
low-high 0.247 0.218 0.313 0.283 
high-low 0.097 0.095 0.122 0.121 
high-mid 0.095 0.084 0.102 0.099 
high-high 0.116 0.139 0,169 0.170 
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Table 5B. 3. The influence of R&D intensity on analyst forecast dispersion 
The table reports the coefficient estimates and values of t-statistics (in parentheses) that have been estimated by running 
the following panel data regression during 1990-2003: Dispersion = ao+ a, RD+ a2BM+a3MV+a4STDEV+a3AF+e 
. 
The 
dependent variable Dispersion equals analyst forecast dispersion defined as the standard deviation in one year ahead 
analyst forecasts of EPS for a pgrticular month divided by the absolute value of the mean forecast in the specific month. 
There are used forecasts 12 and 6 months prior to year end RD equals R&D/Sales or R&D/Total Assets or R&D/Market 
value of equity at year end, BM and MV the book-to-market ratio and MVE at year end respectively. STDEV equals the 
standard deviation of reported E('S for a three year period prior to base year (e. g. 1988-1990 for the base year 1990) and 
finally AF represents analyst following and is equal to the number of analysts that issued one year ahead EPS forecasts for 
a particular firm for a particular rponth, using minus 12 or 6 month prior to year end data, depending on what data are used 
for dispersion each time. The regression is run using OLS and Whites Heteroskedasticity robust standard errors. 
Observations above the 98 and bdlow the 2 percentile were eliminated. All variables have been transformed using natural 
logs. In the last column appear the F statistics and their p-values. * 
12 month prior to year end EPS forecast data 
Adjusted R F- 
C RD BM MV STDEV AF squared statistic 
RI=RDS 1.8886 0.0179 0.0963 
-0.0768 0.1143 0.0598 0.3058 328.0436 
(17.9249) (2.0404) (2.8674) (-3.5485) (113678) (1.4815) (0.0000) 
RD=RDTA 1.8847 0.0188 0.0976 
-0.0756 0.1145 0.0594 0.3059 328.1197 (17.8721) (2.2001) (2.9045) (-3.4919) (11.3766) (1.4706) (0.0000) 
RT=RDMV 1.8799 0.0185 0.0935 
-0.0753 0.1144 0.0588 03058 328.0586 (17.8166) (2.0803) (2.7850) (-3.4760) (11.3708) (1.4577) (0.0000) 
6 month prior to year end EPS forecast data 
RD=RDS 1.8276 0.0167 0.1500 
-0.0514 0.1479 0.0298 0.3199 349.8872 
(17.9462) (1.8610) (43649) (-23984) (14.1226) (0.7149) (0.0000) 
RD=RDTA 1.8253 0.9120 0.1502 
-0.0522 0.1480 0.0288 0.3197 349.4979 (17.8986) (1.3485) (4.3684) (-2.4307) (14.1189) (0.6922) (0.0000) 
RD=RwMV 1.8177 0,0204 0.1470 
-0.0488 0.1480 0.0290 0.3201 350.2121 
(17.8317) (2.1231) (4.2789) (-2.2672) (14.1287) (0.6962) (0.0000) 
1 month prior to year end EPS forecast data 
RD=RDS 2.1921 0.0047 0.1663 
-0.1056 0.0631 0.0864 0.2954 306.1121 
(19.8963) (0.5139) (4.9846) (-4.8396) (6.1466) (2.1386) (0.0000) 
RD=RDTA 2.1897 0.0097 0.1673 
-0.1038 0.0632 0.0874 0.2955 306.2872 (19.8583) (1.0735) (5.0130) (-4.7384) (6.1572) (2.1678) (0.0000) 
1w=iwMV 2.1849 0.9149 0.1645 
-0.1019 0.0632 0.0877 0.2957 306.5850 
(19.8239) (1.6429) (4.9364) (-4.6616) (6.1653) (2.1741) (0.0000) 
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Table SB. 6. Time series regressions according to five dispersion portfolios 
The table reports the coefficient estimates and values of t-statistics (in parentheses) that have been 
estimated by running the following time-series regression using monthly data from July 1991-June 2004: 
(Rp-Rf) = alpha+ ß1(RM-Rf)++ß2SMB+ß3HML+ß4RDFactor+c 
(Rp-Rf) equals the difference between the equal-weighted monthly returns of five annually rebalanced 
dispersion portfolios and the risk flee rate (I month UK Treasury Bill rate). One month prior to year end 
1 year ahead analyst forecast data are used for dispersion calculation. The analysis is repeated by 
including only the R&D, zero R&D and firms with an R&D/Sales ratio above median according to 5 
dispersion portfolios. (RM-Rf) egµals the difference between the monthly value-weighted return of all 
the sample firms and the risk free rate. SMB equals the size factor, calculated by using the difference 
between the average equal-weighted monthly returns of three small and three large MVE portfolios: 
(SL+SM+SH)/3-(BL+BM+BH)/3. HML equals the value factor, defined as the difference between the 
average equal-weighted monthly rFturns between two high BM and two low BM portfolios: (SH+BH)/2- 
(SL+BL)/2. The RD Factor is constructed by subtracting the average monthly returns of the zero R&D 
firms from the returns of high R&D portfolio (R&D/Sales above 70th percentile): (High RD-Zero RD), 
Panel A reports the results for the regressions run without an RD factor according to 5 dispersion 
portfolios from D1 (Low) to D5 (High) for the whole sample, the R&D, zero R&D firms and firms with 
an R&D/Sales ratio above the median. Panel B reports the results with an RD factor calculated on its 
own by subtracting the returns of the zero RD firms from the returns of the R&D firms with an 
R&D/Sales ratio above 70th percgntile (High RD-ZRD) with equal-weighted returns, for the whole 
sample, the R&D, zero R&D firms and firms with an R&D/Sales ratio above the sample median The 
regressions are run using OLS anti' Whites Heteroskedasticity robust standard errors. In the last column 
appear the F statistics and their p-values. 
Panel A: No RD factor 
Sample 
alpha RM SMB FIML Adjusted R-squared F-statistic 
DI (low) 0.001 1.021 0.562 0.144 0.720 133.875 
(0.3744) (18.5310) (8.7435) (22214) 
D2 0.000 1.011 0.395 0.240 
(-0.0743) (17.9991) (5.5471) (2.9281) 
D3 





(-1.0831) (202158) (7.8657) (5.0280) (0.0000) 
D4 
-0.002 1.179 0.676 0.415 0.719 133.286 (-0.8051) (173601) (10.0707) (5.6700) (0.0000) 
D5 (High) 
-0.002 1.419 1.079 0.464 0.754 159.529 (-1.0027) (195701) (12.5593) (5.6053) (0.0000) 
71 
Table 5B. 6. Panel A Continued 
R&D firms 
D1(low) 0.002 1.075 0.456 
-0.032 0.724 136.796 
(0.8866) (17.3868) (5.5462) (-0.4674) (0.0000) 
D2 0.000 1.018 0.213 0.180 0.657 99.988 
(0.0332) (17.7453) (2.4024) (2.2294) (0.0000) 
D3 
-0.001 1.194 0.532 0.274 0.644 94.660 
(-0.2773) (15.8515) (5.8193) (3.3267) (0.0000) 
D4 0.001 1.141 0.548 0.260 0.664 102.913 
(0.2027) (15.1334) (6.1589) (3.1688) (0.0000) 
D5 (High) 
-0.002 1.40$ 0.967 0.176 0.693 117.542 (-0.6012) (163391) (9.1063) (1.6908) (0.0000) 
Zero R&D (inns 
D1 (low) 0.000 0.993 0.651 0.250 0.656 99.349 
(-0.1123) (15.9466) (9.3927) (3.4396) (0.0000) 
D2 
-0.001 1.0g2 0.539 0.286 0.626 87.490 (-0.2554) (15.6306) (7.3027) (3.1222) (0.0000) 
D3 
-0.004 1.180 0.650 0.452 0.690 115.843 
(-1.5805) (19.3412) (7.9244) (5.3787) (0.0000) 
D4 
-0.003 1.179 0.754 0.508 0.694 117.926 
(-13974) (16.5846) (10.1892) (6.4830) (0.0000) 
D5 (High) 
-0.002 1397 1.080 0586 0.718 132364 
(-0.9707) (18.0429) (10.6762) (6.7050) (0.0000) 
R&D firms with RD/. Sales> median 
Dl (low) 0.006 1.193 0.568 
-0.257 0.638 92.058 
(2.1328) (11.8476) (3.9522) (-2.6762) (0.0000) 
D2 0.000 1.108 0.411 
-0.112 0.571 69.870 (0.1053) (133273) (3.3586) (-1.0897) (0.0000) 
D3 0.000 1351 0.725 
-0.061 0.571 69.752 (0.0400) (10.1896) (5.5988) (-0.4589) (0.0000) 
D4 0.008 1.383 0.811 
-0.205 0.532 59.663 
(1.8870) (10.4338) (5.7004) (-1.5218) (0.0000) 
D5 (High) 0.001 1.44v 1.189 
-0.337 0.601 78.919 (0.2803) (12.5005) (8.5276) (-2.0003) (0.0000) 
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Table 5B. 6. Continued 
-Panel B: Time-series regressions run with an RD factor calculated as (High RD- 
Zero RD' 
Sample 
RD Adjusted R- F- 
alpha RM SMB HML Factor squared statistic 
D1 (low) 0.000 0.99$ 0541 0241 0.100 0.722 101.650 
(-0.0134) (17.5095) (8.5105) (2.3534) (1.2886) (0.0000) 
D2 
-0.001 0.986' 0.372 0.345 0.108 0.687 86.107 
(-0.4532) (16.7172) (5.0526) (3.2478) (1.2418) (0.0000) 
D3 
-0.003 1.165 0.572 0.470 0.091 0.716 98.767 (-1.3706) (18.7173) (7.2646) (4.4690) (1.0561) (0.0000) 
D4 
-0.003 1.146 0.645 0.556 0.145 0.724 102.445 
(-1.2602) (16.6637) (9.4347) (4.9982) (1.6955) (0.0000) 
D5 (High) 
-0.004 1362 1.026 0.709 0.251 0.766 127.733 
(-1.7405) (17.6245) (12.0390) (6.1596) (2.6263) (0.0000) 
R&D 
firms 
D1 (low) 0.000 1.025 0.409 0.183 0.221 0.738 110.394 
(0.1125) (16.5148) (5.2380) (1.7029) (2.6390) (0.0000) 
D2 
-0.001 0.975 0.173 0363 0.187 0.667 78.604 (-0.5615) (16.4777) (1.9316) (3.3021) (2.0955) (0.0000) 
D3 
-0.002 1.152 0.493 0.454 0.184 0.651 73.269 
(-0.7910) (15.3627) (5.3087) (3.5819) (1.7987) (0.0000) 
D4 
-0.001 1.121 0.492 0.517 0.263 0.680 83.460 
(-0.5205) (153251) (5.7029) (3.8539) (2.6103) (0.0000) 
D5 (High) 
-0.005 129a 0.861 0.668 0.504 0.739 110.575 (-2.0544) (14.9299) * (8.8906) (5.4557) (5.0652) (0.0000) 
Zero RD firms 
D1 (low) 0.000 0.987 0.646 0.274 0.025 0.654 74.095 
(-0.1926) (15.4744) (9.2675) (2.3658) (0.2891) (0.0000) 
D2 
-0.001 0.993 0531 0.323 0.038 0.624 65.327 (-0.3646) (14.5551) (6.8062) (2.6864) (0.3957) (0.0000) 
D3 
-0.004 1.175 0.646 0.473 0.022 0.688 86.367 (-1.6094) (17.7170) (7.5204) (4.0392) (0.2364) (0.0000) 
D4 
-0.004 1.163 0.741 0.568 0.061 0.693 88.302 
(-1.5583) (15.3691) (9.7177) (4.9818) (0.7235) (0.0000) 
D5 (High) 
-0.003 1376 1.061 0.674 0.091 0.718 99.441 (-1.1659) (16.7517) (10.3990) (5.0673) (0.8498) (0.0000) 
R&D firms with RD/. Sales> median 
D1 (low) 0.003 1.094 0.477 0.166 0.434 0.674 81.232 
(1.0586) (11.9140)' (3.7342) (1.0835) (3.4201) (0.0000) 
D2 
-0.003 1.019 0329 0268 0.389 0.604 60.096 
(-0.8111) (11.7264) (2.7744) (1.8767) (3.0261) 
D3 
-0.002 1.271 0.653 0.275 0.345 (-0.6322) (9.9129) (5.3718) (1.4554) (2.1982) 
D4 0.004 1.247 0.687 0.372 0.591 
(0.9027) (10.3807) (5.3615) (1.6007) (3.1060) 
D5 (High) 







(-1.4953) (10.7765)' (8.3007) (2.7448) (6.4122) (0.0000) 
73 























p OU 24- 
0 ý 
' CÜ . 'O 





























00 0 o 00 Oý 
4y N-N 



























N 00 Gt 


































N M o M 3 
C? Ö !ý 
N of 
o0 00 Cý r7 N ý N 
^ý Ö O O ! 







00 00 .O 
4y N 00 
P4 ö Ö ö 
F. 0 






























5 4 0 N 
N 0 O 








U 4) 'v a) w 
ce 
9 




`o a0i «w 
OUNNG 








w a0i'C O tu O 
~> 
ÄÄJ, 3.0 C) 
1-- 0 önä W `ý 0 O20e: 
. 
x3 c 
^o cäp ajýýý,,,, ä. 
coma°< 
° 
'0 30>, W 
' 




.2a in .009: 6 u 
U^ 
T'ý' 
ld y ice.. it 
4"W E0 vi 
ý 
Q c° ü 
A üq :iZUö. ö 
41L1: 10 Pd C. ) 00 W0 
.E .e 9w 




UUyO iý YN 
rz g* t0L0 äA - Chi -L Ei ~e 
vÖQ. - V1 
c Z. n om aý 
in %0 
:Z :Z wl (> 0% ulb " 00 - «e 00 























N t, ei O N 












































r- v1 ý 
























































































fA Vl M 
ff 
d ý ä 
` 
ýA3 o ý A 3 .c A 3 
-. o 
A 3 p" Q a: N 
ä ä S ä 
,ý x cý ,S 
SI) 
n 




cvj OO O0 
cC O OO ä Z 
42. 10 
r. N 
Ny 41 y ý"'ý N 25 
tr, Q 
tz 4 ) (3 w AN i HH 
'S Q. ca. v ty u 
N~ NNV. w 
"MN 
V1 M 




O' 00 O 
b 
00 G 
00 O ýD 
ti, u0 
N 
M fV mNN N- ý+ t- %0 Yl 4 d4 V 
o 
N Mm r 
Z o 92. 
N. ä ij y Cq 0 
'ý 2c Q d %4D 
O% NO 
%O M %O 
NM 00 
ýn NNh 
%0 O, tN V. 
l`; 19 ho 
NN 
%0 OO 
O r1 %D 
h ýO Oý 
'0 1- vl 
o0 '. O O NC /] 9 
yb b^ Ü N ý+ j "+ ""+ tV 
ý 
. -+ OC tV e! fV q 
ö= ü Q. ü 
. 
Ei 
Ay 3b 4) Na d0u 
pG2° 02°25 
"° ß" 
°ý' ä° ö. 9, 
" 
ý 
.L la G ýp + 
" 
b ý ýw a0i ^  0 
V] 
y 
.ýa i O cd 
=ww° ýw ° a°'i 94 " tý ýo 'o OOa 
- 
ýr eý . -" o, °O a ýr O N Ný 
'3 b 
. 










du u00N yb ý-r . -+ 
Ö 




"y 4r iý :O iý ý'; 
I0 N p ý""ý OO Owa, 
'O a+ 'p 
OO v1 
N 'ýt' IN 
Oý h 
00 OO 'O O'. [- O' 
-e 
"r o0 O 
TV 
o'. CD O* mM 
a0 NN l- 
.r of .+ NOO 
vä %O N 






-w EL., 0 -0 u. 0u 
y O'0'' %O 42 'C 
0N4: 

















To 22 22 _ ° 3 3 3 
° ýf. 
w° 




< ID Ili 
7s g q 
ýy (Q 
EÖW üY 













bg ýW E 
ÜyNZ- 
















GV 4) -O 
aC 
>Q 
4) .ZO 0 öA p av 
aj U22 




OU aý Oý 
























ý ('4 ON V Oý MV 
Ö 
r+ OOO 




't W) M "QO ö; l roe CC . -ý CCG 
qN "O Ö CA Ö C? ÖC 
ý 00 Oa lO lt o 













- er ON %ýO 14 N to mONr 
Öý OOÖG 
1' vi co %n t- NN %0 oo _ O "D l"t q- ÖÖOÖÖc 
IMO 
oo 
-r er oo t- t- c 
"tý0ý 
-iIN c ööö0oc 
O, n ýt O l- Qý ÖÖqÖG 
V'> 00 













I(14 oo O oo t- eF 
T ON M I-t M 
O 't e+ý ON 't 
O 
.+ÖÖÖÖ 
IGO tt 0' N cn vý 
cn C) on C> O ýt NON et 
G? ÖÖcÖÖ 
%V (D M O, 
O Oý 00 vl 00 e0 
ý ýO ýO OOO 
OÖÖÖÖÖ 
" oo e4 O% O %O 
N 00 t7 MM- 
O ao et O-M 
9ÖÖÖÖÖ 
'ý N f- v1 M 
f O' Ol ", O nN %0 
ööö ööö 
















rý QC `ý 
Ö 
CG dýj Ový 
o 3t°ýo ai 
0, N- 
0C 
tA0 tA 0- 
cd 
0 4) r_ til 019 
aý 
y> 03 > 
-ci 
fn a_ 9¢Öb 
cl ID. 
cm 





N f-"Y rr H 
d w =.. sZ dZ> 







.2 Ei ö 
-0 






cn 3u°. ';,, y 0 >. 5 5: u 
~y~' 4) 
ww°Ö N 
V'b ht- 'na a 00 %0 a oo r 110 1? rr hq 
en 00 00 00 Go 
O-N vy 
O er N 00 
ýýýh4 
%0 N %n vl O 
N rf O [- ý Oý N 
." Oý 
et N 'ý oö h 




vi d tZ ri 
0 
333 öb moo ýi N .. r 
o co o% GO dv 
Co C! O0 0; o cn 
oN-a 
- %n %0 MN 





aua 00 F-n MOON v) 00 
OO OIIO Ný 00 
m *a %0 It en M NO 't Oý %0 It 
MM h lý V., Ö 
er O% - tý G? 
hest- aa* t- oo NON e0 Ir  
aq MO OO Oý %R 
00 NÖ f+1 






Table 5B. 12. The impact of R&q intensity on analyst forecast errors 
The table reports the coefficient estimates and values of t-statistics (in parentheses) that have been estimated by 
running the following panel data regression for the period 1990-2003: Forecast errors =ao+ a1RD+ 
a2BM+a3MV+a4PASTR+a5STDEV +E,,. The dependent variable Forecast Error is defined in two ways, using one 
year ahead mean EPS analyst forecasts scaled either by stock price or by the absolute value of actual EPS, and 
using analyst forecast data 12 and 6 months prior to year end: 
(1 year ahead mean Forecasted EPS using data for 12 and 6 month prior to year end-Actual EPS)/Share Price 12 
months prior to year end 
(1 year ahead mean Forecasted EPS using data for 12 and 6 month prior to year end-Actual EPS)/Absolute value 
of Actual EPS 
There have been used absolute (Panel A) and non absolute (Panel B) errors. RD equals R&D/Sales or R&D/Total 
Assets or R&D/Market value of equity at year end, BM the Book to market ratio at year end, MV the MVE at year 
end, PASTR equals the 6 month prior to previous year end geometric average of monthly stock returns, STDEV 
equals the standard deviation of reported EPS for a three year period prior to base year. The regression is run using 
OLS and Whites Heteroskedasticity robust standard errors. Observations above the 98 and below the 2 percentile 
were eliminated. All variables have been transformed using natural logs. In the last column appear the F statistics 
and their p-values. * 
Panel A: Absolute errors: Errors scaled by price: 
c RD BM MV PASTR STDEV Adj. R-sq. F-stat. 
12 month prior to year end EPS forecast data 
RD=RDS 
-1.2383 0.0092 0.0266 -0.2682 13128 0.7032 03424 4832907 
(-17.6019) (1,1651) (1.0313) (-20.1647) (3.9342) (36.4023) (0.0000) 
RI=RDTA 
-1.2388 9.0028 0.0259 -02703 1.3138 0.7032 0.3423 482.9964 
(-17.6113) (0.3482) (1.0002) (-20.1061) (3.9374) (36.3962) (0.0000) 
RD=RDMV 
-12414 0.0134 0.0245 -0.2666 1.3178 0.7026 0.3426 483.5904 
(-17.6687) (1.5896) (0.9515) (-19.9937) (3.9478) (36.3585) (0.0000) 
6 month prior to y ear end EPS forecast data 
RD=RDS 
-1.2816 9.0049 0.0991 -0.2829 -0.2358 0.5381 0.2804 349.9511 
(-17.7157) (0.5431) (3.2914) (-20.0522) (-0.6593) (26.9206) (0.0000) 
RD°RDTA 
-1.2825 0.0070 0.0997 -0.2820 -0.2348 0.5380 0.2804 350.0212 
(-17.7371) (0.7578) (3.3087) (-19.8985) (-0.6564) (26.9132) (0.0000) 
RD=RDMV 
-1.2846 0.0131 0.0975 -0.2800 -0.2309 0.5377 0.2806 350.3450 
(-17.7792) (13896) (3.2379) (-19.7616) (-0.6455) (26.9111) (0.0000) 
Panel A: Absolute Errors: Errors scaled by actual EPS: 
12 month prior to year end EPS forecast data 
RD=RDS 
-1.1949 0.0061 0.0400 -0.2002 -2.2966 0.6373 0.2788 373.8812 
(-15.7440) (0.7130) (1.3902) (-13.7906) (-6.1080) (29.7396) (0.0000) 
RD-=RDTA 
-1.1949 -0.0005 0.0394 -0.2025 -2.2944 0.6374 0.2787 373.7716 
(-15.7403) (-0.0609) (1.3660) (-13.8165) (-6.1058) (29.7350) (0.0000) 
RD=RDMV 
-1.1972 0.0107 0.0384 -0.1986 -2.2927 0.6368 0.2789 374.0791 
(-15.7921) (1.1835) (13318) (-13.6661) (-6.0966) (29.7138) (0.0000) 
6 month prior to year end EPS forecast data 
RD=RDS 
-1.1967 0.0032 0.1224 -0.2203 -4.2338 0.4898 0.2567 338.5104 
(-15.2301) (0.3261) (3.8486) (-142510) (-10.7452) (23.4279) (0.0000) 
RD=RDTA 
-1.1972 0.0048 0.1227 -0.2197 -42333 0.4897 0.2567 338.5390 
(-15.2433) (Q. 4692) (3.8581) (-14.1513) (-10.7436) (23.4203) (0.0000) 
RD=RDMV 
-1.1992 9.0106 0.1208 -0.2177 -4.2316 0.4895 0.2569 338135 




Table SB. 12. Continued 
Panel B: Non Absolute errors: Errors scaled by price: 
Adj. R- 
c RD BM MV PASTR STDEV sq. F-stat. 
12 month prior to year end EPS forccast data 
RI-RDS 0.0037 
-40001 0.0009 -0.0007 -0.0206 0.0011 0.2705 344.5537 
(10.3110) (-4.1286) (6.5400) (-10.0048) (-12.2972) (9.3280) (0.0000) 
RD=RDTA 0.0037 
-9.0001 0.0009 -0.0007 -0.0206 0.0011 0.2706 344.6839 
(10.3461) (-43530) (6.4818) (-10.0294) (-12.3161) (9.3445) (0.0000) 
RD=RDMV 0.0038 
-0.0001 0.0009 -0.0007 -0.0206 0.0011 0.2695 342.6944 
(10.3497) (-3,1381) (6.6913) (-9.8341) (-12.3193) (9.3402) (0.0000) 
6 month prior to y ear end EPS forecast data 
RD=RDS 0.0029 
-0.0001 0.0007 -0.0005 -0.0120 0.0007 0.1906 211.9738 
(11.1219) (-33055) (6.6536) (-10.1581) (-8.4352) (8.3448) (0.0000) 
RD=RDTA 0.0029 
-0.0001 0.0007 -0.0005 -0.0120 0.0007 0.1909 212.3054 
(11.1592) (-3.6711) (6.5993) (-10.1757) (-8.4556) (8.3559) (0.0000) 
RD=RDMV 0.0029 
-0.0001 0.0007 -0.0005 -0.0120 0.0007 0.1901 211.1981 
(11.1579) (-2.9372) (6.7913) (-10.0280) (-8.4614) (8.3545) (0.0000) 
Panel B. Non Absolute errors: Errors scaled by actual EPS: 
Adj. R- 
c RD BM MV PASTR STDEV sq. F-stat. 
12 month prior to year end EPS forecast data 
RD-RDS 0.0048 
-0.0003 0.0026 -0.0006 -0.0452 0.0017 0.1245 138.2182 
(6.3609) (-3.7046) (8.6581) (-4.2766) (-8.0800) (7.4028) (0.0000) 
RD RDTA 0.0048 
-0.0003 0.0026 -0.0006 -0.0452 0.0017 0.1244 138.0951 
(6.3827) (-3.6139) (8.6283) (-4.2934) (-8.0850) (7.4184) (0.0000) 
RD=RDMV 0.0048 
-0.0002 0.0027 -0.0006 -0.0452 0.0018 0.1233 136.7498 
(6.3625) (-2.4930) (8.7544) (-4.0070) (-8.0823) (7.4279) (0.0000) 
6 month prior to year end EPS forecast data 
RD=RDS 0.0038 
-0.0002 0.0019 -0.0004 -0.0258 0.0010 0.0809 87.1088 
(6.2120) (-3.3656) (7.6223) (-3.8459) (-53244) (5.7334) (0.0000) 
RD=RDTA 0.0038 
-0.0002 0.0019 -0.0004 -0.0258 0.0010 0.0807 86.8671 
(6.2322) (-3,1404) (7.5872) (-3.8386) (-53278) (5.7454) (0.0000) 
R13=RDMV 0.0038 40001 0.0020 
-0.0004 -0.0259 0.0010 0.0798 85.8156 
(6.2061) (-2. Q486) (7.7290) (-3.5452) (-5.3305) (5.7551) (0.0000) 
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Table 5B. 13. The impact of R&D intensity on one year ahead mean EPS forecast revisions 
The table reports the coefficient Fstimates and values of t-statistics (in parentheses) that have been estimated by 
running the following panel 
-data regression for the period 1990-2003: Revisions =ao+ atRD+ 
a2BM+a3MV+a4PASTR+a5STDF, V+e; t. The dependent variable Revisions is defined in four ways, using one 
year ahead mean EPS analyst forecasts scaled either by stock price or by median EPS forecast: 
Forecast Revision: 12 6 (Mean Fprecast 12m prior to year end-Mean Forecast 6m prior to year end)/Share price 
12m prior to year end * 100 or the Absolute value of median forecast 12m prior to year end * 100 
Forecast Revision: 12 1 Mean Fotecast 12m prior to year end-Mean Forecast 1 in prior to year end)/Share price 
12m prior to year end * 100 or the"Absolute value of median forecast 12m prior to year end * 100 
There have been used both absolute (Panel A) and non absolute revisions (Panel B). RD equals R&D/Sales or 
R&D/Total Assets or R&D/Markpt value of equity at year end, BM the Book to market ratio at year end, MV 
the MVE at year end, PASTR equals the 6 month prior to previous year end geometric average of monthly 
stock returns, STDEV equals the standard deviation of reported EPS for a three year period prior to base year. 
The regression is run using OLS and Whites Heteroskedasticity robust standard errors. Observations above the 
98 and below the 2 percentile wete eliminated. Non absolute revisions have been adjusted as follows in order to 
be able to use logs: (100+revisioq)/100 e. g. if a revision was 3%, it will appear as 103 or 97 for 
-3% In the last 
column appear the F statistics an4 their p-values. * 
Panel A: Absolute revisions, revisions scaled by price 
126 c RD BM MV PASTR STDEV Adj. R-sq. F-stat 
RD=RDS 2.7826 
-0.9112 0.0584 -0.2270 0.5704 0.3021 0.1753 189.8803 
(34.0227) (-1.1433) (1.8033) (-13.9930) (1.3984) (132781) (0.0000) 
RD=RDTA 2.7852 
-0. Q183 0.0572 -0.2300 0.5710 03023 0.1757 190.2922 
(34.0844) (-1.8015) (1.7653) (-14.1176) (1.4002) (13.2984) (0.0000) 
RD=RDMV 2.7853 
-0.0113 0.0606 -0.2272 0.5646 0.3024 0.1753 189.8687 
(34.0166) (-1.1190) (1.8695) (-13.9402) (13846) (132876) (0.0000) 
121 
RD=RDS 2.9748 0.0076 0.0132 
-0.2046 2.4557 0.4391 0.2061 238.1093 
(46.8908) (1.0044) (0.5442) (-16.7082) (6.6016) (23.5869) (0.0000) 
RD=RDTA 2.9745 0.0040 0.0130 
-0.2057 2.4563 0.4390 0.2060 237.9536 
(46.8639) (0.5179) (0.5377) (-16.6513) (6.6055) (23.5857) (0.0000) 
RD=RDMV 2.9718 0.0126 0.0113 
-0.2027 2.4628 0.4387 0.2064 238.4261 
(46.8668) (1.6026) (0.4638) (-16.5150) (6.6214) (23.5652) (0.0000) 
Panel A: Absolute Revisions, Revisions scaled by abs. value of 
-12m median EPS forecast: 
126 c RD BM MV PASTR STDEV Adj. R-sg. F-stat. 
RD=RDS 2.8282 0.0064 
-0.0885 -0.1800 -0.6659 0.2780 0.1511 158.5143 
(33.0947) (0.6298) (-2.6713) (-10.6330) (-1.6352) (12.0148) (0.0000) 
RD=RDTA 2.8286 
-0.0018 -0.0894 -0.1829 -0.6651 0.2779 0.1510 158.4460 (33.0978) (-0.1808) (-2.6954) (-10.7471) (-1.6328) (12.0142) (0.0000) 
RD=RDMV 2.8274 0.0033 
-0.0895 -0.1810 -0.6640 0.2779 0.1510 158.4581 
(33.0650) (0.3106) (-2.6986) (-10.6329) (-1.6299) (12.0062) (0.0000) 
121 
RD=RDS 3.0166 0.9235 
-0.1449 -0.1616 1.1397 0.4309 0.1802 200.7703 
(43.2652) (2.8211) (-5.4595) (-11.9673) (3.1030) (21.6189) (0.0000) 
RD=RDTA 3.0143 0.0190 
-0.1444 -0.1626 1.1431 0.4306 0.1798 200.1747 
(43.1730) (2.2549) (-5.4343) (-11.9251) (3.1139) (21.5904) (0.0000) 
RD=RDMV 3.0099 0.0272 
-0.1496 -0.1599 1.1527 0.4300 0.1805 201.1418 
(43.2047) (3.1103) (-5.6133) (-11.8240) (3.1374) (21.5684) (0.0000) 
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Table SB. 13. Continued 
Panel B: Non absolute revisions, Revisions scaled by Price 
Adj. R- 
126 c RD BM MV PASTR STDEV sq. F-stat. 
RI=RDS 
-0.0151 0.0033 -0.0288 0.0047 1.1632 -0.0324 0.0914 89.5801 
(-0.8261) (1.6963) (-4.1183) (1.3569) (10.2923) (-5.6300) (0.0000) 
R13=RDTA 
-0.0155 0.0034 -0.0287 0.0049 1.1629 -0.0325 0.0914 89.6070 
(-0.8503) (1.7245) (-4.0945) (1.3881) (10.2897) (-5.6404) (0.0000) 
RD=RDMV 
-0.0153 0.0014 -0.0293 0.0041 1.1641 -0.0325 0.0910 89.1515 
(-0.8333) (0.7644) (-4.1614) (1.1634) (10.2969) (-5.6396) (0.0000) 
121 
RI=RDS 
-0.0412 0.004 -0.0443 0.0111 2.4658 -0.0362 0.1544 164.4701 
(-2.3161) (25186) (-6.2402) (3.3524) (18.8245) (-5.8019) (0.0000) 
RD=RDTA 
-0.0417 0.0047 -0.0441 0.0112 2.4659 -0.0363 0.1543 1643952 
(-2.3448) (2.4162) (-6.2064) (3.3643) (18.8254) (-5.8176) (0.0000) 
RD=RDMV 
-0.0420 0.0037 -0.0450 0.0108 2.4672 -0.0363 0.1540 163.9797 
(-2.3550) (2.0544) (-6.3380) (3.2501) (18.8359) (-5.8197) (0.0000) 
Panel B, Non Absolute Revisiongr Revisions scaled by abs. value of 
-12m median EPS forecast: 
Adj. R- 
126 c RD BM MV PASTR STDEV sq. F-stat 
RD RDS 0.0214 0.0033 
-0.0351 -0.0003 1.6007 -0.0256 0.1030 101.2056 
(0.9433) (1.6373) (-42859) (-0.0675) (11.2361) (-3.9848) (0.0000) 
RD=RDTA 0.0209 0.0030 
-0.0349 -0.0001 1.6011 -0.0257 0.1031 101.2549 
(0.9198) (1.7493) (-4.2588) (-0.0191) (11.2427) (-3.9952) (0.0000) 
RI3`RDMV 0.0210 0.002Q 
-0.0356 -0.0007 1.6022 -0.0257 0.1028 100.9520 
(0.9225) (1.0274) (-4.3465) (-0.1673) (112500) (-3.9984) (0.0000) 
121 
RD=RDS 
-0.0103 0.0054 -0.0453 0.0109 3.3704 -0.0374 0.1577 167.7805 
(-0.5083) (2.7464) (-4.7108) (2.6979) (19.1(41) (-4.6722) (0.0000) 
R1kRDTA 
-0.0111 0.006( -0.0450 0.0112 33709 -0.0375 0.1578 167.8409 (-0.5449) (2.8493) (-4.6713) (2.7472) (19.1123) (-4.6902) (0.0000) 
RD=RDMV 
-0.0113 0.0049 -0.0462 0.0107 3.3736 -0.0376 0.1574 167.3851 
(-0.5570) (2.4087) (-4.8208) (2.6401) (19.1094) (-4.6986) (0.0000) 
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APPENDIX 5B. A 
Appendix 5B. A Part A: The Appendix 5B. A Part A contains information on analyst forecast 
dispersion for the whole sample, the R&D, zero R&D firms and according to R&D intensity 
quartiles (using R&D/Sales, R&D/TA and R&D/MV as proxies) when including only the firms 
with more than 1 year ahead EPS 5 analyst forecasts issued for a particular month. The table 
below is equivalent to Table 5B. 1, and shows the average sample period dispersion with the 
inclusion of only the firms with more than 1 year ahead EPS S analyst forecasts issued for a 
particular month, using again minus 12,6 and 1 month prior to year end analyst forecasts. 
12 6 1 
Sample 0.085 0.093 0.097 
R&D firms 0.085 0.091 0.094 





0.086 0.095 0.087 
0.081 0.085 0.093 
High 0.124 0.117 0.144 
R&D/TA 
Low 0.078 0.078 0.086 
0.084 0.092 0.081 
0.093 0.109 0.116 





0.075 0.078 0.077 
0.113 0.102 0.098 
High 0.126 0.168 0.173 
TA 
Low 0.128 0.070 0.132 
0.110 0.111 0.110 
0.089 0.101 0.117 
High 0.087 0.096 0.097 
MV 
Low 0.203 0.189 0.201 
0.148 0.159 0.162 
0.085 0.098 0.110 
high 0.078 0.085 0.089 
BM 
" 
Low 0.071 0.077 0.083 
0.071 0.090 0.082 
0.093 0.106 0.112 
High 0.153 0.158 0.171 
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Appendix SB. A Part B: After decomposing forecast dispersion into an uncertainty part (V) and 
a differences of opinion part (1-p) (definitions appear in text), following Doukas, Kim and 
Pantzalis (2006), Table 1 of the Appendix 5B. A Part B reports the average V and 1 (1-p) (and 
also D=scaled variance of analyst forecasts multiplied by 10) for the whole sample, the R&D, 
zero R&D firms and according to R&D intensity quartiles (using R&D/Sales, R&D/TA and 
R&D/MV as proxies) using minus I month prior to year end analyst forecasts for all measure 
calculations (observations below/above 0.02/0.98 percentile have been removed). Table 2 reports 
V calculated as V= D/(1-p), where (1-p) was calculated as in p. 603 of Doukas, Kim and Pantzalis 
(by using deflation by absolute actual EPS in the components of p where deflation is necessary), 
and D is the scaled variance (squared standard deviation or squared dispersion of Diether, Malloy 
and Scherbina employed else in the thesis), using the Diether, Malloy and Scherbina dispersion 
definition, which involves scaling by absolute mean EPS forecast. Table 3 reports D (=scaled 
variance of analyst forecasts multiplied by 10), V and (1-p) where V =D/(1-p), with D to be the 
scaled variance (squared standard deviation or squared dispersion of Diether, Malloy and 
Scherbina 
- 
multiplied by 10- employed else in the thesis), using the Diether, Malloy and 
Scherbina dispersion definition, which involves scaling by absolute mean EPSforecast, and (1-p) 
to be calculated by using here again by scaling by the absolute mean EPS forecast when scaling 
is necessary for p calculation. Minus one month prior to year end forecast data have been used for 
D, V and (1-p) calculation. 
So for Table 1: D=V(1-p)ý, where 1- p represents differences of opinion (p =correlation of 
forecast errors across analysts, a measure of analyst consensus) and V is uncertainty of the 
forecast 
D= ((standard deviation in forecasts) *(standard deviation in forecasts)/(absolute value of actual 
EPS)) * 10, with the standard deviation of forecasts to be the one used on p. 61 for dispersion 
calculation (standard deviation in forecasts scaled by absolute mean EPS forecast equals 
dispersion used in p. 61). p =h/(h+s), V=D/(1-p), where h=precision of common information and 
s=precision of idiosyncratic information, h=(SE-(D/N))/((SE-(D/N))+D)2, s=D/((SE-(D/N))+D)2, 
with SE = squared error of the mean forecast (deflated by the absolute value of actual EPS) at 
year end as reported else in the thesis, D= defined right above, N= the number of forecasts 
For Table 2: V= D as of page 85 divided with (1-p) of p. 87 
For Table 3: D=V(1-p), D= ((standard deviation in forecasts) *(standard deviation in 
forecasts)/(absolute value of mean EPS forecast)) *10, with the standard deviation of forecasts to 
be the one used on p. 61 for dispersion calculation, p =h/(h+s), V=D/(1-p), where h=precision of 
common information and s=precision of idiosyncratic information, h=(SE-(D/N))/((SE- 
(D/N))+D)2, s=D/((SE-(D/N))+D)2. SE = squared error of the mean forecast (deflated by the 
absolute value of actual EPS at year end as reported else in the thesis, D= defined right above, N 





forecasts Lack of Consensus 
D=V(1- p) 1 ýJncertainty V1 (1-p) 1 
Sample 0.992 Sample 1.829 Sample 0.800 
R&D firms 1.023 R&D firms 1.892 R&D firms 0.795 
Zero R&D Zero R&D 
firms 0.959 firms 1.807 Zero R&D firms 0.804 
R&D/Sales jt&D/Sales R&D/Sales 
Low 0.441 Low 1.236 Low 0.873 
0.594 1.012 0.816 
1.078 1.873 0.814 
High 2.632 Tigh 4.165 High 0.621 
R&D/TA R&D/TA R&D/TA 
Low 0.418 Low 1.135 Low 0.882 
0.716 1.178 0.798 
1.273 2.449 0.796 
High 2.474 tligh 3.512 High 0.653 
R&D/MV R&D/MV R&D/MV 
Low 0.424 Low 0.671 Low 0.902 
1.002 1.864 0.806 
1.999 2.654 0.751 
High 1.264 ýigh 3.209 High 0.660 
TA TA TA 
Low 1.467 Low 3.221 Low 0.688 
1.227 1.919 0.779 
1.034 1.837 0.808 
High 0.827 1-1igh 1.622 High 0.827 
MV my MV 
Low 1.835 Low 3.864 Low 0.669 
0.818 1.797 0.788 
1.167 2.067 0.803 
High 0.757 
- 
gh 1.285 High 0.824 
BM 1M BM 
Low 1.076 Low 1.466 Low 0.774 
0.519 1.063 0.837 
0.993 1.711 0.827 








































Scaled variance in 
forecasts D=V((1-p) 1 Uncertainty V I 
Lack of Consensus 
(1-p) 1 
Sample 0.631 Sample 1.163 Sample 0.775 
R&D firms 0.736 R&D firms 1.250 R&D firms 0.774 
Zero R&D 
Zero R&D firms 0.714 firms 1.108 Zero R&D firms 0.788 
R&D/Sales R&D/Sales R&D/Sales 
Low 0210 Low 0.897 Low 0.801 
0.428 0.739 0.765 
0.491 1.429 0.780 
High 1.167 High 2.499 High 0.638 
R&D/TA R&D/TA R&D/TA 
Low 0.201 'Low 0.805 Low 0.800 
0.451 0.908 0.747 
0.620 1.892 0.779 
High 1.104 High 1.889 High 0.660 
R&D/MV R&D/MV R&D/MV 
Low 0.208 Low 0.363 Low 0.827 
0332 1.300 0.743 
0.697 1383 0.741 
High 1.117 High 2.733 High 0.676 
TA TA TA 
Low 0.908 'Low 1.602 Low 0.767 
0.564 1.276 0.771 
0.980 1.407 0.793 
High 0344 High 0.865 High 0.755 
MV MV MV 
Low 1394 ow 2.209 Low 0.770 
0.666 1.491 0.792 
0.790 1.333 0.769 
High 0.303 High 0.670 High 0.758 
BM M BM 
Low 0.625 w 1.033 Low 0.764 
0.286 0.638 0.791 
0.529 1.063 0.778 
High 1.253 High 2.257 High 0.761 
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APPENDIX 5B. B 
Appendix 5B. B contains robustness checks for results of Table 5B. 3. 
Appendix 5B. B Part A: The table below is equivalent to Table 5B. 3, but this time with 
replacing MV with a variaple that accounts for firm age (defined as the natural log of the 
difference in years between 'year t and the year when data is recorded for the first time for a 
particular firm in LSPD-iten1 G6). 
12 month prior to year end EPS f9recast data 
C RD BM AGE STDEV AF Adjusted R-squared F-statistic 
RDS 1.6942 0.0195 0.1570 
-0.0173 0.1166 -0.0157 0.3092 342.9950 
(13.1084) (2.2615) (5.2253) (-0.4712) (11.7442) (-0.4699) (0.0000) 
RDTA 1.6971 0.0200 0.1575 
-0.0185 0.1167 -0.0150 0.3093 (343.0485) (13.1260) (2.3835) (5.2459) (-0.5034) (11.7476) (-0.4471) (0.0000) 
RDMV 1.6948 0.0205 0.1526 
-0.0189 0.1166 -0.0150 0.3093 343.0879 (13.1214) (2.3456) (5.0657) (-0.5140) (11.7402) (-0.4502) (0.0000) 
6 month prior to year end EPS forecast data 
RDS 1.6703 0.0180 0.1813 
-0.0003 0.1480 -0.0256 03207 360.7981 (13.4379) (2.0659) (6.0384) (-0.0080) (14.2238) (-0.7586) (0.0000) 
RDTA 1.6743 0.0126 0.1824 
-0.0037 0.1480 -0.0273 03204 3603059 (13.4605) (1.4625) (6.0825) (-0.1058) (14.2152) (0.8088) (0.0000) 
RDMV 1.6696 0.0211 0.1764 
-0.0009 0.1480 -0.0237 0.3209 361.1365 (13.4334) (2.4697) (5.8610) (-0.0260) (14.2175) (-0.7023) (0.0000) 
I month prior to year end EPS forecast data 
RDS 1.9363 0.0080. 0.2378 
-0.0355 0.0649 -0.0064 0.2955 314.5005 (14.9099) (0.8952) (7.7659) (-0.9548) (6.4012) (-0.1884) (0.0000) 
RDTA 1.9361 0.0129 0.2375 
-0.0343 0.0649 -0.0036 0.2957 314.7634 (14.9101) (1.4718) (7.7621) (-09237) (6.4069) (-0.1067) (0.0000) 
RDMV 1.9327 0.0196 0.2318 
-0.0324 0.0649 -0.0008 0.2961 315.3207 (14.8891) (2.2329) (7.5703) (-0.8725) (6.4110) (-0.0231) (0.0000) 
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Appendix 5B. B Part B: In Appendix 5B. B Part B, there is assessed the impact of R&D intensity 
on analyst forecast dispersign when controlling for industry factors. In specific, Part B of the 
Appendix 5B. B reports the regression results as in table 5B. 3, when minus twelve month forecast 
data are used and R&D intensity is defined as R&D/Sales, with the inclusion of four industry 
dummy variables to account for four sectors perceived as intensive in R&D activity: Information 
Technology (INDDI), Chemicals (INDD2), General Industries (INDD3) and Health grouped 
together with Pharmaceuticals and Biotechnology ('Pharma' 
-INDD4). INDDUMMY takes the 
value of I if the firm belongs to the specific industry, and 0 otherwise. The industry dummies are 
used both in a simple form as well as multiplicative with R&D. 
Simple dummy variables 
- 
Results with MV among the regressors: 
Adjusted R- F- 
C RD BM MV STDEV AF INDDI squared statistic 
1.8717 0.0181 0.0998 
-0.0748 ' 0.1144 0.0613 0.1348 0.3058 281.3514 
(17.6546) (2.0555) (2.9493) (-3.4472) (11.3810) (1.5162) (0.8409) (0.0000) 
Adjusted R- F- 
C RD BM MV STDEV AF 1NDD2 squared statistic 
1.8886 0.0179 0.0963 
-0.0768 0.1143 0.0598 -0.0009 0.3057 281.1171 (17.9132) (2.0152) (2.8671) (-3.5462) (11.3615) (1.4788) (-0.0088) (0.0000) 
Adjusted R- F- 
C RD BM MV STDEV AF INDD3 squared statistic 
1.8949 0.0170 0.0955 
-0.0774 0.1143 0.0592 -0.0253 0.3057 281.1415 (17.6901) (1.8932) (2.8299) (-3.5603) (11.3613) (1.4645) (-0.3348) (0.0000) 
Adjusted R- F- 
C RD BM MV STDEV AF INDD4 squared statistic 
1.8924 0.0179 0.0943 
-0.0769 0.1141 0.0593 -0.0994 0.3057 281.2050 (17.9040) (2.0364) (2.7835) (-3.5497) (11.3395) (1.4696) (-0.6009) (0.0000) 
Simple dummy variables 
- 
Results with AGE among the regressors: 
Adjusted R- F- 
C RD BM AGE STDEV AF INDD1 squared statistic 
1.6607 0.0197 0.1592 
-0.0101 0.1166 -0.0119 0.1761 0.3094 2943232 (12.7764) (2.2835) (5.2765) (-0.2753) (11.7576) (-0.3544) (1.0830) (0.0000) 
Adjusted R- F- 
C RD BM AGE STDEV AF INDD2 squared statistic 
1.6949 0.0196 0.1570 
-0.0176 0.1166 -0.0157 0.0059 0.3091 293.9319 (13.0171) (2.2483) (5.2247) (-0.4713) (11.7420) (-0.4714) (0.0585) (0.0000) 
Adjusted R- F- 
C RD BM AGE STDEV AF INDD3 squared statistic 
1.6943 0.0199 0.1572 
-0.0183 0.1166 -0.0149 0.0141 0.3091 293.9392 (13.1064) (2.2631) (5.2198) (-0.4953) (11.7418) (-0.4445) (0.1886) (0.0000) 
Adjusted R- F- 
C RD BM AGE STDEV AF INDD4 squared statistic 
1.8924 0.0179 0.0943 
-0.0769 0.1141 0.0593 -0.0994 03057 281.2050 
(17.9040) (2.0364) (2.7835) (-3.5497) (11.3395) (1.4696) (-0.6009) (0.0000) 
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Multiplicative dummy variables 
- 
Results with MVE among the regressors: 
Adjusted R- F- 
C RD BM MV STDEV AF RD*INDDI squared statistic 
1.8940 0.0170 0.0943 
-0.0777 0.1143 0.0595 0.0391 0.3058 281.2578 
(17.9434) (1.9223) (2.8003) (-3.5845) (11.3706) (1.4726) (0.7630) (0.0000) 
Adjusted R- F- 
C RD BM MV STDEV AF RD*INDD2 squared statistic 
1.8888 0.0186 0.0964 
-0.0767 0.1144 0.0592 -0.0109 0.3057 281.1448 (17.9317) (2.0732) (2.8703) (-3.5454) (113673) (1.4642) (-0.4667) (0.0000) 
Adjusted R- F- 
C RD BM MV STDEV AF RD*INDD3 squared statistic 
1.9032 0.0129 0.0937 
-0.0787 0.1143 0.0582 0.0230 03059 281.4296 (17.9584) (13944) (2.7748) (-3.6268) (113679) (1.4409) (1.2599) (0.0000) 
Adjusted R- F- 
C RD BM MV STDEV AF RD*INDD4 squared statistic 
1.8872 0.0182 0.0971 
-0.0765 0.1145 0.0596 -0.0180 0.3057 281.1385 (17.8857) (2.0646) (2.8779)' (-3.5240) (113804) (1.4733) (-0.3107) (0.0000) 
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Multiplicative dummy variables 
- 
Results with AGE among the regressors: 
Adjusted R- F- 
C RD BM AGE STDEV AF RD*INDD1 squared statistic 
1.6999 0.0189 0.1561 
-0.0186 0.1166 -0.0166 0.0291 0.3091 294.0097 (13.1538) (2.1752) (5.1881) (-0.5071) (11.7482) (-0.4962) (0.5623) (0.0000) 
Adjusted R. F- 
C RD BM AGE STDEV AF RD"INDD2 squared statistic 
1.6985 0.0201 0.1571 
-0.0188 0.1166 -0.0160 -0.0098 0.3091 293.9537 (13.0425) (2.2843) (5.2269) (-0.5053) (11.7431) (-0.4801) (-0.4126) (0.0000) 
Adjusted R- F- 
C RD BM AGE STDEV AF RD*INDD3 squared statistic 
1.6913 0.0168 0.1561 
-0.0143 0.1167 -0.0180 0.0138 0.3092 294.0461 (13.0943) (1.8533) (5.1831) (-0.3891) (11.7534) (-0.5382) (0.7648) (0.0000) 
Adjusted R- F- 
C RD BM AGE STDEV AF RD*INDD4 squared statistic 
1.6927 0.0198 0.1576 
-0.0169 0.1167 -0.0157 -0.0185 0.3091 293.9545 (13.1148) (2.2879) (5.2328) (-0.4609) (11.7597) (-0.4699) (-03203) (0.0000) 
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Appendix 5B. B Part C: Appendix 5B. B Part C reports controls for time period effects as a result 
of the New Economy. Part C of the Appendix 5B. B reports the regression results as in table 513.3, 
when minus twelve month forecast data are used and R&D intensity is defined as R&D/Sales, but 
by a) running the regressions by excluding the years 1999-2001, and b) running the regression 
for the whole sample period 1990-2003 with the inclusion of a year dummy variable, taking the 
value of 1 if the data refer to year 1999 or 2000 or 2001, and zero otherwise, when either MV or 
AGE is included among the regressors. 
Regression run by excluding the years 1999-2001: 
Adjusted R- F- 
C RD BM MV STDEV AF squared statistic 
1.8167 0.0201 0.0431 
-0.0569 0.1104 0.0046 0.3256 266.3243 (14.2558) (1.9010) (1.0687 (-2.1973) (9.5477) (0.1002) (0.0000) 
Adjusted R- F- 
C RD BM AGE STDEV AF squared statistic 
1.6485 0.0214 0.0882 
-0.0049 0.1131 -0.0536 0.3335 284.4376 
(10.4181) (2.0756) (2.4667) (-0.1065) (9.9136) (-1.3809) (0.0000) 
Regression run with the inclusion of a time dummy: 
Time Adjusted R- F- 
C RD BM MV STDEV AF Dummy squared statistic 
1.8971 0.0181 0.0956' 
-0.0775 0.1142 0.0627 -0.0315 0.3058 281.2649 (17 9285) (2.0636) (2.8424) (-3.5802) (113448) (1.5492) (-0.8278) (0.000 
, 
Time Adjusted R- F- 
C RD BM AGE STDEV AF Dummy squared statistic 
1.6983 0.0197 0.1569 
-0.0174 0.1165 -0.0142 -0.0207 0.3091 
293.9985 
(13 1052) (2.2913) (5.2141) (-0.4718) (117271) (-0.4248) (-0.5539) (0.0000) 
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Appendix 5B. B Part D: Appendix 5B. B Part D reports controls for period fixed-random effects 
in the regression in Table 5B. 3. Part D of the Appendix 5B. B reports the regression results as in 
table 5B. 3, when minus twelve month forecast data are used and R&D intensity is defined as 
R&D/Sales, by running the regression (using MV among the regressors) using period fixed and 
random effects. The model is not run by adding an AR(1) term in order to correct for serial 
correlation (Park, Sickles and Simar, 2003; Baltagi and Chang, 1992) because econometric 
software did not permit its application along with period fixed and random effects. 
Period fixed effects: 
Adjusted R- 
C RD BM MV STDEV AF squared F-statistic 
1.5506 0.0140 0.1499 
-0.1330 0.1753 0.3014 0.1371 53.7994 (27.6993) (2.4837) (7.1255) (-8.7600) (17.1037) (9.5467) (0.0000) 
Period Random effects: 
Adjusted R- 
C RD BM MV STDEV AF squared F-statistic 
1.5393 0.0152 0.1602' 
-0.1146 0.1766 0.2664 0.1072 144.6128 
(22.9589) (2.6969) (7.6380) (-7.6887) (17.2575) (8.5595) (0.0000) 
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APPENDIX 5B. C 
Appendix 5B. C Part A: Part A of the Appendix 511.6 presents the results as in Table 5B. 6 Panel 
B but with the RD factor calculated with equal-weighted returns in different ways: 
1) Appendix 5B. C Part A Panel A reports the results with an RD factor calculated as in Al- 
Horani, Pope and Stark (2003) by taking the difference between the average (equal- 
weighted) monthly rcturns of three R&D reporting BM port folios and three zero R&D 
portfolios: (LRD+MRD+HRD)/3-(LZRD+MZRD+HZRD)/3, for the whole sample, the 
R&D, zero R&D firms and firms with an R&D/Sales ratio above the sample median. 
2) Appendix 5B. C Part A Panel B reports the results with an RD factor calculated on its 
own by subtracting the average monthly returns of low R&D (R&D/Sales below 30th 
percentile) and zero R&D firms from the returns of mid and high R&D 
portfolios(R&D/Sales between 30th and 70d' percentile and above 70th percentile 
respectively): (High RD+Mid RD)/2-(Low RD+Zero RD)/2 with equal-weighted returns, 
for the whole sample, the R&D, zero R&D firms and firms with an R&D/Sales ratio 
above the sample median. 
3) Appendix 5B. C Part A Panel C reports the results with an RD factor calculated on its own 
by subtracting the returns of the R&D firms with an R&D/Sales ratio below the 30th 
percentile from the returns of the R&D firms with an R&D/Sales ratio above 70th 
percentile (High RD-Low RD) with equal-weighted returns, for the R&D firms and for 
firms with an R&D/Sales ratio above the sample median. 
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Anoendix 5B. C Part A Panel A: Time-series regressions run with an RD factor as in Al Horani et at (2003 
Sample 
Adjusted R- F- 
alpha RM SMB HML RD Factor squared statistic 
Dl (low) 0.001 1.019 0.566 0.151 0.040 0.718 99.828 
(0.3216) (18.1964) (8.5109) (2.1401) (0.2979) (0.0000) 
D2 0.000 1.013 0.389 0.232 
-0.049 0.683 84.464 
(-0.0154) (17.9958) (5.3271) (2.7160) (-0.3817) (0.0000) 
D3 
-0.002 1.191 0.581 0.366 -0.088 0.714 97.878 
(-0.9768) (19.0810) (7.6338) (4.6128) (-0.6026) (0.0000) 
D4 
-0.002 1.176 0.682 0.425 0.057 0.718 99.436 
(-0.8449) (17.4664) (9.5743) (53807) (03527) (0.0000) 
D5 (High) 
-0.002 1.425 1.067 0.446 -0.102 0.753 119.231 (-0.8781) (19.1512) (11.8565) (5.0036) (-0.5694) (0.0000) 
R&D firms 
DI (low) 0.001 1.049 0.506 0.047 0.452 0.740 111.471 
(0.3710) (17.3987) (6.3512) (0.6088) (3.1659) (0.0000) 
D2 
-0.001 0-999 0.249 0.238 0.332 0.665 77.908 (-0.3077) (16.9f53) (2.7697) (2.7158) (2.2340) (0.0000) 
D3 
-0.002 1,172 0.573 0339 0372 0.652 73.513 
(-0.6331) (16.2120) (6.1808) (3.6933) (2.0645) (0.0000) 
D4 
-0.001 1.152 0.602 0.346 0.492 0.679 82.965 
(-0.2546) (16.0000) (6.8278) (3.8006) (2.5646) (0.0000) 
D5 (High) 
-0.003 1: 377 1.025 0.268 0.527 0.705 93.505 (-1.0540) (15.7866) (10.1868) (2.5826) (2.6879) (0.0000) 
Zero R&D firms 
D1 (low) 0.000 1.005 0.627 0.212 
-0.215 0.658 75.545 
(0.1344) (16.4407) (8.6373) (2.7133) (-1.4354) (0.0000) 
D2 0.000 1.021 0.502 0.227 
-0339 0.635 68.320 
(0.1144) (16.3183) (6.4418) (2.4095) (-23376) (0.0000) 
D3 
-0.003 1.205 0.603 0.377 -0.425 0.702 92.094 (-1.1500) (19.3729) (7.3119) (4.4655) (-2.6092) (0.0000) 
D4 
-0.003 1.192 0.729 0.468 -0.229 0.696 89.526 (-1.1235) (16.4358) (9.4450) (5.5756) (-1.4305) (0.0000) 
D5 (High) 
-0.001 1.422 1.034 0.513 -0.418 0.726 103.420 (-0.5777) (18.4484) (9.4530) (5.3849) (-2.0838) (0.0000) 
_ R&D firms with RD/Sales> median 
D1 (low) 0.005 1.154 0.642 
-0.142 0.661 0.660 76.067 
(1.6064) (12.5926) (4.2647) (-1.2823) (2.7840) (0.0000) 
D2 
-0.001 1.085 0.455 -0.043 0.391 0.578 54.086 
(-0.1892) (12.6675) (3.5072) (-0.3691) (1.5323) (0.0000) 
D3 
-0.001 1319 0.784 0.031 0.532 0.580 54.555 (-0.2954) (10.5271) (5.7312) (0.2171) (1.8750) (0.0000) 
D4 0.007 1.342 0.890 
-0.081 0.709 0.546 47.654 
(1.4826) (10.61556) (6.3285) (-0.5273) (1.9638) (0.0000) 
D5 (High) 
-0.001 1.395 1.289 -0.180 0.902 0.624 65323 
(-0.2683) (11.7790) (9.6806) (-1.1241) (3.3355) (0.0000) 
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Appendix 5B. C Part A Panel B: Time-series regressions run with an RD factor calculated as (High 
RD+Mid RDV2-(Low RD+Zero RDY2 
Sample 
RD Adjusted R- F- 
alpha RM SMB HML Factor squared statistic 
DI (low) 0.000 0. Q66 0.496 0346 0.319 0.738 109.981 
(-0.2391) (17.8993) (7.8452) (3.7992) (3.1190) (0.0000) 
D2 
-0.002 0.938 0.307 0.509 0.424 0.717 99.230 (-0.8137) (16.4773) (4.2607) (5.0632) (3.3838) (0.0000) 
D3 
-0.004 1.121 0.512 0.623 0.380 0.735 108.491 
(-1.6928) (20.0172) (6.4461) (6.3510) (3.2220) (0.0000) 
D4 
-0.003 1.111 0.593 0.669 0.399 0.741 111.984 (-1.5085) (17.5338) (8.1859) (6.4061) (3.3042) (0.0000) 
D5 (High) 
-0.004 1328 0.969 0.802 0.532 0.782 140.206 
(-1.8344) (17.8501) (11.1273) (7.6361) (4.0817) (0.0000)' 
R&D firms 
Dl (low) 0.000 0.997 0.361 0.259 0.459 0.757 121.577 
(0.0878) (16.4515) (4.8730) (2.6533) (4.0000) (0.0000) 
D2 
-0.002 0.934 0.110 0.494 0.494 0.697 90.147 (-0.7515) (16.88Q5) (1.2317) (4.7004) (3.7638) (0.0000) 
D3 
-0.003 1.095 0.412 0.643 0.580 0.686 85.598 
(-1.1130) (16.9635) (4.5199) (5.2111) (3.9379) (0.0000) 
D4 
-0.001 1.091 0.439 0.594 0.526 0.699 90.993 (-0.5526) (16.7277) (4.8709) (4.8718) (3.9850) (0.0000) 
D5 (High) 
-0.005 1.259 0.786 0.730 0.872 0.762 125341 (-1.9773) (153015) (7.9893) (6.3757) (6.2640) (0.00(0) 
Zero R&D firms 
D1 (low) 
-0.001 0.954 0.605 0.392 0.225 0.663 77.194 
(-0.4836) (15.8716) (8.5032) (3.7702) (2.0121) (0.0000) 
D2 
-0.002 0.943 0.468 0.506 0.345 0.645 71.443 
(-0.7779) (13.8124) (6.0585) (4.4191) (2.4855) (0.0000) 
D3 
-0.005 1.141 0.602 0.598 0.231 0.695 89.445 (-1.8933) (18.1759) (6.7537) (5.6039) (1.8488) (0.0000) 
D4 
-0.004 1. j26 0.690 0.704 0.308 0.705 93.672 
(-1.8957) (15.4112) (8.6766) (6.4120) (2.4003) (0.0000) 
D5 (High) 
-0.004 1.342 1.013 0.791 0.323 0.727 103.995 (-1.3676) (16.7026) (9.8201) (6.2307) (2.1394) (0.0000) 
R&D firms with RD/Sales> median 
D1 (low) 0.003 1.056 0.402 0.253 0.804 0.702 92.251 
(1.2143) (11.9534) (3.3425) (1.8102) (4.7049) (0.0000) 
D2 
-0.003 0.964 0.237 0.423 0.842 0.651 73388 (-0.9139) (11.4045) (2.0268) (3.1151) (4.5622) (0.0000) 
D3 
-0.003 1.190 0.531 0.535 0.939 0.639 52.095 (-0.9106) (10.2505) (4.7067) (2.8297) (4.3802) (0.0000) 
D4 0.004 1.171 0.555 0.582 1.239 0.630 66.887 
(0.9582) (11.4432) (4.5166) (3.0290) (5.6901) (0.0000) 
D5 (High) 
-0.004 1.08 0.899 0.554 1.403 0.714 97.555 
(-1.1952) (10.734) (7.1784) (3.1566) (7.6111) (0.0000) 
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Appendix 5B. C Part A Panel C: Time-series regressions run with an RD factor calculated as (High RD- 
Low RD) 
R&D firms 
RD Adjusted R- F- 
alpha RM SMB HML Factor squared statistic 
DI (low) 0.000 1.019 0332 0.191 0.189 0.738 110.248 
(0.2157) (16.0677) (3.8404) (1.8275) (2.6518) (0.0000) 
D2 
-0.001 0.957 0.080 0.420 0.203 0.674 81.104 (-0.6272) (16.7504) (0.7600) (3.8450) (2.5318) (0.0000) 
D3 
-0.002 1.130 0.392 0.527 0.214 0.658 75.599 
(-0.8650) (15.4865) (3.6466) (4.1292) (2.4694) (0.0000) 
D4 
-0.001 1.111 0.397 0.533 0.232 0.681 83.752 
(-0.4531) (15.1660) (3.7622) (4.1924) (2.9654) (0.0000) 
D5 (High) 
-0.005 1.255 0.635 0.776 0.509 0.756 121.299 
(-2.1984) (15.8169) (5.5527) (6.1170) (6.0561) (0.0000) 
R&D firms with RD/Sales> median 
D1 (low) 0.003 1.071 0.302 0.224 0.409 0.682 83.921 
(1.1664) (11.3238) (2.1980) (1.5553) (4.0090) (0.0000) 
D2 
-0.003 0.974 0.121 0.414 0.446 0.631 67.231 (-1.0211) (11.4792) (0.8564) (3.1681) (4.1316) (0.0000) 
D3 
-0.003 1. A28 0.460 0.419 0.408 0.604 60.076 
(-0.7612) (9.5948) (3.2739) (2.2188) (3.2693) (0.0000) 
D4 0.003 1.183 0.377 0.580 0.667 0.607 60.883 
(0.8278) (10.7491) (2.3805) (2.8184) (4.8263) (0.0000) 
D5 (High) 
-0.005 1.192 0.634 0.667 0.853 0.713 97.081 (-1.5751) (11.4935) (4.8175) (3.4041) (7.6609) (0.0000) 
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Appendix 5B. C Part B: Part B of the Appendix 5B. C presents the results as in Table 5B. 6 Panel 
B and Appendix 5B. C Part A Panels A, B and C but this time by using an RD factor calculated 
from value instead of equal weighted returns. 
Appendix 5B. C Part B- Table equivalent to table 5B. C Panel B: Time-series regressions run with an RD factor 
calculated as (Rieh RD-Zero RD) 
Sample 
alpha RM SMB 1 -IMI, RD Factor Adjusted R-squared F-statistic 
D1 (low) 
-0.001 0.545 0.485 0.170 -0.513 0.777 135.665 
(-03446) (6.2349) (7.6273) (2.9217) (-5.9729) (0.0000) 
D2 
-0.002 0.391 0.294 0.275 -0.668 0.781 139.575 (-1.1101) (3.8248) (4.3581) (4.2121) (-6.1444) (0.0000) 
D3 
-0.004 0.497 0.479 0.419 -0.742 0.808 163.596 
(-2.3391) (4.9333) (6.8362) (6.9956) (-6.7014) (0.0000) 
D4 
-0.004 0.509 0.567 0.452 -0.722 0.808 163.559 (-1.8975) (5.2236) (8.8550) (7.1137) (-7.5450) (0.0000) 
D5 (High) 
-0.004 0.695 0.961 0.504 -0.780 0.826 185.202 (-2.2018) (6.6324) (12.3354) (7.2445) (-7.2729) (0.0000) 
R&D firms 
D1 (low) 0.001 0.744 0.402 
-0.014 -0.357 0.746 115.064 
(0.4871) (6.8476) (4.9587) (-0.2134) (-3.6607) (0.0000) 
D2 
-0.001 0.559 0.138 0.206 -0.495 0.704 93.051 (-0.5541) (4.1318) (15363) (2.9645) (-3.1447) (0.0000) 
D3 
-0.002 0.585 0.433 0.308 -0.657 0.707 94.382 
(-0.9737) (4.2105) (4.7298) (4.1932) (-4.3909) (0.0000) 
D4 
-0.001 0.595 0.453 0.292 -0.632 0.724 102.773 (-0.4438) (45848) (4.9243) (3.8106) (-5.1108) (0.0000) 
D5 (High) 
-0.004 0.733 0.857 0.213 -0.727 0.748 116.186 (-1.3608) (5.1559) (8.0413) (2.1476) (-4.9880) (0.0000) 
Zero RD firms 
Dl (low) 
-0.002 0.435 0.561 0.280 -0.601 0.732 106.919 
(-0.9181) (4.3307) (8.1170) (4.3512) (-6.1004) (0.0000) 
D2 
-0.003 0.277 0.422 0.326 -0.781 0.751 117.816 (-1.4107) (25856) (6.2490) (4.5025) (-7.8446) (0.0000) 
D3 
-0.006 0.422 0.527 0.493 -0.817 0.798 154.556 (-3.1447) (4.0965) (7.0790) (7.5126) (-7.5777) (0.0000) 
D4 
-0.005 0.450 0.636 0.549 -0.786 0.794 150.423 
(-2.7228) (4.3550) (9.7172) (8.4339) (-7.4490) (0.0000) 
D5 (High) 
-0.004 0.652 0.959 0.627 -0.803 0.793 149.252 (-2.1097) (5.4707) (10.3436) (8.8297) (-6.9801) (0.0000) 
R&D firms with RD/Sales> median 
D1 (low) 0.005 0.7? 6 0.502 
-0.235 -0.439 0.658 75.680 
(1.8501) (4.7384) (3.4638) (-2.5334) (-3.3947) (0.0000) 
D2 
-0.001 0.577 0.325 -0.082 -0.573 0.613 62.319 (-0.3823) (2.7688) (2.5209) (-0.9056) (-2.8876) (0.0000) 
D3 
-0.002 0.6$3 0.617 -0.025 -0.720 0.616 63.155 (-0.4426) (2.919) (4.7452) (-0.1891) (-3.2376) (0.0000) 
D4 0.006 0.340 0.649 
-0.150 -1.082 0.617 63.553 
(1.3620) (1.7329) (4.6030) (-0.2382) (-6.7007) (0.0000) 
D5 (High) 
-0.001 0.616 1.058 -0.292 -0.875 0.650 73.050 (-0.2821) (2.8673) (7.6515) (-1.7416) (-3.6382) (0.0000) 
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Appendix 5B. C Part B- Table equivalent to table in Appendix 513. B Part A Panel A: Time-series 
regressions run with an RD factor as in Al Horani et al (2003) 
Sample 
Adjusted R- F- 
alpha RM SMB H ML RD Factor squared statistic 
Df (low) 0.001 0.923 0.469 0.233 
-0.715 0.781 139.478 
(0.6104) (20.1183) (7.2540) (4.3090) (-6.1585) (0.0000) 
D2 0.000 0. $86 0.276 0.353 
-0.907 0.784 141.718 (0.1255) (21.4891) (3.9740) (5.7186) (-6.2478) (0.0000) 
D3 
-0.002 1. Q46 0.457 0.509 -1.025 0.813 169.820 
(-1.1110) (22.7436) (6.5851) (9.1880) (-7.2627) (0.0000) 
D4 
-0.001 1.451 0.554 0.531 -0.936 0.802 157.591 (-0.7303) (16.6431) (8.0916) (9.0562) (-6.7598) (0.0000) 
D5 (High) 
-0.002 1.267 0.933 0.603 -1.114 0.836 198.825 
(-1.0127) (21.5103) (11.9293) (9.4296) (-8.1005) (0.0000) 
R&D firms 
D1 (low) 0.002 1.006 0.389 0.031 
-0.510 0.750 117.109 (1.0307) (15.6$15) (4.6808) (0.5071) (-3.8324) (0.0000) 
D2 0.000 0.930 0.128 0.261 
-0.648 0.701 92.053 (0.1576) (20.6108) (1.4186) (4.0768) (-3.2052) (0.0000) 
D3 0.000 1.078 0.421 0380 
-0.849 0.702 92384 
(-0.1648) (15.1274) (4.5168) (5.3943) (-4.2646) (0.0000) 
D4 0.001 1.981 0.452 0.351 
-0.733 0.708 95.170 (0.3278) (13.0658) (4.5577) (5.0434) (-3.9950) (0.0000) 
D5 (High) 
-0.001 1.275 0.839 0.297 -0.976 0.748 116.286 (-0.5045) (15.7178) (7.4398) (2.9663) (-4.9817) (0.0000) 
Zero RD firms 
D1 (low) 0.000 0.878 0.541 0.354 
-0.840 0.739 110.649 
(0.0515) (17.6641) (7.7893) (5.9754) (-63223) (0.0000) 
D2 0.000 0.852 0.397 0.422 
-1.091 0.762 125.055 (-0.0813) (17.1729) (5.6504) (5.9239) (-8.2552) (0.0000) 
D3 
-0.003 1.021 0.498 0.597 -1.167 0.813 170.022 (-1.7932) (22.6740) (6.9214) (9.7011) (-8.6595) (0.0000) 
D4 
-0.003 1.032 0.614 0.642 -1.077 0.799 154.738 
(-1.4678) (17.6761) (9.4710) (10.2988) (-7.6344) (0.0000) 
D5 (High) 
-0.002 1.236 0.927 0.732 -1.176 0.808 163.897 (-0.9794) (19.2902) (10.4270) (11.5057) (-8.2728) (0.0000) 
R&D firms with RD/Sales> median 
Dl (low) 0.007 1.107 0.486 
-0.179 -0.629 0.662 76.782 (2.2935) (9.9199) (3.2106) (-2.0399) (-3.5408) (0.0000) 
D2 0.001 0.996 0.304 
-0.010 -0.818 0.619 63.879 (0.2244) (12.1609) (2.3619) (-0.1148) (-3.6439) (0.0000) 
D3 0.000 1.232 0.612 0.046 
-0.867 0.607 60.785 (0.1310) (8.9207) (4.4648) (0.3435) (-2.8892) (0.0000) 
D4 0.009 1.316 0.652 
-0.053 -1.220 0.592 57.118 
(2.0763) (8.4371) (4.1704) (-0.4753) (-5.1049) (0.0000) 
D5 (High) 0.002 1.477 1.026 
-0.182 -1.251 0.657 75.325 (0.4315) (11.8290) (7.1228) (-1.0870) (-4.1155) (0.0000) 
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Appendix 5B. C Part B- Table equivalent to table in Appendix 5B. B Part A Panel B: Time-series regressions 
run with an RD factor calculated as (High RD+Mid RDY2-Low RD+Zero RD)12 
Sample 
Adjusted R- F- 
alpha RM SMB HML RD Factor squared statistic 
D1 (low) 0.000 0.952 0.566 0.102 
-0208 0.726 103.820 
(0.1902) (12.1183) (9.0296) (1.6690) (-1.7331) (0.0000) 
D2 
-0.001 0.938 0.399 0.196 -0.220 0.692 87.961 (-0.2740) (11.7007) (5.7770) (2.5591) (-1.5551) (0.0000) 
D3 
-0.003 1. Q85 0.597 0319 -0309 0.727 104.375 
(-1.3810) (13.3535) (8.3098) (4.3230) (-2.2929) (0.0000) 
D4 
-0.002 1. Q89 0.681 0.360 -0.275 0.728 104.868 (-1.0564) (12.1405) (10.3608) (5.3395) (-1.8598) (0.0000) 
D5 (High) 
-0.003 1.329 1.084 0.409 -0274 0.760 123.859 
(-1.2440) (14.5899) (13.0755) (5.2315) (-1.9627) (0.0000) 
R&D firms 
DI (low) 0.002 1. Q20 0.459 
-0.066 -0.169 0.727 104.243 
(0.7651) (13.4705) (5.6758) (-0.9611) (-1.4131) (0.0000) 
D2 0.000 1.903 0.213 0.171 
-0.045 0.655 74.611 (-0.0013) (12.1757) (2.4243) (2.0665) (-0.3295) (0.0000) 
D3 
-0.001 1.134 0.535 0.238 -0.182 0.646 71.810 (-0.4057) (11.2099) (5.9651) (2.7608) (-1.1688) (0.0000) 
D4 0.000 1.123 0.551 0.224 
-0.178 0.666 78.121 (0.0842) (11.0214) (6.2034) (2.6064) (-1.1040) (0.0000) 
D5 (High) 
-0.002 1.322 0.972 0.124 -0.262 0.697 90.178 (-0.7751) (12.3769) (9.2643) (1.2232) (-1.5955) (0.0000) 
Zero RD firms 
D1 (low) 
-0.001 0.911 0.656 0200 -0.248 0.665 77.799 
(-0.3236) (10.0845) (9.6752) (3.0412) (-1.8751) (0.0000) 
D2 
-0.001 0. ß93 0.546 0.220 -0329 0.643 70.678 (-0.5346) (10.2199) (7.6833) (2.6775) (-2.0909) (0.0000) 
D3 
-0.004 1. g45 0.659 0.369 -0.412 0.711 96.549 (-1.9734) (12.9094) (8.4242) (4.6054) (-3.0064) (0.0000) 
D4 
-0.004 1.070 0.761 0.442 -0.332 0.707 94.495 
(-1.7282) (11.9327) (10.5646) (6.5196) (-2.2109) (0.0000) 
D5 (High) 
-0.003 1.301 1.086 0.527 -0.293 0.725 102.911 (-1.2056) (13.6374) (11.0719) (6.2498) (-2.0280) (0.0000) 
R&D firms with RD/Sales> median 
D1 (low) 0.006 1.151 0.571 
-0.283 -0.129 0.637 69.078 
(2.0669) (10.2310) (3.9702) (-2.7156) (-0.8329) (0.0000) 
D2 0.000 1.121 0.410 
-0.104 0.039 0.569 69.517 (0.1284) (10.2851) (33644) (-0.9290) (0.2309) (0.0000) 
D3 0.000 1.? 61 0.731 
-0.116 -0.274 0.574 53.201 (-0.0846) (7.41§2) (5.7428) (-0.8022) (-1.1862) (0.0000) 
D4 0.008 1.163 0.813 
-0.217 -0.062 0.529 44.496 
(1.8334) (7.5698) (5.6902) (-1.5092) (-0.2317) (0.0000) 
D5 (High) 0.000 1.312 1.198 
-0.420 -0.415 0.608 61.209 (0.1066) (8.9638) (8.7633) (-2.5175) (-1.7545) (0.0000) 
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Appendix 5B. C Part B- Table equivalent to table in Appendix 5B. B Part A Panel C: Time-series regressions 
run with an RD factor calculated as (High RD-Low RD) 
R&D firms 
Adjusted R- F- 
alpha RM SMB HML, RD Factor squared statistic 
D1 (low) 0.002 1.113 0.449 
-0.014 0.058 0.723 102.273 
(0.9838) (12.5752) (53937) (-0.1992) (0.5293) (0.0000) 
D2 0.000 1.076 0.202 0.207 0.088 0.657 75.062 
(0.1701) (9.2808) (2.2875) (2.4298) (0.6771) (0.0000) 
D3 
-0.001 1.225 0.526 0.289 0.047 0.642 70.637 
(-0.2196) (9.4845) (5.6436) (3.1667) (0.3065) (0.0000) 
D4 0.000 1.170 0.550 0.255 
-0.017 0.661 76.693 (0.1742) (9.4337) (5.8870) (2.8040) (-0.1102) (0.0000) 
D5 (High) 
-0.002 1.423 0.964 0.183 0.023 0.691 87.602 (-0.5697) (11.7517) (9.1026) (1.6927) (0.1821) (0.0000) 
R&D firms with RD/Sales> median 
D1 (low) 0.007 1.279 0.553 
-0.217 0.132 0.638 69.259 (2.2599) (11.2857) (3.6245) (-2.0991) (0.8034) (0.0000) 
D2 0.001 1.248 0386 
-0.046 0.213 0.575 53.500 (0.3458) (9.6817) (3.1936) (-0.4332) (1.4535) (0.0000) 
D3 0.000 1372 0.722 
-0.052 0.032 0.568 51.992 (0.0701) (6.4783) (5.2851) (-03540) (0.1381) (0.0(00) 
D4 0.009 1.491 0.792 
-0.154 0.165 0.531 44.856 
(1.9122) (7.2467) (5.2748) (-1.0476) (0.7097) (0.0000) 
D5 (High) 0.001 1.472 1.185 
-0326 0.037 0599 58.824 (03135) (8.9933) (8.6209) (-1.8302) (0.2194) (0.0000) 
_ 
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Appendix 5B. C Part C: Part C of the Appendix 5B. C presents the time-series regression results 
as in Table 5B. 6 Panel B run with an RD factor calculated as (High RD- Zero RD) with equal 
weighted returns, and using R&D/TA as a proxy for R&D intensity (Pearson correlation 
coefficient between RD factqr and Rm-Rf: 0.245, SMB: 0.324 and IIML: 
-0.79 1). 
Sample 
RD Adjusted R- F- 
alpha RM SMB HML Factor squared statistic 
D1(low) 
-0.0001 1.9053 0.5423 0.2316 0.0936 0.7212 101.2590 
(-0.0289) (17.0380) (8.5145) (2.1278) (1.0921) (0.0000) 
D2 
-0.0009 0.9952 0.3755 0.3269 0.0924 0.6857 85.5266 (-0.4349) (16.5251) (5.1303) (2.9917) (1.0436) (0.0000) 
D3 
-0.0033 1.1685 0.5689 0.4795 0.1051 0.7166 99.0045 
(-1.4496) (18.7509) (7.2708) (4.4376) (1.2238) (0.0000) 
D4 
-0.0028 1.1573 0.6483 0.5374 0.1309 0.7219 101.6110 
(-1.2657) (16.514) (9.5192) (4.6379) (1.4544) (0.0000) 
D5 (High) 
-0.0042 1.3815 1.0309 0.6767 0.2273 0.7624 125.3550 (-1.7295) (17.4112) (12.0620) (5.5634) (2.3061) (0.0000) 
R&D firms 
D1 (low) 0.0001 1.0397 0.4108 0.1683 0.2141 0.7361 109.0957 
(0.0533) (16.0340) (5.2045) (1.4985) (2.3718) (0.0000) 
D2 
-0.0012 0.9926 0.1804 0.3240 0.1534 0.6622 76.9635 (-0.5071) (16.0977) (1.9756) (2.7554) (1.6151) (0.0000) 
D3 
-0.0026 1.1559 0.4835 0.4889 0.2291 0.6545 74.4160 
(-0.9962) (15.3998) (5.2615) (3.6696) (2.1960) (0.0000) 
D4 
-0.0013 1.1433 0.5002 0.4724 0.2270 0.6741 81.1661 
(-0.4815) (15.0335) (5.6749) (33542) (2.0934) (0.0000) 
D5 (High) 
-0.0055 1.1290 0.8671 0.6209 0.4752 0.7295 105.4936 (-2.0950) (15.0647) (8.6192) (4.7145) (4.4644) (0.0000) 




0004 0.9903 0.6479 0.2636 0.0150 0.6534 74.0462 
(-0.1662) (15.2799) (9.2336) (2.1751) (0.1608) (0.0000) 
D2 
-0.0008 0.9957 0.5320 0.3188 0.0346 0.6239 65.2942 (-0.3644) (14.6192) (6.9389) (2.6554) (03607) (0.0000) 
D3 
-0.0039 1.1779 0.6473 0.4646 0.0140 0.6877 863312 (-1.5915) (18.1103) (7.5513) (3.9472) (0.1500) (0.0000) 
D4 
-0.0036 1.1681 0.7405 0.5691 0.0648 0.6926 88.3125 
(-1.6000) (15.3898) (9.7345) (4.9452) (0.7482) (0.0000) 
D5 (High) 
-0.0031 13849 1.0647 0.6544 0.0735 0.7169 99.1093 (-1.1273) (16.9506) (10.5101) (4.7285) (0.6674) (0.0000) 
R&D firms with RD/Sales> median 
D1 (low) 0.0029 1.1226 0.4795 0.1397 0.4244 0.6692 79.3904 
(0.9651) (11.4297) (3.5785) (0.9504) (33602) (0.0000) 
D2 
-0.0026 1.0471 0.3342 0.2322 0.3674 0.5972 58.4526 (-0.8209) (11.8010) (2.7761) (1.4587) (2.5771) (0.0000) 
D3 
-0.0033 1.2797 0.6362 03367 0.4254 0.5945 57.8030 (-0.9132) (9. $399) (53138) (1.6378) (2.4938) (0.0000) 
D4 0.0040 1.2965 0.7022 0.2823 0.5206 0.5611 50.5308 
(0.8812) (10.9681) (5.2715) (1.1115) (2.4116) (0.0000) 
D5 (High) 
-0.0057 1.3069 1.0119 0.4556 0.8469 0.6748 81.4227 (-1.6287) (11.1782) (8.0195) (2.3257) (5.8025) (0.0(00) 
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Appendix 5B. C Part D: Pact D of the Appendix 5B. C presents the regression results as in Table 
5B. 6 and Appendix 5B. C Pert A Panel A for the whole sample, and R&D and zero R&D firm 
portfolios separately, when using dispersion data for portfolio formation as of June t but only for 
these firms whose accounting years end between July t- December t, with June t to be the closest 
month for which I have forecast data for dispersion calculation prior to the firms month of return 
calculation. 
Panel A: No RD factor 
Sample alpha RM SMB HML Adjusted R-squared F-statistic 
D1 (low) 0.0065 0. ß769 0.3766 
-0.0734 0.6684 105.1527 
(3.1848) (15.4389) (4.8456) (-13145) (0.0000) 
D2 0.0034 0.9659 03473 
-0.0670 0.6678 104.8691 (1.5215) (14.405) (4.6254) (-1.1321) (0.0000) 
D3 
-0.0004 1.0645 0.3184 0.0555 0.7097 1273112 
(-0.1550) (16.5944) (4.1951) (0.9053) (0.0000) 
D4 
-0.0014 1.1337 0.6177 0.1409 0.6416 93.4906 (-0.4758) (13.1955) (5.9249) (1.4140) (0.0000) 
D5 (High) 
-0.0023 1.4303 0.9511 0.0551 0.6605 101.4980 (-0.6085) (14.0457) (6.9207) (05053) (0.0000) 
_ R&D firms 
Dl (low) 0.0049 0.9494 0.3220 
-0.1524 0.6418 935729 
(2.1493) (14.0735) (3.4993) (-2.1713) (0.0000) 
D2 
-0.0005 1.9586 0.1783 -0.0519 0.6612 101.8402 (-0.1984) (15.7734) (1.9573) (-0.7610) (0.0000) 
D3 0.0025 1.9185 0.2238 0.0170 0.6565 99.7578 
(1.0406) (16.1472) (2.6112) (03041) (0.0000) 
D4 
-0.0003 1.1784 0.6469 0.1691 0.5991 78.2205 
(-0.0957) (10.8745) (5.2325) (1.7482) (0.0000) 
D5 (High) 0.0032 1.3771 0.9073 
-0.0941 0.5416 62.0544 (0.6869) (11.2635) (6.2028) (-0.7150) (0.0000) 
Zero R&D firms 
D1 (low) 0.0073 0.8327 0.4148 
-0.0385 0.5904 75.4824 
(3.0461) (13.4085) (4.9144) (-0.6079) (0.0000) 
D2 0.0058 0.9045 0.4547 
-0.0691 0.5722 70.1115 (2.2607) (11.5056) (5.0658) (-0.9639) (0.0000) 
D3 
-0.0023 1.0964 0.3916 0.0915 0.6392 92.5277 
(-0.8120) (14.2654) (4.6607) (1.1906) (0.0000) 
D4 
-0.0020 1.1053 0.5724 0.1152 05590 66.4866 
(-0.5619) (11.7324) (4.2859) (0.9603) (0.0000) 
D5 (High) 
-0.0052 1.4398 0.9693 0.1221 0.6536 985007 (-1.4169) (13.866) (6.0851) (1.1813) (0.0000) 
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Panel B: Time-series regressions run with an RD factor as (High R&D-Zero R&D) calculated with equal- 
weiehted returns 
Sample 
Adjusted R- F- 
alpha RM SMB HML RD Factor squared statistic 
D1 (low) 0.0071 0.8968 0.4273 
-0.1530 -0.1443 0.6759 81.8134 (3.4343) (15.3656) (5.6601) (-2.2832) (-1.9659) (0.0000) 
D2 0.0038 0.9778 0.3777 
-0.1148 -0.0866 0.6685 79.1553 (1.7129) (13.5351) (4.9441) (-1.6683) (-1.1080) (0.0000) 
D3 0.0008 1.0981 0.4042 
-0.0789 -0.2439 0.7284 104.9278 (0.3673) (16.5873) (5.6917) (-1.1669) (-3.6081) (0.0000) 
D4 
-0.0011 1.1432 0.6419 0.1029 -0.0689 0.6405 70.0363 (-0.3708) (12.3775) (6.0962) (0.8218) (-0.6451) (0.0000) 
D5 (High) 
-0.0022 1.4311 0.9532 0.0518 -0.0060 0.6582 75.6247 (-0.6299) (12.9101) (7.5885) (0.3739) (-0.0364) (0.0000) 
R&D firms 
D1 (low) 0.0048 0.9473 0.3167 
-0.1441 0.0151 0.6395 69.7434 (2.0997) (13.6674) (3.4429) (-1.6449) (0.1581) (0.0000) 
D2 
-0.0005 1.0605 0.1832 -0.0596 -0.0139 0.6590 75.8985 (-0.1733) (14.9463) (1.9423) (-0.7066) (-0.1740) (0.0000) 
D3 0.0027 1.0265 0.2441 
-0.0149 -0.0579 0.6554 74.7080 (1.1399) (15.6237) (2.8191) (-0.2091) (-0.7108) (0.0000) 
D4 
-0.0015 1.1439 0.5590 0.3069 0.2500 0.6109 61.8442 
(-0.4760) (9.9375) (4.4240) (2.3690) (1.8439) (0.0000) 
D5 (High) 0.0018 1.3347 0.7990 0.0756 03078 0.5521 48.7742 
(0.4092) (10.1179) (5.5753) (0.4864) (1.5616) (0.0000) 
Zero R&D firms 
D1 (low) 0.0084 0.8053 0.4980 
-0.1689 -0.2364 0.6131 62.4142 (3.4473) (13.8233) (6.1424) (-2.2616) (-3.1909) (0.0000) 
D2 0.0064 0.9223 0.5001 
-0.1403 -0.1291 0.5755 53.5434 (2.4819) (10.879) (5.5346) (-1.6244) (-1.1963) (0.0000) 
D3 
-0.0005 1.1473 0.5215 -0.1122 -0.3694 0.6770 82.2150 (-0.1919) (14.3974) (6.5721) (-13216) (-4.5756) (0.0000) 
D4 
-0.0007 1.1434 0.6695 -0.0371 -02762 05750 53.4300 (-0.1901) (11.6306) (5.7869) (-0.2400) (-1.9630) (0.0000) 
D5 (High) 
-0.0043 1.4(52 1.0341 0.0205 -0.1844 0.6568 75.1723 (-1.2080) (13.4239) (7.3724) (0.1457) (-1.1819) (0.0000) 
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Panel C: Time-series regressions run with an RD factor in Al Horani et al (2003) calculated with equal- 
weiehted returns 
Sample 
Adjusted R- F- 
alpha RM SMB 1-IML RD Factor squared statistic 
D1 (low) 0.0066 0.8858 03803 
-0.0797 -0.1155 0.6685 79.1552 (3.2189) (15.7472) (5.1195) (-1.4015) (-0.9591) (0.0000) 
D2 0.0036 0.9$20 03541 
-0.0782 -0.2083 0.6719 80.3571 (1.6344) (14.47$6) (4.8988) (-1.3290) (-1.8775) (0.0000) 
D3 
-0.0001 1.0801 03250 0.0447 -0.2019 0.7130 97.2907 (-0.0447) (16.7526) (4.5452) (0.7446) (-1.9396) (0.0000) 
D4 
-0.0014 1.1393 0.6200 0.1370 -0.0723 0.6397 69.8122 (-0.4450) (12.9717) (6.0107) (1.3451) (-0.5025) (0.0000) 
D5 (High) 
-0.0019 1.4516 0.9601 0.0403 -0.2753 0.6629 77.1921 (-0.5221) (14.1408) (7.3809) (03652) (-1.2237) (0.0000) 
_R&D 
firms 
D1 (low) 0.0048 0.9463 03207 
-0.1503 0.0398 0.6396 69.7838 (2.0961) (13.8182) (3.4614) (-2.0996) (03034) (0.0000) 
D2 
-0.0007 1.0462 0.1731 -0.0433 0.1599 0.6621 76.9122 (-0.2688) (15.5850) (1.9151) (-0.6225) (13370) (0.0000) 
D3 0.0023 1.0078 0.2192 0.0245 0.1388 0.6568 75.1469 
(0.9596) (15.4750) (2.4642) (0.4223) (0.8832) (0.0000) 
D4 
-0.0011 1.1321 0.6273 0.2012 0.5991 0.6274 66.2474 
(-0.3288) (10.7886) (53923) (2.1619) (3.7951) (0.0000) 
D5 (High) 0.0027 13418 0.8923 
-0.0695 0.4574 0.5498 48.3134 (0.5843) (11.0592) (5.8595) (-0.5259) (1.5126) (0.0000) 
Zero R&D firms 
D1 (low) 0.0076 0.8502 0.4222 
-0.0507 -0.2263 0.5964 58.2599 (3.1498) (13.7870) (53675) (-0.7950) (-1.6947) (0.0000) 
D2 0.0064 0.9392 0.4694 
-0.0933 -0.4500 0.5973 58.4679 
(2.5209) (12.0450) (5.8382) (-13464) (-3.1774) (0.0000) 
D3 
-0.0017 1.1305 0.4061 0.0677 -0.4420 0.6582 75.6314 (-0.6360) (14.8425) (5.2574) (0.9112) (-3.6666) (0.0000) 
D4 
-0.0014 1.1434 0.5885 0.0888 -0.4928 0.5785 54.1922 (-0.3898) (12.4413) (4.8792) (0.7295) (-2.4174) (0.0000) 
D5 (High) 
-0.0043 1.4497 0.9904 0.0875 -0.6456 0.6765 82.0273 (-1.2367) (14.5769) (6.9225) (0.8405) (-2.9440) (0.0000) 
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Appendix 5B. C Part E: Pakt E of the Appendix 5B. C presents the regression results as in Table 
5B. 6 Panels A and B with and without including an RD (RD factor as high R&D-Zero R&D in 
Panel B and as in Al-Horapi et at (2003) in Panel C) with equal weighted returns with the 
regressions run by excluding the months from January 1999 until December 2001 (total sample 
period July 1991-June 2004). 
Panel A: No RD factor 
Sample alpha RM SMB HMIL Adjusted R-squared F-statistic 
Dl (low) 
-0.0010 1.9313 0.5869 0.0993 0.7623 128.1861 
(-0.5209) (183995) (8.4398) (1.1238) (0.0000) 
D2 
-0.0019 1.4248 0.4346 0.1534 0.7916 151.6294 
(-1.0963) (21.9107) (6.5238) (1.6095) (0.0000) 
D3 
-0.0037 1. f 746 0.6351 0.3251 0.7819 143.2372 (-1.7059) (22.8419) (9.2942) (3.2695) (0.0000) 
D4 
-0.0046 1.1766 0.6698 0.5273 0.8046 1643229 
(-2.2696) (17.8529) (9.7323) (5.2947) (0.0000) 
DS (High) 
-0.0054 1.4141 1.0760 0.5409 0.8130 173.4291 (-2.2939) (19.4420) (12.6547) (4.9208) (0.0000) 
R&D firms 
DI (low) 0.0010 1.1329 0.5091 
-0.1616 0.7619 127.9097 (0.4729) (17.1991) (5.7547) 
-(1.5628) (0.0000) 
D2 
-0.0010 1.9326 0.2496 0.1821 0.7568 124.4098 
(-0.5141) (22.2246) (2.9196) (1.8760) (0.0000) 
D3 
-0.0021 1.2070 0.5243 0.2680 0.6976 92.5100 (-0.7711) (15.9420) (5.6896) (2.0864) (0.0000) 
D4 
-0.0017 1.1691 0.6085 03765 0.7251 105.6461 
(-0.6728) (13.9217) (6.2926) (3.2473) (0.0000) 
D5 (High) 
-0.0059 1.4004 0.9677 0.1672 0.7386 113.0800 (-2.0789) (16.0692) (8.2814) (1.2444) (0.0000) 
Zero R&D firms 
Df (low) 
-0.0025 0.9774 0.6694 0.2317 0.7010 94.0020 (-1.1459) (153647) (8.8136) (2.2529) (0.0000) 
D2 
-0.0027 1.0129 0.5840 0.1406 0.7336 110.2328 
(-1.3301) (17.5991) (8.0922) (1.1971) (0.0000) 
D3 
-0.0050 1.1517 0.7341 03574 0.7652 130.2913 (-2.1667) (21.1067) (9.6427) (3.2537) (0.0000) 
D4 
-0.0062 1.1794 0.6963 0.6253 0.7971 156.7937 
(-3.0211) (18.5045) (10.0200) (5.6574) (0.0000) 
D5 (High) 
-0.0047 13935 1.0749 0.6801 0.7872 147.7026 (-0.8471) (17.5246) (10.9052) (5.5735) (0.0000) 
R&D firms with RD/. Sales> median 
D1 (low) 0.0076 1.2708 0.6711 
-05097 0.6427 723408 (2.2720) (11. (630) (3.96%) (-3.3611) (0.0000) 
D2 
-0.0013 1.1096 0.4669 -0.0354 0.6048 61.7135 
(-0.4430) (12.7336) (3.5776) (-0.2465) (0.0000) 
D3 
-0.0002 1.1123 0.7325 -0.0712 0.5826 563547 (-0.0524) (8.7346) (5.1115) (-0.4066) (0.0000) 
D4 0.0016 1.3672 0.9157 
-0.0285 0.5230 44.4849 (0.3348) (8.648) (5.5848) (-0.1184) (0.0000) 
D5 (High) 
-0.0071 1.4799 1.1048 -0.2684 0.6356 70.2017 (-1.9354) (13.1484) (7.7852) (-13661) (0.0000) 
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Panel B: Time-series regressions run with an RD factor as (High R&D-Zero R&D) calculated with equal- 
weiehted returns 
Sample 
Adjusted R- F- 
alpha RM SMB 1IML RD Factor squared statistic 
D1 (low) 
-0.0013 1.0154 0.5754 0.1483 0.0616 0.7617 96.0961 
(-0.6559) (17.3288) (8.2936) (1.3328) (0.6942) (0.0000) 
D2 
-0.0020 1.0167 0.4288 0.1785 0.0315 0.7902 113.0218 (-1.1441) (22.2492) (6.4473) (1.7664) (03728) (0.0000) 
D3 
-0.0039 1.1639 0.6274 03582 0.0416 0.7806 106.8327 
(-1.7904) (20.3718) (9.0205) (3.0385) (0.4948) (0.0000) 
D4 
-0.0050 1.1496 0.6503 0.6108 0.1049 0.8063 124.8152 (-2.5169) (17.1310) (9.2193) (5.0348) (1.1186) (0.0000) 
D5 (High) 
-0.0063 13592 1.0363 0.7105 0.2131 0.8209 137.3608 (-2.6883) (17.2336) (12.7030) (5.2840) (2.1562) (0.0000) 
R&D firms 
D1 (low) 0.0003 1.0849 0.4744 
-0.0134 0.1862 0.7712 101.2686 
(0.1267) (16.1932) (5.5934) (-0.1099) (1.9205) (0.0000) 
D2 
-0.0015 1.0Q59 0.2303 0.2647 0.1038 0.7588 94.5779 (-0.7092) (21.7038) (2.7685) (2.2953) (1.3297) (0.0000) 
D3 
-0.0026 1.1715 0.4987 0.3776 0.1378 0.7000 70.4204 (-1.0023) (15.1733) (5.3560) (2.4689) (1.2178) (0.0000) 
D4 
-0.0028 1.1030 0.5607 0.5809 0.2568 0.7418 86.4838 
(-1.1115) (14.7714) (6.1028) (4.2468) (2.3667) (0.0000) 
D5 (High) 
-0.0077 1.2891 0.8873 0.5111 0.4320 0.7746 103.2399 (-2.8883) (14.7439) (8.5616) (3.3047) (4.2751) (0.0000) 
Zero R&D firms 
Dl (low) 
-0.0025 0.9816 0.6724 0.2189 -0.0161 0.6985 69.9273 
(-1.1340) (15.0412) (8.7960) (1.6767) (-0.1648) (0.0000) 
D2 
-0.0026 1.0224 0.5909 0.1111 -0.0370 0.7318 82.1863 
(-1.2437) (18.0035) (7.8814) (0.9342) (-0.3651) (0.0000) 
D3 
-0.0049 1.1592 0.7396 0.3342 -0.0292 0.7635 97.0166 (-2.1095) (18.9140) (9.6716) (2.5736) (-0.3391) (0.0000) 
D4 
-0.0063 1.1777 0.6951 0.6304 0.0065 0.7953 116.5905 
(-3.0873) (16.6627) (9.5295) (4.8211) (0.0711) (0.0000) 
D5 (High) 
-0.0050 1.3746 1.0612 0.7387 0.0736 0.7864 110.5415 (-1.9531) (16.4003) (10.9216) (5.0984) (0.6452) (0.0000) 
R&D firms with RD/Sales> median 
DI (low) 0.0056 1.1485 0.5827 
-0.1316 0.4749 0.6875 66.4618 
(1.7591) (10.9350) (3.9211) (-0.7495) (3.1029) (0.0000) 
D2 
-0.0025 1.0351 0.4131 0.1947 0.2890 0.6244 50.4640 (-0.8073) (11.7416) (3.3874) (1.1494) (23105) (0.0000) 
D3 
-0.0015 1.2x93 0.6725 0.1853 0.3223 0.5986 45.3700 (-0.4179) (8.7917) (5.2960) (0.8695) (1.8286) (0.0000) 
D4 
-0.0007 1.2252 0.8130 0.4106 0.5516 0.5661 39.8159 (-0.1608) (8.6759) (5.7041) (1.4202) (2.5671) (0.0000) 
D5 (High) 
-0.0101 1.2908 0.9681 0.3161 0.7342 0.7164 76.1397 (-3.0602) (11.6232) (8.3549) (1.5518) (5.6592) (0.0000) 
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Panel C: Time-series regressions run with an RD factor as in Al-iiorani et al (2003) calculated with equal- 
weiehted returns 
Sample 
Adjusted R- F- 
alpha RM SMB HML, RD Factor squared statistic 
DI (low) 
-0.0011 1.0262 0.5940 0.1074 0.0591 0.7606 95.5065 
(-0.5702) (17.5657) (8.2564) (1.1329) (0.3711) (0.0000) 
D2 
-0.0019 1.0; 59 0.4330 0.1516 -0.0132 0.7898 112.7549 (-1.0657) (22.4928) (6.1046) (1.5697) (-0.0894) (0.0000) 
D3 
-0.0037 1.1748 0.6348 0.3248 -0.0023 0.7800 106.5021 (-1.7114) (21.6593) (8.9553) (3.2014) (-0.0149) (0.0000) 
D4 
-0.0048 1.1(57 0.6850 0.5447 0.1267 0.8042 123.2144 
(-23499) (18.1273) (9.4266) (5.1843) (0.7326) (0.0000) 
D5 (High) 
-0.0054 1.4125 1.0782 0.5434 0.0186 0.8114 128.9670 (-2.3031) (18.3775) (11.9703) (4.7056) (0.0992) (0.0000) 
R&D firms 
DI (low) 0.0003 1.0953 0.5619 
-0.1013 0.4390 0.7770 104.6692 (0.1408) (16.5409) (6.6828) (-0.9164) (2.7589) (0.0000) 
D2 
-0.0016 1.0043 0.2894 0.2276 0.3312 0.7661 98.4273 
(-0.7582) (20.9611) (3.1992) (2.2992) (1.9841) (0.0000) 
D3 
-0.0028 1.1707 0.5753 0.3262 0.4236 0.7079 73.1039 (-1.0801) (16.1935) (6.1636) (2.3108) (1.9792) (0.0000) 
D4 
-0.0027 1.1203 0.6770 0.4549 0.5703 0.7483 89.4662 
(-1.0718) (14.9296) (7.1906) (3.7393) (2.6976) (0.0000) 
D5 (High) 
-0.0070 1.3488 1.0401 0.2499 0.6023 0.7566 93.4528 (-2.5149) (14.8676) (9.7034) (1.7656) (3.0845) (0.0000) 
Zero R&D firms 
D1 (low) 
-0.0022 0.9927 0.6481 0.2073 -0.1777 0.7018 71.0211 (-1.0440) (15.7755) (8.0196) (1.9222) (-0.9991) (0.0000) 
D2 
-0.0022 1.0374 0.5495 0.1012 
-0.2864 0.7401 85.7270 (-1.1575) (19.77Q6) (6.9424) (0.8951) (-1.7692) (0.0000) 
D3 
-0.0045 1.1787 0.6962 0.3141 -0.3156 0.7716 101.5064 (-1.9989) (21.2135) (9.0446) (3.0689) (-2.0480) (0.0000) 
D4 
-0.0060 1.1928 0.6775 0.6038 
-0.1561 0.7973 117.9914 (-2.9214) (18.3359) (9.2601) (5.4934) (-0.9946) (0.0000) 
D5 (High) 
-0.0043 1.4145 1.0454 0.6464 
-0.2453 0.7887 112.0188 (-1.7144) (17.8692) (9.3751) (5.4323) (-1.1404) (0.0000) 
R&D firms with RD/Sales> medien 
Df (low) 0.0063 1.2Q42 0.7645 
-0.4029 0.7769 0.6745 62.6427 (1.9508) (11.4597) (4.3775) (-2.7065) (3.0186) (0.0000) 
D2 
-0.0020 1.0732 0.5179 0.0229 0.4240 0.6149 48.4981 
(-0.6341) (11.8572) (3.6337) (0.1470) (1.4327) (0.0000) 
D3 
-0.0013 1.2533 0.8152 0.0233 0.6880 0.6033 46.2510 (-0.3692) (9.11b2) (5.3411) (0.1231) (2.1015) (0.0000) 
D4 0.0003 1.3Q05 1.0093 0.0785 0.7789 0.5445 36.5565 
(0.0539) (8.3841) (6.5502) (0.2989) (1.8900) (0.0000) 
D5 (High) 
-0.0086 1.4057 1.2087 -0.1495 0.8650 0.6641 59.8285 (-2.4585) (12.0165) (9.1198) (-0.7535) (3.1851) (0.0000) 
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Appendix 5B. C Part F: Part F of the Appendix 5B. C presents the average number of 
observations for dispersion portfolios used in the regression in Table 5B. 6. 
The table reports the average nur ber of observations according to dispersion quintiles for the 
whole sample, the R&D, zero R&D and R&D intensive firms (firms with R&D/Sales>median) 
from D1 (low) to D5 (High). 
Sample R&D fir ms Zero R&D firms RD/Sales above median 
D1 (low) 95 38 57 22 
D2 93 40 53 17 
D3 93 40 53 18 
D4 91 35 56 14 
D5 (High) 92 29 62 15 
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Appendix 5B. C Part G: Pafft G of the Appendix 5B. C presents the average number values of the 
factors included in the Fama-French time-series regressions on Table 5B. 6 and Appendix 5B. C 
Parts A and B for the 156 months used in the regressions (July 1991-June 2004), and also the 




Market monthly value-weighted return 0.0072 
1 month UK Treasury Bill Rate 0.0586 
1 month UK Treasury Bill rate converted to geometric monthly rate 0.0047 
Sample VW return-1 month UK Treasury Bill monthly rate (Rm-PfRM) 0.0024 
RD factor as in Al-Horani et Al (2003) with equal-weighted returns 0.0011 
RD factor as in Al-Horani et Al (2003) with value-weighted returns 0.0003 
RD factor calculated as (High RD+Mid RD)/2-(Low RD+Zero RD)/2 with EW 
returns 0.0009 
RD factor calculated as (High RD+Mid RD)/2-(Low RD+Zero RD)/2 with VW 
returns 
-0.0036 
RD factor calculated as (High RD-Zero RD) with EW returns 0.0027 
RD factor calculated as (High Rp-Zero RD) with VW returns 
-0.0050 
RD factor calculated as (High IRL-Low RD) with EW returns 0.0033 
RD factor calculated as (High RD-Low RD) with VW returns 
-0.0065 
(R&D intensity above is expressed as R&D/Sales) 
Monthly equal weighted returns pf the 5 dispersion portfolios, based on 
annually rebalanced dispersion data, using forecast data Im before year end 




D5 (High) 0.0124 
Monthly equal weighted excess rFtums (Rp-Rf) of the 5 dispersion portfolios, based on 
annually rebalanced dispersion data, using forecast data Im before year end 
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APPENDIX 5B. D 
Appendix 5B. D Part A: Appendix 5B. D Part A shows the sample period average signed forecast 
errors according to TA, MV and BM quintiles. 
The table reports the average signed forecast errors for quartiles formed according to TA, MV, BM Forecast errors have been 
calculated as a) (Forecasted EPS-Actual EPS)/Absolute value of Actual EPS and b) (Forecasted EPS-Actual EPSYStock Price 
12 months prior to year end. In the case of the mean forecasted one year ahead EPS, there have been used all of the minus 12, 
6 and 3 month prior to year end median forecasts. Actual and forecasted EPS observations above the 0.98 and below the 0.02 
percentile have been eliminated. 
Error (F-A)/A Abs Forecast-12m Forecast-6m Forecast 
-1 m Error (F-A)/P Forecast-12m Forecast-6m Forecast -1 m 
According to TA 
Low 1.069 0.616 
-0.824 0325 0305 0.272 
0.727 0.672 0.545 0223 0.200 0.178 
0.861 0.542 0.417 0.106 0.103 0.122 
High 0.543 0.308 0.233 0.086 0.070 0.083 
According to MV 
Low 1.541 1.001 
-0.598 0.596 0.316 0.439 
0.815 0.492 0.348 0.143 0.136 0.134 
0.444 0.360 0.353 0.027 0.043 0.076 
High 0.404 0.273 0.191 0.005 0.017 0.041 
According to BM 
Low 0.249 0.438 0.043 
-0.012 0.032 0.071 
0.538 0.544 0.423 0.044 0.064 0.083 
1.074 0.687 0.484 0.135 0.117 0.119 
High 1.240" 0.408 
-0.528 0.539 0.437 0359 
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Appendix 5B. D Part B: Appendix 5B. D Part B shows the sample period absolute forecast errors 
for the whole sample, R&D and zero R&D firms and according to R&D/Sales, R&D/TA, 
R&D/MV, TA, MV and BM quartiles. 
Forecast errors have been calculated (using absolute values) as a) (Forecasted EPS-Actual 
EPS)/Absolute value of Actpal EPS and b) (Forecasted EPS-Actual EPS)/Stock Price 12 months 
prior to year end. In the case of the mean forecasted one year ahead EPS, there have been used all 
of the minus 12,6 and 3 mpnth prior to year end median forecasts. Actual and forecasted EPS 
observations above the 0.98 and below the 0.02 percentile have been eliminated. 
Error 












Abs 12m 6m 1m A)/P 12m 6m IM 
Sample 1.615 1.449 1.213 0.345 0.268 0.195 
R&D 
firms 1.657 1.494 1.218 0347 0271 0.197 
Zero R&D firms 1.671 1.569 1.327 0.368 0.285 0.206 
R&D firms according to R&D/Sales 
Low 1.187 0.906 0.796 0.293 0.226 0.167 
1315 1.111 0.893 0.302 0.231 0.174 
1.482 1.197 0.928 0.275 0.216 0.158 
High 2.172 1.816 1.631 0.352 0.284 0.204 
R&D firms according to R&D/TA 
Low 1.003 0.773 0.620 0.273 0.207 0.151 
1.377 0.940 0.929 0.324 0.246 0.188 
1.755 1.562 1.231 0.284 0.229 0.166 
High 1.998 1.708 1.453 0.337 0.270 0.195 
R&D firms according to R&D/MV 
Low 0.756 0.534 0.407 0.216 0.162 0.112 
0.941 0.841 0.680 0.260 0.188 0.146 
2.021 1.690 1512 0.309 0.244 0.187 
High 2486 1.913 1.634 0.445 0372 0.266 
Sample firms according to TA 
Low 3.928 2.921 2.818 0.499 0.400 0.291 
1.591 1.182 0.963 0.365 0.283 0.216 
1.307 1.162 0.721 0309 0145 0.176 
High 0.? 07 0.661 0.553 0.248 0.183 0.131 
Sample firms according to MV 
Low 3586 3.444 3.172 0.611 0.488 0374 
1,453 1.090 0.868 0.372 0.295 0.212 
1.912 0.809 0.627 0.259 0.204 0.148 
High 0.704 0.623 0.512 0.201 0.146 0.104 
Sample fines according to BM 
Low 1.103 1.043 0.530 0.241 0.188 0.129 
1.156 0.897 0.689 0.262 0.202 0.150 
1470 1.118 0.907 0342 0.271 0.192 
High 21757 2.806 2.861 0.547 0.426 0322 
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APPENDIX SB. E 
Appendix SB. E Part A: Appendix 5B. E Part A shows the average sample period signed forecast 
revisions according to quartiles formed by TA, MV and BM (from low to high). There are used 
four types of forecast revisions defined as follows: 
Scaling revisions by stock price: 
Forecast Revision: 12 6 (Forecast 6m prior to year end-Forecast 12m prior to year end)/Share 
price 12m prior to year end* 100 
Forecast Revision: 12 1(Forgcast lm prior to year end-Forecast 12m prior to year end)/Share 
price 12m prior to year end * 100 
Scaling revisions by the absglute value of median forecast 12m prior to year end: 
Forecast Revision: 12 6 (Forecast 6m prior to year end-Forecast 12m prior to year end)/Abs value 
of median forecast 12m prior to year end * 100 
Forecast Revision: 12 1(Forecast Im prior to year end-Forecast 12m prior to year end)/Abs value 
of median forecast 12m prior to year end * 100 
One year ahead mean forecasts are used. If revision exceeds +/-100% data are considered outliers 
and are removed. 
Scaled by Price 12 6 121 Scaled by Median 126 121 
TA 







-0.181 1.630 0.754 3.534 
MV 
Low 





high 1.677 3.890 3.059 6.811 
BM 
LAW 4.867 7.835 
1.958 3.980 
0.998 0.441 




-3.875 -6.237 -3395 -6.765 
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Appendix 5B. E Part B: Appendix 5B. E Part B shows the sample period absolute forecast 
revisions for the whole sample, R&D and zero R&D firms and according to R&D/Sales, 
R&D/TA, R&D/MV, TA, MV and BM quartiles. 
Scaled by scaled by 
price 126 121 median 126 121 
Sample 14.790 19.078 18.115 23.602 
R&D fins 14.811 19.125 18.274 23.779 
Zero R&D firms 15.523 20.049 18.819 24500 
R&D/Sales 
Low 13.502 17.386 14.761 18.997 
14367 17.944 17.160 21309 
12340 16.120 17.449 23371 
High 13.681 17.885 19.428 25.399 
R&D/TA 
Low 12.822 16.627 14.273 18.009 
14.570 17.860 17.334 21.861 
12.487 16.881 17.327 23.408 
High 14.204 17.849 19.483 25.541 
R&D/MV 
Low 11.649 14.691 14.534 17.762 
12.045 15.509 15388 20.354 
14.169 18241 17.290 22.815 
High 16.631 21392 21.717 28.629 
Sample firms according to TA 
Low 21.420 25.554 24.715 30.019 
16.101 20.031 19388 24.858 
12.791 17.552 16.789 22.785 
High 10.971 15.481 13.847 19.279 
Sample firms according to MV 
Low 23.984 28.999 25.818 31.426 
16.253 20579 19.295 25.022 
12.050 16.644 16337 22378 
High 9.810 13.575 13.677 18.737 
Sample firms according to BM 
Low 11.979 15.605 17.863 23.977 
12.023 15.741 15.766 20.443 
15.855 19.933 18.246 22.762 
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Simple industry dummies, excluding MV and BM as regressors: 
Panel A: Absolute errors 
Adj. R- 
c RD PASTR STDEV INDDUMMY sq. F-stat. 
INDDU MY=INDD1 
-2.6353 0.0525 0.5795 0.7504 0.2950 0.2939 502.2137 
(-683969) (5.8320) (1.7499) (36.9461) (2.4633) (0.0000) 
INDDUMMY=INDD2 
-2.6216 0.0519 0.5629 0.7511 -0.0487 02931 500.1344 
(-67.8258) (5.6872) (1.6966) (36.9639) (-0.4478) (0.0000) 
INDDUM1MY=INDD3 
-2.6440 0.0603 0.5681 0.7518 0.2147 0.2944 5032656 
(-67.6782) (6.5119) (1.7124) (37.0670) (3.3407) (0.0000) 
INDDUMMY=1NDD4 
-2.6110 0.0525 0.5594 0.7496 -0.2322 0.2935 501.2158 
(-67.7652) (5.8268) (1.6805) (36.9346) (-1.6582) (0.0000) 
Panel B: Non Absolute errors 
INDDUMMY=INDDI 
-0.0005 0.0000 -0.0223 0.0013 0.0006 0.2396 380.4925 
(-3.6461) (0.3592) (-13.2075) (10.7133) (1.1034) (0.0000) 
INDDUMMY=INDD2 
-0.0004 0.0000 -0.0223 0.0013 0.0006 0.2395 380.3808 
(-3.5720) (0.5591) (-132176) (10.7287) (1.5733) (0.0000) 
INDDUM MY=INDD3 
-0.0005 0.0000 -0.0223 0.0013 0.0007 0.2401 381.5908 
(-3.943$) (1.0116) (-13.2160) (10.7704) (2.6101) (0.0000) 
INDDUMMY=INDD4 
-0.0004 0.0000 -0.0223 0.0013 0.0003 0.2394 380.0847 
(-3.5371) (0.3555) (-13.2204) (10.7343) (0.7029) (0.0000) 
Multiplicative industry dummies, excluding MV and BM as regressors: 
Panel A: Absolute errors 
Adj. R- 
c RD PASTR STDEV INDDUMMY RD"INDDUMMY sq. F-stat 
INDDUMMY=INDD 1 
-2.6330 0.0547 0.5704 0.7515 0.1706 -0.0741 0.2940 418.8850 
(-68.2916) (6.0061) (1.7213) (36.9761) (1.1354) (-1.3097) (0.0000) 
INDDUMMY=INDD2 
-2.6234 0.0507 0.5629 0.7511 0.0899 0.0407 0.2930 416.8310 
(-67.8129) (5.4872) (1.6966) (36.9556) (0.4279) (0.7313) (0.0000) 
INDDIJMMY=INDD3 
-2.6423 0.0616 0.5684 0.7519 0.1862 -0.0099 0.2943 419.3475 
(-67.2195) (6.2515) (1.7131) (37.0653) (1.7668) (-0.3448) (0.0000) 
1NDDUMMY=1NDD4 
-2.6086 0.0542 0.5559 0.7494 -0.3518 -0.0730 0.2936 417.9407 
(-67.6275) (5.9569) (1.6662) (36.9298) (-1.9312) (-1.1666) (0.0000) 
Panel B: Non Absolute errors 
INDDUMMY=INDDI 
-0.0005 0.0000 -0.0223 0.0013 0.0009 0.0002 0.2395 317.1403 
(-3.6978) (0.2161) (-13.2050) (10.6619) (1.2421) (0.6332) (0.0000) 
INDDUN04Y=I DD2 
-0.0005 0.0000 -0.0223 0.0013 0.0012 0.0002 0.2395 317.0676 
(-3.6289) (0.4082) (-13.2163) (10.7278) (1.4385) (0.9001) (0.0000) 
INDDUMMY=INDD3 
-0.0005 0.0000 -0.0223 0.0013 0.0011 0.0002 0.2402 318.2873 
(-4.0635) (0.4640) (-13.2163) (10.7678) (2.3005) (1.1954) (0.0000) 
INDDUMMY=INDD4 
-0.0004 0.0000 -0.0223 0.0013 -0.0001 -0.0003 0.2394 316.9506 
(-3.4389) (0.5393) (-13.2199) (10.7389) (-0.2093) (-0.9378) (0.0000) 
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APPENDIX 5G. H 
The impact of R&D intensity on analyst forecast revisions when controlling for industry factors. 
The Appendix reports the regression results as in table 5B. 13, when forecast revisions (both 
absolute and non absolute) are scaled by the absolute value of the median minus twelve month 1 
year ahead EPS forecast and R&D intensity is defined as R&D/Sales, revisions are the ones 
between minus 12 an 1 month prior to year end and industry dummy variables are used to 
account for industry factors. In specific, there are used four industry dummy variables to account 
for four sectors perceived as intensive in R&D activity: Information Technology (INDD1), 
Chemicals (INDD2), General Industries (INDD3) and Health grouped together with 
Pharmaceuticals and Biotecj nology ('Pharma' 
-INDD4). INDDUMMY takes the value of 1 if 
the firm belongs to the specific industry, and 0 otherwise. The industry dummies are used both in 
a simple form as well as multiplicative with R&D. 
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Simple industry dummies, INDD1, INDD2, INDD3 and INDD4 for absolute and non absolute 
revisions: 
Absolute revisions 

















Non absolute revisions 



































Non absolute revisions 



































Non absolute revisions 



































Non absolute revisions 






















c RD BM MV PASTR STDEV INDDI RD"INDDI sq. F-stat. 
2.9735 0.0260 
-0.1262 -0.1530 1.1471 0.4293 0.3092 -0.0519 0.1828 153.4433 
(42.4572) (3.0983) (-4.7342) 
-(11.3023) (3.1577) (21.6042) (2.3897) (-0.9391) (0.0000) 
Non absolute revisions 
Adj. R- 
c RD BM MV PASTR STDEV INDDI RD'INDDI sq. F-stat. 
-0.0103 0.0060 -0.0454 0.0109 3.3688 -0.0373 -0.0140 -0.0078 0.1574 125.8253 
(-0.4996) (2.7869) 
-(4.5942) (2.6446) (19.0799) (-4.6387) (-0.3536) (-0.5840) (0.0000) 
Absolute revisions 
Adj. R- 
c RD BM MV PASTR STDEV INDD2 RD'INDD2 sq. F-stat. 
3.0177 0.0197 
-0.1443 -0.1606 1.1304 0.4294 -0.1439 0.0233 0.1808 151.4213 
(43.2801) (2.3057) (-5.4488) (-11.9236) (3.0789) (21.5779) (-0.8568) (0.5180) (0.0000) 
Non absolute revisions 
Adj. R- 
c RD BM MV PASTR STDEV INDD2 RD'INDD2 sq. F-stat. 
-0.0093 0.0056 -0.0452 0.0110 3.3673 -0.0376 -0.0626 -0.0087 0.1577 126.0921 
(-0.4579) (2.5441) 
-(4.6989) (2.7170) (19.0680) (-4.7032) (-1.4267) (-0.8556) (0.0000) 
Absolute revisions 
Adj. R- 
c RD BM MV PASTR STDEV INDD3 RD"IND3 sq. F-stat. 
3.0050 0.0335 
-0.1403 -0.1585 1.1400 0.4313 -0.0562 -0.0477 0.1808 151.4246 
(42.7617) (3.5731) (-5.2529) (-11.7130) (3.0986) (21.6520) -(0.5635) (-1.7936) (0.0000) 
Non absolute revisions 
Adj. R- 
c RD BM MV PASTR STDEV INDD3 RD"INDD3 sq. F-stat. 
-0.0049 0.0055 -0.0460 0.0103 3.3674 -0.0378 -0.0324 -0.0048 0.1577 126.0851 
(-0.2380) (2.4334) (-4.7196) (2.5222) (19.0960) (-4.7200) (-1.2857) (-0.7168) (0.0000) 
Absolute revisions 
Adj. [L- 
c RD BM MV PASTR STDEV INDD4 RD'INDD4 sq. F-stat. 
3.0131 0.0237 
-0.1423 -0.1611 1.1412 0.4313 0.0684 -0.0118 0.1800 150.6292 
(43.2121) (2.8146) (-5.3283) (-11.9346) (3.1077) (21.6146) (0.4485) (-0.2262) (0.0000) 
Non absolute revisions 
Adj. R- 
c RD BM MV PASTR STDEV INDD4 RD*INDD4 sq. F-stat. 
-0.0093 0.0059 -0.0463 0.0108 33698 -0.0375 -0.0416 -0.0067 0.1576 125.9617 
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Appendix 5B. J 
Controlling for period fixed and random effects in the error and revisions 
regressions. The regressions from Tables 5B. 12 for errors and 5B. 13 for revisions 
(using absolute and non absolute errors, scaled by stock price, with 12 month prior to 
year end forecast data and absolute and absolute and non absolute revisions, scaled 
by the absolute value of the median minus 12 months prior to year end 1 year ahead 
EPS forecast, taking revisions between 12 and 1 month prior to year end) are 
estimated in the tables below making use of period fixed and random effects model 
specifications. R&D intensity is defined as R&D/Sales. 
Controlling for fixcd and random effects in panel data error regression: 
Dependent variable: analyst forecast error (Forecasted 
-Actual 1 year ahead EPS) scaled by stock 
price 12 months prior to year end, using 12 month prior to year end forecast data) 
Period Fixed effects 
Panel A: Absolute errors 
Adj. R- 
c RD BM MV PASTR STDEV sq. F-stat. 
-1.1502 0.0045 0.0697 -0.2361 1.1058 0.5268 0.2912 172.6144 
(-26.9285) (0.8108) (3.8731) (-28.0166) (33130) (36.9620) (0.0000) 
Panel B: Non Absolute errors 
0.0022 
-0.0001 0.0008 -0.0004 -0.0285 0.0008 0.2160 116.0844 (10.4106) (-5.0630) (8.8993) (-9.9113) (-13.6802) (11.2254) (0.0000) 
Period Random effects 
Panel A: Absolute errors 
c RD BM MV PASTR 
Adj. R- 
STDEV sq. F-star. 
-1.1462 0. Q049 (-22.6377) (0.8890) 
0.0741 







Panel B: Non Absoluýe errors 
0.0022 
-0.0001 (6.0593) (-5.0577) 
0.0008 






Controlling for fixed and random effects in panel data revisions regression: 
Dependent variable: analyst 1 year ahead EPS forecast revisions, taken between 12 and I month 
prior to year end, scaled by the absolute value of the median minus 12 months prior to year end I 
year ahead EPS forecast 
Period Fixed effects 
Panel A: Absolute recisions 
c RD BM MV PASTR 
Adj. R- 






















Period Random effects 
Panel A: Absolute revisions 
c RD BM MV PASTR 
Adj. R- 
STDEV sq. F-stat 
3.1598 0.0239' 







Panel B: Non Absolute revisions 
0.0631 0.0051 
-0.0468 









APPENDIX 5B. K 
Appendix 5B. K Part A: Appendix 5B. K Part A contains information on data 
availability for tables 5B. 3,5B. 12,5B. 13 and the main table in the Appendix 5B. C 
Part H. The table below reports information on the number of cross-sections used 
and number of the total panel (unbalanced) observations for Tables 5B. 3,5B. 12, 
5B. 13 and the mail Table in the Appendix 5B. C Part H. 
Data information for Tables 5B. 3,5B. 12 and 5B. 13 and Appendix 5B. C Part H 
Number of cross- 
sections used 
Total panel (unbalanced) 
observations 
Analyst forecast dispcrsion 
12 month prior to year Fnd EPS forecast data 
6 month prior to year end EPS forecast data 







Regression in Table in Appendix 5B. C Part H 774 3,872 
Analyst forecast errors: Errors scaled by price 
12 month prior to year end EPS forecast data 





Analyst forecast erro{s: Errors scaled by absolute actual EPS 
12 month prior to year end EPS forecast data 
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APPENDIX SB. L 
Explanation of w4y signed errors decrease (implying decrease in optimism as year 
end approaches), qnd signed revisions are positive, implying higher forecasts as year 
end approaches. 
Table Appendix SB. L. 1 Mean and median signed forecast errors and revisions for 1990-2003 
The table shows the mean and median signed errors 1990-2003 using minus 12,6 and I month prior to 
year end forecast dato when actual and forecasted EPS observations above the 0.98 and below the 0.02 
percentile have been eliminated (Panel A) and when above the outlier elimination procedure followed for 
Panel A, error observations above the 0.98 and below the 0.02 percentile have been eliminated (Panel B). 
Forecast errors are scaled by the absolute value of actual EPS. 
At the bottom of the t4ble appear the mean and median signed forecast revisions (revisions +/-100% have 
been eliminated) between 12 and 6 and 12 and 1 month prior to year end. Forecast revisions are scaled by 
the absolute value of the median EPS forecast 12 months prior to year end. 
Panel A 
12 61 
mean 0.780 0.530 0.129 
median 
-0.088 -0.031 -0.012 
Panel B 
12 61 
mean 0.226 0.164 0.117 
median 
-0.086 -0.031 -0.012 
Forecast revisions 
126 121 
mean 2.269 3.545 
median 3.694 7.178 
134 
Table Appendix 5B. LI1. Positive and negative errors and revisions 
The table shows the number of firm-year error observations for the period 1990-2003, using minus 12,6 
and 1 month prior to year end forecast data and the number of positive and negative error observations 
included, as well as their relative percentages, when actual and forecasted EPS observations above the 
0.98 and below the 0.02 percentile have been eliminated (Panel A) and when above the outlier elimination 
procedure followed for Panel A, error observations above the 0.98 and below the 0.02 percentile have 
been eliminated (Panel B). Forecast errors are scaled by the absolute value of actual EPS. 
At the bottom of the table appear firm year observations for forecast revisions (revisions +/-100% have 
been eliminated) betwFen 12 and 6 and 12 and 1 month prior to year end and the number of positive and 
negative revision observations included, as well as their relative percentages. Forecast revisions are scaled 
by the absolute value of the median EPS forecast 12 months prior to year end. 
























































>0 4621 0.581 
<0 3335 0.419 
Total 7956 1.000 
12 1% 
>0 4941 0.626 
<0 2949 0.374 
Total 7890 1.000 
135 
Table Appendix SB. L. 111. The magnitude of positive and negative errors and revisions 
The table shows the magnitude (mean and median values) of forecast errors and revisions for the whole 
sample, and then for positive and negative errors and revisions separately for the period 1990-2003. For 
the calculation of errqrs, there have been used minus 12,6 and 1 month prior to year end forecast data 
when actual and forecasted EPS observations above the 0.98 and below the 0.02 percentile have been 
eliminated (Panel A) and when above the outlier elimination procedure followed for Panel A, error 
observations above the 0.98 and below the 0.02 percentile have been eliminated (Panel B). Forecast errors 
are scaled by the absolute value of actual EPS. 
At the bottom of the t4ble appears the same information (mean and median revisions for the sample and 
then for positive and negative revisions) for forecast revisions (revisions +/-100% have been eliminated) 
between 12 and 6 and 12 and I month prior to year end. Forecast revisions are scaled by the absolute 
value of the median EPS forecast 12 months prior to year end. 
Panel A 
Sample >0 <0 
12 61 12 61 12 61 
mean 0.780 0.530 0.129 2.727 2.098 1.364 
-0.730 -0.848 -1.000 
median 
-0.088 -0.031 -0.012 0.400 0.267 0.202 -0.211 -0.167 -0.089 
Panel B 
Sample >0 <0 
12 61 12 61 12 61 
mean 0.226 0.164 0.117 0.874 0.653 0.479 
-0.312 -0.300 -0.245 
median 
-0.086 -0.031 -0.012 0.365 0.243 0.180 -0.203 -0.158 -0.084 
Forecast revisions 
Sample >0 <0 
126 121 126 121 126 121 
mean 2.269 3.545 17.602 21.614 
-18.107 -24.987 
median 3.694 7.178 13.021 16.753 
-10.732 -18.683 
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APPENDIX 5B. M 
Appendix 5B. M Part A: Appendix 5B. M Part A reports the average signed errors 
and revisions, (errprs scaled by price or by absolute actual EPS, using 12-6-1 month 
prior to year end forecast data, and revisions scaled by price and absolute value of 
median EPS, between 12-6 and 12-1 months prior to year end) according to 5 
Dispersion quintiles from D1 (low) to D5 (High) using 12-6-1 month prior to year 
end data for dispersion calculation. 
Appendix 5B. M tart B: Appendix 5B. M Part B reports the same information as 
Appendix 5B. M Part A but this time for absolute errors and revisions. 
Appendix 5B. M Part C: Appendix 5B. M Part C reports the Pearson correlation 
coefficients between the various definitions of errors, revisions (both non absolute) 
and analyst forecast dispersion. 
Appendix 5B. M Part A: 
Signed errors: 




-12 month error data Abs -12 month error data 
D12m D6m Dim D12m D6m Dim 
D10.182 0.206 0.226 D10.760 0.794 0.597 
D2 0.052 
-0.013 -0.031 D2 0.498 0.310 0.241 
D3 0.118 0.051 0.006 D3 0.709 0.601 0.315 
D4 0.202 0.205 0.126 D4 1.150 0.954 1.121 
D5 0.289 0.348 0.431 D5 1.188 1.426 2.319 
-6 month error data -6 month error data 
D12m D6m Dim D12m D6m Dim 
D1 0.169 0.175 0.202 D1 0.535 0.532 0.430 
D2 0.076 0.031 0.010 D2 0.407 0.374 0.257 
D3 0.113 0.081 0.021 D3 0.560 0.729 0.387 
D4 0.164 0.203 0.118 D4 0.955 0.838 0.778 
D5 0.244 0.262 0.356 D5 0.464 0.441 1.229 
-1 month error data -I month error data 
D12m D6m Dlm D12m D6m Dlm 
D1 0.167 0.167 0.178 DI 
-0.161 -0.103 -0.180 
D2 0.071 0.049 0.042 D2 0.391 0.337 0.250 
D3 0.112 0.076 0.051 D3 0.473 0.516 0.363 
D4 0.148 0.184 0.124 D4 0.791 0.674 0.709 
D5 0.249 0.277 0340 D5 0338 0350 0.734 
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Signed revisions: 
Revisions scaled by price 
126 121 
D12m D6m Dlm D12m D6m Dlm 
DI 3.331 2.542 2.625 DI 3.977 3.581 3.515 
D2 2.870 4.089 4.264 D2 3.024 5.832 7.259 
D3 0.003 2.856 1.557 D3 0.539 3.452 4.482 
D4 
-2.027 0.417 -0.528 D4 -1.082 -1.299 -0.119 
D5 
-3.118 -7.876 -6.377 D5 -2.438 -7.531 -11.085 
Revisions scaled by 
median 
126 121 
D12m D6m Dim D12m D6m Dim 
D1 4.931 4.094 4.118 D1 5.980 5.765 5.653 
D2 4.260 6.157 6.371 D2 5.566 9.230 10.630 
D3 1325 4.736 3.184 D3 2.843 6.046 7.461 
D4 
-0.678 2.046 0.679 D4 0.972 0.642 1.759 
D5 
-3.383 -9.794 -7.403 D5 -1.741 -9.338 -13.302 
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-12 month error data Abs 
-12 month error data 
D12m D6m Dlm D12m D6m Dlm 
D1 0.367 0.373 0.385 D1 1.957 1.954 1.869 
D2 0.232 0.208 0.190 D2 0.723 0.548 0.485 
D3 0.265 0.247 0.227 D3 0.972 0.852 0.603 
D4 0.342 0332 0.322 D4 1.443 1.287 1.420 
D5 0.470 0.497 0.509 D5 2.039 2.439 2.965 
-6 month error data 
-6 month error data 
D12m D6m Dlm D12m D6m Dlm 
D1 0.292 0.288 0.294 D1 1.893 1.767 1.714 
D2 0.182 0.164 0.141 D2 0.567 0.524 0.406 
D3 0.201 0.191 0.185 D3 0.750 0.901 0.623 
D4 0.252 0.274 0.255 D4 1.233 1.123 1.392 
D5 0.369 0.385 0.417 D5 1.401 1.968 2.195 
-1 month error data 
-I month error data 
D12m D6m Dlm D12m D6m Dim 
D1 0.209 0.207 0.211 D1 1.530 1.418 1.420 
D2 0.124 0.118 0.106 D2 0.506 0.428 0.330 
D3 0.153 0.136 0.131 D3 0.628 0.646 0.521 
D4 0.186 0.205 0.183 D4 1.034 0.894 1.249 
D5 0.274 0.283 0.314 D5 1.140 1.599 1.610 
Absolute Revisions: 
Revisions scaled by nrice 
12 6 121 
D12m D6m Dlm D12m D6m Dlm 
DI 15.978 16.173 16.519 DI 19.737 20250 20.613 
D2 9.238 9.024 9.875 D2 13.520 13.259 13.176 
D3 10.743 10.881 10.806 D3 15.686 15.386 14.554 
D4 14.854 13.637 13.970 D4 19.839 18.677 19.135 
D5 21.339 22.209 19.863 D5 26.026 26.743 25.758 
Revisions scaled by 
median 
126 121 
D12m D6m Dim D12m D6m Dlm 
D1 19.181 19.446 19.986 D1 24.019 24.521 25.254 
D2 12.091 11.743 12.800 D2 17.372 17.383 17.554 
D3 13.353 13.710 13.560 D3 19380 19.334 18.763 
D4 18.434 17.530 17.724 D4 24.494 23.588 23.558 








Gvy1, U 0 
y 
o. a) 
0 C p" o\ 
- i 
öo 
y - O Oli 
oa w 
" ýö 











"0 en pN O Ö c ml 
m-o 
GM 
w d ö q 9 
O M M 












vfi vi Vi ö 
n N oo N O .ý p . " 
i r' N 







°n ö ýO 
- 
W ööö u , q 4 ý? ý? 
b 19 
" 









w pööö 9 9 9 9 
aai 00 ihr 
4- 
000 ýh}- N h N N C. 00 OOO M '" M ýT 
wý 0A ööööd q q c? Al w i oq 
Ü"N 
_ QNp "ý 
00 NNNÖ ý Mr h 
OW cý 6) N -: -i OOO 
00 ÖÖÖ -+ N . - N 
, 
0 q q q 9 
o A 




ý0 cs c; c5 q4 q 4 Cl 






- Ö 00 
N 
y N 
v1 VOOOOOO O O O 
0 
v) O u; CU ,.,., Ooo co oOC; O q O q q 
bOO 
a" 





(yý+ OO N N F. Fr N N N 












































































































. -: O vl 
N Co 
N CD, NM 
N 
gn CD 












f4 O O ' py O 
_e m ÖNN pý tý 




N f/1 ý 'CJ 
W 






o oý o a o ö 
b 
N 




ý of 00 
rO 
-i %n Öý ÖN 
U ~ U U 







O ;'MO, In 
00 O 00 00 00 NÖ h [- O 
0 00 Ö ýOFZ 




4 9C? qq 
'0 N ZO ÖN 
00 















d ^'0 ^Mý 00 =ý 4n OMOO c- 
OÖOO 
O4 fV 4Ö 
M-0 CJ C'4 
ÖÖNÖo 
NÖ ý+ 
N^ ýD ^ O, ý' 
M-ON o0 t- 
ÖÖ 00 OON ÖvÖvÖ 
N^ as ^ OS o^ 
cc - 
en 



















. -° N tý 00 
, 





Co 4: > 00 
Q CV Q en pi C? 

















ONÖ ON Ö °O lý oo Oý OvOvÖ 
.ýoN ÄýÄ 










00 10 G 
ZZ 09 VW y 





























ý C4 z9 CJ 
C., 10 8 


































fn (D %A <D 00 C> (D (D V-t OM 0 O nO 
MO v) O 
, 
< CO 55 O 
O-Ö k d C) 
Mý 
NOÖO n 00 Ö~ ÖÖ Ö 
_ OÖ r4 clý 
OÖ +i CD (D 4 OO Oý O 











O t- O 
OO 00 
0 



































. ter en 
















O t- O 
Oi N4 



























o^ vl ^ 
W) C4 Ö0 N 
NON 
v 














in en IN t- 





Ö fon eel 
-OO 
'It 4 tV QN 




























M_ ^ V1 ^ ON ý en 
















































N M ýTi N~ý~O y rl Ov .rC y ý r Ov . -ý Oý 
.O O> %O 00 0. 
ACO 
x' OO CO 
,bOO 10 OO OO 0,0 
ý ei, N 'd N 'd 
Qy QH QN 
" ý--ý ýo 
ÖNÖ O> ÖÖ vl 
o ÖNÖ 
N 
OO O OO 
"0 ONNO O, OO N N ÖN Oý N 09 00 ÖCÖ N q 
w w 
Q' 
NNN P M^ N N p NMN %Q 
C> CP% Z CD 
CD (D 
fl c 
c> C> O 
ci 
`t O "0 
C> 
C> 0 (7, C> N 00 00 oý O 0O O0 




ÖM 00 00 000 00 






v1 0h e' N-- 
~ O O O' 041 
v-i 
OMO "" 
OMON p(> p 




Oý Cý V N ono "ý Ö 
oe V 1 V) M cr, ° ° GO 
00 
MM 
0°m O l En " "v , O O CO )- CQ < - - Cl) Q - v ý. 
a a 
N%0 
N NN 00 O Opp 00 
N 
0ý0 Ö eý 
M ;z 
p0 
b n 00 Ö N 


















o 00 N 
O, e l 
O `n c> 
apOp OM 
O ° O O Oý . O 
`, v U U 
ma 







00 C) en (D 
O pp C 
HOO Ov - Ov 
1 'r r- 














































































n kn n 00 
OnO^ 
0MO cý ý 1-t 
M'1 M r` 
co It, 
- Ö 00 Ö 
.O 
Vgl 00 ^ 
OO 
ÖýÖý 






















co 'It co MMMh 
OO 4n 
$ ', R $- 
-- 
m 
O 00 O en 
pNp Oý 
ývý 





c' cý M 
ÖNÖN 
ý, r"- ., vl V»8 %0 t- 
OMO 
ýOvOý 










N^ 00 ^ 












o 'IT o 
°ö4 
IG n %n 
ÖÖ W'l 
iv.., 
°v r$ to 
00 N r- cn 
o0 
v 
NM 1-1 1111 ("mal In 
pÖQÖ 
ý? 99 
O /^N r 
r- 00 Q> O 
f4 p rq en 
1ÖGÖ9 
ýý Ov ýO 




ý, O ^ oo ý_` 
O 00 O 10 
OO 
4Q9 fV 
Ö 00 N M 





CD O. Ö %0 
lý 0 00 
v '. o öö 
öö 
CO "' - 





go GO co - 
'N~N 
It 
ONO to OO O lV 
ýN 






00 n CC) 
N on N 
00 
ÖQ ÖN 00 
TMQM 
M 





















aý 0 0 
0 

















ý--ý N O 














: d^v QC, 
O^OM ÖýÖ 
O v0 ý7 Nr 
C> CD Ö O v N ¢, 
r- öö 
öö 





C> %0 0 
CD C> CD 
N 
N OO O 
GO2 



















ö'f ö ON 
O 00 O ON 
















n_ 00 CA N Cl N M [--ý N 119 
. 
00 OýOý Q 
v pr 
ON N- 
t- (4 00 " ýD OO 
. -r t{ OO 
v 
P4 
r4 %n in 0% %0 









p Ö~ M 







%0 ' O, ötöN 
ONO 
MM0 




O 00 .., 
O 
rO ^' NM 
C 
v ý. 
00 M '^ 





N yý ý "w 
OhO OO Ö-Ö- 
ää 
00 
APPENDIX 5B. 0 
Appendix 513.0 Part A: Appendix 513.0 Part A reports the regression results as in 
Tables 5B. 12 and 5B. 13 (the impact of R&D intensity on forecast errors and 
revisions) by including this time the same regressors as in Table 5B. 3. This 
practically means removing the Past return PASTR regressor and adding a variable 
to account for analyst following-AF. Simple removal of the PASTR variable without 
adding AF does not change the results qualitatively compared to the results reported 
below. AF refers to the number of analysts issuing forecasts 12 or 6 months prior to 
year end for errors, depending on whether 
-12m or -6m data are used, and in the case 
of revisions, 
-6m data every time. 
Errors: 
Absolute errors 
Panel A: Errors scaled by price: 
Adj. R- 
c ]RD BM MV STDEV AF sq. - F-stat 
12 month prior to year end EPS forecast data 
RD=RDS 
-1.2949 0.0145 0.0411 -0.2649 0.7157 0.0309 0.3576 428.1276 (-16.2898) (1.7532) (1.4392) (-13.6688) (35.5003) (0.8226) (0.0000) 
RD=RDTA 
-1.2951 0.0082 0.0413 -0.2663 0.7155 0.0293 0.3574 427.6113 (-16.2789) (0.9817) (1.4464) (-13.6670) (35.4752) (0.7810) (0.0000) 
RD=RDMV 
-1.3016 0.0186 0.0383 -02627 0.7150 0.0304 0.3579 428.5207 (-16.4001) (2.1119) (1.3397) (-13.5303) (35.4437) (0.8117) (0.0000) 
6 month prior to year end EPS forecast data 
RD=RDS 
-1.2616 0.0146 0.1140 -0.2771 0.5588 -0.0193 02800 284.4997 (-14.3692) (1.4946) (3.4280) (-12.4304) (25.3022) (-0.4443) (0.0000) 
RD=RDTA 
-1.2655 0.0188 0.1155 -0.2750 0.5588 -0.0191 0.2803 284.8295 (-14.4164) (1.8709) (3.4727) (-12.2872) (25.2950) (-0.4388) (0.0000) 
mj=RD1V 
-1.2713 0.0227 0.1109 -0.2732 0.5584 -0.0194 0.2805 285.1733 (-14.4832) (2.2119) (3.3407) (-12.2292) (25.3061) (-0.4471) (0.0000) 
Panel B: Errors scaled by actual EPS: 
12 month prior to year end EPS forecast data 
RD=RDS 
-1.1140 0.0161 0.0757 -0.2081 0.6507 0.0125 0.2782 307.4280 (-12.3042) (1.7549) (2.3179) (-9.1814) (28.1077) (0.2930) (0.0000) 
RD==RDTA 
-1.1146 0.0105 0.0763 -0.2093 0.6506 0.0111 02780 307.0441 (-12.3038) (1.1300) (2.3335) (-9.1872) (28.0888) (0.2608) (0.0000) 
RD=RDMV 
-1.1219 0.0219 0.0723 -0.2053 0.6499 0.0122 0.2785 307.9151 (-12.4223) (2.2871) (2.2082) (-0.0624) (28.0793) (0.2859) (0.0000) 
6 month prior to year end EPS forecast data 
RD=RDS 
-1.1110 0.0207 0.1535 -0.2262 0.5300 -0.0111 0.0977 87.1234 (-10.7207) (1.9015) (4.1686) (-8.4889) (22.2163) (-0.2258) (0.0000) 
RD=RDTA 
-1.1149 0.0233 0.1553 -0.2244 0.5299 -0.0113 0.0978 87.1539 (-10.7645) (2.0636) (4.2148) (-8.3930) (22.2066) (-0.2291) (0.0000) 
RD=RDMV 
-1.1218 0.0271 0.1495 -0.2226 0.5294 -0.0121 0.0970 86.3693 (-10.8379) (2.3854) (4.0634) (-8.3379) (22.2060) (02444) (0.0000) 
Non Absolute Errors 
Panel A: Errors scaled by p rice: 
Adj. R- 
c RD BM MV STDEV AF sq. F-stat. 
12 month prior to year end EPS forecast data 
RD=RDS 0.0045 
-0.0001 0.0008 -0.0011 0.0013 0.0007 0.2559 264.9400 (10.1183) (-3.3890) (4.8251) (-10.2156) (9.8801) (4.0530) (0.0000) 
RI=RDTA 0.0045 
-0.0901 0.0008 -0.0011 0.0013 0.0007 0.2565 265.7124 
(10.1751) (-3.7256) (4.7832) (-103726) (9.9053) (4.0444) (0.0000) 
RD=RDMV 0.0045 
-0.0001 0.0008 -0.0011 0.0013 0.0007 0.2552 263.8842 (10.1823) (-2.1998) (4.8790) (-10.2622) (9.9050) (4.1120) (0.0000) 
6 month prior to year end EPS forecast data 
R1=RDS 0.0035 0.0000 0.0007 
-0.0008 0.0009 0.0006 0.1863 167.8900 (11.2158) (-0.2937) (5.4628) (-9.5271) (8.3276) (4.1756) (0.0000) 
RII=RDTA 0.0035 
-0.0001 0.0006 -0.0008 0.0009 0.0006 0.1874 169.1279 (11.2539) (-2.7468) (5.4044) (-9.6526) (8.3243) (4.1053) (0.0000) 
RI-RDMV 0.0035 0.0000 0.0007 
-0.0008 0.0009 0.0006 0.1863 167.8900 (11.2158) (-1.2937) (5.4628) (-9.5271) (8.3276) (4.1756) (0.0000) 
Panel B: Errors scaled by actual EPS: 
12 month prior to year end EPS forecast data 
RI3=RDS 0.0059 
-0.0002 0.0028 -0.0011 0.0018 0.0012 0.2359 238.1405 (6.5410) (-2.6628) (8.0324) (-4.9952) (7.3377) (2.9247) (0.0000) 
RD=RDTA 0.0059 
-0.0002 0.0028 -0.0011 0.0018 0.0012 0.2360 2383349 (6.5581) (-2.7054) (7.9984) (-5.0127) (7.3445) (2.9382) (0.0000) 
RD=RDMV 0.0059 
-0.0001 0.0028 -0.0011 0.0018 0.0012 0.2363 238.6179 
(6.5128) (-1.4997) (8.0783) (-4.8774) (7.3592) (2.9872) (0.0000) 
6 month prior to year end EPS forecast data 
RD=RDS 0.0049 
-0.0901 0.0016 -0.0009 0.0010 0.0009 0.0622 51.9307 (6.8514) (-2.0511) (6.2175) (-5.1414) (5.5512) (2.8410) (0.0000) 
RD=RDTA 0.0049 
-0.0901 0.0016 -0.0009 0.0010 0.0009 0.0622 51.9399 
(6.8569) (-2.0484) (6.1906) (-5.1473) (5.5589) (2.8557) (0.0000) 
RD=RDMV 0.0049 
-0.0601 0.0016 -0.0009 0.0011 0.0009 0.0616 51.4218 
(6.7996) (-0.9664) (6.2506) (-5.0165) (5.5766) (2.8988) (0.0000) 
150 
Revisions: 
Panel A: Absolute revisions, revisions scaled by price 
Adj. R- 
126 c RD BM MV STDEV AF 6 sq. F-stat. 
RD=RDS 2.7501 
-0.0084 0.0559 -0.2174 0.3073 -0.0026 0.1825 204.5143 (32.5735) (-0.8513) (1.7276) (-10.3467) (13.6760) (-0.4732) (0.0000) 
RD=RDTA 2.7510 
-0.0150 0.0550 -0.2195 0.3074 -0.0028 0.1827 204.8157 (32.6143) (-1.5135) (1.6991) (-10.4242) (13.6898) (-0.5107) (0.0000) 
R] =RDMV 2.7527 
-0.0084 0.0574 -0.2178 0.3075 -0.0025 0.1825 204.5041 (32.5937) (-0.8183) (1.7710) (-10.3100) (13.6818) (-0.4582) (0.0000) 
121 
RD=RDS 2.8716 0.0126 
-0.0183 -0.1797 0.4481 -0.0072 0.2113 248.0344 (41.9427) (1.6445) (-0.7500) (-10.4432) (24.4761) (-1.5642) (0.0000) 
RD=RDTA 2.8692 0.0087 
-0.0179 -0.1801 0.4479 -0.0074 0.2111 247.7278 (41.9403) (1.1244) (-0.7329) (-10.4265) (24.4711) (-1.6198) (0.0000) 
RD=RDMV 2.8677 0.0171 
-0.0212 -0.1781 0.4477 -0.0071 0.2116 248.4405 (41.9826) (2.1580) (-0.8663) (-103319) (24.4575) (-15566) (0.0000) 
Panel A: Absolute Revisions, Revisions scaled by abs. value of 
-12m median EPS forecast 
Adj. R- 
126 c RD BM MV STDEV AF 6 sq. F-stat 
RD=RDS 2.7097 0.0112 
-0.0358 -0.1276 0.3008 -0.0846 0.1525 139.3073 
(27.0090) (1.0395) (-0.9906) (-5.2974) (12.1490) (-1.8253) (0.0000) 
RD=RDTA 2.7102 0.0050 
-0.0358 -0.1291 0.3005 -0.0862 0.1523 139.1467 (26.9916) (0.4667) (-0.9909) (-5.3357) (12.1346) (-1.8601) (0.0000) 
RD=R MV 2.7073 0.0086 
-0.0373 -0.1278 03004 -0.0858 0.1524 139.2188 (26.9352) (0.7727) (-1.0334) (-5.2635) (12.1315) (-1.8532) (0.0000) 
121 
RD=RDS 2.9711 '0.0304 
-0.1668 -0.1258 0.4616 -0.1017 0.1950 187.9302 (36.5461) (3.4475) (-5.9397) (-63568) (21.6595) (-2.5943) (0.0000) 
RD=RDTA 2.9677 '0.0280 
-0.1651 -0.1252 0.4612 -0.1035 0.1947 187.5212 (36.4527) (3.1696) (-5.8720) (-6.2770) (21.6241) (-2.6384) (0.0000) 
RD=RDMV 2.9600 '0.0344 
-0.1722 -0.1229 0.4607 -0.1032 0.1955 188.4242 (36.4302) (3.7420) (-6.1100) (-6.1848) (21.6137) (-2.6336) (0.0000) 
151 
Panel B: Non absolute revisions, Revisions scaled b y Price 
126 c RD BM MV STDEV AF 6 Adj. R-sq. F-stat. 
R1=RDS 
-0.0541 0.0045 -0.0360 0.0141 -0.0385 -0.0017 0.0640 62.6052 (-2.7387) (2.1228) (-5.0616) (3.1355) (-6.6866) (-1.6100) (0.0000) 
RD=RDTA 
-0.0548 0.0049 -0.0357 0.0144 -0.0386 -0.0017 0.0641 62.7212 (-2.7697) (2.26$4) (-5.0251) (3.1901) (-6.7006) (-1.6219) (0.0000) 
RD=RDMV 
-0.0554 0.0023 -0.0365 0.0137 -0.0386 -0.0018 0.0634 61.9619 (-2.7921) (1.1931) (-5.0970) (3.0466) (-6.7031) (-1.7501) (0.0000) 
RD=RDS 
-0.1210 0.0052 -0.0712 0.0243 -0.0437 -0.0014 0.0636 62.2961 (-5.6063) (2.5047) (-8.8906) (4.7069) (-6.2856) (-1.1244) (0.0000) 
RD=RDTA 
-0.1218 0.0053 -0.0709 0.0246 -0.0437 -0.0014 0.0636 62.2970 (-5.6519) (2.5127) (-8.8526) (4.7573) (-6.2974) (-1.1523) (0.0000) 
RD=RDMV 
-0.1225 0.0036 -0.0718 0.0241 -0.0438 -0.0015 0.0631 61.7674 (-5.6792) (1.8624) (-8.9573) (4.6659) (-6.3005) (-1.2306) (0.0000) 
Panel B, Non Absolute Revisions, Revisions scaled by abs. value of 
-12m median EPS forecast 
126 c RD BM MV STDEV AF 6 Adj. R-sq. F-star. 
RD-RDS 
-0.0469 0.0037 -0.0424 0.0123 -0.0352 -0.0029 0.0693 573436 (-1.7301) (1.5495) (-4.6806) (1.9664) (-5.2878) (-0.2226) (0.0000) 
RD=RDTA 
-0.0476 0.0040 -0.0421 0.0126 -0.0352 -0.0030 0.0694 57.4104 (-1.7519) (1.7130) (-4.6453) (2.0152) (-52955) (-02316) (0.0000) 
RD=RDMV 
-0.0473 0.0022 -0.0428 0.0120 -0.0353 -0.0034 0.0690 57.0916 (-1.7383) (0.9605) (-4.7339) (1.9268) (-5.3090) (-02622) (0.0000) 
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RI=RDS 
-0.1289 0.0059 -0.0777 0.0402 -0.0461 -0.0359 0.0558 45.8317 (-4.7926) (2.4017) (-6.9897) (5.7655) (-4.8923) (-2.5945) (0.0000) 
RI=RDTA '-0.1301 0.006 
-0.0773 0.0407 -0.0461 -0.0361 0.0560 46.0048 (-4.8257) (2.6853) (-6.9440) (5.8320) (-4.9004) (-2.6154) (0.0000) 
Ri=RDMV 
-0.1293 0.0038 -0.0783 0.0397 -0.0462 -0.0366 0.0552 452929 (-4.8018) (1.6170) (-7.0537) (5.7094) (4.9126) (-2.6516) (0.0000) 
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Appendix 5B. O Part B: Appendix 5B. O Part B reports the regression results as in 
Tables 5B. 12 and, 5B. 13 (the impact of R&D intensity on forecast errors and 
revisions) by including this time the regressors one by one. This means adding an 
R&D, MV, BM, and STDEV regressor one by one to see how the results evolve, 
when defining errors and revisions according to all mentioned definition in the 
chapter. 
Errors: 
Non Absolute errors: Errors scaled by price: 
12 month prior to year end EPS forecast data 
c RD Adj. R-sq. F-scat. 
RD=RDS 0.0013 0.0000 0.1405 537.5289 
(9.0057) (0.5577) (0.0000) 
RD=RDTA 0.0013 0.0000 0.1405 537.3965 
(8.8679) (0.2372) (0.0000) 
RD=RDMV 0.0015 0.0002 0.1421 544.5856 
(10.1114) (3.6498) (0.0000) 
c RD MV Adj. R-sq. F-stat. 
RD=RDS 0.0007 
-0.0002 -0.0012 0.1822 469.1880 (14.5091) (-3.9409) (-14.7475) (0.0000) 
c RD BM Adj. R-sq. F-slat. 
RD=RDS 0.0024 0.0000 0.0020 0.1796 456.8759 
(14.2079) (-0.3180) (14.1244) (0.0000) 
c RD MV BM Adj. R-sq. F-stat. 
RD=RDS 0.0054 
-0.0001 -0.0007 0.0012 0.1868 347.0051 (13.3561) (-3.4273) (-10.0109) (8.5199) (0.0000) 
c RD MV BM STDEV Adj. R-sq. F-stat. 
RD=RDS 0.0042 
-0.0001 -0.0008 0.0010 0.0012 0.2220 331.6308 (11.5113) (-3.5399) (-10.7360) (7.0588) (10.2889) (0.0000) 
RD=RDTA 0.0042 
-0.0001 -0.0008 0.0010 0.0012 0.2223 332.2113 (11.5473) (-3.7986) (-10.8339) (7.0122) (10.3089) (0.0000) 
RD=RDMV 0.0042 
-0.0001 -0.0008 0.0011 0.0012 0.2212 329.9640 (11.559$) (-2.2559) (-10.6209) (7.1697) (10.2972) (0.0000) 
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Non Absolute errors: Errors scaled by price: 
6 month prior to year end EPS forecast data 
c RD Adj. R-sq. F-stat. 
RD=RDS 0.0011 0.0001 0.0887 309.0729 
(10.6502) (1.7424) (0.0000) 
RD=RDTA 0.0011 0.0000 0.0886 308.6075 
(10.587$) (1.4029) (0.0000) 
RD=RDMV 0.0012 0.0001 0.0908 316.9661 
(11.6108) (4.5370) (0.0000) 
c RD MV Adj. R-sq. F-stat. 
RD=RDS 0.0048 
-0.0001 -0.0008 0.1271 296.8959 (14.7308) (-2.8481) (-14.3251) (0.0000) 
c RD BM Adj. R-sq. F-slat. 
RD=RDS 0.0019 0.0000 0.0014 0.1215 279.0548 
(14.8781) (-0.5999) (13.1164) (0.0000) 
c RD MV BM Adj. R-sq. F-stat 
RD=RDS 0.0040 
-0.0001 -0.0005 0.0009 0.1328 223.9649 (13.8788) (-2.4567) (-10.0703) (8.3450) (0.0000) 
c RD MV BM STDEV Adj. R-sq. F-stat. 
RD=RDS 0.0032 
-0.0001 -0.0006 0.0007 0.0009 0.1653 222.6594 (12.1513) (-2.4653) (-10.8018) (6.8523) (9.2238) (0.0000) 
RI=RDTA 0.0032 
-0.0001 -0.0006 0.0007 0.0009 0.1657 2233113 (12.1823) (-2.9370) (-10.8868) (6.8117) (9.2374) (0.0000) 
RD=RDMV 0.0033 0.0000 
-0.0006 0.0007 0.0009 0.1648 221.9641 (12.1829) (-1.6871) (-10.7058) (6.9251) (9.2298) (0.0000) 
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Absolute errors: Errors scaled by price: 
12 month prior to year end EPS forecast data 
c RD Adj. R-sq. F-stat. 
RD=RDS 
-1.7643 0.0507 0.1114 412.0802 
(-64.1K33) (5.4462) (0.0000) 
RE)=RDTA 
-1.7719 0.0463 0.1107 409.2257 (-63.9598) (4.8897) (0.0000) 
RD=RDMV 
-1.7303 0.0739 0.1154 428.9329 (-62.7922) (7.6763) (0.0000) 
c RD MV Adj. R-sq. F-stat 
RD=RDS 
-0.5020 0.0048 -0.2630 0.1590 398.2804 (-7.4604) (0.5535) (-20.8638) (0.0000) 
c RD BM Adj. R-sq. F-stat 
RD=RDS 
-1.5323 0.0437 0.3686 0.1345 324.4762 (-48.2410) (4.9494) (13.8386) (0.0000) 
c RD MV BM Adj. R-sq. F-stat 
RD=RDS 
-0.5838 0.0082 -0.2251 0.1633 0.1590 285.8219 (-8.5357) (0.9624) (-16.1241) (5.8085) (0.0000) 
c RD MV BM STDEV Adj. R-sq. F-stat 
RI=RDS 












-1.2610 0.0172 -0.2610 0.0100 0.6913 0.3416 601.9906 (-19.0166) (2.0834) (-20.5986) (0.4086) (37.1089) (0.0000) 
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Absolute errors: Errors scaled by price: 
6 month prior to year end EPS forecast data 
c RD Adj. R-sq. F-stat. 
RD=RDS 
-2.0993 0.0540 0.1303 474.9949 (-68.4Q74) (5.0440) (0.0000) 
RD=RDTA 
-2.0907 0.0594 0.1310 477.9494 (-67.9Q81) (5.4290) (0.0000) 
RD=RDMV 
-2.0564 0.0822 0.1348 494.1529 (-67.0254) (7.6539) (0.0000) 
c RD MV Adj. R-sq. F-saat. 
RI=RDS 
-0.0261 0.0034 -0.3038 0.1842 459.7532 (-8.7661) (0.3637) (-22.3911) (0.0000) 
c RD BM Adj. R-sq. F-star. 
RD=RDS 
-1.8309 0.0455 0.4202 0.1561 372.8161 (-51.6207) (4.5148) (14.0349) (0.0000) 
c RD MV BM Adj. R-sq. F-stat. 
RD=RDS 
-0.7155 0.0062 -0.2589 0.2017 0.1856 332.8258 (-9.9757) (0.6674) (-17.4644) (6.5637) (0.0000) 
c RD M. V BM STDEV Adj. R-sq. F-star. 
RI=RDS 
-1.2407 0.0066 -0.2887 0.0899 0.5399 0.2850 447.1816 (-17.9549) (0.7524) (-21.2975) (3.1303) (27.9570) (0.0000) 
RD=RDTA 
-1.2417 0.0082 -0.2879 0.0905 0.5398 0.2850 447.2640 (-17.9j50) (0.9087) (-21.1586) (3.1484) (27.9494) (0.0000) 
RD=RDMV 
-1.2440 0.0153 -0.2856 0.0879 0.5395 0.2852 447.8203 (-18.0405) (1.6592) (-20.9882) (3.0594) (27.9492) (0.0000) 
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Non Absolute Errors; Errors scaled by the absolute value of actual EPS 
12 month prior to ye4r end EPS forecast data 
c RD Adj. R-sq. F-stat. 
RD=RDS 0.0024 
-0.0001 0.0415 149.9834 
(10.0526) (-0.8910) (0.0000) 
RD=RDTA 0.0025 0.0000 0.0414 149.8166 
(10.2790) (0.6189) (0.0000) 
RD-RDMV 0.0028 0.0002 0.0422 152.5504 
(11.4456) (3.1679) (0.0000) 
c RD MV Adj. R-sq. F-stat 
RD=RDS 0.00? 1 
-0.0003 -0.0012 0.0569 133.5388 (10.1207) (-3.8372) (-8.4835) (0.0000) 
c RD BM Adj. R-sq. F-stat 
RD=RDS 0.0050 
-0.0001 0.0039 0.0780 1853250 (12.8823) (-1.9923) (12.2329) (0.0000) 
c RD MV BM Adj. R-sq. F-stat. 
RD=RDS 0.0072 
-0.0002 -0.0005 0.0034 0.0800 137.7012 (9.5276) (-3.2667) (-3.9467) (10.8947) (0.0000) 
c RD MV BM STDEV Adj. R-sq. F-stat 
RD=RDS 0.0055 
-0.0002 -0.0006 0.0031 0.0017 0.0925 1243006 (7.2839) (-32708) (-4.5210) (10.0238) (7.4350) (0.0000) 
RI=RDTA 0.0055 
-0.0002 -0.0006 0.0031 0.0017 0.0924 124.0524 (7.2989) (-3.0596) (-4.5066) (10.0004) (7.4448) (0.0000) 
KITT=BONN 0.0035 
-0.0001 -0.0006 0.0031 0.0017 0.0915 122.7699 (7.2791) (-1.7785) (-4.2279) (10.0957) (7.4517) (0.0000) 
157 
Non Absolute Errors: Errors scaled by the absolute value of actual EPS 
6 month prior to year end EPS forecast data 
c RD Adj. R-sq. F-stat. 
RD=RDS 0.0017 
-0.0001 0.0268 98.2194 (9ä860) (-0.9639) (0.0000) 
RD=RDTA 0.0018 0.0000 0.0267 97.9529 
(9.9728) (0.5250) (0.0000) 
R1=RDMV 0.0020 0.0001 0.0273 100.1454 
(10.9924) (2.7367) (0.0000) 
c RD MV Adj. R-sq. F-scat. 
RD=RDS 0.0057 
-0.0002 -0.0008 0.0411 97.7013 (9.1154) (-3.2246) (-7.5664) (0.0000) 
c RD BM Adj. R-sq. F-stat. 
RD=RDS 0.0034 
-0.0001 0.0026 0.0514 121.7524 (11.5130) (-2.1546) (10.3078) (0.0000) 
c RD MV BM Adj. R-sq. F-star. 
RD=RDS 0.0052 
-0.0002 -0.0004 0.0023 0.0573 98.8592 (8.6327) (-3.1305) (-3.9913) (9.1782) (0.0000) 
Adj. R- 
c RD MV BM STDEV sq. F-star. 
RD=RDS 0.0044 
-0.0002 -0.0005 0.0022 0.0009 0.0635 84.1657 (72347) (-33490) (-4.3837) (8.6820) (5.2751) (0.0000) 
RD=RDTA 0.0045 
-0.0002 -0.0005 0.0022 0.0009 0.0632 83.7905 (7.2514) (-3.0122) (-4.3443) (8.6529) (5.2829) (0.0000) 
RD=RDMV 0.0045 -0.0001 
-0.0004 0.0022 0.0009 0.0623 82.5449 (7.2264) (-1.7133) (-4.0393) (8.7718) (5.2909) (0.0000) 
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Absolute Errors: Errors scaled by the absolute value of actual EPS 
12 month prior to ye4r end EPS forecast data 
c RD Adj. R-sq. F-stat. 
RD=RDS 
-1.4162 0.0421 0.0978 373.9362 
(-52.8203) (4.5101) (0.0000) 
RD=RDTA 
-1.4234 0.0379 0.0972 371.7311 (-52.7289) (4.0338) (0.0000) 
RD=BO1N 
-1.3861 0.0627 0.1007 386.3491 (-51.2421) (6.6572) (0.0000) 
c RD MV Adj. R-sq. F-stat. 
RD=RDS -0.4183 0.0050 
-0.2085 0.1275 322.3020 (-5.8958) (0.5537) (-15.8298) (0.0000) 
c RD BM Adj. R-sq. F-stat 
RD=RDS 
-1.2329 0.0323 0.3301 0.1138 280.6383 (-36.6437) (3.5211) (12.2049) (0.0000) 
c RD MV BM Adj. R-sq. F-stat. 
RD=RDS 
-0.4969 0.0048 -0.1734 0.1766 0.1277 231.0188 (-6.8300) (0.5289) (-11.9008) (6.0818) (0.0000) 
c RD MV BM STDEV Adj. R-sq. F-stat. 
RD=RDS 
-1. j349 0.0089 -0.2042 0.0455 0.6311 0.2659 438.9443 (-15.3Q63) (1.0373) (-14.4312) (1.6331) (30.4145) (0.0000) 
RD=RDTA 
-1.1356 0.0025 -0.2062 0.0450 0.6312 0.2658 438.6916 (-15.3159) (0.2881) (-14.4366) (1.6133) (30.4112) (0.0000) 
RD=RDMV 
-1.1380 0.0146 -0.2021 0.0432 0.6305 0.2661 439.3616 (-15.3694) (1.6259) (-4.2457) (1.5499) (30.3850) (0.0000) 
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Absolute Errors: Errors scaled by the absolute value of actual EPS 
6 month prior to year end EPS forecast data 
c RD Adj. R-sq. F-stat. 
RD=RDS 
-1.6972 0.0507 0.1375 563.5487 
(-55.8665) (4.6774) (0.0000) 
RD=RDTA 
-1.6910 0.0548 0.1379 565.5495 (-55.4792) (4.9417) (0.0000) 
RD=BONN 
-1.6595 0.0764 0.1409 579.5828 (-542617) (7.0796) (0.0000) 
c RD MV Adj. R-sq. F-stat. 
RD=RDS 
-0.4699 0.0066 -0.2592 0.1705 464.1920 (-6.1215) (0.6437) (-17.7386) (0.0000) 
c RD BM Adj. R-sq. F-stat. 
RD=RDS 
-1.4663 0.0368 0.4117 0.1559 412.6539 (-39.5576) (3.4924) (13.7452) (0.0000) 
c RD MV BM Adj. R-sq. F-stat. 
RD=RDS 
-0.5793 0.0050 -0.2098 0.2359 0.1708 332.4411 (-73727) (0.4860) (-12.9267) (73675) (0.0000) 
c RD MV BM STDEV Adj. R-sq. F-stat. 
RD=RDS 
-1.0525 0.0062 -0.2365 0.1397 0.4893 0.2399 387.8341 (-13.4270) (0.6270) (-15.2795) (4.4839) (23.8711) (0.0000) 
RD=RDTA 
-1.0533 0.0078 -0.2358 0.1403 0.4893 02399 387.8902 (-13.4449) (0.7560) (-15.1759) (4.4987) (23.8626) (0.0000) 
RD=RDMV 
-1.0556 0.0141 -0.2337 0.1376 0.4890 0.2401 388.2381 (-13.454) (1.3723) (-15.0358) (4.4145) (23.8530) (0.0000) 
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Revisions: 
Non Absolute Revisions scaled by Price 
126 
c RD Adj. R-sq. F-stat. 
RD=RDS 
-0.0199 0.0009 0.0379 124.6836 (-3.1234) (0.4632) (0.0000) 
RD=RDTA 
-0.0198 0.0010 0.0379 124.7015 (-3.1259) (0.5019) (0.0000) 
RD=RDMV 
-0.0267 -0.0033 0.0383 125.8076 (-4.1469) (-1.7467) (0.0000) 
c RD MV Adj. R-sq. F-stat. 
RD=RDS 
-0.1094 0.0050 0.0189 0.0449 94.7304 (-5.3006) (2.3147) (5.3695) (0.0000) 
c RD BM Adj. R-sq. F-scat. 
RD RDS 
-0.0496 0.0030 -0.0543 0.0510 106.9968 (-5.9223) (1.5391) (-8.1244) (0.0000) 
c RD MV BM Adj. R-sq. F-stat. 
R1=RDS 
-0.0816 0.0043 0.0077 -0.0465 0.0514 78.4589 (-4.2496) (2.1011) (2.1598) (-6.4139) (0.0000) 
Adj. R- 
c RD MV BM STDEV sq. F-stat. 
RD=RDS 
-0.0426 0.0044 0.0089 -0.0397 -0.0365 0.0593 70.4130 (-22653) (2.1115) (2.4645) (-5.5789) (-6.4046) (0.0000) 
RD=RDTA 
-0.0432 0.0046 0.0091 -0.0394 -0.0366 0.0594 70.4931 (-2.2907) (2.1964) (2.5052) (-5.5404) (-6.4163) (0.0000) 
RD=RDMV 
-0.0431 0.0021 0.0082 -0.0402 -0.0366 0.0587 69.6576 (-2.2798) (1.1092) (2.2623) (-5.6443) (-6.4167) (0.0000) 
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Non Absolute Revisions scaled by Price 
121 
c RD Adj. R-sq. F-stat. 
RI=RDS 
-0.0193 -0.0006 0.0125 41.4077 
(-2.7323) (-0.2693) (0.0000) 
RD==RDTA 
-0.0196 -0.0008 0.0125 41.4354 
(-2.7934) (-0.3707) (0.0000) 
RD=RDMV 
-0.0278 -0.0060 0.0135 44.6792 
(-3.9202) (-3.0760) (0.0000) 
C RD MV Adj. R-sq. F-stat. 
RD=RDS 
-0.1804 0.0066 0.0344 0.0313 66.8151 (-8.1102) (2.9743) (9.1669) (0.0000) 
C RD BM Adj. R-sq. F-stat. 
RD=RDS 
-0.0821 0.0015 -0.0998 0.0475 1013055 
(-8.1797) (0.7932) (-12.9885) (0.0000) 
C RD MV BM Adj. R-sq. F-stet. 
RD=RDS 
-0.1498 0.0045 0.0168 -0.0838 0.0499 77.5709 (-7.3673) (22402) (4.9258) (-10.7150) (0.0000) 
Adj. R- 
C RD MV BM STDEV sq. F-star. 
RD=RDS 
-0.1067 0.0045 0.0185 -0.0762 -0.0413 6.0601 72.7673 (-5.6644) (2.2363) (5.2391) (-9.9408) (-6.1647) (0.0000) 
RD=RDTA 
-0.1072 0.0044 0.0186 -0.0760 -0.0413 0.0601 72.7002 (-0.6842) (2.1484) (5.2333) (-9.9020) (-6.1760) (0.0000) 
RI-RDMV 
-0.1073 0.0026 0.0179 -0.0768 -0.0413 0.0597 72.1595 (-5.6874) (1.3767) (5.0687) (-10.0314) (-6.1748) (0.0000) 
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Absolute Revisions scaled by Price 
126 
RD Adj. R-sq. F-scat. 
RD=RDS 2.0333 0.0304 0.1306 479.4684 
(643070) (2.9231) (0.0000) 
RD=RDTA 2.0280 0.0273 0.1303 478.5345 
(64.0050) (2.6077) (0.0000) 
RD=RDMV 2.0490 0.0412 0.1314 483.0915 
(65.3217) (3.9476) (0.0000) 
c RD MV Adj. R-sq. F-stat. 
RD=RDS 3.1572 
-0.0117 -0.2341 0.1546 371.0330 (41.5303) (-1.1822) (-16.1649) (0.0000) 
c RD BM Adj. R-sq. F-star. 
RD=RDS 2.1826 0.0236 0.2640 0.1357 314.9608 
(61.0216) (2.3259) (8.7084) (0.0000) 
c RD MV BM Adj. R-sq. F-stat. 
RI=RDS 3.1521 
-0.0083 -0.2206 0.0931 
. 
0.1537 264.0670 
(41.1023) (0.8339) (-13.7845) (2.8787) (0.0000) 
c RD MV BM " STDEV Adj. R-sq. F-stat. 
RD=RDS 2.8086 
-0.0105 -0.2338 0.0389 0.3118 0.1838 252.1014 (35.7430) (-1.0791) (-14.9125) (1.2348) (14.0230) (0.0000) 
Rl>=RDTA 2.81Q8 
-0.0176 -0.2367 0.0376 0.3119 0.1841 252.5834 (35.8052) (-1.8049) (-15.0313) (1.1944) (14.0416) (0.0000) 
RD=RDMV 2.8115 
-0.0115 -0.2344 0.0410 0.3120 0.1838 252.1333 (35.7329) (-1.1367) (-14.8445) (1.3021) (14.0320) (0.0000) 
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Absolute Revisions scaled by Price 
121 
c RD Adj. R-sq. F-stat. 
RD=RDS 2.4846 0.0381 0.0823 295.8498 
(98.2468) (4.3678) (0.0000) 
RD=RDTA 2.4848 0.0385 0.0823 295.9068 
(98.4839) (4.3835) (0.0000) 
RD=RDMV 2.5091 0.0546 0.0850 306.1697 
(100.2645) (6.1701) (0.0000) 
c RD MV Adj. R-sq. F-stat. 
RD=RDS 3.4(43 0.0018 
-0.2035 0.1190 283.0450 (54.98p4) (0.2128) (-17.2783) (0.0000) 
c RD BM Adj. R-sq. F-stat. 
RD=RDS 2.6171 0.0345 0.2162 0.0910 207.2168 
(86.8330) (4.0193) (8.7821) (0.0000) 
c RD MV BM Adj. R-sq. F-stat. 
RD=RDS 3.4517 0.0045 
-0.1931 0.0581. 0.1179 200.2925 (53.7985) (0.5385) (-14.8970) (22607) (0.0000) 
c RD MV 
" 
BM STDEV Adj. R-sq. F-stat. 
RD=RDS 2.9552 0.0073 
-0.2058 -0.0283 0.4385 0.2088 304.0300 (47.8695) (0.9761) (-17.2977) (-1.2118) (24.3739) (0.0000) 
RD=RDTA 2.9548 0.0031 
-0.2071 -0.0286 0.4384 0.2087 303.8337 (47.8597) (0.4086) (-17.2517) (-1.2198) (24.3778) (0.0000) 
RD=RDMV 2.9527 0.0110 
-0.2044 -0.0301 0.4382 0.2089 304.2866 (47.8558) (1.4092) (-17.1045) (-1.2835) (24.3603) (0.0000) 
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Non Absolute revisions scaled by the absolute value of the 
-12m median EPS forecast 
126 
c RD Adj. R-sq. F-star 
RD=RDS 0.0037 0.0020 0.0346 112.2503 
(0.5206) (0.9728) (0.0000) 
RD=RDTA 0.0037 0.0020 0.0346 112.2489 
(0.5239) (0.9833) (0.0000) 
RD=RDMV 
-0.0018 -0.0014 0.0345 112.0467 
(-0.2470) (-0.6590) (0.0000) 
c RD MV Adj. R-sq. F-stat. 
RD=RDS 
-0.0618 0.0051 0.0141 0.0397 82.7085 (-2.6715) (2.2624) (3.4852) (0.0000) 
c RD BM Adj. R-sq. F-stat. 
RD=RDS 
-0.0317 0.0041 -0.0583 0.0478 99.1946 (-3.3404) (2.0200) (-7.1633) (0.0000) 
c RD MV BM Adj. R-sq. F-stat. 
RD=RDS 
-0.0467 0.0046 0.0039 -0.0535 0.0470 70.8600 (-1.9914) (2.0811) (0.8764) (-5.7981). (0.0000) 
Adj. R- 
c RD MV BM STDEV sq. F-star. 
RD=RDS 
-0.0171 0.0048 0.0061 -0.0475 -0.0334 0.0539 63.1775 (-0.7180) (2.1085) (13118) (-4.8307) (-4.5079) (0.0000) 
RD=RDTA 
-0.0178 0.0049 0.0063 -0.0473 -0.0334 0.0539 63.1823 (-0.7445) (2.1641) (1.3481) (-4.7988) (-4.5158) (0.0000) 
R1)--RDMV 
-0.0178 0.0029 0.0055 -0.0482 -0.0335 0.0535 62.6826 (-0.7439) (1.2744) (1.1771) (-4.9367) (4.5170) (0.0000) 
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Non Absolute revisions scaled by the absolute value of the 
-12m median EPS forecast 
12 1 
c RD Adj. R-sq. F-stat. 
RD=RDS 0.0051 0.0004 0.0031 10.7760 
(0.6350) (0.1865) (0.0000) 
RD=RDTA 0.0054 0.0006 0.0031 10.7921 
(0.68Q0) (02809) (0.0000) 
RD=RDMV 
-0.0043 -0.0055 0.0037 12.8620 
(-0.5211) (-2.4425) (0.0000) 
c RD MV Adj. R-sq. F-stat 
RD=RDS 
-0.1685 0.0080 0.0375 0.0192 40.6193 (-7.1008) (3.2970) (9.0756) (0.0000) 
c RD BM Adj. R-sq. F-scat 
RD=RDS 
-0.0696 0.0030 -0.1186 0.0404 85.1831 
(6.6441) (1.4240) (-13.8453) (0.0000) 
c RD MV BM Adj. R-sq. F-scat 
RD=RDS 
-0.1411 0.0059 0.0182 -0.1005 0.0408 62.4697 (-63789) (2.6365) (4.3552) (-10.6884) (0.0000) 
Adj. R- 
c RD MV BM STDEV sq. F-stat 
RD=RDS 
-0.0946 0.0059 0.0200 -0.0928 -0.0448 0.0512 61.1051 (-42767) (2.5849) (4.5977) (-93771) (-53920) (0.0000) 
RD=RDTA 
-0.0953 0.0061 0.0202 -0.0925 -0.0449 0.0512 61.1319 (-0.3035) (2.6565) (4.6255) (-9.3311) (-5.4054) (0.0000) 
RD=RDMV 
-0.0954 0.0037 0.0193 -0.0936 -0.0449 0.0506 60.3805 (-4.3094) (1.6741) (4.4414) (-9.4893) (-5.4090) (0.0000) 
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Absolute revisions scaled by the absolute value of the 
-12m median EPS forecast 
126 
c RD Adj. R-sq. F-stat. 
R1=RDS 2.3846 0.0327 0.1267 460.7585 
(77.9792) (3.2266) (0.0000) 
RD=RDTA 2.3751 0.0270 0.1262 458.9427 
(77.3297) (2.6532) (0.0000) 
RB=RDMV 2.38$2 0.0359 0.1269 461.7026 
(78.3197) (3.4934) (0.0000) 
c RD MV Adj. R-sq. F-scat. 
RD=RDS 3.1782 0.0049 
-0.1646 0.1375 321.9264 (40.8457) (0.4854) (-11.1855) (0.0000) 
c RD BM Adj. R-sq. F-stat. 
RD=RDS 2.4204 0.0310 0.0994 0.1231 280.4134 
(66.8546) (3.0384) (3.3216) (0.0000) 
c RD MV BM Adj. R-sq. F-stat. 
RD=RDS 3.2139 0.0060 
-0.1814 -0.0513 0.1348 225.5845 (40.1946) (0.5907) (-10.9234) (-1.5546) (0.0000) 
c RD MV BM STDEV Adj. R-sq. F-scat 
RD=RDS 2.9052 0.0062 
-0.1942 -0.1065 02876 0.1609 213.9172 (35.1000) (0.6092) (-11.7781) (-32877) (12.7696) (0.0000) 
RD=RDTA 2.9052 
-0.0022 -0.1970 -0.1075 0.2877 0.1609 213.8433 (35.1033) (0.2114) (-11.8841) (-3.3135) (12.7712) (0.0000) 
RI=RDMV 2.9045 0.0021 
-0.1955 -0.1074 0.2876 0.1609 213.8421 (35.06! 4) (0.1960) (-11.7665) (-3.3124) (12.7636) (0.0000) 
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Absolute revisions scaled by the absolute value of the 
-12m median EPS forecast 
12 1 
c RD Adj. R-sq. F-star 
RD=RDS 2.8453 0.0426 0.0934 337.0485 
(113.2752) (4.8551) (0.0000) 
RD=RDTA 2.8426 0.0413 0.0932 336.0441 
(112.9356) (4.6722) (0.0000) 
RD=RDMV 2.8606 0.0537 0.0952 344.0585 
(114.3923) (5.9661) (0.0000) 
c RD MV Adj. R-sq. F-stat 
RD=RDS 3.4953 0.0191 
-0.1349 0.1082 252.5329 (52.8167) (2.1711) (-10.8752) (0.0000) 
c RD BM Adj. R-sq. F-stat 
RD=RDS 2.8620 0.0424 0.0585 0.0906 204.8995 
(93.1153) (4.7774) (2.3467) (0.0000) 
c RD MV BM Adj. R-sq. F-stat. 
R>RDS 3.5173 0.0191 
-0.1520 -0.0724 0.1065 177.6057 (51.7978) (2.1638) (-11.0026) (-2.6675) (0.0000) 
c RD MV BM STDEV Adj. R-sq. F-staL 
RD=RDS 3.0385 0.0239 
-0.1669 -0.1696 0.4332 0.1896 267.9373 (44.7498) (2.8825) (-12.7135) (-6.6704) (22.3986) (0.0000) 
RD-RDTA 3.0359 0.0189 
-0.1679 -0.1691 0.4330 0.1891 267.1468 (44.6594) (2.2672) (-12.6755) (-6.6416) (22.3786) (0.0000) 
RD=RDMV 3.0318 0.0271 
-0.1653 -0.1743 0.4324 0.1898 268.3385 (44.6936) (3.1363) (-12.5625) (-6.8304) (22.3589) (0.0000) 
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APPENDIX 5B. P 
The Appendix 5B. P contains the results of Fama-French time series regressions 
according to 5 analyst divergence of opinion portfolios (1-p) for the whole sample, 
the R&D, zero R&D, and R&D/Sales above the sample median firms. When the RD 
factor is added, this is calculated with equal-weighted returns either by subtracting 
the returns the zero R&D firms from the returns of the top 30 percentile R&D/Sales 
firms as in Table 5B. 6, or as in Al Horani-Pope and Stark (2003), as is done in 
Appendix 5B. C Part A. Panel A. The scaling used for (1-p) calculation in Appendix 
5B. P is by the absolute value of actual EPS and is consistent with the scaling used for 
D calculation on the Tables on p. 85 of this second Volume. 
Panel A: No RD factor 
Sample 
Adjusted R- F- 
alpha RM SMB HML squared statistic 
(1-p) (low) 0.0008 1.2456 0.8648 0.0950 
. 
0.7460 152.7479 
(0.3445) (19.8931) (9.2307) (1.1698) (0.0000) 
(1-p)2 
-0.0016 1.2982 0.8111 0.3929 0.7172 131.9984 (-0.6612) (18.0533) (10.0001) (4.7483) (0.0000) 
(1-p)3 0.0010 1.1332 0.4595 0.3183 0.7141 130.0541 
(0.4804) (16.5604) (6.1429) (3.7835) (0.0000) 
(1-p)4 
-0.0005 1.1092 0.3025 0.3209 0.7421 149.6570 (-0.2643) (22.1462) (4.2698) (4.7910) (0.0000) 
(1-p)5 
(High) 
-0.0035 1.0636 0.8096 0.2579 0.6661 104.0910 (-1.5111) (16.4335) (9.2996) (3.1913) (0.0000) 
R&D firms 
(1-p) (low) 0.0034 1.3141 0.8977 
-0.1488 0.6701 105.9595 
(1.1616) (15.8529) (6.7435) (-1.5346) (0.0000) 
(1-p)2 
-0.0004 1.3791 0.6023 0.1782 0.6727 107.1809 (-0.1140) (15.9019) (5.5715) (1.7443) (0.0000) 
(1-p)3 0.0016 1.0954 0.3586 0.1880 0.7041 123.9707 
(0.7737) (185128) (5.2520) (2.1428) (0.0000) 
(1-p)4 
-0.0004 1.1203 0.2468 0.2439 0.7164 131.5186 (-0.1792) (19.7253) (2.7988) (3.6563) (0.0000) 
(1-p)5 
(High) 
-0.0030 0.9725 0.6972 0.0614 0.5740 70.6260 (-1.1545) (13.8879) (6.7350) (0.6994) (0.0000) 
Zero R&D firms 
(1-p) (low) 
-0.0005 1.1967 0.8491 0.2396 0.7186 132.9120 (-0.2119) (19.2573) (9.0399) (2.7836) (0.0000) 
(1-p)2 
-0.0021 1.2601 0.9328 05208 0.6797 110.6493 (-0.8215) (16.4485) (9.9919) (6.0396) (0.0000) 
(1-p)3 0.0004 1.1654 0.5527 0.4189 0.6585 100.6143 
(0.1583) (13.9852) (5.7486) (4.5395) (0.0000) 
(1-p)4 
-0.0011 1.1097 0.3767 03884 0.6901 116.0438 (-0.4937) (18.4126) (5.1363) (4.8433) (0.0000) 
(1-p)5 
(High) 
-0.0037 1.0887 0.8563 0.3362 0.6475 95.8859 (-1.4986) (15.4556) (9.2841) (3.9065) (0.0000) 
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Panel A Continued 
R&D firms w ith RD/Sales> median 
(1-p) (low) 0.0083 13995 
(2.1187) (12.4376) 
(1-p)2 0.0020 1.3877 
(0.5207) (12.6300) 
(1-p)3 0.0069 1.2465 
(2.0102) (13.6654) 
(1-p)4 
-0.0043 1.4256 (-1.1326) (10.8753) 
(1-p)5 
1.0920 
-0.5738 0.6242 86.8082 (5.7232) (-4.1137) (0.0000) 
0.6572 
-0.1376 0.6116 82.3496 (5.0715) (-1.0598) (0.0000) 
0.4960 
-0.2123 0.5627 67.4807 (3.5555) (-1.4627) (0.0000) 
0.6480 
-0.0143 0.5492 63.9457 (3.5920) (-0.1245) (0.0000) 
(High) 0.0006 0.9527 0.6427 
-0.2107 0.4264 39.4097 (0.1744) (8.8149) (4.2752) (-1.8399) (0.0000) 
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Panel B: Time-series regressions run with an RD factor calculated as (High RD-Zero RD) with equal-weighted 
returns 
Sample 
Adjusted R- F- 
alpha RM SMB HML RD Factor squared statistic 
(1-p) (low) 
-0.0008 1.1951 0.8186 0.3094 02198 0.7565 121.4085 (-0.3499) (18.1600) (8.8494) (2.6587) (2.4022) (0.0000) 
(1-p)2 
-0.0033 1.2433 0.7608 0.6262 0.2393 0.7293 105.4062 (-13768) (17.4261) (10.0430) (5.0657) (2.5758) (0.0000) 
(1-p)3 0.0004 1.1153 0.4431 0.3945 0.0781 0.7142 97.8200 
(0.1892) (15.4174) (5.8103) (3.4455) (0.9780) (0.0000) 
(1-p)4 
-0.0013 1.0832 0.2788 0.4312 0.1131 0.7447 114.0337 (-0.6600) (20.7101) (3.9734) (4.2788) (1.4476) (0.0000) 
(1-p)5 (High) 




-0.0001 1.2044 0.7973 0.3171 0.4778 0.7096 95.6889 (-0.0177) (15.0691) (6.2952) (2.1182) (3.9875) (0.0000) 
(1-p)2 
-0.0040 1.2649 0.4978 0.6630 0.4972 0.7195 100.3929 (-1.3687) (16.0015) (5.0389) (4.6605) (4.3509) (0.0000) 
(1-p)3 
-0.0001 1.0411 0.3089 0.4183 0.2362 0.7206 100.9209 (-0.0671) (16.7532) (4.7422) (3.5977) (2.8545) (0.0000) 
(1-p)4 
-0.0017 1.0770 0.2071 0.4281 0.1888 0.7258 103.5446 (-0.8184) (19.6598) (2.5008) (3.7910) (2.1041) (0.0000) 
(1-p)5 (High) 
-0.0038 0.9463 0.6733 0.1726 0.1140 0.5753 53.4985 (-1.4203) (13.0647) (6.3691) (1.3649) (1.1915) (0.0000) 
Zero RD firms 
(1-p) (low) 
-0.0010 1.1798 0.8336 0.3115 0.0737 0.7182 99.7590 (-0.4359) (17.3493) (8.7461) (2.5921) (0.7896) (0.0000) 
(1-p)2 
-0.0026 1.2418 0.9160 0.5987 0.0799 0.6792 83.0245 (-1.0294) (16.1251) (10.0545) (4.3230) (0.7739) (0.0000) 
(1-p)3 0.0007 1.1753 0.5617 0.3770 
-0.0430 0.6567 75.1354 (0.2755) (13.4241) (5.7581) (2.9310) (-0.4729) (0.0000) 
(1-p)4 
-0.0014 1.0988 03667 0.4347 0.0475 0.6887 86.7477 (-0.6207) (17.1929) (4.7965) (3.8126) (0.5400) (0.0000) 
(1-p)5 (High) 
-0.0035 1.0954 0.8625 0.3076 
-0.0293 0.6454 71.5217 (-1.3959) (14.4725) (9.0609) (2.6272) (-0.2982) (0.0000) 
R&D firms with RD/Sales> median 
(1-p) (low) 0.0015 1.1872 0.8976 0.3278 0.9246 0.7189 100.1054 
(0.4143) (11.5689) (5.3787) (1.6502) (5.7589) (0.0000) 
(1-p)2 
-0.0035 1.2153 0.4994 0.5945 0.7507 0.6984 90.7253 (-1.0070) (12.0097) (3.9690) (3.3921) (5.2047) (0.00(0) 
(1-p)3 0.0030 1.1246 0.3844 0.3053 0.5308 0.6088 61.3124 
(0.9482) (11.0532) (3.0929) (1.4803) (3.2973) (0.0000) 
(1-p)4 
-0.0086 1.2909 0.5247 0.5578 0.5867 0.5955 58.0434 (-2.2048) (123565) (3.5419) (2.3000) (2.8495) (0.0000) 
(1-p)5 (High) 
-0.0014 0.8889 0.5843 0.0601 0.2777 0.4386 31.2755 (-0.3426) (8.1982) (3.9832) (0.3188) (2.0327) (0.0000) 
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Panel C: Time-series regressions run with an RD factor calculated as in Al Horani et at (2003) with equal- 
weighted returns 
Sample 
Adjusted R- F- 
alpha RM SMB HML RD Factor squared statistic 
0 
-p) (low) 0.0006 1.2400 0.8753 0.1115 0.0946 0.7449 114.1654 (0.2433) (19.2270) (9.2741) (1.2650) (0.5424) (0.0000) 
(1-p)2 
-0.0019 1.2895 0.8274 0.4186 0.1474 0.7167 99.0299 (-0.7840) (17.9701) (9.6662) (4.5530) (0.8526) (0.0000) 
(1-p)3 0.0016 1.1495 0.4288 02700 
-0.2765 0.7187 100.0270 (0.8241) (17.1467) (5.8495) (3.1195) (-1.9778) (0.0000) 
(1-p)4 
-0.0006 1.1068 0.3069 0.3278 0.0394 0.7405 111.5847 (-0.3110) (21.7615) (4.2283) (4.6533) (0.3253) (0.0000) 
(1-p)5 (High) 
-0.0027 1.0833 0.7725 0.1994 -0.3347 0.6737 80.9884 (-1.1759) (16.6508) (8.9249) (2.4415) (-2.3103) (0.0000) 
R&D firms 
(1-p) (low) 0.0015 1.2672 0.9862 
-0.0095 0.7979 0.6989 90.9569 (0.5207) (15.2009) (7.9346) (-0.0895) (3.1923) (0.0000) 
(1-p)2 
-0.0023 1.3321 0.6907 0.3175 0.7978 0.7041 93.2258 (-0.7502) (16.8806) (6.7101) (2.8145) (4.3189) (0.0000) 
(1-p)3 0.0010 1.0819 0.3838 0.2278 0.2280 0.7068 94.3914 
(0.5184) (17.4851) (5.4017) (2.5982) (1.6712) (0.0000) 
(1-p)4 
-0.0014 1.0940 0.2964 0.3220 0.4471 0.7313 106.4657 (-0.7224) (21.0755) (3.5155) (4.2895) (3.1274) (0.0000) 
(1-p)5 (High) 
-0.0032 0.9675 0.7066 0.0762 0.0847 0.5718 52.7491 (-1.2132) (13.6011) (6.7224) (0.8245) (0.5076) (0.0000) 
Zero RD firms 
(1-p) (low) 0.0002 1.2148 0.8149 0.1858 
-0.3080 0.7237 102.4985 (0.1089) (18.9618) (8.3198) (2.0985) (-1.8386) (0.0000) 
(1-p)2 
-0.0015 1.2750 0.9048 0.4766 -0.2527 0.6818 84.0095 (-0.5834) (16.8565) (8.9096) (4.9741) (-1.2887) (0.0000) 
(1-p)3 0.0020 1.2045 0.4790 0.3030 
-0.6638 0.6894 87.0073 (0.8805) (15.5919) (5.4755) (3.2663) (-4.1154) (0.0000) 
(1-p)4 
-0.0004 1.1270 03441 03371 -0.2941 0.6954 89.4665 (-0.1841) (18.9681) (4.5442) (4.1396) (-2.2360) (0.0000) 
(1-p)5 (High) 
-0.0025 1.1185 0.8002 0.2477 -0.5064 0.6659 78.2474 (-1.0348) (15.9091) (8.8632) (2.8684) (-3.2232) (0.0000) 
R&D firms with RD/Sales> median 
(I-P) (low) 0.0053 1.3266 
. 
1.2292 
-0.3576 1.2379 0.6682 79.0224 (1.3506) (11.9392) (6.7165) (-2.4391) (3.5632) (0.0000) 
(1-p)2 
-0.0005 1.3251 0.7750 0.0479 1.0628 0.6568 75.1488 (-0.1439) (13.1237) (6.1592) (0.3538) (5.0001) (0.0000) 
(1-p)3 0.0061 1.2258 0.5349 
-0.1509 0.3513 0.5655 51.4380 (1.8040) (13.0282) (3.6606) (-1.0172) (1.5443) (0.0000) 
(1-p)4 
-0.0068 1.3650 0.7623 0.1656 1.0304 0.5867 56.0168 (-1.8435) (12.8541) (4.2159) (1.1343) (2.8525) (0.0000) 
(1-p)5 (High) 0.0012 0.9654 0.6188 
-0.2483 -0.2157 0.4252 29.6633 (0.3046) (9.1117) (3.8330) (-1.9080) (-0.7320) (0.0000) 
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The table reports the average number of observations according to divergence in 
opinion (1-p) quintiles for the whole sample, the R&D, zero R&D and R&D 
intensive firms (firms with R&D/Sales>median) from (1-p)l (low) to (1-p)5 (High). 
The scaling used for (1-p) calculation is by the absolute value of actual EPS. 
Sample 
R&D Zero R&D 
firms firms RD/Sales above median 
(1-p) (low) 94 34 59 11 
(1-p)2 94 35 59 18 
(1-p)3 95 42 53 17 
(1-p)4 95 44 51 17 
(1-p)5 (High) 92 28 64 14 
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APPENDIX 5B. Q 
The Appendix reports the average 156 month (July 199 1 
-June2004) monthly returns, 
both raw and risk-adjusted for the whole sample and the R&D, zero R&D, and R&D 
intensive firms (firms with an R&D/Sales ratio above the sample median for a 
particular year) according to 5 analysts forecast dispersion (D) and 5 analyst 
diversity in opiniop portfolios (1-p) from low (1) to high (5). Dispersion is defined as 
the standard deviation in 1 year ahead EPS forecasts, standardized by the absolute 
value of the mean forecast, and (1-p) is defined as in text. The scaling used for (1-p) 
calculation is by the absolute value of actual EPS. One month prior to year end data 
are used for Dispersion and (1-p) calculation. 
For the calculation of risk-adjusted returns, sample firms are divided into two size 
portfolios, using the median MVE as of the end of June in each year t. Then the firms 
in each of the two portfolios are divided into three BM portfolios: one containing the 
lower 30% of values for BM, another one with the middle 40%, and finally, a 
portfolio containing the top 30% of BM ratios. The BM ratio is calculated using the 
book value at the end of the accounting year t-1 and the MVE at the end of 
December of t-1. In order to allow for financial data to be made public, the first 
month for which rptums are calculated is July at year t. This results in six size-value 
portfolios, for which the breakpoints are rebalanced every year. The abnormal return 
for a firm for a specific month equals its return for the month minus the value- 
weighted return of the corresponding size-value reference portfolio for the specific 
month. The value weights for the calculation of the value weighted returns are 
rebalanced every year, and have been calculated according to market values at the 
end of June in year t. There are used total returns, which include dividends. 
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Raw average monthly returns for 156 months 
Zero R&D 
Sample R&D firms firms RD/Sales above median 
(1-p) (low) 0.0122 0.0136 0.0116 0.0168 
(1-p)2 0.0115 0.0109 0.0122 0.0116 
(1-p)3 0.0120 0.0114 0.0124 0.0151 
(1-p)4 0.0099 0.0094 0.0100 0.0061 
(1-p)5 (High) 0.0082 0.0069 0.0087 0.0087 
Sample R&D firms 
Zero R&D 
fans RD/Sales above median 
DI (low) 0.0108 0.0106 0.0107 0.0144 
D2 0.0099 0.0091 0.0102 0.0085 
D3 0.0096 0.0104 0.0089 0.0104 
D4 0.0108 0.0116 0.0102 0.0180 
D5 (High) 0.0124 0.0109 0.0130 0.0115 
Risk-adjusted avera ge monthly returns for 156 months 
Zero R&D 
Sample R&D firms firms RD/Sales above median 
(I-P) (low) 0.0035 0.0056 0.0025 0.0094 
(1-p)2 0.0029 0.0028 0.0033 0.0041 
(1-p)3 0.0034 0.0030 0.0036 0.0076 
(1-p)4 0.0013 0.0012 0.0012 
-0.0006 (1-p)5 (High) 
-0.0005 -0.0012 -0.0002 0.0013 
$ample R&D firms 
Zero R&D 
fins RD/Sales above median 
Df (low) 0.0025 0.0026 0.0023 0.0069 
D2 0.0014 0.0009 0.0015 0.0014 
D3 0.0009 0.0020 0.0002 0.0031 
D4 0.0014 0.0025 0.0006 0.0099 
05 (High) 0.0026 0.0018 0.0029 0.0036 
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APPENDIX 5B. R 
Appendix 5B. R Part A: Appendix 5B. R Part A contains the results of Fama-French 
time series regressions according to 5 analyst divergence of opinion portfolios (1-p) 
for the whole sample, the R&D, zero R&D, and R&D/Sales above the sample 
median firms. When the RD factor is added, this is calculated with equal-weighted 
returns either by subtracting the returns the zero R&D firms from the returns of the 
top 30 percentile R&D/Sales firms, as in Table 5B. 6, or as in Al Horani-Pope and 
Stark (2003), as is done in Appendix 5B. C Part A. Panel A. 
Appendix 5B. R Part B: Appendix 5B. R Part B contains the results described as in 
Appendix 5B. R Part A but this time by running Fama-French time series regressions 
according to 5 analyst forecast uncertainty V portfolios. 
The scaling used for (1-p) and V calculation in Appendix 5B. R is by the absolute 
value of the mean EPS forecast 1 month prior. to accounting year end, and is 
therefore consistent with the scaling used for dispersion calculation on the Tables on 
p. 61 of this second Volume. 
(1-p) and V calculation, using one year ahead EPS forecast data I month prior to 
year end: 
D=V(1-p), 
Where D= ((standard deviation in forecasts) *(standard deviation in 
forecasts)/(absolute value of mean EPS forecast)) * 10, with the standard deviation of 
forecasts to be the one used on p. 61 for dispersion calculation (standard deviation in 
forecasts scaled by absolute mean EPS forecast equals dispersion reported in p. 61) 
p =h/(h+s) 




SE = squared error of the mean forecast (deflated by the absolute value of actual EPS 
at year end as reported else in the thesis). 
D= defined right above 
N= the number of forecasts 
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Appendix 5B. R Part A: 
Panel A: No RD factor 
Sample 
Adjusted R- 
alpha RM SMB IIML squared F-statistic 
(1-01 (low) 
-0.0007 1.2665 0.8654 0.1839 0.7301 140.7459 (-0.3157) (18.8729) (8.5239) (2.2194) (0.0000) 
(1-p)2 
-0.0007 1.1820 0.6333 0.2661 0.6849 113.2933 (-0.2945) (16.8024) (8.4546) (3.2467) (0.0000) 
(1-p)3 
-0.0007 1.1442 0.4515 0.3937 0.7533 158.7614 (-0.3614) (19.9351) (7.0590) (5.6613) (0.0000) 
(1-p)4 0.0004 1.1207 0.3508 0.3332 0.7545 159.7717 
(0.2367) (21.7614) (53905) (4.8022) (0.0000) 
(1-p)5 (High) 
-0.0025 1.1301 0.9079 0.2181 0.6865 114.1132 (-1.0327) (16.6238) (10.5584) (2.5706) (0.0000) 
R&D firms 
(1-p)l (low) 0.0014 1.3114 0.8025 0.0227 0.6639 103.0378 
(0.5021) (15.5109) (6.3694) (02512) (0.0000) 
(1-p)2 
-0.0002 1.2345 0.4132 0.0296 0.6261 87.5299 (-0.0753) (15.1219) (4.2080) (0.2748) (0.0000) 
(1-p)3 
-0.0011 1.0888 0.2709 03250 0.7241 136.6076 (-0.5515) (19.5205) (4.0805) (4.5363) (0.0000) 
(1-p)4 0.0017 1.1243 0.2734 0.1647 0.7403 148.2845 
(0.8876) (20.0847) (3.6740) (23552) (0.0000) 
(1-p)5 (High) 
-0.0031 1.1313 0.8963 -0.0091 0.6431 94.0917 (-1.0978) (16.3900) (8.9020) (-0.0904) (0.0000) 
Zero R&D firms 
(1-p)1(low) 
-0.0022 1.2316 0.9159 02883 0.7007 121.9591 (-0.8877) (18.1031) (8.7152) (3.1989) (0.0000) 
(1-p)2 
-0.0009 1.1691 0.7782 0.4114 0.6513 97.4873 (-0.3825) (15.0178) (9.4813) (4.7825) (0.0000) 
(1-p)3 
-0.0005 1.1889 0.5740 0.4435 0.7079 126.2066 (-0.2442) (17.1529) (7.2739) (5.7186) (0.0000) 
(1-p)4 
-0.0007 1.1140 0.4017 0.4571 0.6898 115.8730 (-0.3021) (17.2591) (5.4464) (5.6588) (0.0000) 
(1-p)5 (High) 
-0.0024 1.1250 0.9009 0.3019 0.6492 96.6236 (-0.9237) (14.9102) (9.2798) (3.4334) (0.0000) 
R&D firms with RD/Sales> median 
(1-p)1 (low) 0.0067 1.4312 1.0000 
-0.4430 0.6293 88.7203 (1.8283) (12.2730) (5.5384) (-3.6339) (0.0000) 
(1-p)2 0.0033 1.2563 0.4961 
-0.2247 0.5429 62.3596 (0.8560) (11.7798) (3.5484) (-1.7550) (0.0000) 
(1-p)3 
-0.0012 1.3159 0.4188 0.0314 0.5281 58.8200 (-0.3111) (10.3407) (2.5045) (0.2411) (0.0000) 
(1-p)4 0.0007 1.3556 0.6016 
-0.2229 0.6318 89.6416 (0.2222) (13.1160) (4.7039) (-1.9999) (0.0000) 
(1-p)5 (High) 
-0.0001 1.1898 1.1149 -0.2667 0.5329 59.9373 (-0.0278) (11.8839) (7.1613) (-2.1603) (0.0000) 
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Panel B: Tim e-series regressions run with an RD factor calculated as in Al Horani et al (2003) with EW returns 
Sample 
Adjusted R- F- 
alpha RM SMB HML RD Factor squared statistic 
(1-p)l 
(low) 
-0.0010 1.2594 0.8787 02048 0.1199 0.7292 105.3651 (-0.4320) (18.6236) (8.4718) (2.2549) (0.6475) (0.0000) 
(1-p)2 
-0.0007 1.1802 0.6366 0.2712 0.0296 0.6829 84.4364 (-0.3148) (16.5575) (8.0939) (3.0516) (0.1925) (0.0000) 
(1-p)3 
-0.0003 1.1549 0.4313 0.3619 -0.1819 0.7546 120.1458 (-0.1331) (19.8454) (6.4826) (4.8835) (-1.3845) (0.0000) 
(1-p)4 0.0006 1.1259 0.3410 03177 
-0.0884 0.7536 119.4921 
(0.3563) (21.7187) (4.9232) (43388) (-0.7265) (0.0000) 
(1-p)5 
(High) 




-0.0003 1.2679 0.8845 0.1519 0.7399 0.6910 87.6741 (-0.1237) (15.6921) (7.6553) (1.5223) (3.4272) (0.0000) 
(1-p)2 
-0.0018 1.1952 0.4873 0.1462 0.6679 0.6499 72.9206 (-0.6279) (15.2971) (5.0871) (1.2972) (4.1630) (0.0000) 
(1-p)3 
-0.0017 1.0742 0.2984 0.3682 0.2473 0.7278 104.6300 (-0.8342) 
- 
(19.1353) (4.4428) (4.6480) (1.7263) (0.0000) 
(1-p)4 0.0008 1.1032 0.3132 0.2274 03596 0.7497 117.0338 
(0.4395) (20.5502) (4.2740) (3.1498) (2.7208) (0.0000) 
(1-p)5 
(High) 
-0.0038 1.1119 0.9327 0.0483 03286 0.6477 72.2568 (-1.3746) (16.0620) (9.2907) (0.4651) (1.9468) (0.0000) 
Zero RD firms 
(1-p)1 
(low) 
-0.0014 12503 0.8807 0.2329 -0.3178 0.7056 93.8742 
-(0.5946) (18.2881) (7.8913) (2.4960) (-1.7370) (0.0000) (1-p)2 
-0.0001 1.1896 0.7396 0.3506 -03481 0.6578 75.5024 (-0.0350) (15.5170) (8.4112) (3.6679) (-1.8797) (0.0000) 
(1-p)3 0.0007 1.2193 0.5167 0.3533 
-0.5165 0.7267 104.0206 
(0.3292) (17.8898) (6.4368) (42547) (-33887) (0.0000) 
(1-p)4 0.0004 1.1404 0.3521 0.3790 
-0.4470 0.7046 93.4113 (0.1949) (18.6836) (4.5732) (4.5053) (-3.2159) (0.0000) 
(1-p)5 
(High) 
-0.0013 1.1513 0.8514 0.2240 -0.4464 0.6619 76.8530 (-0.5384) (15.3759) (9.0401) (2.5556) (-3.0982) (0.0000) 
R&D firms with RD/Sales> median 
(1-p)1 
(low) 0.0041 13652 1.1242 
-02473 1.1205 0.6682 79.0292 (1.1727) (12.6195) (6.6078) (-1.9244) (4.0629) (0.0000) 
(1-p)2 0.0009 1.1981 0.6055 
-0.0523 0.9872 0.5826 55.0888 (0.2417) (11.2802) (4.2001) (-0.3843) (3.6207) (0.0000) 
(1-p)3 
-0.0033 1.2636 0.5172 0.1863 0.8874 0.5595 50.2097 (-0.8418) (12.5742) (2.8792) (1.1462) (2.4648) (0.0000) 
(1-p)4 
-0.0009 1.3167 0.6748 -0.1076 0.6608 0.6485 72.4882 (-0.2729) (13.7158) (5.1269) (-0.9364) (2.6946) (0.0000) 
(1-p)5 
(High) 
-0.0006 1.1784 1.1363 -0.2330 0.1931 0.5312 44.9141 (-0.1405) (11.7441) (6.8292) (-1.6686) (0.6571) (0.0000) 
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Panel C: Tim e-series regressions run with an RD factor calculated from the returns of (High RD-Zero RD) 
firms 
Sample 
Adjusted R- F- 
alpha RM SMB HML RD Factor squared statistic 
(1-p)I (low) 
-0.0022 1.2192 0.8221 03848 0.2060 0.7388 110.6067 (-0.9324) (17.9304) (8.1972) (3.1548) (2.0739) (0.0000) 
(1-p)2 
-0.0018 1.1450 0.5994 0.4231 0.1611 0.6901 87.2879 (-0.7586) (15.7263) (8.0346) (3.4592) (1.8637) (0.0000) 
(1-p)3 
-0.0013 1.1249 0.4339 0.4755 0.0839 0.7540 119.7658 (-0.6661) (18.4244) (6.7720) (4.5689) (1.1057) (0.0000) 
(1-p)4 
-0.0002 1.1019 0.3336 0.4131 0.0819 0.7551 120.5027 (-0.0917) (20.7091) (5.2701) (4.0860) (1.0894) (0.0000) 
(1-p)5 
(High) 
-0.0033 1.1054 0.8852 0.3231 0.1077 0.6877 86.3325 (-1.3466) (15.2971) (9.9217) (2.8263) (1.1331) (0.0000) 
R&D firms 
(1-p)1 (low) 
-0.0016 1.2175 0.7165 0.4217 0.4092 0.6954 89.574 (-0.5644) (15.3016) (5.8878) (3.0252) (3.5477) (0.0000) 
(1-p)2 
-0.0032 1.1404 0.3271 0.4292 0.4098 0.6607 76.4395 (-1.1072) (14.8299) (3.4194) (2.9038) (4.0053) (0.0000) 
(1-p)3 
-0.0024 1.0479 0.2335 0.4986 0.1780 0.7331 107.4205 (-1.1787) (18.4012) (3.6642) (4.4733) (2.1398) (0.0000) 
(1-p)4 0.0004 1.0838 0.2362 0.3369 0.1766 0.7486 116.3863 














Zero RD firms 
(1-p)l (low) 
-0.0027 1.2167 0.9023 0.3515 0.0648 0.6998 91.3269 (-1.0449) (17.1363) (8.5248) (2.7990) (0.6538) (0.0000) 
(1-p)2 
-0.0010 1.1650 0.7746 0.4286 0.0176 0.6490 72.6612 (-0.4110) (14.3529) (9.3906) (3.1414) (0.1775) (0.0000) 
(1-p)3 
-0.0005 1.1886 0.5738 0.4444 0.0010 0.7060 94.0323 (-0.2392) (15.9893) (7.1909) (3.8353) (0.0115) (0.0000) 
(1-p)4 





















R&D firms with RD/Sales> median 
(1-p)1 (low) 0.0007 1.2417 0.8265 03616 0.8251 0.7109 962647 
(0.2127) (12.1413) (53522) (2.0081) (5.2262) (0.0000) 
(1-p)2 
-0.0020 1.0894 0.3433 0.4842 0.7269 0.6268 66.0827 (-0.5993) (11.2739) (2.5907) (23786) (4.7203) (0.0000) 
(1-p)3 
-0.0069 1.1370 0.2551 0.7908 0.7788 0.6246 65.4669 (-1.8925) (11.5741) (1.9873) (3.6031) (4.4905) (0.0000) 
(1-p)4 
-0.0028 1.2443 0.4997 02498 0.4848 0.6680 78.9710 (-0.8784) (13.7907) (4.3638) (1.5264) (3.4382) (0.0000) 
(1-p)5 
(High) 
-0.0029 1.1023 1.0348 0.1049 03811 0.5511 48.5778 (-0.7417) (9.7040) (6.6160) (0.4594) (2.0463) (0.0000) 
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Appendix 5B. R Part B: 
Panel A: No RD factor 
Sample 
Adjusted R- F- 
alpha RM SMB HM1, squared statistic 
V1 (low) 0.0003 0.9390 0.3364 0.1579 0.6957 119.0939 
(0.1898) (18.4291) (5.1780) (2.3519) (0.0000) 
V2 0.0003 1.0588 0.4567 0.2228 0.7210 134.4904 
(0.1557) (19.2243) (6.8048) (33823) (0.0000) 
V3 
-0.0006 1.1054 0.5111 0.3536 0.7060 125.0997 (-0.2649) (17.1939) (7.2149) (5.1762) (0.0000) 
V4 
-0.0013 1.2472 0.7960 0.3497 0.7184 132.8312 (-0.5442) (19.4082) (10.5029) (4.0485) (0.0000) 
V5 (High) 
-0.0031 1.5055 1.1223 0.3193 0.7481 154.4090 (-1.1399) (20.0309) (12.0088) (3.1914) (0.0000) 
R&D firms 
V1 (low) 
-0.0007 0.9202 02294 0.0234 0.6977 1202385 (-0.3706) (19.2170) (3.3341) (0.3775) (0.0000) 
V2 0.0016 1.0475 0.4304 0.1465 0.6878 114.8299 
(0.7674) (19.5430) (5.7201) (1.8903) (0.0000) 
V3 0.0003 1.0882 0.2981 0.2568 0.6320 89.7181 
(0.1064) (14.2973) (3.4343) (3.3413) (0.0000) 
V4 
-0.0005 1.2805 0.6777 0.1976 0.6920 117.0808 (-0.1904) (17.4902) (6.6442) (1.9643) (0.0000) 
V5 (High) 0.0000 1.4944 0.9575 0.0290 0.6723 106.9761 
(0.0139) (16.1215) (6.8496) (0.2836) (0.0000) 
Zero R&D firms 
V1 (low) 0.0006 0.9455 0.4131 0.2357 0.6213 85.7491 
(0.2751) (15.5234) (53841) (2.8881) (0.0000) 
V2 
-0.0007 1.0784 0.4999 0.2888 0.6763 108.9402 (-0.3245) (16.9810) (6.2568) (3.7608) (0.0000) 
V3 
-0.0014 1.1175 0.6672 0.4181 0.6869 114.3734 (-0.6043) (15.9367) (7.7351) (5.6534) (0.0000) 
V4 
-0.0015 1.2208 0.8522 0.4372 0.6675 104.7172 (-0.6080) (16.7922) (9.8337) (4.9176) (0.0000) 
V5 (High) 
-0.0042 1.4779 1.1818 0.4905 0.6996 121.3018 (-1.3960) (18.1371) (11.4809) (4.4120) (0.0000) 
R&D firms with RD/Sales> median 
VI (low) 0.0012 0.9124 0.3076 
-0.2419 0.6269 87.8072 (0.4984) (13.4187) (3.0848) (-3.3593) (0.0000) 
V2 0.0033 1.1631 0.5100 
-0.2338 0.5588 66.4312 (1.0068) (12.3944) (3.7287) (-2.5568) (0.0000) 
V3 0.0014 1.2394 0.4659 0.0264 0.4204 38.4700 
(0.3069) (8.1943). (2.8863) (02073) (0.0000) 
V4 0.0018 1.4733 1.0777 
-0.1927 0.5773 715756 (0.4222) (12.7216) (6.2725) (-1.3429) (0.0000) 
V5 (High) 0.0049 1.5449 1.0418 
-0.4804 0.6720 106.8525 (1.2931) (15.6878) (6.5935) (-3.5814) (0.0000) 
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Panel B: Time-series regressions run with an RD factor calculated as in Al Horani et at (2003) with EW 
returns 
Sample 
Adjusted R- F- 
alpha RM SMB HML RD Factor squared statistic 
vf (low) 0.0007 0.9487 03182 0.1294 
-0.1636 0.6968 90.0560 (0.4023) (18.7360) (4.7685) (1.8425) (-1.5729) (0.0000) 
V2 0.0004 1.0603 0.4538 0.2183 
-0.0259 0.7192 100.2364 (0.1853) (18.7693) (6.6184) (3.0908) (-0.2095) (0.0000) 
V3 
-0.0001 1.1172 0.4888 03185 -0.2009 0.7077 94.8262 (-0.0347) (17.0912) (6.6751) (4.3080) (-13771) (0.0000) 
V4 
-0.0011 1.2516 0.7879 0.3368 -0.0737 0.7170 99.1532 (-0.4654) (19.2518) (10.2066) (3.8354) (-0.4835) (0.0000) 
V5 (High) 




-0.0011 0.9108 0.2471 0.0514 0.1603 0.6987 90.8476 (-0.5490) (18.6611) (3.4102) (0.7490) (1.2949) (0.0000) 
V2 0.0005 1.0199 0.4824 0.2284 0.4689 0.7064 94.2189 
(0.2283) (18.9929) (6.9161) (2.8520) (3.7148). (0.0000) 
V3 
-0.0004 1.0730 0.3268 0.3020 0.2584 0.6349 683771 (-0.1408) (14.4971) (3.6913) (3.4445) (13360) (0.0000) 
V4 
-0.0007 1.2752 0.6876 0.2132 0.0894 0.6905 87.4373 (-0.2700) (17.4909) (6.4872) (2.0358) (0.4605) (0.0000) 
V5 (High) 
-0.0025 1.4319 1.0752 0.2143 1.0617 0.7170 99.1868 (-0.8369)_ (17.7680) (8.6633) (1.9925) (4.5301) (0.0000) 
Zero RD firms 
Vf (low) 0.0015 0.9694 0.3680 0.1648 
-0.4066 0.6365 68.8409 (0.7588) (16.3791) (4.5716) (1.9497) (-32137) (0.0000) 
V2 0.0001 1.0975 0.4640 0.2322 
-03238 0.6836 84.7059 (0.0398) (17.2962) (5.7498) (2.9278) (-2.3613) (0.0000) 
V3 
-0.0001 1.1493 0.6073 0.3238 -0.5401 0.7098 95.7582 (-0.0285) (16.8327) (7.2377) (42147) (-3.9164) (0.0000) 
V4 
-0.0011 1.2322 0.8307 0.4034 -0.1939 0.6679 78.9194 (-0.4224) (16.9168) (8.9594) (4.2853) (-1.0370) (0.0000) 
V5 (High) 
-0.0031 1.5030 1.1346 0.4160 -0.4264 0.7062 94.1442 (-1.0944) (18.7271) (10.2852) (3.6120) (-1.9071) (0.0000) 
R&D firms with RD/Sales> median 
Vf (low) 0.0007 0.8992 0.3324 
-0.2028 0.2235 0.6289 66.6719 (0.2649) (13.2405) (3.1022) (-2.5685) (13115) (0.0000) 
V2 0.0020 1.1322 0.5681 
-0.1423 0.5241 0.5700 52.3707 (0.6386) (12.3068) (3.9271) (-1.3864) (2.1285) (0.0000) 
V3 
-0.0001 1.2041 0.5324 0.1310 0.5995 0.4308 30.3296 (-0.0174) (8.7396) (3.0436) (0.8133) (1.3648) (0.0000) 
V4 0.0011 1.4572 1.1079 
-0.1451 0.2730 0.5770 53.8507 (0.2572) (12.7192) (6.0877) (-0.9102) (0.7861) (0.0000) 
V5 (High) 0.0019 1.4723 1.1784 
-0.2652 1.2323 0.7158 98.6160 (0.5635) (16.7927) (7.9213) (-2.0779) (5.1740) (0.0000) 
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Panel C: Tim e-series regressions run with an RD factor calculated from the returns of (High RD-Zero RD) 
firms 
Sample 
Adjusted R- F- 
alpha RM SMB HML RD Factor squared statistic 
vi (low) 0.0003 0.9375 0.3350 0.1644 0.0066 0.6937 88.7409 
(0.1520) (17.3133) (5.0502) (1.7660) (0.1023) (0.0000) 
V2 
-0.0002 1.0435 0.4426 0.2878 0.0667 0.7207 101.0113 
(-0.0986) (18.0030) (6.6133) (2.9171) (0.9731) (0.0000) 
V3 
-0.0010 1.0907 0.4976 0.4161 0.0641 0.7055 93.8206 (-0.4787) (16.1081) (6.6894) (3.8384) (0.7364) (0.0000) 
V4 
-0.0021 1.2212 0.7722 0.4601 0.1133 0.7200 100.6253 (-0.8732) (18.2684) (9.7244) (4.0688) (1.2211) (0.0000) 
V5 (High) 
-0.0060 1.4123 1.0371 0.7149 0.4057 0.7762 1353732 (-2.3718) (19.3603) (12.3222) (5.4362) (3.8576) (0.0000) 
R&D firms 
vf (low) 
-0.0007 0.5690 0.0043 0.0166 0.2350 0.7466 115.1450 (-0.4019) (6.4702) (0.0537) (03276) (4.5698) (0.0000) 
V2 0.0016 0.5132 0.0881 0.1361 0.3576 0.7808 139.0180 
(0.8852) (6.5082) (1.0561) (2.0177) (7.5946) (0.0000) 
V3 
-0.0007 1.0564 0.2690 0.3921 0.1387 0.6353 68.5027 (-02937) (13.9331) (2.9749) (2.8815) (1.1928) (0.0000) 
V4 
-0.0018 12378 0.6386 0.3789 0.1859 0.6982 90.6313 (-0.7127) (17.0931) (62543) (2.8367) (1.7235) (0.0000) 
V5 (High) 
-0.0049 1.3374 0.8138 0.6956 0.6836 0.7431 113.0719 
(-1.6977) (17.2803) (6.4841) (4.9648) (6.0863) (0.0000) 
Zero RD firms 
V1 (low) 0.0009 0.9553 0.4220 0.1943 
-0.0425 0.6195 64.0825 (03960) (14.6833) (5.3926) (1.6814) (-0.5360) (0.0000) 
V2 
-0.0007 1.0787 0.5002 0.2874 -0.0014 0.6741 81.1679 (-0.3096) (16.1538) (6.1138) (2.6670) (-0.0184) (0.0000) 
V3 
-0.0013 1.1192 0.6687 0.4112 -0.0071 0.6849 85.2220 (-0.5585) (15.0605) (7.6888) (3.6004) (-0.0817) (0.0000) 
V4 
-0.0019 12077 0.8402 0.4928 0.0570 0.6661 78.3106 (-0.7478) (16.1440) (9.4399) (3.7232) (0.5269) (0.0000) 
VS (High) 
-0.0056 1.4314 1.1392 0.6881 0.2027 0.7049 93.5559 (-1.9597) (17.0724) (11.1054) (4.3490) (1.5511) (0.0000) 
R&D firms with RD/Sales> median 
Vf (low) 
-0.0001 0.8727 0.2712 
-0.0731 0.1731 0.6345 68.2778 
(-0.0296) (12.8818) (2.7739) (0.6742) (2.1918) (0.0000) 
V2 
-0.0001 1.0574 0.4133 0.2149 0.4601 0.5968 58.3586 (-0.0254) (11.2245) (3.3508) (1.3088) (3.2511) (0.0000) 
V3 
-0.0021 1.1310 0.3666 0.4869 0.4723 0.4498 32.6757 (-0.4978) (8.4344) (2.4550) (1.7293) (1.8376) (0.0000) 
V4 
-0.0023 1.3448 0.9601 0.3529 0.5596 0.6128 62.3159 
(-0.5559) (114400) (5.8450) (1.6524) (2.9162) (0.0000) 
VS (High) 
-0.0018 1.337 0.8484 0.4166 0.9198 0.7660 127.8305 (-0.5803) (15.8420) (6.2066) (2.6672) (7.6322) (0.0000) 
182 
Chapter 6: The Impact of R&D on the Persistence of Stock 
Returns: Compensation for Risk or Market Mispricing: A 
Brief Note 
In Chapter 5 Part A, there have been observed exceptionally high and persistent 
abnormal stock returns for R&D intensive firms. The hypothesis was in favour of a 
positive relation between R&D and persistence in excess market returns, that could 
in theory be attributed to either some form of mispricing or risk compensation, while 
not attempting to explain whether such patterns were due to mispricing or risk; my 
aim was to broaden the understanding on the implications of R&D investment. There 
were indeed testified empirically such high and persistent returns for very R&D 
intensive firms, and the Chapter did not attempt to separate the two possible effects, 
despite the fact that after having adjusted stock returns for risk arising from 
differences in firm size and the book-to-market factor, I interpreted the weight of my 
evidence as consistent with al least some form of mispricing related to the market's 
slow adjustment to the emerging evidence of significant enhancement in operating 
performance following recent R&D investment. 
Despite this last observation, there is made in this Chapter a short attempt to 
investigate into the causes of these high and persistent returns for R&D intensive 
firms. It may seen} contradictory that on one hand, I state that the scope of this study 
is not to decide whether R&D-related market performance is the result of risk or 
mispricing, and oil the other hand there is much discussion dedicated to whether the 
observed high and persistent returns of R&D intensive firms are due to risk or 
mispricing. I view though that when research is undertaken on R&D and any aspect 
or attribute of future market performance, the discussion on the risk versus 
mispricing issue is inevitable merely because of the need to interpret the results. In 
other words, this study may not wish to examine whether R&D-related market 
performance persistence is the result of risk versus mispricing, the need though to put 
the empirical fmdipgs of this study into the more general perspective of the empirical 
evidence on the valuation implications of R&D investments, as well as to provide a 
very thorough examination of the research question, justifies the discussion on the 
risk-mispricing mgtter that has been dedicated in this Chapter. 
Until this point of time in the literature, there have been proposed two 
explanations with respect to the testified positive relationship between R&D and 
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excess stock returns: a compensation for risk or a market mispricing explanation, as 
discussed for example in Chan, Lakonishok and Sougiannis (2001). In this context, 
there have been performed some simple tests in order to assess whether these high 
and persistent returns reflect indications for the risk of R&D intensive firms or could 
be evidence of market mispricing. 
The above mentioned mispricing explanation, as in Chambers, Jennings and 
Thomson (2002), predicts that the excess returns of R&D intensive firms would be 
simply the result of increased earnings due to R&D investment reductions and vice 
versa. Therefore close to a similar control by Chambers, Jennings and Thomson 
(2002), I calculate the median ratios of the change in the R&D intensity, over the 
next one to five years from each base year in the sample period, according to four 
R&D intensity portfolios. R&D intensity is expressed as R&D/Sales or R&D/TA or 
R&D/MVE. The relevant results are presented in Table 6.1. As can be observed from 
the table, there exists no pattern of increases or decreases in R&D activity depending 
on the degree of R&D intensity that a firm exhibits. Low R&D intensity firms in 
terms of R&D/Sales or R&D/ TA appear to show larger decreases in R&D activity in 
the long run, whereas high R&D intensity firms in terms of R&DIMVE realise the 
largest decreases in R&D activity 
Insert Table 6.1 here. 
In order now to assess directly the impact of changes in R&D on stock 
returns, I regress stock returns on both the level as well as the change in R&D 
activity, after controlling for operating performance. 
I run the following regression using panel data for the period 1991-2002: 




the 12 month risk-adjusted equal weighted abnormal 1) CAR and 2) BAH, 
from July of year t until June of year t+1. CAR and abnormal BAIiR have 
been calculated with respect to the monthly value-weighted total returns of 6 
annually rebalanced MV-BM portfolios. The first month for which the return 
is included is July 1992 for the base year 1991 and the last one is June 2004. 
Returns have been calculated as in Section 5A. 4 of the study. 
RD 
- 
R&D/Sales or R&D/TA or R&D/MVE ratio as at the end of year W. R&D 
represents the R&D expense for the accounting year that ended during the 
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calendar year t-1, and Sales and TA also refer to the year t-1. MV is the 
market value of equity at the end of December of year t-1. 
DRD- the change in the R&D/Sales or R&D/TA or R&D/MVE (depending on 
what RD represents each time) ratio between the accounting years that end in 
t-2 and t-1 respectively. 
GI 
-. 
the per share growth in Gross Income (Sales 
-COGS) between the accounting 
years t-2 and t-1. 
The regression is run using OLS and White's heteroskedasticity robust 
errors. Observations above the 0.98 or below the 0.2 percentile have been eliminated. 
The starting year is 1991 (and not 1990) in order to allow for financial results to 
become public, given that two independent variables represent changes in operating 
figures and thus I lose one year in the calculation of the change. The results for this 
regression are presented in Table 6.2. 
Insert Table 6.2 here. 
As can be observed from the table, the R&D intensity variable is generally 
positive and significant, with the exception of the case when it is defined as 
R&D/Sales where it is not significant in either the CAR or BAH regressions and also 
negative in the BAH regression. GI is also always positive and significant. The 
change in R&D intensity variable though DRD though is always negative and of 
limited significance in the CAR regressions but generally negative and significant at 
10% significance level in the BAH ones. This negative sign of DRD is not influenced 
by time period effects that relate to the New Economy years, as can be observed 
from the Appendix of the Chapter. This negative sign is the consistent with the 
mispricing scenario, in which when R&D decreases, earnings increase and so do 
returns, and also consistent with the results of Chambers, Jennings and Thomson 
(2002) and Eberhart, Maxwell and Sidique (2004) about the existence of mispricing 
as a result of changes in R&D activity. 
- 
On the other hand, in order to assess whether R&D intensity implies more 
risk in terms of volatility of measures of operating performance, I go one step further 
and calculate the average three-year median standard deviation in growth in sales, 
gross income and EPS for the R&D, zero R&D, and R&D intensive firms in the 
sample (firms with R&D/Sales or R&D/TA ratios above the median for a particular 
year). Standard deviation of growth has been calculated using three consecutive year 
growth observations, for example using the growth rates in operating measures 
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between 1990-1991,1991-1992 and 1992-1993 in order to calculate the three-year 
standard deviation in growth for the period 1990-1993. R&D intensity is measured 
as of the starting year used for the calculation of standard deviation in growth, for 
example as of the base year 1990 when assessing the three-year standard deviation 
for the period 1990-1993. As can be observed from Table 6.3, R&D and R&D 
intensive firms do not exhibit more volatile growth in terms of sales, GI or EPS than 
zero R&D firms, without controlling for other firms characteristics. 
I then assess the average three-year median standard deviation in growth in 
sales, gross income and EPS for the R&D, zero R&D, and R&D intensive firms 
according to six MVE-BM portfolios, rebalanced every year. The MVE-BM 
portfolios have been constructed as in Section 5A. 3 of the study. As can be observed 
from Table 6.3, when one controls for firm size and BM, the R&D reporting and 
R&D intensive firms do not exhibit greater standard deviation in their growth in sales 
and gross income compared to the zero R&D firms. They do though exhibit greater 
standard deviation in the growth of EPS, when one takes firm size and BM 
characteristics into account (when not controlling for MV-BM, R&D reporting and 
R&D intensive firms still do not exhibit greater standard deviation in the growth of 
EPS than zero R&D firms). In the extent to which the volatility in operating growth 
is perceived as a proxy for risk, the overall results from Table 6.3 result constitute 
quite mixed evidence regarding the validity of the risk hypothesis as an explanation 
for persistence in excess stock returns due to R&D. 
Insert Table 6.3 here. 
In other words, if one controls for the firm characteristics of size and BM, 
R&D intensive firms are found to exhibit greater volatility in growth than R&D in 
general and zero R&D firms in terms of EPS, but not so in terms of sales or GI. The 
fact that the R&D intensive firms do not exhibit greater volatility in Sales or GI 
growth than R&D in general or zero R&D firms would be a counter indication for 
risk for these firms. They do though exhibit greater volatility in terms of EPS growth 
when taking firm size and BM into account, and EPS is the only measure of 
operating performance after the expensing of R&D. This latter fact could provide the 
financial markets with risk indications. The issue here is whether one should expect 
that the financial markets reflect the behaviour of Sales /GI as opposed to EPS at this 
point. Depending on whether one expects that all available information is 
incorporated into stock prices, if one assumes that returns are influenced by the 
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behaviour of Sales/GI, the risk explanation for excess stock returns as a result of 
R&D intensity is not strong and therefore evidence is in favour of the mispricing 
scenario. The opposite way, if stock prices reflect EPS growth patterns, stock returns 
for R&D intensive firms should be compensated for the greater risk they carry and 
therefore the excess risk-adjusted stock returns could very well be a compensation 
for risk. 
Another source of information on the validity of the risk as opposed to the 
mispricing explanation for excess stock returns would be the characteristics of 
analyst forecasts for R&D intensive firms. As seen on Chapter 5 Part B, I find that 
R&D intensity is positively associated with higher dispersion in analyst forecasts, 
after controlling for other firm characteristics. The decomposition of forecast 
dispersion into an uncertainty and a divergence of opinion component, gives us 
though indications that the influence of R&D is primarily on the uncertainty 
component of analyst forecasts. 
In addition, there is confirmed a negative relationship between dispersion 
and returns, consistent with Diether, Malloy and Scherbina (2002) for the US, with 
the bottom dispersion portfolio to exhibit a positive alpha in the traditional Fama- 
French time-series three factor model, which is not statistically significant, and 
alphas tend to get negative for higher dispersion portfolios, which are also most 
times not statistically significant. After decomposing dispersion into uncertainty and 
pure differences in opinion, there is found that as R&D intensity increases, the ability 
of R&D to influence returns also increases for high dispersion and high forecast 
uncertainty firms, but the ability of R&D to influence returns is very week for high 
divergence of opinion firms. This finding implies that in the presence of high R&D 
intensity, dispersion has an impact on returns mainly through the forecast uncertainty 
component of forecast dispersion, and not through the divergence of opinion 
component. Finally, the influence of R&D intensity on both errors and revisions was 
found to be positive although statistically significant only in the case of long-time 
revisions, after controlling for other factors. 
Taking the findings from the characteristics of analyst forecasts for R&D 
intensive firms into consideration, there is not a clear indication as to whether there is 
more risk involved for these firms compared to their non R&D counterparts. On the 
one hand, R&D intensity is found to be associated with greater analyst forecast 
dispersion, which would be an indication for greater risk for these firms, if one 
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assumes that dispersion is indeed a purely risk proxy, which is a issue in debate in 
the literature (Barron and Stuerke, 1998). In the same direction, R&D intensity is 
found to relate positively to analyst forecast errors and revisions, with a stronger 
influence on revisions. On the other hand though, decomposing dispersion into 
uncertainty and pure differences in opinion shows that in the presence of high R&D 
intensity, dispersion has an impact on returns mainly through the forecast uncertainty 
component of forecast dispersion, and not through the divergence of opinion 
component. When trying to interpret this finding by using the Doukas, Kim and 
Pantzalis (2006) conceptual framework, high uncertainty in forecasts should be 
associated with lower returns, and therefore this testified strong uncertainty 
component should be driving returns downwards for these high R&D intensity firms. 
This is not the case at all though for high R&D firms, given that high R&D firms 
have been generally associated with very high returns. Following this line of 
reasoning, the returns of these high R&D and high forecast uncertainty firms should 
be more due to market mispricing. 
Under these circumstances, the risk and the mispricing explanation for the 
observed high and particularly persistent excess returns for R&D intensive firms 
appear to co-exist: we get evidence on the existence of both, and the existence of one 
would not preclude the other. A very useful insight into this discussion was provided 
by the fording that after having made use of stock returns adjusted for risk arising 
from differences in firm size and the book-to-market factor, there has been still 
observed undervaluation of R&D intensive firms for a number of years after R&D 
investments are initially undertaken, and therefore I interpret my evidence at this 
point to be consistent with at least some form of market mispricing mainly related to 
the market's slow adjustment to emerging evidence of significant enhancement in 
operating performance due to R&D. The fact that the observed relation between 
R&D and persistence in market performance is observed at the sample level 
independent of industry factors, while the link of R&D and operating growth is at the 
industry level only provides further weight to the mispricing interpretation. Despite 
this evidence though that led to clearly stating that the mispricing explanation cannot 
be precluded, I cannot completely discard the risk compensation explanation given 
other kinds of evidence discussed in Chapter 6 on R&D and risk. In addition, 
evidence on R&D, the attributes of analyst forecasts and subsequent stock returns 
from Chapter 5B also indicates the existence of possible market mispricing for R&D 
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intensive firms. Therefore this study may not have the scope to assess whether the 
association between R&D and market performance is due to risk or mispricing, but 
thorough its empirical findings and their interpretation there are observed some 
evidence on market mispricing as a result of R&D investment. Having argued that 
the empirical evidence of this study does not provide (and was not meant to provide) 
an definitive answer on whether R&D-related market performance is due to risk or 
mispricing, despite getting evidence that is in some support of the direction of the 
mispricing explanation, a final comment would be that both of these explanations 
could be valid to some extent, and the direction to which they can lead is the 
existence of high and persistent excess returns for R&D intensive firms, which is 
exactly what is testified - empirically. 
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Chapter 6 Tables: 
Table 6.1. Changes in R&D investment for firms that differ in R&D intensity 
The table reports the median change in R&D intensity over the next I to 5 years after 
each base year 1990-1998 (from t+1 to t+5), according to R&D intensity portfolios 
(1=lowest, 4 highest). R&D intensity portfolios are defined as R&D/Sales, R&D/Total 
Assets and R&D/Market value of equity, with MVE as of the end of the calendar year. 
R&D intensit y--R&D/Sales 
1 2 3 4 
t+l 
-0.056 -0.018 -0.015 -0.026 
t+2 
-0.114 -0.078 -0.027 -0.058 
t+3 -0.222 
-0.183 -0.069 -0.075 
t+4 
-0.310 -0.247 -0.150 -0.184 
t+5 
-0.667 -0.330 -0.257 -0.147 
R&D intensit y--R&D/TA 
1 2 3 4 
t+l 
-0.087 0.010 -0.013 -0.022 
t+2 
-0.152 -0.025 -0.035 -0.069 
t+3 
-0.333 -0.111 -0.068 -0.105 
t+4 
-0.479 -0.209 -0.193 -0.197 
t+5 
-0.692 -Q. 357 -0.329 -0.258 
R&D intensit y=R&D/MVE 
1 2 3 4 
t+l 
-0.058 0.030 -0.095 -0.130 
t+2 
-0.128 0.982 -0. A95 -0.314 
t+3 
-0.229 0.027 -0.1,10 -0.428 
t+4 
-0360 -Q. ý, jr45 -0.1 f52 -0.561 
t+5 
-0.481 -0, $ gi 7"p4 -0.656 
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Table 6.3. Volatility in operating growth for R&D, zero R&D and R&D intensive firms 
The table reports the sample period average of the median three-year standard deviation in growth in sales, gross income (GI) 
and positive EPS for the R&D, zero R&D and R&D intensive firms (firms with R&D/Sales or R&D/TA ratios above the sample 
median for a particular year) according to 6 MV-BM portfolios for the period 1990-2003. The portfolios have been constructed 
as explained in Chapter 5.3. Standard deviation of growth has been calculated using three consecutive year growth observations, 
for example using the growth rates in operating measures between 1990-1991,1991-1992 and 1992-1993 in order to calculate 
the three-year standard deviation in growth for the period 1990-1993. R&D intensity is measured as of the starting year used for 
the calculation of standard deviation in growth, for example as of the base year 1990 when assessing the three-year standard 
deviation for the period 1990-1993. The table also reports the averages of the median three-year standard deviation in growth in 
sales, gross income and EPS for all the R&D, zero R&D and R&D intensive firms in the sample. 
R&D Zero R&D R&D/TA above median 
firms firms firms R&D/Sales above median firms 
MVE-BM 
Sales low-low 0.193 0.205 0.204 0.199 
low-mid 0.141 0.153 0.141 0.146 
low-high 0.127 0.138 0.138 0.138 
high-low 0.155 0.172 0.164 0.168 
high-mid 0.116 0.121 0.112 0.109 
high-high 0.099 0.123 0.176 0.173 
All firms 0.129 0.147 0.142 0.144 
GI low low 0.228 0.249 0.233 0.253 
low-mid 0.173 0.190 0.171 0.178 
low-high 0.221 0.204 0.195 0.217 
high-low 0.186 0205 0.201 0.202 
high-mid 0.148 0.157 0.144 0.144 
high-high 0.134 0.169 0.170 0.168 
All firms 0.164 0.193 0.179 0.176 
EPS low-low 0.354 0318 0.360 0.375 
low-mid 0.469 0.371 0383 0.438 
low-high 0.621 0.496 0.647 0.454 
high-low 0.286 0.231 0.269 0.265 
high-mid 0.313 0.235 0.332 0.337 
high-high 0.307 0.278 0.460 0.316 
All firms 0.325 0.300 0.303 0.291 
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APPENDIX CHAPTER 6 
This appendix contains controls for time period effects as a result of the New Economy 
in the late 1990's/early 2000 on stock returns in the regressions in Table 6.2 of the 
Chapter. 
The regression in Table 6.2 is repeated by excluding the base years 1998 to 2000. The 
relevant results are presented in the table below. I also repeat the regressions for the 
whole sample period 1990-2002 by including a dummy variable that takes the value of I 
if the data refers to the base years 1998 or 1999 or 2000, and zero other wise. The 
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Chapter 7: Conclusion 
The first scope of this PhD thesis is to build on existing evidence about the relation 
between R&D and future operating and stock market performance by focusing for the 
first time on the consistency and persistence aspect of future performance. At the same 
time there is provided, for the first time, a complete characterisation of the UK pattern of 
growth and persistence of sales, gross earnings and earnings per share across the whole 
spectrum of firms listed on the London Stock Exchange (LSE) and the Alternative 
Investment Market (AIM). The Thesis extends previous UK evidence by assessing the 
impact of R&D on consistency in operating performance, when previous research for the 
UK on R&D-related valuation issues has simply focused on the relation between R&D 
and market performance. Unlike previous studies, the Thesis also covers the period 
1999-2003, which is a period of increased R&D activity for the UK. There is examined 
for the first time whether R&D investments lead to higher subsequent operating growth 
in a persistent manner, defining persistence as achieving growth rates above the sample 
growth rate median for a consecutive number of years. The research hypothesis is in 
favour of a positive relation between R&D intensity and future persistent operating 
growth due to certain fundamental economic characteristics of the R&D investment. 
Furthermore, this study performs industry sector analysis on R&D and subsequent 
consistency in operating performance growth, which is an issue that provides better 
understanding of the implications of R&D investments depending on the R&D intensity 
of the sector in which the investment is undertaken. 
There are used all UK listed non financial firms for the period 1990-2003 and 
after controlling for firm size and the book-to-market factors, there is indeed found a 
relation between R&D intensity and consistent growth is sales and gross income, but 
only in the cases when taking the sector in which a firm operates into account. On 
average, an R&D intensive firm is not found to show more persistent growth compared 
to a non-R&D firm. But when I assess persistence in growth among firms that engage in 
R&D, because of the sector in which they belong or the general nature of their 
operations, R&D intensity appears to be playing a role for persistent growth. This result 
could also be a manifestation of the fact that company resilience depends not only on the 
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amount of R&D spent being wise and balanced, but also on good choices from a 
strategic point of view and excellence in firm operations. The above finding though is 
found to apply only to measures of operating performance in the higher steps of the 
income statement, sales and gross income specifically; R&D does not appear to play a 
role for EPS persistence for R&D intensive industries. Finally, judging from the results 
about the significance of the R&D intensity variable when I regress future growth in 
sales, gross income and EPS on R&D intensity and other control variables, R&D 
intensity appears to be consistently an influencing factor for future growth in operating 
performance, which constitutes the first evidence of this kind on the impact of R&D 
investments on future operating performance for the UK. 
The study also builds on the existing literature on R&D and subsequent stock 
market performance by examining for the first time explicitly the relation between R&D 
intensity and persistence in risk-adjusted excess stock returns for up to five years ahead, 
taking into account risk differences that arise from differences in firm size and book-to- 
market ratios, when previous research on R&D and future market performance has 
mainly focused on the association between R&D and future stock returns in general, 
without assessing the sustainability of these returns. I hypothesise in favour of a positive 
relation between R&D and consistency in stock market performance that could in theory 
be attributed to either some form of mispricing or risk compensation. There is indeed 
found for the UK market a positive relation between R&D intensity and subsequent 
abnormal risk-adjusted stock returns, both cumulative and buy-and-hold. But the returns 
of the R&D firms are on average, not found to be higher than the returns of the zero- 
R&D firms, with the exception of the highest R&D intensity portfolios, which exhibit 
the highest returns. More importantly though, I build on existing literature by finding 
that R&D intensity also improves persistence in stock returns, expressed as achieving 
excess returns above the median excess return of the sample for a consecutive number of 
years: the highest R&D intensity firms are found to earn higher risk-adjusted excess 
returns than the sample median return more consistently, compared to lower R&D 
intensity, as well as zero-R&D firms. Although the underlying rationale for the positive 
relation between RfcD intensity and stock market performance basically goes beyond 
the scope of the thesis, these findings provide some insight into the discussion of 
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whether R&D-related market performance is the result of market compensation for risk 
or market mispricing. Having made use of stock returns adjusted for risk arising from 
differences in firm size and the book-to-market factor, there has been still observed 
undervaluation of R&D intensive firms for a number of years after R&D investments are 
initially undertaken, and therefore I interpret the weight of my evidence as consistent 
with some form of mispricing related to the market's slow adjustment to the emerging 
evidence of significant enhancement in operating performance following recent R&D 
investment. 
A limitation that exists by construction in this type of study has to do with the 
existence of possible survivorship biases: when assessing persistence in growth or stock 
returns for the next one to five years, there are taken into account only the firms that 
survive during this time period. Given that they survive, these firms could be more 
successful. By including the growth rates and returns of the surviving firms, I could be 
including the rates and returns of the more successful firms, and thus the growth rates 
and returns could be biased upwards. This problem is also recognised by Chan, Karceski 
and Lakonishok (2003) as a limitation of their study on persistent growth. This problem, 
on the other hand, although well admitted, appears to be self-built in a study on 
persistent performance, and therefore the study is undertaken despite recognising a 
limitation it contains by construction. 
The PhD thesis also examines two research questions that relate to analysts' 
earnings forecasts in the presence of R&D investments. Existing literature has associated 
R&D intensity both theoretically and empirically with higher analyst forecast dispersion 
and stock returns. At the same time, existing research testifies that high analyst 
dispersion is associated with lower returns. In this context, there is examined for the first 
time whether R&D plays a role in the relationship between dispersion and returns, given 
that it has be testified empirically that it has an influencing power on both forecast 
dispersion and stock returns individually. This examination is performed by additionally 
contributing to existing literature with the assessment of this issue using a very detailed 
definition of forecast dispersion, by decomposing dispersion in analyst forecasts into 
pure lack of consensus among analysts and uncertainty in analyst forecasts. 
197 
There are again used all UK listed firms during the period 1990-2003 with 
analyst forecasts on the IBES database and there is found for the first time that R&D 
intensity is a contributing factor for analyst forecast dispersion for the UK, even after 
controlling for other firm characteristics. The finding is consistent with prior findings for 
the US. Forecast dispersion is further decomposed into an uncertainty and a divergence 
of opinion component, and I get indications that the influence of R&D is primarily on 
the uncertainty component of analyst forecasts. 
I also confirm a negative relationship between dispersion and returns, consistent 
with Diether, Malloy and Scherbina (2002) for the US, with the bottom forecast 
dispersion portfolio to be exhibiting a positive but not statistically significant excess 
return (alpha), and alphas to be getting negative for higher dispersion portfolios, which 
are generally not statistically significant as well, even after controlling for the role of 
R&D for returns After decomposing dispersion into analyst forecast uncertainty and a 
pure differences in opinion part, as R&D intensity increases, the ability of R&D to 
influence returns is also found to increase for high dispersion and high forecast 
uncertainty firms, but the ability of R&D to influence returns is found to be very weak 
for high divergence of opinion firms. This finding implies at the same time that in the 
presence of high R&D intensity, dispersion has an impact on returns mainly through the 
forecast uncertainty component of forecast dispersion, and not through the divergence of 
opinion component. Despite the fact that the theoretical relation between dispersion and 
subsequent returns is an issue of fierce academic debate this moment, with contradicting 
views in the field, when trying to interpret this finding by using the Doukas, Kim and 
Pantzalis (2006) conceptual framework, high uncertainty in forecasts should be 
associated with lower returns. Therefore this testified strong uncertainty component 
should be driving returns downwards for these high R&D intensity firms, which is not 
the case at all though for high R&D firms, given that high R&D firms have been 
generally associated with very high returns in the literature in general and also in this 
study in specific in Chapter 5A. Following this line of reasoning, the returns of these 
high R&D and high forecast uncertainty firms should be more due to market mispricing, 
and thus the empirical findings at this point also provide some insight into the discussion 
on whether R&D intensity and high market returns are due to market mispricing. 
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In addition, existing empirical research has identified R&D intensity as a factor 
to contribute to analyst forecast errors, implying more optimism. Starting from forecast 
errors, the study goes one step further and assesses for the first time the impact of R&D 
intensity on the magnitude of forecast revisions. The research hypothesis states that 
when financial analysts revise their earnings forecasts for R&D intensive firms, they are 
called to improve their accuracy in the presence of a highly uncertain investment. In 
such case, the amount by which they adjust their predictions can also be uncertain and 
therefore earnings revisions are expected to be greater in the presence of high R&D 
intensity. The assumption underneath this expectation is that analysts improve their 
learning as the end of the financial year approaches, but the outcome of this learning 
process is influenced by the uncertain nature of R&D, leading to higher revisions in the 
presence of high R&D investments. In the process of assessing the impact of R&D 
investments on analyst forecast revisions, the study also examines for the first time the 
impact of R&D on analyst forecast errors for the UK context, and also provides some 
insight into the joint impact of the analyst forecast characteristics of dispersion, errors 
and revisions on subsequent stock returns. 
The study finds no steady linear positive trend for signed errors and revisions to 
increase as R&D intensity increases, without controlling for other factors, regardless of 
the definition of R&D intensity. There is though found such a relationship when using 
unsigned errors and revisions. There is also observed a contradiction in the behaviour of 
errors and revisions: forecast errors indicate a decrease in analyst optimism as year end 
approaches, but at the same time forecast revisions are found to be positive, which 
implies that forecasts get more optimistic as year end approaches, when we get 
indications from errors that earnings' forecasts become less optimistic. There is 
observed though that optimism decreases for forecast errors in terms of mean and 
median errors, but the values in absolute terms of the positive errors are much larger 
than the ones of the negative errors, providing this way an explanation on why revisions 
are positive in terms of mean and median values when the magnitude of the errors 
indicates a decrease in optimism as year end approaches. There is also found that R&D 
intensity is associated positively with (mostly unsigned) forecast errors and revisions, 
and that this relationship is generally statistically significant in the case of revisions, 
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when there exists a reasonable amount of time between the initial and the revised analyst 
forecast, but not for errors, after controlling for other factors. 
There is also found evidence that both signed and unsigned analyst forecast 
errors and revisions increase as analyst forecast dispersion increases. Finally, I get 
evidence that stock returns relate negatively with revisions and errors, well and above 
analyst forecast dispersion, and this relationship is statistically significant in all cases, 
which constitutes evidence for the first time of for the UK that forecast dispersion, errors 
and revisions can both individually as well as in terms of joint influence be negatively 
associated with subsequent stock returns in a statistically significant manner. 
As a final comment, there are certainly two issues that have to taken into 
consideration as possible study limitations, present in any type of research on R&D and 
related valuation issues. The first one relates to the probability that a firm may try to 
manage/smooth its earnings by deciding on how much R&D it should spend. This way, 
the amount of R&D that is observed on the income statement and that I use in the study 
will receive influence by factors that cannot be controlled. This issue becomes even 
more serious if one considers that a firm may try to meet analyst EPS targets by 
managing the amount of R&D spending. In such cases, the R&D amount is clearly 
affected by managerial/earnings management decisions and would not reflect the real 
amount of R&D that a firm may need to spend in order to reach analyst or corporate or 
competition targets. 
The second issue relates to the fact that the EPS figures, used particularly in the 
second part of the study on R&D and analyst forecasts, actual or forecasted, refer to 
earnings after the expensing of R&D. Therefore any change in R&D spending, or major 
managerial decision to increase/decrease R&D will affect the final EPS figures and 
show increased or decreased earnings that simply reflect changes in R&D spending, and 
not sales or gross income changes. This problem exists by definition when an earnings 
measure in the lower steps of_the income statement such as EPS is used. These issues 
though, appear more or less self built in the very design of the study, but nonetheless 
there is recognised the need to acknowledge them. 
200 
References 
Abarbanell, J. and Lehavy, R. (2003) `An Explanation for Why Prior Stock Returns and 
Analysts' Earnings Forecast Revisions Predict Earnings Management and Forecast 
Errors', unpublished working paper, University of North Carolina at Chapel Hill, 
University of Michigan 
Abdel-Khalik, R. (1975) `Advertising Effectiveness and Accounting Policy', The Accounting 
Review, 50 (4), pp. 657-670 
Aboody, D. and Lev, B. (1998) `The Value-Relevance of Intangibles: The Case of Software 
Capitalization', Journal ofAccounting Research, 36 (Supplement), pp. 161-191 
Aboody, D. and Lev, B. (2000) `Information Asymmetry, R&D, and Insider Gains', Journal of 
Finance, 55 (6), pp. 2747-2766 
Aitken, M. Frino, A. and Winn, R. (1996) `Consensus Analysts' Earnings Forecasts and 
Security Returns', 4sia Pacific Journal of Management, 13 (2), pp. 101-110 
Al-Horani, A. Pope, P. F. and Stark, A. W. (2003) `Research and Development Activity and 
Expected Returns in the United Kingdom', European Finance Review, 7, pp. 27-46 
All, A., Klein, A. and Rosenfeld, J. (1992) `Analysts' Use of Information about Permanent and 
Transitory Earnings Components in Forecasting Annual EPS', The Accounting Review, 
67 (1), pp. 183-198 
Amir, E., Guan, Y. and Livne, G. (2007) The Association of R&D and Capital Expenditures 
with Subsequent Earnings Variability', Journal of Business Finance and Accounting, 34 
(1) & (2), PP. 222-246 
201 
Amir, E., Lev, B. and Sougiannis, T. (2003) `Do Financial Analysts Get Intangibles?, European 
Accounting Review, 12 (4), pp. 635-659 
Bah, R. and Dumontier, P. (2001) `R&D Intensity and Corporate Financial Policy: Some 
International Evidence', Journal of Business Finance and Accounting, 28 (5) & (6), pp. 
671-692 
Ballester, M., Garcia-Ayuso, M. and Livnat, J. (2003) `The Economic Value of the R&D 
Intangible Asset', European Accounting Review, 12 (4), pp. 605-633 
Baltagi, B. and Chang, Y. J. (1992) `Monte Carlo Evidence on Panel Data Regressions with 
AR(1) Disturbances and an Arbitrary Variance on the Initial Observations', Journal of 
Econometrics, 52 (3), pp. 371-380 
Barron, 0., Byard, D., Idle, C. and Riedl, E. (2002) `h igh-Technology Intangibles and 
Analysts' Forecasts', Journal of Accounting Research, 40 (2), pp. 289-312 
Barron, 0. Kim, 0., Lim, S. and Stevens D. (1998) `Using Analysts' Forecasts to Measure 
Properties of Analysts' Information Environment', Accounting Review, 73 (4), pp. 421- 
433 
Barron, 0. and Stuerke, P. (1998) ` Dispersion in Analysts' Earnings Forecasts as a Measure of 
Uncertainty', Journpl ofAccountin& Auditing and Finance, 13 (3), pp. 245-270 
Barry, C. and Jennings, R, (1992) `Information and Diversity of Analyst Opinion', Journal of 
Financial and Quantitative Analysis, 27 (2), pp. 169-183 
Barth, M. and Kasznik, R. (1999) `Share Repurchases and Intangible Assets', Journal of 
Accounting and Ecgnomics, 28, pp. 211-241 
202 
Barth, M., Kasznik, R. and McNichols, M. (2001) `Analyst Coverage and Intangible Assets'. 
Journal ofAccounting Research, 39 (1), pp. 1-34 
Ben-Zion, U. (1978) `The Investment Aspect of Nonproduction Expenditures: An Empirical 
Test', Journal of Economics and Business, 30, pp. 224-229 
Bhaskar, K. and Morris, R. (1984) `The Accuracy of Brokers' Profit Forecasts in the UK', 
Accounting and Business Research, Spring 1984, pp. 113-124 
Bike, B. and Park, C. (2003) `Dispersion of Analysts' Expectations and the Cross-Section of 
Stock Returns', Applied Financial Economics, 13, pp. 829-839 
Bond, S. and Cummings, J. (2003) `The Stock Market and Investment in the New Economy: 
Some Tangible Facts and Intangible Fictions' in: J. Hand and B. Lev (eds. ), Intangible 
Assets, Values, Measures and Risks, Oxford Management Readers, Oxford, pp. 95-119 
Brown, L. and Rozeff, M. (1978) `The Superiority of Analyst Forecasts as Measures of 
Expectations: Evidence from Earnings', Journal of Finance, 33 (1), pp. 1-16 
Brown, L., Hagerman, R., Griffin, P. and Zmijewski, M. (1987) `Security Analyst Superiority 
Relative to Univariate Time-Series Models in Forecasting Quarterly Earnings', Journal 
ofAccounting and Economics, 9, pp. 61-87 
Bryan, D. and Tiras, S. (2007) `The Influence of Forecast Dispersion on the Incremental 
Explanatory Power of Earnings, Book Value and Analyst Forecasts on Market Prices', 
Accounting Review, forthcoming 
Bublitz, B. and Ettredge, M. (1989) `The Information in Discretionary Outlays: Advertising, 
Research and Development', The Accounting Review, 64 (1), pp. 108-124 
203 
Bushee, B. (1998) `The Influence of Institutional Investors on Myopic R&D Investment 
Behavior', The Accounting Review, 73 (3), pp. 305-333 
Butler, K. and Lang, L. (1991) `The Forecast Accuracy of Individual analysts: Evidence of 
Systematic Optimism and Pessimism', Journal of Accounting Research, 29 (1), pp. 150- 
156 
Capstaff, J., Paudyal, K. end Rees, W. (1995) `The Accuracy and Rationality of Earnings 
Forecasts by UK Analysts', Journal of Business Finance andAccounling, 22 (1), pp. 67- 
85 
Chambers. D., Jennings, R. and Thompson, R. (2002) `Excess Returns to R&D Intensive 
Firms', Review ofAccounting Studies, 7, pp. 133-158. 
Chan, L. Jegadeesh N. and Lakonishok, J. (1996) `Momentum Strategies', Journal of Finance, 
51(5), pp. 1681-1713 
Chan, L., Karceski, J. and Lakonishok, J. (2003) ` The Level and Persistence of Growth Rates', 
Journal of Finance, 58 (2), pp 
. 
643-84 
Chan, S., Martin, J. and Kensinger, J. (1990) `Corporate Research and Development 
Expenditures and Share Value', Journal of Financial Economics, 26, pp. 255-276 
Chan, L., Lakonishok, J. and Sougiannis, T. (2001) `The Stock Market Valuation of Research 
and Development Expenditures', Journal of Finance, 56 (6), pp. 2431-2456 
Chauvin, K. and Hirschey, M. (1993) ` Advertising, R&D Expenditures and the Market Value of 
the Firm', Financial Management, 22 (4), pp. 128-140 
Chen, J., Harrison, H. and Stein, J. (2002) ` Breadth of Ownership and Stock Returns', Journal 
of Financial Economics, 66 (2) & (3), pp. 171-205 
204 
Chen, S. and Jiambalvo, J. (2004) `The Relation between Dispersion in Analysts' Forecasts and 
Stock Returns: Optimism Versus Drift', unpublished working paper, University of 
Washington 
Choi, W., Kwon, S. and Lobo, G. (2000) `Market Valuation of Intangible Assets', Journal of 
Business, 49, pp. 35-45 
Ciccone, S. (2003) `Does Analyst Optimism about Future Earnings Distort Stock Prices? ', 
Journal of Behavioral Finance, 4 (2), pp. 59-64 
Clement, M., Frankel, R. and Miller, J. (2003) `Confirming Management Earnings Forecasts, 
Earnings Uncertainty and Stock Returns', Journal of Accounting Research, 41 (4), pp. 
653-679 
Cockburn, I. and Griliches, Z. (1988) `Industry Effects and Appropriability Measures in the 
Stock Market's Valuation of R&D and Patents', American Economic Review, 78, pp. 
419-423 
Crichfield, T., Dyckman, T. and Lakonishok, J. (1978) `An Evaluation of Security Analysts' 
Forecasts', The Accpunting Review, 53 (3), pp. 651-668 
Das, S., Levine, C. and Sivaramakrishnan, K, (1998) `Earnings Predictability and Bias in 
Analysts' Earnings Forecasts', The Accounting Review, 73 (2), pp. 277-294 
DeBont, W. and Thaler, R. (1990) `Do Security Analysts Overreact? ', American Economic 
Review, 80, pp. 52-57 
Demers, E. (2002) `Discµssion of High-Technology Intangibles and Analysts' Forecasts', 
Journal ofAccountlpg Research, 40 (2), pp. 313-319 
205 
Diether, K, Malloy, C. and Scherbina, A. (2002) `Differences in Opinion and the Cross Section 
of Stock Returns', Journal of Finance, 57 (5), pp. 2113-2141 
Dosi, G. (1988) `Sources, Procedures, and Microeconomic Effects of Innovation', Journal of 
Economic Literaturc, 26, pp. 1120-1171 
Doukas, J. Kim, C. and Pantzalis, C. (2006) `Divergence of Opinion and Equity Returns', 
Journal of Financial and Quantitative Analysis, 41 (3), pp. 573-606 
Doukas, J. and Switzer, L. (1992) ` The Stock Market's Valuation of R&D Spending and Market 
Concentration', Journal of Economics and Business, 44, pp. 95-114 
DTI (2005) The 2005 R&D Scoreboard, UK Department of Trade and Industry, report 
Easterwood, J. and Nutt, S. (1999) `Inefficiency in Analysts' Earnings Forecasts: Systematic 
Misreaction or Systematic Optimism? ', Journal of Finance, 54 (5), pp. 1777-97 
Eberhart, A., Maxwell, W. and Sidique, A. (2004) `An Examination of Long-Tenn Abnormal 
Stock Returns and Operating Performance Following R&D Increases'. Journal of 
Finance, 59 (2), pp. 623-650 
Fama, E. and French, K. (1992) `The Cross-Section of Expected Stock Returns', Journal of 
Finance, 47 (2), pp. 427-465 
Fama, E. and French, K. (1993) `Common Risk Factors in the Returns on Stocks and Bonds', 
Journal of Financial Economics, 33 (1), pp. 3-56 
Fried, D. and Givoly, D. (1982) `Financial analysts' Forecasts of Earnings: A Better Surrogate 
for Market ExpectaIions', Journal ofAccounting and Economics, 4, pp. 85-107 
206 
Givoly, D. and Lakonishok, J. (1984) `Properties of Analysts' Forecasts of Earnings: A Review 
and Analysis', Journal ofAccounting Literature, 3, pp. 107-52 
Green, J. P., Stark, A. and Thomas, H. (1996) 'UK Evidence on the Market Valuation of 
Research and Development Expenditures' Journal of Business Finance and Accounting, 
23 (2), pp. 191-216 
Greene, W. (1981) `Sample Selection Bias as a Specification Error: comment', Econometrica, 
49, pp. 795-798 
Gu, F. and Lev, B. (2001) `Markets in Intangibles: Patent Licensing', unpublished working 
paper, Boston University, New York University 
Gu, F. and Wang, W. (2005) `Intangible Assets, Information Complexity and Analysts' 
Earnings Forecasts', Journal of Business Finance and Accounting, 32 (9) & (10), pp. 
1673-1702 
Guellec, D. (2000) `Research and development as a Source of Technological Change' in: 
Buigues, P., Jacquemin, A. and Marchipont, J: F. (eds. ) 'Competitiveness and the Value 
of Intangible Assets', EE, Edward Elgar Publishing Limited 
Hall, J. (1993) `The Stock Market's Valuation of R&D Investments During the 1980's', 
American Economic Review, 83 (2), pp. 259-264 
Hall, B and Oriani, R. (2004) `Does the Market Value R&D Investment in European Firms? 
Evidence from a Panel of Manufacturing Firms in France, Germany and Italy', NBER 
working paper 
Hand, J. (2003) `The Increpsing Returns-to-Scale of Intangibles', in: J. Iland and B. Lev (cds. ), 
Intangible Assets, Values, Measures and Risks, Oxford Management Readers, Oxford, 
pp. 303-331 
207 
Hayes, R. (1998) `The Impact of Trading Commission Incentives on analysts' Stock Coverage 
Decisions and Earnings Forecasts', Journal of Accounting Research, 36, pp. 299-320 
Heckman, J. (1979) Sample Selection Bias as a Specification Error, Econometrica, 47, pp. 153- 
161 
Helbok, G. and Walker, M. (2004) `On the Nature and Rationality of Analysts' Forecasts under 
Earnings Conservatism', British Accounting Review, 36, pp. 45-77 
Higson, C. (1996) `Discussion of UK Evidence on the Market Valuation of Research And 
Development Expepditures' Journal of Business Finance and Accounting, 23 (2), pp. 
217-219 
Hirschey, M. (1982) `Intangible Capital Aspects of Advertising and R&D Expenditures', The 
Journal of Industrial Economics, 30 (4), pp. 375-390 
Hirschey, M. and Weyganot, J. (1985) `Amortization Policy for Advertising and Research and 
Development Expenditures', Journal ofAccounting Research, 23 (1), pp. 326-335 
Ho, Y. K., Xu, Z. and Yap, C. M. (2004) `R&D Investment and Systematic Risk', Accounting 
and Finance, 44, pp. 393-418 
Hodgkinson, L. (2001) `Analysts' Forecasts and the Broker Relationship', Journal of Business 
Finance and Accounting, 28 (7) & (8), pp. 943-961 
Hussain, S. (1996) `Over-reaction by Security Market Analysts: The Impact of Broker Status 
and Firm Size', Journal of Business Finance and Accounting, 23 (9) & (10), pp. 1223- 
1244 
Jackson, A. (2005) ` Trade Generation, Reputation and Sell-Side Analysts', Journal of Finance, 
60 (2), pp. 673-717 
208 
Jackson, A. and Johnson, T. (2006) `Unifying Underreaction Anomalies', Journal of Business, 
79, pp. 75-114 
Johnson, T. (2004) `Forecast Dispersion and the Cross-Section of Expected Returns', Journal of 
Finance, 59 (5), pp. 1957-1978 
Kallapur, S. and Kwan, 5. (2004) `The Value Relevance and Reliability of Brand Assets 
Recognized by UK Firms', The Accounting Review, 29 (1), pp. 151-172 
Kothari, S., Laguerre, T. acid Leone, A. (2002) `Capitalization versus Expensing: Evidence on 
the Uncertainty o Future Earnings from Current Investments in PP&E versus R&D', 
Review ofAccounting Studies, 7 (4), pp. 355-382 
Kross, W., Byung, R. and Schroeder, D. (1990) `Earnings Expectations: The Analysts' 
Information Advantage', The Accounting Review, 65 (2), pp. 461-476 
Kwon, S. (2002) `Financial Analysts' Forecast Accuracy and Dispersion: High Tech versus 
Low Tech Firms', Review of Quantitative Finance and Accounting, 19, pp. 65-91 
Lev, B. (2001) Intangibles: Management, Measurement, and Reporting, Brookings Institution, 
Washington D. C. 
Lev, B., Nissim, D and Thomas, J. (2005) `On the Informational Usefulness of R&D 
Capitalization and Amortization', unpublished working paper, New York University, 
Columbia University, Columbia University 
Lev, B. Radhakrishnan, S. and Ciftci, M. (2006) `The Stock Market Valuation of R&D 
Leaders', SSRN unpublished working paper, New York University, University of Texas 
at Dallas, University of Texas at Dallas 
209 
Lev, B., Sarath, B. and Sougiannis, T. (2005) `R&D Reporting Bias and Their Consequences', 
Contemporary Accounting Research, 22 (4), pp. 977-1026. 
Lev, B. and Sougiannis, T. (1996) `The Capitalization, Amortization and Value-relevance of 
R&D', Journal ofAccounting and Economics, 21, pp. 107-38 
Lev, B. and Sougiannis, T. (1999) `Penetrating the Book-to-Market Black Box: The R&D 
Effect', Journal of Business Finance and Accounting, 26 (3) & (4), pp. 419-449 
Lev, B. and Zarowin, P. (1998) `The Market Valuation of R&D Expenditures', unpublished 
working paper, Nevy York University, New York University 
Lim, T. (2001) `Rationality and Analysts' Forecast Bias', Journal of Finance, 56 (1), pp. 369- 
385 
McNichols, M. and O'Brien, P. (1997) `Self-Selection and Analyst Coverage', Journal of 
Accounting Research, 35 (Supplement), pp. 167-199 
Megna, P. and Mueller, D, (1991) ` Profit Rates and Intangible Capital', Review of Economics 
and Statistics, 73, pp. 632-642 
Miller, E. (1977) `Risk, Uncertainty and Divergence of Opinion', Journal of Finance, 32, pp. 
1151-1168 
Morck, R. and Yeung, B. (2003) `Why Firms Diversify: Internalisation vs. Agency Behaviour', 
in: J. Hand and B. Lev (eds. ), Intangible Assets, Values, Measures and Risks, Oxford 
Management Readers, Oxford, pp. 269-302 
Nakamura, L. (2003) `A Trillion Dollars a Year in Intangible Investment and the New 
Economy', in: J. H4nd and B. Lev (eds. ), Intangible Assets, Values, Measures and Risks, 
Oxford ManagemerAt Readers, Oxford, pp. 19-47 
210 
O'Brien, P. (1988) `Analysts' Forecasts as Earnings Expectations', Journal of Accounting and 
Economics, 10, pp. 53-83 
O'Hanlon, J. and Whiddett, R. (1991) `Do UK Security Analysts Over-react? ', Accounting and 
Business Research, 22 (85), pp. 63-74 
0' Mahony, M. and Vecchi, M. (2000) `Tangible and Intangible Investment and Economic 
Performance': Evidence from Company Accounts', in Buigues, P., Jacquemin, A. and 
Marchipont, J: F. (eds. ) `Competitiveness and the Value of Intangible Assets', EE, 
Edward Elgar Publishing Limited 
Oswald, D. (2000) `The Determinants and value relevance of the Choice of Accounting for 
Research and Development Expenditures in the United Kingdom', London Business 
School Accounting Subject Area Research Paper Series 
Oswald, D. and Zarowin, j'. (2004) `Capitalization of R&D and the Informativeness of Stock 
Prices', unpublished working paper, London Business School, New York University 
Park, C. (2005) `Stock Retµrn Predictability and the Dispersion in Earnings Forecasts', Journal 
of Business, 78 (6), pp. 2351-2375 
Park, B., Sickles, R. and S(mar, L. (2003) 'Semiparametric-efficient Estimation of AR(1) Panel 
Data models', Journal of Econometrics, 117 (2), pp. 279-309 
Pastor, L. and Veronesi, P. (2003) `Stock Valuation and Learning About Profitability', Journal 
of Finance, 58 (5), pp. 1749-1789 
Patz, D. (1989) 'UK analysts' Earnings Forecasts', Accounting and Business Research, 19 (25), 
pp. 267-275 
211 
Richards, M., Benjamin, J. and Strawser, R. (1977) `An Explanation of the Accuracy of 
Earnings Forecasts', Financial Management, Fall 1977, pp. 78-86 
Romer, P. (1998) `The Soft Revolution: Achieving Growth by Managing Intangibles', Journal 
ofApplied Corporate Finance, 11 (2), pp. 8-14 
Shi, C. (2003) `On the Trade-Off between the Future Benefits and the Riskiness of R&D: A 
Bondholder's Perspective', Journal ofAccounting and Economics, 35, pp. 227-254 
Sougiannis, T. (1994) `Thg Accounting Based Valuation of Corporate R&D', The Accounting 
Review, 69 (1), pp. 44-68 
Szewczyk, S. Tsetsekos, G. and Zantout, Z. (1996) `The Valuation of Corporate R&D 
Expenditures: Evidence from Investment Opportunities and Free Cash Flow', Financial 
Management, 25 (1), pp. 105-110 
Toivanen, 0., Stoneman, P. and Bosworth, D. (2002) `Innovation and he Market Value of UK 
Firms, 1989-1995', Oxford Bulletin of Economics and Statistics, 64 (39), pp. 39-61 
Wyatt, A. (2002) Accountiig for Intangibles: the Great Divide between Obscurity in Innovation 
Activities and the Balance Sheet, Singapore Economic Review, 46, pp. 83-117 
Zhang, F. (2006) `Information Uncertainty and Stock Returns', Journal of Finance, 61 (1), pp. 
105-137 
Zhang, X. (2002) `Discussion of "Excess Returns to R&D Intensive Firms"', Review of 
Accounting Studies, 7, pp. 159-162 
212 
